<SEC-DOCUMENT>0001193125-19-122529.txt : 20190426
<SEC-HEADER>0001193125-19-122529.hdr.sgml : 20190426
<ACCEPTANCE-DATETIME>20190426164457
ACCESSION NUMBER:		0001193125-19-122529
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190618
FILED AS OF DATE:		20190426
DATE AS OF CHANGE:		20190426
EFFECTIVENESS DATE:		20190426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HERON THERAPEUTICS, INC. /DE/
		CENTRAL INDEX KEY:			0000818033
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				942875566
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33221
		FILM NUMBER:		19772320

	BUSINESS ADDRESS:	
		STREET 1:		4242 CAMPUS POINT COURT, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8582514400

	MAIL ADDRESS:	
		STREET 1:		4242 CAMPUS POINT COURT, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AP PHARMA INC /DE/
		DATE OF NAME CHANGE:	20010511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED POLYMER SYSTEMS INC /DE/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d655532ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section 14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a party other than the
Registrant&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Pursuant to &#167;240.14a-12</TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>HERON
THERAPEUTICS, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
</B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount previously paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing party:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>HERON THERAPEUTICS, INC. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Notice of Annual Meeting of Stockholders </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>to Be Held on June&nbsp;18, 2019 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">To the Stockholders of Heron Therapeutics, Inc.: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Annual Meeting of Stockholders of Heron Therapeutics, Inc. (&#147;<B><I>Heron</I></B>,&#148; &#147;<B><I>Company</I></B>,&#148; &#147;<B><I>we</I></B>,&#148;
&#147;<B><I>us</I></B>&#148; and &#147;<B><I>our</I></B>&#148;), a Delaware corporation, will be held on June&nbsp;18, 2019 at 9:00 a.m. local time at 4242 Campus Point Court, San Diego, CA 92121, for the following purposes, as more fully described
in the accompanying Proxy Statement: </FONT></P> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">To elect five director nominees named in the accompanying Proxy Statement to serve until the 2020 Annual Meeting of Stockholders and until their
successors are duly elected and qualified; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">To ratify the appointment of OUM&nbsp;&amp; Co. LLP as our independent registered public accounting firm for the year ending December&nbsp;31, 2019;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">To approve, on an advisory basis, compensation paid to our Named Executive Officers during the year ended December&nbsp;31, 2018;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">To approve, on an advisory basis, the frequency of future advisory votes to approve compensation paid to our Named Executive Officers;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">5.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">To amend the Company&#146;s 2007 Amended and Restated Equity Incentive Plan (the &#147;<B><I>2007 Plan</I></B>&#148;) to increase the number of shares
of common stock authorized for issuance thereunder from 18,800,000 to 25,800,000; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">6.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">To amend the Company&#146;s 1997 Employee Stock Purchase Plan, as amended (the &#147;<B><I>ESPP</I></B>&#148;) to increase the number of shares of
common stock authorized for issuance thereunder from 475,000 to 775,000; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">7.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">To transact such other business as may properly come before the meeting or any adjournments or postponements thereof. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Only stockholders of record at the close of business on April&nbsp;22, 2019 will be entitled to notice of, and to vote at, the Annual Meeting or any adjournments
or postponements thereof. A list of stockholders entitled to vote at the meeting will be available for inspection at our offices located at 4242 Campus Point Court, Suite 200, San Diego, CA 92121 for at least ten days prior to the meeting and will
also be available for inspection at the meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%; text-indent:-1%"><FONT STYLE="font-family:ARIAL" SIZE="2">BY ORDER OF THE BOARD OF DIRECTORS </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="43%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2">/s/ David Szekeres</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">David Szekeres, Senior Vice President, General Counsel, Business Development and Corporate Secretary</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">San Diego, California</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">April&nbsp;26, 2019</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>FOR THE 2019 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE&nbsp;18, 2019: </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>The 2019 Proxy Statement and the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>December&nbsp;31, 2018 are available at: <U>http://www.edocumentview.com/hrtx</U>. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1"><B>YOUR VOTE IS IMPORTANT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>You are cordially
invited to attend the Annual Meeting. Whether or not you expect to attend the meeting, you are urged to cast your vote as soon as possible. You may vote your shares via the Internet or via a toll-free telephone number by following the instructions
on the Notice of Internet Availability of Proxy Materials, the proxy card or the voting instruction card, as applicable. In addition, if you received paper copies of the proxy materials by mail, you can also vote by mail by following the
instructions on the proxy card or the voting instruction card. Submitting a proxy or voting instruction card will not prevent you from attending the Annual Meeting and voting in person, if you so desire. Please note, however, that if your shares are
held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain from the record holder a proxy issued in your name. </B></FONT></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>HERON THERAPEUTICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>4242 Campus Point Court, Suite 200 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>San Diego, CA 92121 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>(858) <FONT STYLE="white-space:nowrap">251-4400</FONT> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>PROXY STATEMENT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>2019
ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>QUESTIONS AND ANSWERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>Why have these proxy materials been made available to me? </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The enclosed proxy is being solicited on behalf of
our Board of Directors (&#147;<B><I>Board</I></B>&#148;) for use at the Annual Meeting of Stockholders to be held on June&nbsp;18, 2019 at 9:00 a.m. local time at 4242 Campus Point Court, San Diego, CA 92121, or at any adjournments or postponements
thereof (&#147;<B><I>Annual Meeting</I></B>&#148;). The Notice of Internet Availability of Proxy Materials and the proxy materials, including the 2019 Proxy Statement and the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT><B>
</B>for the year ended December&nbsp;31, 2018, will be made available online at <I><U>http://www.edocumentview.com/hrtx</U></I> and mailed to stockholders, as applicable, on or about May&nbsp;9, 2019. We encourage stockholders to vote well before
the Annual Meeting, even if they plan to attend the Annual Meeting in person, via the Internet (as specified below and in the Notice of Internet Availability of Proxy Materials or the proxy card, as applicable) or by using the toll-free telephone
number provided below or in the proxy card, as applicable. In addition, if you received copies of the proxy materials by mail, you can vote by mail by following the instructions on the proxy card. Stockholders who hold our shares in &#147;street
name&#148; should refer to the voting instructions form provided by their broker, bank or other nominee for details on how to provide voting instructions to each person. For additional details, see &#147;How can I vote at the Annual Meeting?&#148;
below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Why did I receive a Notice of Internet Availability of Proxy Materials in the mail? </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">As permitted by rules adopted by the U.S. Securities and Exchange Commission (&#147;<B><I>SEC</I></B>&#148;), we are making our proxy materials available to
stockholders electronically via the Internet. Accordingly, we are sending the Notice of Internet Availability of Proxy Materials by mail to our stockholders of record containing instructions on how to access the proxy materials and vote by proxy
over the Internet, by telephone or in person. All stockholders have the ability to access the proxy materials on the website referred to in the Notice of Internet Availability of Proxy Materials or request the delivery of a printed set of proxy
materials. If you received a Notice of Internet Availability of Proxy Materials by mail and would like to receive a printed copy of our proxy materials, you should follow the instructions for requesting such materials included in the Notice of
Internet Availability of Proxy Materials. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Who can vote at the Annual Meeting? </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">Only stockholders of record at the close of business on April&nbsp;22, 2019, the record date for the Annual Meeting,<B> </B>will be entitled to vote at the Annual Meeting. At the close of business on the record
date, there were 79,194,227 shares of common stock outstanding and entitled to vote. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">1 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Stockholder of Record: Shares Registered in Your Name</I> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">If at the close of business on the record date, your shares were registered directly in your name, then you are a stockholder of record. As a stockholder of
record, you may vote in person at the Annual Meeting or vote via one of the methods described in the Notice of Internet Availability of Proxy Materials or in the proxy card if you received a hard or emailed copy of the proxy materials. Whether or
not you plan to attend the Annual Meeting in person, we urge you to vote before the Annual Meeting to ensure your vote is counted. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Beneficial Owner:
Shares Registered in the Name of a Broker, Bank or Other Agent</I> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">If at the close of business on the record date, your shares were held, not in your
name, but rather in an account at a brokerage firm, bank or other agent, then you are the beneficial owner of shares held in &#147;street name,&#148; and the Notice of Internet Availability of Proxy Materials or the proxy materials, as applicable,
are being forwarded to you by your broker, bank or other agent. The broker, bank or other agent holding your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">As a beneficial owner, you have the right to direct your broker, bank or other agent on how to vote the shares in your account. However, since you are not the
stockholder of record, you may not vote your shares in person at the Annual Meeting unless you request and obtain a valid proxy issued in your name from your broker, bank or other agent. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>How can I attend the Annual Meeting? </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">You are entitled to attend the Annual Meeting only if you were a
stockholder at the close of business on April&nbsp;22, 2019, or you hold a valid proxy to vote at the meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">If your shares are held in the name of
your broker, bank or other agent, you must obtain from the record holder a proxy issued in your name. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">For directions to the Annual Meeting, you may
contact the Company at (858) <FONT STYLE="white-space:nowrap">251-4400.</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>What am I voting on? </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">There are six Company proposals scheduled for a vote at the Annual Meeting: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Proposal 1: </B>To elect five director nominees named in the accompanying Proxy Statement, to serve until the 2020 Annual Meeting of Stockholders and until
their successors are duly elected and qualified; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Proposal 2: </B>To ratify the appointment of OUM&nbsp;&amp; Co. LLP as our independent registered public accounting firm for the year ending December&nbsp;31,
2019; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Proposal 3:</B> To approve, on an advisory basis, compensation paid to our Named Executive Officers during the year ended December&nbsp;31, 2018;
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">2 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Proposal 4: </B>To approve, on an advisory basis, the frequency of future advisory votes to approve compensation paid to our Named Executive Officers;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Proposal 5: </B>To amend the 2007 Plan to increase the number of shares of common stock authorized for issuance thereunder from 18,800,000 to 25,800,000; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Proposal 6: </B>To amend the ESPP to increase the number of shares of common stock authorized for issuance thereunder from 475,000 to 775,000.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>What are my voting choices and what are the Board&#146;s recommendations? </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">For Proposal 1, you may vote &#147;For&#148; or &#147;Against&#148; or &#147;Abstain&#148; from voting for each director nominee. For Proposals 2 and 3, you may
vote &#147;For&#148; or &#147;Against&#148; or &#147;Abstain&#148; from voting. For Proposal 4, you may vote &#147;For&#148; every &#147;One Year,&#148; &#147;Two Years,&#148; &#147;Three Years&#148; or &#147;Abstain&#148; from voting. For Proposals
5 and 6, you may vote &#147;For&#148; or &#147;Against&#148; or &#147;Abstain&#148; from voting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Board recommends that you vote &#147;For&#148;
each of the director nominees named in Proposal 1, &#147;For&#148; each of Proposals 2 and 3, &#147;For&#148; every &#147;One Year&#148; in Proposal 4 and &#147;For&#148; each of Proposals 5 and 6. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>What if another matter is properly brought before the Annual Meeting? </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">At this time, the Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting. However, if any other matter is properly brought before the Annual Meeting, it is the
intention of the persons named in the proxy card as &#147;proxies&#148; to vote on those matters in accordance with their best judgment and in their discretion. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>How can I vote at the Annual Meeting? </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The procedures for voting are as follows: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Stockholder of Record: Shares Registered in Your Name</I> </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>To vote in person</I>, come to the Annual Meeting and request a ballot. In order to cast your vote you will need to provide satisfactory identification
corresponding to our stockholder records. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>To vote via the Internet</I>, go to <I><U>http://www.edocumentview.com/hrtx</U></I> and follow the instructions provided on the website. In order to cast your
vote, you will be asked to provide the control number from the Notice of Internet Availability of Proxy Materials or the proxy card mailed to you. Your vote must be received by 1:00 a.m., local time, on June&nbsp;18, 2019 to be counted.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>To vote by telephone</I>, call toll free
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-652-VOTE</FONT></FONT></FONT> (8683)&nbsp;within the U.S., U.S. territories and Canada. Proxies voted by telephone must be received by 1:00
a.m., local time, on June&nbsp;18, 2019. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>To vote using the proxy card</I>, simply complete, sign and date the proxy card included with your proxy materials (if you received a hard copy or emailed
copy of the proxy materials) and return it promptly in the envelope provided. If you return </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">3 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:ARIAL" SIZE="2">
your signed and dated proxy card to us before the Annual Meeting with your voting selections, we will vote your shares as you direct. Except for votes cast for shares registered in the name of a
broker, bank or other agent (as described below), if you return your signed and dated proxy card to us before the Annual Meeting without your voting selections, proxies named in the proxy card will vote your shares in accordance with the
Board&#146;s recommendations (as described above). If you received a Notice of Internet Availability of Proxy Materials and would like to request a proxy card by mail, please follow the instructions contained in the Notice of Internet Availability
of Proxy Materials. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Beneficial Owner: Shares Registered in the Name of Broker, Bank or Other Agent</I> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a Notice of Internet Availability of
Proxy Materials or a proxy card and voting instructions with the proxy materials from that institution rather than from us. Simply follow the instructions in the Notice of Internet Availability of Proxy Materials received from your broker, bank or
other agent to vote on the Internet or by telephone or, if you received a proxy card by mail, complete, sign and return the proxy card to ensure that your vote is counted. To vote in person at the Annual Meeting, you must obtain a valid proxy from
your broker, bank or other agent. Follow the instructions from your broker, bank or other agent included in the Notice of Internet Availability of Proxy Materials or with the proxy materials, or contact your broker, bank or other agent to request a
proxy form. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px;padding-top:0px; margin-left:0%"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>We provide Internet proxy voting to
allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your Internet access, such as usage
charges from Internet access providers. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>How many votes do I have? </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">On each matter to be voted on, you have one vote for each share of common stock you own as of the close of business on April&nbsp;22, 2019, the record date for the Annual Meeting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Who is paying for this proxy solicitation? </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">We will pay for
the entire cost of soliciting proxies. In addition to the mailed Notices of Internet Availability of Proxy Materials and/or proxy materials, our directors and employees may also solicit proxies in person, by telephone or by other means of
communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>What does it mean if I receive more than one Notice of Internet Availability of Proxy Materials or proxy card? </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">If you receive more than one<B> </B>Notice of Internet Availability of Proxy Materials or proxy card, your shares are registered in more than one name or are
registered in different accounts. Please follow the voting instructions in <B>each</B> Notice of Internet Availability of Proxy Materials, or complete, sign and return <B>each</B> proxy card to ensure that all of your shares are voted. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">4 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Can I revoke or change my vote after submitting my proxy? </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Yes. You can revoke your proxy and change your vote at any time before the applicable vote deadlines for the Annual Meeting. If you are the record holder of your
shares, you may revoke your proxy in any one of four ways: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">you may submit another properly completed proxy with a later date; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">you may vote again by Internet or telephone at a later time; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">you may send a written notice that you are revoking your proxy to our Corporate Secretary at 4242&nbsp;Campus Point Court, Suite 200, San Diego, CA 92121; or
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">you may attend the Annual Meeting and vote in person (however, simply attending the Annual Meeting will not, by itself, revoke your proxy or change your vote).
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Your most current proxy card or Internet proxy is the one that is counted. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">If your shares are held by your broker, bank or other agent, you should follow the instructions provided by them. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>How can I submit a proposal (including a director nomination) for next year&#146;s annual meeting? </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">Under the rules of the SEC, stockholders who wish to submit proposals for inclusion in the Proxy Statement for the 2020 Annual Meeting of Stockholders must submit such proposals to our Corporate Secretary so as to
be received by us at 4242 Campus Point Court, Suite 200, San Diego, CA 92121, by close of business on or before January&nbsp;10, 2020. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">If a stockholder
intends to make a nomination or present a proposal for other business (other than pursuant to Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> of the Securities Exchange Act of 1934 (the &#147;<B><I>Exchange Act</I></B>&#148;)) at the 2020 Annual
Meeting of Stockholders, the stockholder must deliver written notice to our Corporate Secretary at the address provided above not earlier than February&nbsp;19, 2020 and not later than March&nbsp;20, 2020. Such nomination(s) or proposal(s) may or
may not be included in the Proxy Statement. If the date of the 2020 Annual Meeting of Stockholders changes by more than 30 calendar days from the anniversary of the 2019 Annual Meeting of Stockholders, then stockholder notice must be received not
later than the close of business on the later of: (i)&nbsp;the 90th calendar day prior to such annual meeting; or (ii)&nbsp;the 10th calendar day following the day on which public disclosure of the date of such meeting is first made. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Any stockholder proposal must be a proper matter for stockholder action and must comply either with Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> of the
Exchange Act or the terms and conditions set forth in our <FONT STYLE="white-space:nowrap">By-laws,</FONT> as applicable. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>What are &#147;broker <FONT
STYLE="white-space:nowrap">non-votes&#148;?</FONT> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">If your shares are held by your broker, bank or other agent as your nominee (that is, in
&#147;street name&#148;), you will need to obtain a proxy form from the institution that holds your shares and follow the instructions included on that form regarding how to instruct your broker, bank or other agent to vote your shares. If you do
not give instructions to your broker, bank or other agent, they </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">5 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
can vote your shares with respect to &#147;routine&#148; items, but not with respect to <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> items. On
<FONT STYLE="white-space:nowrap">non-routine</FONT> items for which you do not give instructions to your broker, bank or other agent, the shares will be treated as broker <FONT STYLE="white-space:nowrap">non-votes.</FONT> The only
&#147;routine&#148; proposal that is being presented at this Annual Meeting is Proposal 2 (ratification of our independent registered public accounting firm). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>How are votes counted and how many votes are needed to approve each proposal? </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Votes will be counted by the
inspector of elections appointed for the meeting. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Proposal 1:</B> Directors, in uncontested elections, will be elected by a majority of all votes properly cast with respect to his election, in person or by
proxy, at the Annual Meeting. Election of directors is not considered a routine matter on which a broker or other nominee is empowered to vote. Therefore, if the beneficial owner does not give a broker specific instructions, the beneficially owned
shares may not be voted on the election of directors and will not be counted in determining the number of shares necessary for approval. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the election of
the directors. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Proposal 2:</B> The proposal to ratify the appointment of OUM&nbsp;&amp; Co. LLP as our independent registered public accounting firm for the year ending
December 31, 2019 requires the affirmative vote of a majority of the votes cast, provided a quorum is established. Abstentions will have no effect on the outcome of this proposal because they are not considered to be votes &#147;cast&#148; under
Delaware law. Ratification of the selection of OUM&nbsp;&amp; Co. LLP is considered a routine matter on which a broker or other nominee is empowered to vote. If you are a beneficial owner and do not provide specific voting instructions to your bank
or broker, the institution that holds your shares may vote your shares on the ratification of the appointment of OUM&nbsp;&amp; Co. LLP as our independent registered public accounting firm for the year ending December&nbsp;31, 2019.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Proposal 3:</B> The proposal to approve, on an advisory basis, the compensation paid to our Named Executive Officers requires the affirmative vote of a
majority of the votes cast, provided a quorum is established. Approval, on an advisory basis, of the compensation paid to our Named Executive Officers is not considered a routine matter on which a broker or other nominee is empowered to vote.
Therefore, if the beneficial owner does not give broker specific instructions, the beneficially owned shares may not be voted on the proposal. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the
outcome of this proposal. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Proposal 4: </B>The proposal provides stockholders with the opportunity to approve, on an advisory basis, the frequency of future advisory votes to approve
compensation paid to our Named Executive Officers. The frequency option that receives the most affirmative votes, provided a quorum is established, will be the option deemed to be the recommendation of the stockholders. Approval, on an advisory
basis, of the frequency of future advisory votes to approve compensation paid to our Named Executive Officers is not considered a routine matter on which a broker or other nominee is empowered to vote. Therefore, if the beneficial owner does not
give broker specific instructions, the beneficially owned shares may not be voted on the proposal. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the outcome of this proposal.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Proposal 5: </B>The proposal to amend our 2007 Plan requires the affirmative vote of a majority of the votes cast at the Annual Meeting, provided a quorum is
established. Approval of the amendment to our 2007 Plan is not considered a routine </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">6 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:ARIAL" SIZE="2">
matter on which a broker or other nominee is empowered to vote. Therefore, if the beneficial owner does not give broker specific instructions, the beneficially owned shares may not be voted on
the proposal. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the outcome of this proposal. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Proposal 6:</B> The proposal to amend our ESPP requires the affirmative vote of a majority of the votes cast at the Annual Meeting, provided a quorum is
established. Approval of the amendment to our ESPP is not considered a routine matter on which a broker or other nominee is empowered to vote. Therefore, if the beneficial owner does not give broker specific instructions, the beneficially owned
shares may not be voted on the proposal. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the outcome of this proposal. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>What is the quorum requirement? </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">A quorum of stockholders is necessary to hold a valid meeting. A quorum will
be present if at least a majority of the shares issued and outstanding and entitled to vote at the Annual Meeting as of the close of business on the record date are represented by stockholders present at the meeting or by proxy. At the close of
business on the record date, there were 79,194,227 shares outstanding and entitled to vote. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Abstentions and broker
<FONT STYLE="white-space:nowrap">non-votes</FONT> will be counted towards the quorum requirement. If there is no quorum, a majority of the votes present at the meeting may adjourn the meeting to another date. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>How can I find out the results of the voting at the Annual Meeting? </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> that we expect to file
within four business days after the Annual Meeting. If final voting results are not available to us in time to file a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> within four business days after the Annual Meeting, we intend to
file a Form <FONT STYLE="white-space:nowrap">8-K</FONT> to publish preliminary results and, within four business days after the final results are known to us, file an additional Form <FONT STYLE="white-space:nowrap">8-K</FONT> to publish the final
results. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">7 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>INFORMATION CONCERNING THE BOARD OF DIRECTORS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">Certain information regarding each of our nominees, including each nominee&#146;s age, experience, qualifications, attributes and skills that led the Board to conclude that the individual should serve on the Board
and each nominee&#146;s principal occupation and directorships during the past five years, is set forth below: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Name</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Age</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Position</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Director<BR>Since</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kevin Tang</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Chairman</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart, Pharm.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">62</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">President, Chief Executive Officer and Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Craig Johnson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">57</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">John Poyhonen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">59</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Christian Waage</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Kevin Tang</I> has served as a director of Heron since 2009 and as Chairman since 2012. Mr.&nbsp;Tang has more than 25 years of
experience evaluating, creating and building biotechnology companies that are focused on developing treatments for life-threatening and debilitating diseases and conditions. Since 2013, Mr.&nbsp;Tang has served as the Chairman and Chief Executive
Officer of Odonate Therapeutics, Inc., a pharmaceutical company dedicated to the development of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutics that improve and extend the lives of patients
with cancer. Mr.&nbsp;Tang also serves as the President of Tang Capital Management, LLC, a life sciences-focused investment company he founded in 2002. Since 2014, Mr.&nbsp;Tang has served as a director and Chairman of La Jolla Pharmaceutical
Company. From 2009 through its acquisition by Endo Pharmaceuticals, Inc. in 2010, he served as a director of Penwest Pharmaceuticals Co. In 2006, Mr.&nbsp;Tang <FONT STYLE="white-space:nowrap">co-founded</FONT> Ardea Biosciences, Inc. and served as
a director from inception through its acquisition by AstraZeneca PLC in 2012. From 2001 to 2008, he was a director of Trimeris, Inc. From 1993 to 2001, Mr.&nbsp;Tang held various positions at Deutsche Banc Alex Brown, Inc., an investment banking
firm, most recently serving as Managing Director and head of the firm&#146;s Life Sciences research group. Mr.&nbsp;Tang received a B.S. degree from Duke University. The Board has concluded that Mr.&nbsp;Tang should serve as a director based on his
experience forming and building biotechnology companies, serving as a director of numerous biotechnology companies and serving as a manager of funds specializing in the area of life sciences. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Barry Quart, Pharm.D. </I>has served as a director of Heron since 2012. Dr.&nbsp;Quart was appointed Chief Executive Officer of the Company
in 2013 and President and Chief Executive Officer of the Company in February 2019. Dr.&nbsp;Quart has more than 25 years of experience serving in leadership positions in biotechnology and pharmaceutical companies and developing innovative
pharmaceutical products. In 2006, Dr.&nbsp;Quart <FONT STYLE="white-space:nowrap">co-founded</FONT> Ardea Biosciences, Inc. and served as its President and Chief Executive Officer from its inception through 2013 and as a director through its
acquisition by AstraZeneca PLC in 2012. Previously, he was with Pfizer Inc. as Senior Vice President of Pfizer Global Research and Development, and the director of Pfizer&#146;s La Jolla Laboratories. Prior to Pfizer&#146;s acquisition of the
Warner-Lambert Company, Dr.&nbsp;Quart was President of Research and Development at Agouron Pharmaceuticals, Inc., a division of the Warner-Lambert Company. Dr.&nbsp;Quart joined Agouron in 1993 and was instrumental in the development and
registration of Viracept<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> (nelfinavir). Dr.&nbsp;Quart also served as a director of Synageva Biopharma Corp. from 2012
through its acquisition by Alexion Pharmaceuticals, Inc. in 2015. Since 2015, Dr.&nbsp;Quart has served as a director of Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company. Dr.&nbsp;Quart received a Pharm.D. degree from the University of
California, San Francisco. The Board has concluded that Dr.&nbsp;Quart&#146;s should serve as a director based on </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">8 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
his experience in senior management and as a director with other biotechnology and pharmaceutical companies and his prior drug development experience. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Craig Johnson</I> has served as a director of Heron since 2014. Mr.&nbsp;Johnson has more than 25 years of experience serving in senior financial management
roles and governing corporations, primarily in the biotechnology industry. Mr.&nbsp;Johnson has also served as a director of Odonate Therapeutics, Inc. since 2017, Mirati Therapeutics, Inc. since 2013 and La Jolla Pharmaceutical Company since 2013.
Mr.&nbsp;Johnson also served as a director of Ardea Biosciences, Inc. from 2008 through its acquisition by AstraZeneca PLC in 2012, Adamis Pharmaceuticals Corporation, Inc. from 2011 to 2014 and GenomeDx Biosciences, Inc. from 2015 to 2018. From
2004 through its acquisition by Raptor Pharmaceuticals Corp in 2009, he served as Vice President and Chief Financial Officer of TorreyPines Therapeutics, Inc. and, from 2009 to 2019, as Vice President of a wholly-owned subsidiary of Raptor
Pharmaceutical Corp. From 1994 to 2004, Mr.&nbsp;Johnson held various positions at MitoKor, Inc., most recently as Chief Financial Officer and Senior Vice President of Operations. Prior to 1994, Mr.&nbsp;Johnson held senior financial positions with
several early-stage technology companies and also practiced as a Certified Public Accountant with Price Waterhouse. Mr.&nbsp;Johnson received a B.B.A. degree in accounting from the University of Michigan-Dearborn. The Board has concluded that
Mr.&nbsp;Johnson should serve as a director based on his experience as an executive officer and as a director of numerous life sciences companies. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>John Poyhonen</I> has served as a director of Heron since 2014. Mr.&nbsp;Poyhonen has more than 25 years of experience serving in leadership positions in
biotechnology, pharmaceutical and food ingredient companies and commercializing innovative products. From 2014 through its acquisition by Firmenich, Inc. in November 2018, Mr.&nbsp;Poyhonen was the President, Chief Executive Officer and a director
of Senomyx, Inc. He joined Senomyx, Inc. in 2003 as Vice President and Chief Business Officer; was promoted in 2004 to Vice President and Chief Financial and Business Officer; was named Senior Vice President, Chief Financial and Business Officer in
2006; was promoted to President and Chief Operating Officer in 2009; and promoted to President and Chief Executive Officer in 2014. From 1996 to 2003, Mr.&nbsp;Poyhonen served in various sales and marketing positions for Agouron Pharmaceuticals,
Inc., most recently as Vice President of National Sales. Prior to holding this position, Mr.&nbsp;Poyhonen served as Vice President of Marketing and Vice President of National Accounts. He was previously a director of Ardea Biosciences, Inc. from
2007 through its acquisition by AstraZeneca PLC in 2012. Mr.&nbsp;Poyhonen received a B.A. degree in marketing from Michigan State University and a M.B.A. degree from the University of Kansas. The Board has concluded that Mr.&nbsp;Poyhonen should
serve as a director based on his senior management experience in corporate and commercial strategy, business development, risk management, finance and operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><I>Christian Waage</I> has served as a director of Heron since 2016. Mr.&nbsp;Waage has more than 15 years of regulatory, legal and financial transaction experience primarily in the biotechnology industry. Since
2017, Mr.&nbsp;Waage has served as Executive Vice President and General Counsel of Gossamer Bio, Inc., a publicly traded biotechnology company. From 2013 to 2016, Mr.&nbsp;Waage held various positions at Receptos, Inc., a wholly-owned subsidiary of
Celgene Corporation, most recently serving as Managing Director. Prior to its acquisition by Celgene Corporation in 2015, Mr.&nbsp;Waage served as Senior Vice President and General Counsel of Receptos, Inc. From 2012 through its acquisition by Vista
Equity Partners LLC in 2013, he served as Vice President, General Counsel and Corporate Secretary at Websense, Inc. From 2008 through its acquisition by AstraZeneca PLC in 2012, Mr.&nbsp;Waage served as Vice President, General Counsel and Corporate
Secretary of Ardea Biosciences, Inc. Prior to 2008, Mr.&nbsp;Waage served as a partner at DLA Piper LLP. Mr.&nbsp;Waage received a J.D. from the University of San Diego School of Law and a B.A. degree in economics from the University of California,
San Diego. The Board has concluded that Mr.&nbsp;Waage should serve as a director based on his experience in regulatory, legal and finance matters. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">9 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>INFORMATION CONCERNING EXECUTIVE OFFICERS AND KEY EMPLOYEES </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Executive officers are elected by our Board and hold office until the earlier of resignation, removal or the appointment and election of a successor. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Our executive officers and their ages and positions as of April&nbsp;22, 2019 are as follows: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Name</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Age</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Position</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Officer<BR>Since</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart, Pharm.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">62</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">President, Chief Executive Officer and Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly Manhard</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">59</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">Executive Vice President, Drug Development</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2016</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Hoffman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">53</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">Chief Financial Officer and Senior Vice President, Finance</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Barry Quart, Pharm.D. </I>Dr.&nbsp;Quart&#146;s background is described above under &#147;Information Concerning the Board of
Directors.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Kimberly Manhard</I> joined us as Executive Vice President, Drug Development in 2016. Ms.&nbsp;Manhard served
as a director of Heron from 2014 until she joined the management team. Ms.&nbsp;Manhard has more than 25 years of experience in drug development, regulatory affairs and pharmaceutical operations. From 2008 to 2016, Ms.&nbsp;Manhard served as the
Senior Vice President of Regulatory Affairs and Development Operations at Ardea Biosciences, Inc., a wholly-owned subsidiary of AstraZeneca PLC. In her role at Ardea, Ms.&nbsp;Manhard was instrumental in the development and 2015 regulatory approval
of Zurampic<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> (lesinurad) for the treatment of hyperuricemia associated with gout. Prior to joining Ardea in 2006,
Ms.&nbsp;Manhard was President of her own consultancy firm, Vice President of Regulatory Affairs for Exelixis, Inc. and held multiple regulatory positions at Agouron Pharmaceuticals, Inc., a division of the Warner-Lambert Company, supporting
development and commercialization of anticancer and antiviral products, including Viracept<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> (nelfinavir). She was also
previously with Bristol-Myers Squibb Company in regulatory affairs, responsible for oncology compounds, including Taxol<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>
(paclitaxel) and infectious disease compounds, including Videx<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> (didanosine) and Zerit<FONT
STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> (stavudine). Ms.&nbsp;Manhard began her industry career in clinical research with Eli Lilly and Company and G.H. Besselaar
Associates (Covance Inc.). Ms.&nbsp;Manhard received a B.S. degree in zoology and a B.A. degree in French from the University of Florida. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Robert
Hoffman</I> joined us as Chief Financial Officer and Senior Vice President, Finance in 2017. Mr.&nbsp;Hoffman has more than 20 years of experience in financial management. From 2016 to 2017, Mr.&nbsp;Hoffman served as Executive Vice President and
Chief Financial Officer of Innovus Pharmaceuticals, Inc., a biopharmaceutical company. Prior to joining Innovus Pharmaceuticals, Inc., Mr.&nbsp;Hoffman was Chief Financial Officer of AnaptysBio, Inc., a biopharmaceutical company, from 2015 until
2016. He was part of the founding management team of Arena Pharmaceuticals, Inc. in 1997, a biopharmaceutical company, ultimately serving as Senior Vice President, Finance and Chief Financial Officer until March 2011, and then again from August 2011
until July 2015. From March 2011 to August 2011, he served as Chief Financial Officer for Polaris Group, a biopharmaceutical company. Mr.&nbsp;Hoffman is a member of the board of directors of Kura Oncology, Inc., a biopharmaceutical company, DelMar
Pharmaceuticals, Inc., a biopharmaceutical company, Aravive, Inc., a biopharmaceutical company, and ASLAN Pharmaceuticals, Inc., a biopharmaceutical company. He also&nbsp;is a member of the Financial Accounting Standards
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">10 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
Board&#146;s Small Business Advisory Committee and is a member of the steering committee of the Association of Bioscience Financial Officers. Mr.&nbsp;Hoffman received his B.B.A. from St.
Bonaventure University and is licensed as a C.P.A. (inactive) in the State of California. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Our other key employees and theirs ages and positions as of
April&nbsp;22, 2019 are as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Name</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Age</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Position</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Employee<BR>Since</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Paul Blake, FRCP</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">71</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Chief Medical Officer</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Thomas Ottoboni, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">60</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Chief Scientific Officer and Senior Vice President, Pharmaceutical and Translational Sciences</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">David Szekeres</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">45</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Senior Vice President, General Counsel, Business Development, and Secretary</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2016</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Michael Mathews</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">56</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Senior Vice President, Pain Franchise</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Jesse Hollingsworth</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">48</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Senior Vice President, Oncology Franchise</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Chris Storgard, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">53</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Senior Vice President, Clinical Development</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2018</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Anita Gupta, D.O., Pharm.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">43</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Senior Vice President, Medical Strategy and Government Affairs</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">John Arthur, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">53</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Vice President, Manufacturing and Supply</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Sean Ristine</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">49</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Vice President, Human Resources</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Paul Blake, M.D.</I> joined us as Chief Medical Officer in December 2017. Dr.&nbsp;Blake has more than 25
years of experience in clinical research and medical affairs. From January 2017 to November 2017, Dr.&nbsp;Blake served as Senior Vice President of Clinical, Medical, and Regulatory Affairs at BioDelivery Sciences International, Inc. From 2014 to
2016, Dr.&nbsp;Blake served as Chief Development Officer at Oxford BioMedica PLC. From 2007 to 2014, Dr.&nbsp;Blake served as Chief Medical Officer and Senior Vice President of Clinical Research and Development at Aeterna Zentaris Inc.
Dr.&nbsp;Blake has also held various leadership positions in biopharmaceutical companies, including Cephalon, Inc. and SmithKline Beecham Pharmaceuticals Ltd. Over his career, Dr.&nbsp;Blake has contributed to more than 40 NDAs and sNDAs, including
products for the treatment of pain such as Relafen<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(nabumetone), a nonsteroidal anti-inflammatory drug that reduces
hormones that cause pain and inflammation, and Fentora<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>(fentanyl), an opioid pain medication. Other drugs that
Dr.&nbsp;Blake has been involved in developing include Kytril<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(granisetron), Tenormin<FONT
STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(atenolol), Zestril<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(lisinopril), Paxil<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>(paroxetine),
Coreg<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(carvedilol), Havrix<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(hepatitis A vaccine),
Hycamtin<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(topotecan), Famvir<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(famciclovir),
Requip<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(ropinirole), Avandia<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(rosiglitazone) and
Provigil<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(modafinil). Dr.&nbsp;Blake is qualified in medicine from the Royal Free Hospital School of Medicine,
London University. He is a Fellow of the Royal College of Physicians, a Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians and a Fellow of the American College of Clinical Pharmacology. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Thomas Ottoboni, Ph.D.</I> joined us as Vice President of Pharmaceutical Development in 2012. Dr.&nbsp;Ottoboni was promoted to Senior Vice President of
Pharmaceutical and Preclinical Research and Development in 2014 and promoted to Chief Scientific Officer and Senior Vice President of Pharmaceutical and Translational Sciences in January 2019. Dr.&nbsp;Ottoboni has more than 20 years of drug
development experience. From 2010 until 2011, Dr.&nbsp;Ottoboni was Vice President of Research and Development at Talima Therapeutics, Inc., where he worked on the development of a drug delivery implant to treat onychomycosis.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">11 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
From 1996 to 2008, Dr.&nbsp;Ottoboni served as Executive Vice President of Strategy and Operations at POINT Biomedical Corp., where he developed several imaging and drug delivery systems. From
1994 through 1996, Dr.&nbsp;Ottoboni served as Manager of Systems Development and Drug Delivery Research for InSite Vision Inc., where he developed ophthalmic pharmaceutical delivery systems. He previously served as Director of Drug Delivery at
Vitaphore Corp. Dr.&nbsp;Ottoboni is an inventor on more than 20 U.S. patents in organic and macromolecular chemistry. He received a B.S. degree in chemistry and a Ph.D. in organic chemistry from the University of California, Berkeley. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>David Szekeres</I> joined us as Senior Vice President, General Counsel, Business Development, and Corporate Secretary in 2016. Mr.&nbsp;Szekeres has more than
15 years of legal and financial experience, primarily in the biotechnology industry. From 2014 to 2015, Mr.&nbsp;Szekeres served as General Counsel, Chief Business Officer, Principal Financial and Accounting Officer, and Corporate Secretary at
Regulus Therapeutics Inc. In that role, Mr.&nbsp;Szekeres played a critical role in overseeing the company&#146;s business, financial and legal responsibilities as it developed into a clinical-stage corporation. From 2008 through its acquisition by
Thermo Fisher Scientific Inc. in 2014, Mr.&nbsp;Szekeres served as Head of Mergers and Acquisitions, Governance and Securities and Assistant Corporate Secretary at Life Technologies Corporation. From 2001 to 2006, Mr.&nbsp;Szekeres served as
Corporate Attorney at a number of law firms, including O&#146;Melveny&nbsp;&amp; Myers LLP and Latham&nbsp;&amp; Watkins LLP. Prior to 2001, Mr.&nbsp;Szekeres served as Senior Associate in Investment Banking at investment bank Robertson Stephens.
Mr.&nbsp;Szekeres is a member of the board of trustees for the Sanford Burnham Prebys Medical Institute. Mr.&nbsp;Szekeres received a B.A. degree from the University of California, Irvine and a J.D. degree from Duke University School of Law.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Michael Mathews</I> joined us as the Senior Vice President of the Pain Franchise in 2017. Mr.&nbsp;Mathews has more than 25 years of life sciences
experience in sales and marketing. From 2015 to 2017, Mr.&nbsp;Mathews served as the Vice President for Acute Care at Mallinckrodt Pharmaceuticals. From 2012 to 2014, Mr.&nbsp;Mathews served as Senior Vice President International at KCI, an Acelity
L.P. Inc. company. Mr.&nbsp;Mathews has also held various leadership positions at Bayer AG, including Senior Vice President North America for Diabetes Care and Head of Hematology for the Specialty Medicine Division, where he led the sales and
marketing efforts of Bayer Aspirin, both in the U.S. and globally. Mr.&nbsp;Mathews was a member of Bayer AG&#146;s Global Leadership Circle, which consisted of the top 250 executives globally. Mr.&nbsp;Mathews completed Stanford University&#146;s
graduate school executive program. He also holds an MBA from Thunderbird American School of International Management in international marketing, and a B.S. in international economics, finance and commerce from the Edmund A. Walsh School of Foreign
Service at Georgetown University. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Jesse Hollingsworth</I> joined us as the Vice President of Oncology Sales in 2013 and was promoted to Senior Vice
President of the Oncology Franchise in November 2018. Mr.&nbsp;Hollingsworth has more than 20 years of life sciences experience in sales and marketing. From 2011 to 2013, Mr.&nbsp;Hollingsworth was the Executive Director, Group Purchasing
Organization and Trade at Dendreon Pharmaceuticals LLC, where he was responsible for the development and implementation of Dendreon&#146;s clinic and hospital contracting strategy, as well as building and leading a team of national group purchasing
organization and trade directors. Mr.&nbsp;Hollingsworth has also held various leadership positions at Amgen Inc. and ION Solutions. He received his B.S. at the University of Florida and his Master of Health Administration from the University of
South Florida. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Chris Storgard</I> joined us as Senior Vice President, Clinical Development in November 2018. Dr.&nbsp;Storgard has more than 25
years of experience in clinical research. Prior to joining Heron Therapeutics, Dr.&nbsp;Storgard served as Chief Medical Officer at Fate Therapeutics, since June 2016. From 2013 to 2016, Dr.&nbsp;Storgard served as Vice President of Clinical
Research and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">12 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:ARIAL" SIZE="2">
Development at Ardea Biosciences, a member of the AstraZeneca Group, leading the ZURAMPIC<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> global clinical program to successful U.S. and European regulatory approvals. Dr.&nbsp;Storgard has also held various senior leadership positions at Biogen-Idec and
Amgen, leading biologic and small molecule development programs within inflammation and oncology. From 2001 to 2004, Dr.&nbsp;Storgard served as Senior Associate Consultant, Division of Rheumatology, and Assistant Professor and Member of the
Molecular Medicine Program at the Mayo School of Medicine, Mayo Clinic in Minnesota. He received his B.S. degree in biology and his M.D. from the University of Saskatchewan. Dr.&nbsp;Storgard completed a fellowship in rheumatology at Scripps Clinic
and Research Center, San Diego. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Anita Gupta, D.O., Pharm.D.</I>, joined us as Senior Vice President of Medical Strategy and Government Affairs in
2017 and is a board-certified anesthesiologist and internationally recognized pain specialist. From 2012 to 2017,&nbsp;Dr.&nbsp;Gupta&nbsp;was Vice Chair, Division of Pain Medicine and Regional Anesthesiology in the Department of Anesthesiology and
Perioperative Medicine at Drexel University College of Medicine and Assistant Professor, Division of Pain Medicine at the University of Pennsylvania.&nbsp;Dr.&nbsp;Gupta&nbsp;also served as an anesthesiologist at both Johns Hopkins University and
Washington Hospital Center.&nbsp;Dr.&nbsp;Gupta&nbsp;was a Food and Drug Administration Special Government Employee from 2015 to 2018 during which time she served as a member of the FDA&#146;s Anesthetic and Analgesic Drug Products Advisory
Committee. From 2016 to 2018,&nbsp;Dr.&nbsp;Gupta&nbsp;served as a director of Amorsa Therapeutics, Inc., a biopharmaceutical company.&nbsp;Dr.&nbsp;Gupta&nbsp;received a B.S. degree and a Pharm.D. degree from Rutgers University College of Pharmacy,
a D.O. degree from the University of Medicine&nbsp;&amp; Dentistry of New Jersey, and a MPP and HHP from Princeton University&#146;s Woodrow Wilson School of Public and International Affairs. She completed a residency in anesthesiology at Georgetown
University, a fellowship in interventional pain management at Johns Hopkins University and clinical scientist training in toxicology at the National Institutes of Health. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><I>John Arthur, Ph.D.</I> joined us as Vice President of Manufacturing and Supply in April 2017. Dr.&nbsp;Arthur has more than 20 years of experience in pharmaceutical manufacturing. From 2013 to 2016,
Dr.&nbsp;Arthur was Vice President of Manufacturing and CMC at Mast Therapeutics, Inc., a biopharmaceutical company, where he led all CMC activities for multiple Phase 2 and Phase 3 clinical programs. From 2012 to 2013, Dr.&nbsp;Arthur was Senior
Director of Manufacturing at Auspex Pharmaceuticals, Inc., a biopharmaceutical company. Prior to his role at Auspex, Dr.&nbsp;Arthur held several positions of increasing responsibility at various biopharmaceutical companies, including Cadence
Pharmaceuticals, Inc., Kanisa Pharmaceuticals, Inc., Salmedix, Inc., Prometheus Laboratories Inc., Maxim Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc. Dr.&nbsp;Arthur received a B.S. in Biochemistry from Western Washington University, a
Ph.D. in organic chemistry from the University of South Carolina, Columbia and conducted his postdoctoral research at Michigan State University. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Sean Ristine</I> joined us as Senior Director of Human Resources in 2014 and was promoted to Vice President of Human Resources in 2015. Mr.&nbsp;Ristine has
more than 20 years of experience in human resources and business leadership. From 2009 to 2014, Mr.&nbsp;Ristine held key Human Resources positions at Cadence Pharmaceuticals, Inc., most recently as Senior Director of Human Resources and was
instrumental in that function as Cadence grew to a commercial-stage company with more than 200 employees located throughout the U.S. From 2004 to 2009, Mr.&nbsp;Ristine held Human Resources management roles of increasing responsibility at Kyocera
Wireless Corp., including Director of Human Resources and Facilities. Prior to this, from 1995 to 2004, Mr.&nbsp;Ristine held positions at Kyocera America, Inc. including Manager of Human Resources. Mr.&nbsp;Ristine received a B.S. degree in
Business and Organization Behavior from Brigham Young University and an M.B.A. degree with an emphasis in Human Resources Management from San Diego State University. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">There are no family relationships among any of our directors or executive officers. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">13 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>CORPORATE GOVERNANCE </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">Our Board met four times during the year ended December&nbsp;31, 2018. Each member of the Board attended 75% or more of the aggregate number of Board and Board committee meetings held during the period for which he
was a director during 2018 and served on such committees. We have a policy of encouraging all directors to attend the Annual Meeting; three of the six then-serving directors attended the 2018 Annual Meeting of Stockholders in person. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Board Independence </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">On an annual basis, the Board reviews
the independence of all directors in light of each director&#146;s (or any family member&#146;s, if applicable) affiliations with the Company and members of management, as well as significant holdings of the Company&#146;s securities. The Board uses
the definition of independence from The Nasdaq Stock Market (&#147;<B><I>Nasdaq</I></B>&#148;) listing standards to assess independence of our directors. The Nasdaq rules have objective tests and a subjective test for determining who is an
&#147;independent director.&#148; Under the objective tests, a director cannot be considered independent if: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">The director is, or at any time during the past three years was, an employee of the Company; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">The director, or a family member of the director, accepted any compensation from the Company in excess of $120,000 during any period of 12 consecutive months
within the three years preceding the independence determination (subject to certain exclusions, including, among other things, compensation for Board or Board committee service); </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">A family member of the director is, or at any time during the past three years was, an executive officer of the Company; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">The director, or a family member of the director, is a partner in, a controlling stockholder of or an executive officer of an entity to which the Company made,
or from which the Company received, payments in the current or any of the past three fiscal years that exceeded 5% of the recipient&#146;s consolidated gross revenue for that year, or $200,000, whichever was greater (subject to certain exclusions);
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">The director, or a family member of the director, is employed as an executive officer of an entity for which at any time during the past three years, any of the
executive officers of the Company served on the compensation committee of such other entity; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">The director, or a family member of the director, is a current partner of the Company&#146;s outside auditor, or at any time during the past three years was a
partner or employee of the Company&#146;s outside auditor, and who worked on the Company&#146;s audit. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The subjective test states
that an independent director must be a person who lacks a relationship that, in the opinion of the Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. The Board has not established
categorical standards or guidelines to make these subjective determinations, but considers all relevant facts and circumstances. Our Board has determined that Messrs. Tang, Johnson, Poyhonen and Waage are &#147;independent directors&#148; as defined
by Nasdaq rules. Dr.&nbsp;Quart is not deemed to be independent under Nasdaq rules by virtue of his current employment with the Company. Our former President, Robert Rosen, who served as director until February&nbsp;5, 2019, was not deemed to be
independent under Nasdaq rules by virtue of his employment with the Company during the time he served on the Board. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">14 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In addition to the Board-level standards for director independence, the directors who serve on the Audit
Committee each satisfy standards established by Nasdaq and the SEC, as no member of the Audit Committee accepts directly or indirectly any consulting, advisory or other compensatory fee from the Company other than their director compensation, or
otherwise has an affiliate relationship with the Company. Similarly, the members of the Compensation Committee each qualify as independent under Nasdaq standards. Under these standards, the Board considered that none of the members of the
Compensation Committee accept directly or indirectly any consulting, advisory or other compensatory fee from the Company other than their director compensation, and that none have any affiliate relationships with the Company or other relationships
that would impair the director&#146;s judgment as a member of the Compensation Committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Board Committees </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Audit Committee. </I>The Audit Committee is composed of three directors: Messrs. Johnson, Poyhonen and Waage. The Audit Committee is responsible for appointing,
overseeing and replacing, if necessary, our independent registered public accounting firm and for evaluating its work. The Audit Committee also assists the Board in overseeing the integrity of our financial statements and accounting and financial
reporting processes, compliance with legal and regulatory requirements, the independent registered public accounting firm&#146;s qualifications and independence and the performance of the Company&#146;s independent registered public accounting firm
and internal audit function. During 2018, the Audit Committee received written disclosures from and communicated with the independent registered public accounting firm; met with management and the independent registered public accounting firm to
discuss our financial statements; met with the independent registered public accounting firm to discuss matters that may affect our financial statements; approved related-party transactions, if any; provided oversight of risk management; and
approved professional services provided to us by the independent public accountants. The Audit Committee, together with the Board, was also responsible for reviewing our plans for providing appropriate financial resources to sustain our operations,
including review of our strategic corporate plan and annual operating budget. The Board has determined that, during 2018, all members of the Audit Committee satisfied applicable independence standards promulgated by Nasdaq and the SEC, and the Board
has determined that Mr.&nbsp;Johnson qualifies as the &#147;audit committee financial expert&#148; (as the SEC has defined such term in Item 407 of Regulation <FONT STYLE="white-space:nowrap">S-K).</FONT> We have adopted an Audit Committee charter,
which is available at <I><U>www.herontx.com</U></I>. The Audit Committee met four times during the year ended December&nbsp;31, 2018. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Compensation
Committee. </I>The Compensation Committee is composed of three directors: Messrs. Poyhonen, Johnson and Tang. The Compensation Committee is responsible for overseeing the Company&#146;s compensation philosophy generally and advising the Board
regarding the compensation of the Board, the President and Chief Executive Officer, and the other executive officers of the Company. The Compensation Committee seeks to align our compensation practices with sound fiscal policy and enable the Company
to attract and motivate qualified and highly skilled personnel, and is responsible for overseeing the Company&#146;s management resources, succession planning, and management development activities. In 2018, the Compensation Committee administered
our benefit and equity incentive plans, and made recommendations to the Board regarding the review and administration of all compensation arrangements for executive officers (including the Chief Executive Officer, as well as our former President,
Mr.&nbsp;Rosen) and the review and establishment of general policies relating to the compensation and benefits of our officers and employees for the year ended December&nbsp;31, 2018. The Compensation Committee also reviewed and approved corporate
goals for our executive officers and evaluated their performance in light of these goals, and reviewed and made recommendations to the Board regarding the compensation paid to the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors.
Subject to applicable laws, the Compensation Committee may form and delegate authority to subcommittees, each consisting of one or more of its </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">15 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
members, with such powers as the Compensation Committee confers. The Board has determined that, during 2018, all members of the Compensation Committee satisfied applicable Nasdaq independence
standards. We have adopted a Compensation Committee charter, which is available at <I><U>www.herontx.com</U></I>. The Compensation Committee met three<B> </B>times during the year ended December&nbsp;31, 2018. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Governance Committee. </I>The Nominating and Corporate Governance Committee (&#147;<B><I>Governance Committee</I></B>&#148;), is composed of three directors:
Messrs. Tang, Johnson and Waage. The Governance Committee is responsible for setting a process for identifying and evaluating nominees and recommending a slate of director nominees to be proposed by the Board to the stockholders (or any director
nominees to be elected by the Board to fill interim vacancies), consistent with the criteria approved by the Board. The Governance Committee also is responsible for establishing and maintaining a policy under which the Company&#146;s stockholders
may recommend a candidate to the Governance Committee for consideration for nomination as a director. Procedures for the consideration of director nominees recommended by stockholders are set forth below. In addition, the Governance Committee is
responsible for recommending directors for membership on Board committees. The Governance Committee also is responsible for reviewing and recommending updates to our Code of Ethics as well as any written corporate governance guidelines. The Board
has determined that, during 2018, all members of the Governance Committee satisfied applicable Nasdaq independence standards. We have adopted a Governance Committee charter, which is available at <I><U>www.herontx.com</U></I>. The Governance
Committee met one time during the year ended December&nbsp;31, 2018. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Pain Franchise Commercial Committee. </I>In December 2018, in connection with
our preparation for the anticipated commercial launch of <FONT STYLE="white-space:nowrap">HTX-011,</FONT> our investigational agent for the management of postoperative pain, the Board established a temporary Pain Franchise Commercial Committee that
is responsible for overseeing and monitoring the Company&#146;s commercial launch efforts related to <FONT STYLE="white-space:nowrap">HTX-011</FONT> and any future pain management drug candidates that we might develop (&#147;<B><I>Pain
Committee</I></B>&#148;). Mr.&nbsp;Poyhonen is the Chairman and sole member of the Pain Committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Compensation Committee Interlocks and Insider
Participation </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In July 2017, Mr.&nbsp;Rosen, our former President and former member of the Board, joined the Board of Directors of Odonate
Therapeutics, Inc. where Mr.&nbsp;Tang serves as Chairman and Chief Executive Officer. During the year ended December&nbsp;31, 2018, none of our executive officers, other than Mr.&nbsp;Rosen, served as a member of the Board of Directors of another
entity where such entity&#146;s executive officers served on our Board. Mr.&nbsp;Rosen retired from his roles as President and member of the Board in February 2019. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>Board Leadership Structure </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The role of our Chairman of the Board is separate from the Chief Executive
Officer. The Board has determined that its structure is appropriate at this time given the Company&#146;s specific characteristics and circumstances, including the Board&#146;s commitment to independent Board and Committee leadership, and to fulfill
the Board&#146;s duties effectively and efficiently so that our business receives the undivided attention of the Chief Executive Officer. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">16 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Director Nomination </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Criteria for Board Membership</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Governance Committee is responsible for assessing the
appropriate balance of experience, skills and other characteristics required of our directors. Nominees for director are selected based on their experience, knowledge, integrity, understanding of our business environment, specific skills and
perspectives they may possess that are helpful to the Company and the willingness to devote adequate time to Board duties. The Governance Committee uses the same selection criteria regardless of whether the candidate has been recommended by a
stockholder or identified by the Board. In selecting candidates to recommend to the Board for appointment or <FONT STYLE="white-space:nowrap">re-election</FONT> to the Board, the Governance Committee considers the current composition of the Board
and the attributes and capabilities of the current directors in order to achieve appropriate balance of experience, skills and other characteristics. The Governance Committee also considers potential independence under the rules of Nasdaq, with the
additional objective that at least one director qualifies as &#147;financial expert&#148; under the rules of the SEC. When evaluating a candidate for our Board, the Governance Committee does not assign specific weight to any of these factors, nor
does the Governance Committee believe that all of the criteria must necessarily apply to every candidate. At minimum, a director&#146;s qualifications and attributes, in light of the above-mentioned criteria, are considered each time the director is
nominated or <FONT STYLE="white-space:nowrap">re-nominated</FONT> for Board membership. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Board Diversity</I></B><B> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">While we do not have a formal written policy regarding diversity in identifying director candidates, the Company believes that a Board comprising directors with
diverse backgrounds, experiences, skills and perspectives contributes to overall Board effectiveness and improves Board decision making. The Governance Committee is committed to continuing to enhance the Board&#146;s diversity by identifying
potential director candidates with varied attributes and perspectives. Accordingly, the Governance Committee actively considers diversity in its development of the pool from which it identifies qualified director candidates who possess the
experience and skills desired for our Board. The Governance Committee looks to incorporate diversity into the Board across a broad spectrum of factors, including race, gender, ethnicity, skills, experiences, specific operational experience and
viewpoints, all with a view to identify candidates that can assist the Board with the performance of is governance and oversight role, in light of the Company&#146;s strategy and evolving needs. The Governance Committee believes that our current
Board reflects a diverse mix of directors on a number of these factors. The Governance Committee evaluates the diversity of the Board as part of the annual nomination process and assesses the effectiveness of its approach to Board diversity as part
of the Board and committee evaluation process. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Stockholder Recommendations</I></B><B> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">It is the Governance Committee&#146;s policy, as described below, to consider written recommendations from stockholders for nominees for director. The Governance
Committee considers persons recommended by our stockholders in the same manner as a nominee recommended by our Board members, management or a third-party executive search firm. Any such recommendations should be submitted to the Governance
Committee, c/o the Secretary, and should include the following information: (i)&nbsp;all information relating to such nominee that is required to be disclosed pursuant to Regulation 14A under the Exchange Act (including such person&#146;s written
consent to being named in the Proxy Statement as a nominee and to serving as a director, if elected); (ii) the names and addresses of the stockholders making the nomination and the number of shares of our
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">17 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
common stock which are owned beneficially and of record by such stockholders; and (iii)&nbsp;appropriate biographical information and a statement as to the qualification of the nominee.
Stockholders seeking to recommend a prospective nominee should follow the instructions under the heading &#147;Communications with Directors&#148; below. The Board did not receive any stockholder recommendations during the year ended
December&nbsp;31, 2018. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Process for Identifying and Evaluating Nominees</I></B><B> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Board believes we are well served by our current directors who provide the Board with experience, skills and characteristics that the Board has determined meet
its requirements with respect to experience, knowledge, integrity, understanding of our business environment, specific skills that are helpful to the Company and the willingness to devote adequate time to Board duties. The Board, following the
recommendation of our Governance Committee, determined that the five incumbent director nominees are best-suited to continue to serve our needs, given our Company&#146;s current anticipated activities. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Oversight of Risk Management </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Our Board is responsible for
oversight of our risk management policies and procedures. We are exposed to a number of risks, including financial risks, strategic, operational and commercial risks and risks relating to regulatory and legal compliance. The Board will regularly
discuss with management our major risk exposures and the steps management has taken to monitor and control such exposures, including the guidelines and policies to govern the process by which risk assessment and risk management are undertaken, and
highlighting any new risks that may have arisen since they last met. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Board manages exposure risks within various areas including: (i)&nbsp;risks
relating to our employment policies, executive compensation plans and arrangements; (ii)&nbsp;financial risks and taking appropriate actions to help ensure quality financial reporting and appropriately conservative investment practices;
(iii)&nbsp;risks associated with the independence of the Board and potential conflicts of interest; and (iv)&nbsp;commercial risks. The Audit Committee reviews policies with respect to risk assessment and risk management and reviews with the
Company&#146;s general counsel, who would also consult with outside counsel as appropriate, any legal matter that could have a significant impact on the Company&#146;s financial statements. The Audit Committee also reviews policies with respect to
financial risk and makes recommendations to the Board. The Board&#146;s administration of its risk oversight function has not affected the Board&#146;s leadership structure, which separates the roles of our Chairman of the Board and our Chief
Executive Officer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>COMMUNICATIONS WITH DIRECTORS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Stockholders and other interested parties who wish to communicate with any director or committee of our Board may do so using the procedures detailed in the
Corporate Governance section of the Investor Resources page on our website at <I><U>www.herontx.com</U></I>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>CODE OF ETHICS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">We have adopted a Code of Ethics that applies to our Principal Executive Officer, Principal Financial and Accounting Officer and to all of our other officers,
directors and employees. The Code of Ethics is available in the Corporate Governance section of the Investor Resources page on our website at <I><U>www.herontx.com</U></I>. We intend to disclose future waivers or material
amend-</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">18 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
ments to certain provisions of our Code of Ethics on the above-referenced website within four business days following the date of such waiver or amendment. To the extent permissible under Nasdaq
rules, if we make any amendments to the Code of Ethics or grant any waiver, including implicit waiver, from a provision of the Code of Ethics to a director or executive officer we intend to disclose the nature of such amendment or waiver in the
manner set forth in the Code of Ethics on our website. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">19 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>SECURITY OWNERSHIP BY CERTAIN BENEFICIAL HOLDERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">The following table sets forth information regarding beneficial ownership of our common stock by: (i)&nbsp;each person known to us to own more than 5% of the outstanding shares of our common stock; (ii)&nbsp;each
of our directors; (iii)&nbsp;each of our Named Executive Officers; and (iv)&nbsp;all current directors and executive officers, as a group. The number of shares reported in the table below is as of April&nbsp;22, 2019, except as otherwise noted
below, and is based on filings with the SEC or other information of which we are aware. The information in this table is based solely on statements in filings with the SEC or other reliable information included in the Company&#146;s records. Unless
otherwise indicated, the address of each of the named individuals is c/o Heron Therapeutics, Inc., 4242&nbsp;Campus Point Court, Suite 200, San Diego, CA 92121. The percentage of ownership is based on 79,194,227 shares of common stock issued and
outstanding as of April&nbsp;22, 2019. Beneficial ownership of shares is determined in accordance with the rules of the SEC and includes voting and investment power with respect to the shares. Shares of common stock subject to outstanding options
and warrants and shares of common stock underlying convertible notes that are exercisable or convertible, as the case may be, within 60 days of April&nbsp;22, 2019 are deemed outstanding for computing the percentage of ownership of the person
holding such options, warrants or convertible notes, but are not deemed outstanding for computing the percentage of any other person. Except as otherwise noted, each person or entity has sole voting and investment power with respect to the shares
shown. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Name</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Number&nbsp;of<BR>Shares<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Percent&nbsp;of<BR>Class<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><B><I>Greater than 5% Holders</I></B></FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Franklin Resources, Inc.</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">8,421,291</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">10.63</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">One Franklin Parkway</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">San Mateo, CA 94403</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">FMR
LLC</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">8,034,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">10.15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">245 Summer Street</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Boston, MA 02210</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Tang Capital Partners, LP</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">7,927,351</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">9.74</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">4747 Executive Drive, Suite 510</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">San Diego, California 92121</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Baker Bros. Advisors LP</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">6,959,460</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">8.58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">860 Washington Street, 3</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">rd</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2"> Floor</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.50em; text-indent:-0.50em"><FONT
STYLE="font-family:ARIAL" SIZE="2">New York, NY 10014</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Vanguard Group Inc.</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> (7)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">6,314,339</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">7.97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">PO Box 2600 V26</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Valley Forge, PA 19482</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Janus Henderson Group PLC</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">5,437,540</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">6.87</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">201 Bishopgate</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">London, X0 EC2M 3AE</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">20 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Name</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Number&nbsp;of<BR>Shares<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Percent&nbsp;of<BR>Class<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">BlackRock, Inc.</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> (9)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,913,006</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">6.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">East 52</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">nd</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2"> Street</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.50em; text-indent:-0.50em"><FONT
STYLE="font-family:ARIAL" SIZE="2">New York, NY 10055</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Wellington Management Group, LLP</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,577,871</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">5.78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">280 Congress Street</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Boston, MA 02210</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><B><I>Current Directors and Named Executive Officers</I></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kevin
Tang</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Chairman of the Board</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">8,143,796</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">9.99</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart,
Pharm.D.</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">President, Chief Executive Officer and Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,597,175</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Craig
Johnson</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">173,840</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">John Poyhonen</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
(13)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">129,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Christian
Waage</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(14)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">61,854</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly
Manhard</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(15)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Executive Vice President, Drug Development</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">346,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert
Hoffman</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(16)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Chief Financial Officer and Senior Vice President, Finance</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">69,113</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Current Executive Officers and Directors as a group (7 persons)</I></FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(17)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">10,522,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12.56</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Indicates ownership of less than one percent. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Derivative securities may have limits on the ability of these holders to exercise or convert these securities into shares of our common stock if, after such
exercise or conversion, the holder would beneficially own more than a stated percentage of our outstanding common stock (<I>e.g.</I>, 9.99%). Where these limits are applicable as of April&nbsp;22, 2019 and cannot be modified for a period of 60 days
or longer, the corresponding shares of common stock underlying these securities have been excluded from the beneficial ownership calculations. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">As applicable, the number of shares of common stock listed as owned by a beneficial holder relies on public filings by such beneficial holder and the number of
shares of common stock reported as beneficially owned. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Based on information set forth in a Schedule 13G/A filed with the SEC on January&nbsp;9, 2019 by Franklin Resources, Inc., Charles Johnson, Rupert Johnson, Jr.
and Franklin Advisers, Inc. and its affiliates (Franklin Advisers, Inc. and Fiduciary Trust Company International) reporting beneficial ownership of 8,421,291 shares as of December&nbsp;31, 2018. The Schedule 13G/A reports that Franklin Advisers,
Inc. has sole voting and dispositive power with respect to 8,388,302 shares, that Fiduciary Trust Company International has sole voting and dispositive power with respect to 26,730 shares and that Franklin Templeton Investments (Asia) Ltd. has sole
voting and dispositive power with respect to 6,259 shares. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Based on information set forth in a Schedule 13G/A filed with the SEC on February&nbsp;13, 2019 by FMR LLC and Abigail P. Johnson reporting beneficial ownership
of 8,034,803 shares as of December&nbsp;31, 2018. The Schedule 13G/A reports that FMR LLC and Abigail Johnson both have sole voting power over 632,595 shares and sole dispositive power with respect to these 8,034,803 shares. The Schedule 13G/A
reports that neither FMR LLC nor Abigail Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the Investment Company Act advised by Fidelity Management&nbsp;&amp;
Research Company, a wholly-owned subsidiary of FMR LLC. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">21 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Based on information set forth in a Form 13F filed with the SEC on February&nbsp;14, 2019 by Tang Capital Partners, LP, Tang Capital Management, LLC (together,
&#147;<B><I>Tang Capital</I></B>&#148;) and Kevin Tang reporting beneficial ownership of 5,753,096 shares for Tang Capital and beneficial ownership of 5,818,541 shares for Kevin Tang. The Form 13F reports that Mr.&nbsp;Tang has sole voting and
dispositive power with respect to 65,445 shares, and Mr.&nbsp;Tang and Tang Capital have shared voting and dispositive power with respect to 5,753,096 shares, which includes 937,500 shares held by Tang (APPA) Holdings, LLC (as described in a
Schedule 13D/A filed with SEC on September&nbsp;13, 2018). In the case of Kevin Tang, the total shares reported on this table include 151,000 shares underlying stock options exercisable within 60 days of April&nbsp;22, 2019. Beneficial ownership of
Tang Capital and Kevin Tang also include 2,174,255 shares issuable upon conversion of the Notes held by the holder within 60 days of April&nbsp;22, 2019. Beneficial ownership for Tang Capital and Kevin Tang exclude 4,808,874 shares that are
potentially issuable on conversion of the principal amount of the Company&#146;s Senior Secured Convertible Notes due 2021, including interest paid in kind as of April&nbsp;1, 2019 (the &#147;<B><I>Notes</I></B>&#148;). The Notes have a limit on the
ability of the holder to convert, to the extent that the holder would beneficially own greater than 9.99% of the Company&#146;s common stock following such conversion, provided that the holder has the ability to increase or decrease this limitation
on exercise or conversion by providing the Company with 61 days of prior written notice. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Based on information set forth in a Schedule 13G/A filed with the SEC on February&nbsp;13, 2019 by Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Felix
J. Baker, and Julian C. Baker, (each, a &#147;<B><I>Baker Advisor</I></B>&#148;), reporting beneficial ownership of 6,908,244 shares as of December&nbsp;31, 2018. Shares deemed beneficially owned by the Baker Advisors are held of record by 667,
L.P., Baker Bros. Life Sciences, L.P. and 14159, L.P. (collectively, &#147;<B><I>Baker Bros</I></B>&#148;). The Schedule 13G/A reports that each Baker Advisor has sole voting and dispositive power with respect to these 6,908,244 shares, which
includes 195,574 shares of common stock that may be acquired upon the exercise of warrants and 1,694,566 shares issuable upon the conversion of Notes held by the holder. Since December&nbsp;31, 2018, the beneficial owner received $20,334.77 and
$20,639.79 principal amount of senior secured convertible notes on January&nbsp;1, 2019 and April&nbsp;1, 2019, respectively, as interest in kind on the existing notes held by the beneficial owner. The conversion of this additional principal is
included in the table above. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Based on information set forth in a Schedule 13G filed with the SEC on February&nbsp;11, 2019 by Vanguard Group Inc. reporting beneficial ownership of 6,314,339
shares as of December&nbsp;31, 2018. The Schedule 13G indicates that Vanguard Group has sole voting power with respect to 143,078 shares, sole dispositive power with respect to 6,169,656 shares, shared voting power with respect to 9,110 shares and
shared dispositive power with respect to 144,683 shares. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Based on information set forth in a Schedule 13G/A filed with the SEC on February&nbsp;12, 2019 by Janus Henderson Group PLC reporting beneficial ownership of
5,437,540 shares as of December&nbsp;31, 2018. The Schedule 13G/A indicates that Janus Henderson Group PLC has shared voting and dispositive power with respect to these 5,437,540 shares. Janus Henderson Group PLC owns Janis Capital Management LLC
which as a result of its role as investment adviser or <FONT STYLE="white-space:nowrap">sub-adviser,</FONT> Janus Capital Management LLC may be deemed to be the beneficial owner of 4,907,184 shares. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Based on information set forth in a Schedule 13G filed with the SEC on February&nbsp;8, 2019 by BlackRock, Inc. reporting beneficial ownership of 4,913,006
shares as of December&nbsp;31, 2018. The Schedule 13G indicates that BlackRock, Inc. has sole voting power with respect to 143,078 shares and shared dispositive power with respect to 4,913,006 shares. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Based on information set forth in a Schedule 13G filed with the SEC on February&nbsp;12, 2019 by Wellington Management Group, LLC reporting beneficial ownership
of 4,577,871 shares as of December&nbsp;31, 2018. The Schedule 13G indicates that Wellington Management Group, LLC has shared voting power with respect to 3,746,035 shares and shared dispositive power with respect to 4,577,871 shares.
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">22 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Consists of 89,275 shares of common stock and 1,507,900 shares underlying stock options exercisable within 60 days of April&nbsp;22, 2019.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Consists of 840 shares of common stock and 173,000 shares underlying stock options exercisable within 60 days of April&nbsp;22, 2019.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(13)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Consists of 10,000 shares of common stock and 119,750<B> </B>shares underlying stock options exercisable within 60 days of April&nbsp;22, 2019.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(14)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Consists of 61,854<B> </B>shares underlying stock options exercisable within 60 days of April&nbsp;22, 2019. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(15)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Consists of 346,500<B> </B>shares underlying stock options exercisable within 60 days of April&nbsp;22, 2019. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(16)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Consists of 1,280 shares of common stock and 67,833<B> </B>shares underlying stock options exercisable within 60 days of April&nbsp;22, 2019.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(17)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Consists of 5,919,936 shares of common stock, 2,427,837<B> </B>shares underlying stock options exercisable within 60 days of April&nbsp;22, 2019 and 2,174,255
shares issuable upon the conversion of Notes. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">23 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Related Person Transactions Policies </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Pursuant to our Code
of Ethics, our executive officers, directors and employees must disclose transactions involving actual or apparent conflicts of interest, such as related person transactions, to the Chairman of the Board. Additionally, the Audit Committee is
responsible for review and approval of all related person transactions in which any officer, director or stockholder has a direct or indirect interest and would be required to be disclosed under Item 404(a) of SEC Regulation <FONT
STYLE="white-space:nowrap">S-K,</FONT> and has written policies and procedures for reviewing, approving or ratifying any transaction required to be reported under Item 404(a) of SEC Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT> In
reviewing related person transactions, the Audit Committee evaluates any transaction in which the Company was or is to be a participant and the amount involved exceeds $120,000, and in which the &#147;related person&#148; (as defined in Item 404(a)
of SEC Regulation <FONT STYLE="white-space:nowrap">S-K)</FONT> had, or will have, a direct or indirect material interest. The Audit Committee also will consider whether the proposed terms are at least as favorable to the Company as could be obtained
from unaffiliated third parties and will confirm that there is a bona fide business purpose for the transaction. There were no related person transactions since the beginning of the Company&#146;s last completed fiscal year that require disclosure
under Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Under Section&nbsp;16(a) of the Exchange Act and SEC rules, each person who, at any time during 2018, was a director, executive officer or beneficial owner of more
than 10% of any class of equity security (&#147;<B><I>Reporting Person</I></B>&#148;) is required to file periodic reports of his or her ownership, and changes in that ownership, with the SEC. Beneficial owners of more than 10% of any class of
equity security file their own reports with the SEC. Based solely on our review of copies of these reports and representations of such reporting persons, we believe that during the year ended December, 31 2018, all Reporting Persons satisfied such
applicable SEC filing requirements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">24 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>EXECUTIVE COMPENSATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>Compensation Discussion and Analysis </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Overview</I></B><B> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The following Compensation Discussion and Analysis describes the material elements of compensation earned in 2018 by each of the executive officers identified in
the Summary Compensation Table below, who are referred to collectively as our &#147;<B><I>Named Executive Officers</I></B>.&#148; Our Named Executive Officers with respect to 2018 were: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart, Pharm.D., President and Chief Executive Officer; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Rosen, former President; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly Manhard, Executive Vice President, Drug Development; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Hoffman, Chief Financial Officer and Senior Vice President, Finance. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">These persons constitute our principal executive officer, our principal financial officer, our only other executive officer, and our former President, all serving during 2018. Mr.&nbsp;Rosen retired from the
Company in February 2019, and Dr.&nbsp;Quart assumed the role of President on Mr.&nbsp;Rosen&#146;s retirement. The 2018 compensation discussion provided below includes payments that were made in 2019 when such payments related to performance in
2018. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:ARIAL" SIZE="2">Key highlights of the Company&#146;s 2018 achievements and success include achieving all primary and key secondary endpoints
in our Phase 3 studies of <FONT STYLE="white-space:nowrap">HTX-011;</FONT> filing the New Drug Application (&#147;<B><I>NDA</I></B>&#148;) with the U.S. Food and Drug Administration (&#147;<B><I>FDA</I></B>&#148;) and obtaining Breakthrough Therapy
and Priority Review designations for <FONT STYLE="white-space:nowrap">HTX-011;</FONT> and exceeding our commercial sales targets for the Chemotherapy Induced Nausea and Vomiting (&#147;<B><I>CINV</I></B>&#148;) portfolio including SUSTOL<FONT
STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> (granisetron) extended-release injection (&#147;<B><I>SUSTOL</I></B>&#148;) and
CINVANTI<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> (aprepitant) injectable emulsion (&#147;<B><I>CINVANTI</I></B>&#148;). These achievements and others created
greater stockholder value and expanded the opportunity for future growth and long-term success. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Compensation Philosophy and
Objectives</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:ARIAL" SIZE="2">Our goal is to provide a competitive total compensation package with significant emphasis on paying for
performance. Our corporate compensation philosophy targets annual base salary and annual incentive bonus payout percentage at or near the 50</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2"> percentile of the market, and equity awards at or near the 75</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2"> percentile of the market when compared to executives with similar roles at similar organizations. We favor equity-based
compensation (which, to date, consists only of stock options) and variable incentive awards over guaranteed cash compensation in order to drive accomplishments that enhance stockholder value and align the interests of our executives and our
stockholders. This means that our executives will not realize the total potential value of their compensation package unless performance goals, the significant majority of which are directly tied to our corporate performance, are achieved. The
Compensation Committee believes that our executive compensation program is appropriately designed and reasonable in light of the executive compensation programs of our peer-group companies. The Compensation Committee also believes that our executive
compensation program is appropriate in that it is designed to incentivize our management team to achieve our short-term and long-term corporate objectives while effectively managing business risks and challenges. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">25 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In implementing the foregoing objectives, our executive compensation program is based on three primary
components: (i)&nbsp;base salary; (ii)&nbsp;annual cash incentive bonuses and (iii)&nbsp;equity-based compensation. The Compensation Committee believes that compensation in the form of base salary and an annual cash incentive bonus provides our
executives with short-term rewards for success in operational performance and meeting established goals and business responsibilities, while compensation through equity awards aligns the objectives of our management team with those of our
stockholders with respect to long-term performance and success. In addition, our executives receive benefits that are generally available to all our employees. The Compensation Committee&#146;s process for setting compensation includes reviewing the
targeted overall compensation for each executive and then allocating that compensation between base salary, annual cash incentive bonuses and equity-based compensation with reference to the competitive market peer-company data as well as market
survey data for public companies of a similar size and market capitalization and at a similar stage of product development and business activity. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Risk Management and Mitigation</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In
reviewing our compensation structure in 2018, the Compensation Committee also considered whether our compensation policies and practices could affect our risk profile and whether such compensation policies and practices could potentially encourage
excessive risk taking by our employees. More specifically, thought was given to the general design philosophy of our policies for employees whose conduct would be most affected by the incentives established under our compensation programs. In
considering these issues, the Compensation Committee did not find that our compensation policies and other policies generally raised undue risks for the Company or potentially could encourage excessive risk taking by our employees. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">With respect to cash incentive bonuses and equity-based compensation for our executive officers, the amount of an individual&#146;s bonus or award depends
principally on overall Company performance, which reduces the incentive for an individual to take undue individual risks in an effort to increase the amount of his or her cash bonus or equity award for a particular year. The Company&#146;s
performance goals are reviewed annually by the Compensation Committee at the beginning of each year to ensure that they are appropriate and would not encourage or reward excessive risk taking. Additionally, the Compensation Committee monitors
Company performance periodically throughout the year and has the opportunity to intervene in the event that actions by individual employees with respect to the Company&#146;s performance goal attainment would raise undue risk. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">With respect to new hire equity awards, these awards typically vest and become exercisable over a period of four years, consisting of an initial <FONT
STYLE="white-space:nowrap">one-year</FONT> cliff vest, followed by monthly vesting. With respect to ongoing equity awards, these awards typically vest and become exercisable ratably each month over a four-year period. We believe that long-term value
creation, contrasted with short-term gain, presents the best opportunity for our employees to profit from these awards. In circumstances where performance-based equity awards have been granted, the events that trigger vesting are generally estimated
to be achieved at least one or more years from the grant date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Consideration of Most Recent Stockholder Advisory Vote to Approve Named
Executive Officer Compensation</I></B><B> </B></FONT></P> <P STYLE="margin-top:13px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In 2018, the percentage of votes cast &#147;For&#148; our advisory <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">say-on-pay</FONT></FONT> vote to approve the Company&#146;s Named Executive Officer compensation was 90.7% of the total votes cast. The Board and Compensation Committee believe that our 2018
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> results are an affirmation of the effectiveness of the Company&#146;s executive compensation program and, therefore, no changes were made to the structure and
elements of the executive compensation program based on the 2018 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> vote results. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">26 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Roles in Determining Compensation</I></B><B> </B></FONT></P>
<P STYLE="margin-top:13px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Compensation Committee</I> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">For 2018, the Compensation
Committee had the responsibility of reviewing the appropriateness of the target total compensation of our executive officers, including the Named Executive Officers. The Compensation Committee engaged in this evaluation while also considering
whether the compensation program was achieving its objectives consistent with our compensation philosophy. The Compensation Committee oversaw and approved all compensation arrangements and actions for our executive officers and other key employees
in 2018, including the Named Executive Officers.<B> </B>While the Compensation Committee drew on a number of resources, including input from the Chief Executive Officer, to make decisions regarding the Company&#146;s executive compensation program,
ultimate decision-making authority rested with the Compensation Committee. The members of the Compensation Committee relied on their judgment in making compensation decisions after reviewing our overall performance and evaluating each
executive&#146;s performance and overall contributions during the year against established goals, operational performance and business responsibilities. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Compensation Consultant</I> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In 2018, the Compensation
Committee engaged the services of Compensia, Inc. (&#147;<B><I>Compensia</I></B>&#148;), a national independent compensation advisory firm that has extensive experience with biotechnology companies and specializes in executive compensation. The
directive for Compensia was to assist the Compensation Committee in its review of executive and director compensation practices, including the competitiveness of pay levels, executive compensation design and review and analysis of competitive market
data with respect to the Company&#146;s peers in the industry. The Compensation Committee has the final authority to engage and terminate services for consultants it may engage. The decision to engage Compensia was not made or recommended by our
management, and Compensia did not provide any services to us outside of its services to the Compensation Committee. The Compensation Committee, after a review of the factors set forth in Section&nbsp;10C(b)(2) of the Exchange Act and Rule <FONT
STYLE="white-space:nowrap">10C-1(b)(4)</FONT> under the Exchange Act, has determined that the work performed by Compensia did not present any conflicts of interest. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><I>Chief Executive Officer</I><B><I> </I></B><I></I> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In 2018, our Chief Executive Officer attended Compensation
Committee meetings at which executive compensation (other than our Chief Executive Officer&#146;s compensation) was discussed, and he worked with the Compensation Committee to develop compensation recommendations for the executive officers (apart
from himself and our former President), based on individual experience and breadth of knowledge, internal considerations, individual performance during the relevant year and other factors deemed relevant by the Compensation Committee. The Chief
Executive Officer&#146;s input was one of the factors considered by the Compensation Committee in determining overall compensation for the other Named Executive Officers (apart from our former President) and other key employees. The Compensation
Committee used Compensia&#146;s analysis to formulate compensation recommendations for the Chief Executive Officer and also for our former President. Discussions regarding compensation for our Chief Executive Officer and our former President were
held by the Compensation Committee in an executive session. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">27 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Competitive Market Review</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">In 2018, the Compensation Committee retained Compensia to assist with identifying a group of peer companies within the biotechnology/biopharmaceutical industry with similar identified characteristics to our Company
to be used to assess compensation levels for the top senior management positions and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. Compensia was involved with the process of selecting an appropriate peer group for our Company and
in collecting and analyzing compensation data of the companies within our peer group. In addition, for some positions, we reviewed other broader market surveys within our industry. While we do not establish compensation levels based solely on
comparative data, pay practices at other companies are an important factor that are considered in assessing the reasonableness of compensation and ensuring that our compensation practices are competitive in the marketplace. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In developing the peer group for 2018, the criteria that were used to identify the peer companies were market capitalization (ranging from $900&nbsp;million to
$3.6 billion) and current stage of product development or business activity (at the commercialization stage or close to potential commercialization). The 15 companies in the peer group for 2018 are listed below. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Agios Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Momenta Pharmaceuticals, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Array BioPharma Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Pacira Biosciences, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Amicus Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">PTC Therapeutics, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Corcept Therapeutics Incorporated</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Supernus Pharmaceuticals, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Halozyme Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">TESARO, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Innoviva, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">The Medicines Company</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Intercept Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Ultragenyx Pharmaceutical Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Ironwood Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">While the Compensation Committee reviewed compensation data pertaining to these companies, it determined that elements such as the
Company&#146;s diversity of clinical development activities and the level of executive experience should also be significant factors in assessing compensation levels. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Compensation Elements</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Base Salary</I> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:ARIAL" SIZE="2">Executive base salaries are based on job responsibilities, accountability and the experience of the individual. For 2018, the Compensation
Committee sought to implement a policy of targeting base salaries for our executives, including the Chief Executive Officer and the former President, at or near the 50</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2"> percentile of salaries of executives with similar roles at similar organizations, based on its review of competitive market
data. In its assessment of executive compensation levels, Compensia provided an analysis that confirmed, using the Company&#146;s identified peer group and broader industry and market survey data for life sciences companies, that our executive base
salaries and target total cash compensation approximated the 50</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2"> percentile.
Through review of the data provided, the Compensation Committee determined that base salaries for the Named Executive Officers appeared to be generally aligned with our compensation philosophy as described above. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">28 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">More specifically, during its review of base salaries for our executives, the Compensation Committee primarily
considered: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">market data drawn from publicly available industry surveys; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">compensation data for companies in our peer group discussed above, which are of a similar size and range of market capitalization and at a similar stage of
product development or business activity (<I>i.e.</I>, commercial-stage and product development companies); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">individual performance of each executive during the year, including achievements and overall contribution to the Company&#146;s growth and business success; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">an internal review of each executive&#146;s overall compensation relative to other executives at a similar level in the Company. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Compensation Committee considered these factors in the aggregate, without assigning weight to any specific factor. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Base salary levels are typically considered annually as part of our performance review process, as well as on promotion or other change in job responsibilities.
Merit increases are awarded based on the Compensation Committee&#146;s overall review of an executive&#146;s performance of his or her job responsibilities. In addition, base salaries are reviewed annually for comparability with market practices.
Market adjustments generally are reserved for those whose base salaries are substantially below market. In December 2018, the Board approved the following base salary increases for 2019 based on performance during 2018: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Executive</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Principal Position</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>2018<BR>Base<BR>Salary</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Base<BR>Salary<BR>Increase<BR>%</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Adjusted<BR>Salary</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>For 2019</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart, Pharm.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">614,414</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4.0%&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">638,991</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Rosen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Former President</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">614,414</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4.0%&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">638,991</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly Manhard</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Executive Vice President, Drug Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">466,796</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">5.0%&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">490,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Hoffman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Chief Financial Officer and Senior Vice President, Finance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">357,438</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">8.8%&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">388,714</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">These salary adjustments were effective commencing with the first pay period in 2019 and were generally in line with merit
increases across the Company. Mr.&nbsp;Hoffman&#146;s salary increase included a market adjustment due to his salary being below market benchmarks. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Annual Cash Incentive Bonus</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT
STYLE="font-family:ARIAL" SIZE="2">The Compensation Committee, consistent with the overall corporate philosophy of maintaining target total cash compensation for our executives at or near the 50</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2"> percentile when compared to executives with similar roles at similar organizations, reviewed the target annual cash incentive
bonus payouts for the Named Executive Officers based on peer group and broader industry and market survey data. The target annual incentive bonus amount is set at a level based on the executive&#146;s accountability and potential impact on the
Company&#146;s performance. Accordingly, the more control and accountability that an executive </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">29 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
has over the Company&#146;s performance, the greater the percentage of that executive&#146;s total target cash compensation is dependent on annual performance-based cash bonus awards. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The target annual cash incentive bonus payout percentages for 2018 set at the beginning of the year were as follows: 60% of base salary for Dr.&nbsp;Quart and
Mr.&nbsp;Rosen; 50% of base salary for Ms.&nbsp;Manhard; and 40% of base salary for Mr.&nbsp;Hoffman. For Dr.&nbsp;Quart, Mr.&nbsp;Rosen, Ms.&nbsp;Manhard and Mr.&nbsp;Hoffman, the target annual cash incentive bonus payout percentages for 2018 were
based solely on the achievement of corporate performance goals. These target percentages were unchanged from 2017. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In determining the actual annual
cash incentive bonus payout for our executive officers, the executive&#146;s annual base salary is multiplied by his or her target annual incentive bonus payout percentage. For Dr.&nbsp;Quart, Mr.&nbsp;Rosen, Ms.&nbsp;Manhard and Mr.&nbsp;Hoffman,
the resulting amount is then multiplied by the corporate performance percentage approved by the Compensation Committee or Board, which is dependent on the achievement of corporate performance goals. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">For annual cash incentive bonuses for our executive officers, a minimum overall goal achievement of greater than or equal to 50% is required for an executive
officer to earn any performance-based cash bonus. The target annual cash incentive bonus can be earned if a goal achievement of 100% is obtained; for extraordinary performance in corporate goal achievement, up to 150% of the target annual cash
incentive bonus for that goal may be awarded. Accordingly, for each executive in 2018, there was the potential to receive up to 150% of his or her overall target annual cash incentive bonus payout. The Compensation Committee retains broad discretion
to modify our target corporate performance goals at any time, including the methodology for calculating the specific bonus amounts. The Compensation Committee may also, in its sole discretion, determine to either increase annual cash incentive bonus
payouts for extraordinary achievement or to reduce payouts if economic and business conditions warrant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Our corporate goals are collectively designed
to emphasize success with respect to our diverse business efforts and encourage our executives to support each goal as a multi-disciplinary function. For 2018, our corporate goals were a combination of the following: (1)&nbsp;achieving all primary
and key secondary endpoints in pivotal Phase 3 trials; (2)&nbsp;filing the NDA for <FONT STYLE="white-space:nowrap">HTX-011;</FONT> (3) filing the sNDA for CINVANTI IV push; (3)&nbsp;completion of certain
<FONT STYLE="white-space:nowrap">pre-commercialization</FONT> efforts with respect to <FONT STYLE="white-space:nowrap">HTX-011;</FONT> (4) exceeding certain commercial sales targets for SUSTOL and CINVANTI; and (5)&nbsp;financing goals, including
adhering to an <FONT STYLE="white-space:nowrap">on-target</FONT> budget. Although these goals were assigned weights, the Compensation Committee&#146;s analysis of the level of achievement for each goal was subjective and the goals were considered in
the aggregate, without a formulaic evaluation. In the aggregate, the Compensation Committee determined that overall, the corporate performance goals had been achieved at a level of 150% due to better than expected results for the Company&#146;s key
goals. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">30 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Performance-based cash bonuses for Dr.&nbsp;Quart, Mr.&nbsp;Rosen, Ms.&nbsp;Manhard and Mr.&nbsp;Hoffman were
approved based on the achievement of corporate performance goals and, therefore, paid at 150% of their target annual cash incentive bonus amount, corresponding to payouts as follows: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Executive</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Principal Position</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>2018&nbsp;Annual&nbsp;Cash<BR>Incentive Bonus</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart, Pharm.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$552,973&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Rosen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Former President</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$552,973&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly Manhard</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Executive Vice President, Drug Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$350,097&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Hoffman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Chief Financial Officer and Senior Vice President, Finance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$214,463&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Equity-Based Compensation</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">Our equity-based compensation program is designed to promote high performance and achievement of corporate goals by employees on a long-term basis, encourage the growth of stockholder value and allow employees to
participate in the long-term success of the Company. Under the 2007 Equity Incentive Plan, the Board (or a committee thereof, including the Compensation Committee) may grant stock options, shares of stock, restricted stock units, stock appreciation
rights and performance awards. In granting these equity awards, the Board (or a committee thereof, including the Compensation Committee) may establish any conditions or restrictions it deems appropriate. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">To date, we have granted equity awards to our executive officers and other employees in the form of stock options. By using stock options, the Compensation
Committee has provided the members of the management team with a significant equity stake in our Company, which we believe aligns the long-term interests of the management team with our stockholders. Because a financial gain from stock options is
only possible if the market price of the Company&#146;s common stock increases over time, the Compensation Committee believes that option grants motivate our executives and other employees to deliver superior performance and focus on behaviors and
initiatives that lead to long-term value creation, which benefits all of our stockholders. The Company typically grants time-based vesting options, but has also granted performance-based options to our Chief Executive Officer, our former President
and certain other executives. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:ARIAL" SIZE="2">Stock option award levels are based on option grant guidelines approved by the Board or the
Compensation Committee and vary among employees based on their level within the Company and their individual performance. Annual awards of stock options to executives are made as part of the annual review of executive performance, which typically
occurs around <FONT STYLE="white-space:nowrap">year-end.</FONT> Newly hired or promoted executives receive their award of stock options on their date of hire or promotion. For 2018, the Compensation Committee targeted stock option award levels for
our executives, including the Chief Executive Officer and the former President, at or near the 75</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:ARIAL" SIZE="2"> percentile of long-term incentive awards of executives with similar roles at similar organizations, based on a review of competitive market data. The Compensation Committee, in line with the Company&#146;s
philosophy to encourage long-term value creation, elected to emphasize the equity portion of each executive&#146;s overall target total direct compensation opportunity by benchmarking above the 50</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2"> percentile for this compensation element. The grant of options by the Company is unrelated to any anticipated major
announcements made by the Company and is not influenced by any material, <FONT STYLE="white-space:nowrap">non-public</FONT> information that may exist at the time of grant. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">31 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In December 2018, annual equity awards were granted to each of our Named Executive Officers, who were then
employed by the Company, after consideration to the performance and achievements by each executive during 2018 and their future anticipated impact on the success of the organization. Annual equity awards vest ratably each month over a four-year
period. In determining the appropriate value of each of these awards, the Compensation Committee used the market analysis and peer group data developed with the assistance of Compensia, as discussed above. With respect to each Named Executive
Officer, the peer-group data and survey data for companies in our industry with similar market capitalization was used to help set the appropriate value of the grant using the Black-Scholes option pricing model. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="21%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Executive</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Principal Position</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Stock&nbsp;Option<BR>Award</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Grant&nbsp;Date&nbsp;Fair<BR>Value</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart, Pharm.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">300,000&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,815,660&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Rosen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Former President</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">300,000&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,815,660&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly Manhard</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Executive Vice President, Drug Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">100,000&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,605,220&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Hoffman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Chief Financial Officer and Senior Vice President, Finance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">71,000&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,139,706&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Employee Benefit Programs</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">The Named Executive Officers are eligible to participate in the Company&#146;s health, welfare, paid <FONT STYLE="white-space:nowrap">time-off,</FONT> retirement savings and employee stock purchase benefit programs
on the same terms as are available to other employees. These benefit programs are designed to enable the Company to attract and retain its workforce in a competitive marketplace. The retirement savings plan helps employees save and prepare
financially for retirement. Our Employee Stock Purchase Plan (&#147;<B><I>ESPP</I></B>&#148;) provides employees with an opportunity for increased equity ownership in the Company. Other than these benefits generally available to all employees, Named
Executive Officers do not receive any other benefits or perquisites. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Our retirement savings plan (&#147;<B><I>401(k) Plan</I></B>&#148;) is a <FONT
STYLE="white-space:nowrap">tax-qualified</FONT> retirement savings plan, pursuant to which all employees, including the Named Executive Officers, are able to contribute the lesser of 100% of their annual compensation (as defined) or the limit
prescribed by the Internal Revenue Service to the 401(k) Plan on a <FONT STYLE="white-space:nowrap">pre-tax</FONT> basis. In 2018, we matched employee contributions to the 401(k) Plan in an amount equal to 50% of each participant&#146;s contribution
during the plan year, up to a maximum amount equal to the lesser of either: (a) 3% of each participant&#146;s annual compensation; or (b) $8,250. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Our
ESPP allows employees, including the Named Executive Officers, to voluntarily purchase common stock under the ESPP twice per calendar year (up to 10% of each employee&#146;s base salary, hourly compensation and any cash bonus paid, subject to
certain limitations) over the <FONT STYLE="white-space:nowrap">six-month</FONT> offering period at 85% of the fair market value of the common stock at specified dates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Employment and Separation Arrangements</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">We have entered into employment agreements with
each Named Executive Officer, the terms of which provide, among other things, for certain termination and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> payments and benefits. Our Board approved the
termination and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> payments and benefits in order to maintain market-competitive compensation practices and to mitigate some of the risk that exists for
executives working in a biopharmaceutical company at our current stage of development, where the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">32 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
possibility exists that we may be acquired if our business efforts succeed. These arrangements are intended to retain highly skilled executives who have, or who may seek, alternatives that may
appear to them to be less risky in terms of the potential loss of their position following a merger or sale, particularly where the services of these executive officers may not be required by the acquirer. We do not provide any of our executives
with <FONT STYLE="white-space:nowrap">gross-up</FONT> protection for &#147;golden parachute&#148; excise taxes in any of these arrangements </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">A summary
of the terms of each of the arrangements we have with any Named Executive Officer who is currently employed by the Company and the potential value of the payments and benefits on termination of employment or change in control is provided in this
Proxy Statement under the headings &#147;Employment Arrangements&#148; and &#147;Payments on Termination or Change in Control.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Tax
Considerations</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In making compensation decisions affecting our executive officers, the Compensation Committee considers our ability to
deduct, under applicable federal corporate income tax law, compensation payments made to executives. Specifically, the Compensation Committee considers the requirements and impact of Section&nbsp;162(m) of the Internal Revenue Code (the
&#147;<B><I>Code</I></B>&#148;), which limits the tax deductibility to us of compensation in excess of $1.0&nbsp;million in any year for certain executive officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">For 2017 and prior years, Section&nbsp;162(m) included an exception from the deductibility limitation for qualified &#147;performance-based compensation.&#148; This exception, however, has been repealed by the Tax
Cuts and Jobs Act of 2017 for tax years beginning in 2018. As such, compensation paid to certain of our executive officers in excess of $1.0&nbsp;million will not be deductible unless it qualifies for certain transition relief applicable for
compensation paid pursuant to a written binding contract that was in effect as of November&nbsp;2, 2017. The Compensation Committee believes that stockholder interests are best served by not restricting the Compensation Committee&#146;s discretion
and flexibility in structuring compensation programs, even if such compensation results in <FONT STYLE="white-space:nowrap">non-deductible</FONT> expenses under applicable law. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Trading Policy</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">We maintain an Insider Trading and Trading Window Policy that, among
other things, prohibits our officers, including our Named Executive Officers, directors and employees from engaging in short sales, hedging of stock ownership positions and transactions involving derivative securities relating to our common stock.
The policy does not provide for exceptions from these rules. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Minimum Stock Ownership Requirements</I></B><B> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">There are no minimum stock ownership guidelines for our executives or employees, although senior members of our management team are encouraged and expected to have
a significant direct interest in the value of our common stock through the receipt of equity awards and/or open market purchases, as the case may be. We strive to design our compensation program to stress long-term ownership in Company equity as the
means of best aligning the interests of our executives with those of our stockholders. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">33 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Compensation Committee Report </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">The Compensation Committee has reviewed and discussed with management the Compensation Discussion and Analysis required by Item 402(b) of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT> Based on this review
and discussion, the Compensation Committee recommended to the Board that the foregoing Compensation Discussion and Analysis be included in this Proxy Statement. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:27.78em; text-indent:-1.11em"><FONT STYLE="font-family:ARIAL" SIZE="2">Submitted by the Compensation Committee</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:27.78em; text-indent:-1.11em"><FONT STYLE="font-family:ARIAL" SIZE="2">John Poyhonen, Chairman</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:27.78em; text-indent:-1.11em"><FONT STYLE="font-family:ARIAL" SIZE="2">Craig Johnson</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:27.78em; text-indent:-1.11em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kevin Tang</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">34 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Summary Compensation Table </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">The following tables and descriptive materials set forth information concerning compensation earned for services rendered to us by our Named Executive Officers during the years ended December&nbsp;31, 2018, 2017
and 2016. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Name and Principal Position</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Year</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Salary</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Option<BR>Awards<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive Plan<BR>Compensation<FONT
STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>All Other<BR>Compensation</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Total</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><U><I>Current Executive Officers:</I></U></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart,
Pharm.D.</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">614,414</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,815,660</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">552,973</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">8,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">5,991,297</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:ARIAL" SIZE="2">Current President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">596,518</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">3,391,524</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">246,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">8,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,243,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">579,143</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2,976,744</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">208,492</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">7,950</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">3,772,329</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly
Manhard</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">466,796</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,605,220</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">350,097</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">8,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2,430,363</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:ARIAL" SIZE="2">Executive Vice President</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">453,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,312,848</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">156,354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">8,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,930,502</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:ARIAL" SIZE="2">Drug Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">401,077</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">5,801,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">132,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">7,950</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">6,342,985</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert
Hoffman</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">357,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,139,706</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">214,463</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">8,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,719,634</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:ARIAL" SIZE="2">Chief Financial Officer and</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">235,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,972,207</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">68,425</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">3,635</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2,279,844</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:ARIAL" SIZE="2">Senior Vice President, Finance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><U><I>Former Executive Officer:</I></U></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert
Rosen</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">614,414</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,815,660</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">552,973</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">5,983,047</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:ARIAL" SIZE="2">Former President</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">596,518</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">3,391,524</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">246,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,235,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">579,143</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2,976,744</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">208,492</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">3,764,379</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">This column represents the aggregate grant date fair value, computed in accordance with Financial Accounting Standards Board (&#147;<B><I>FASB</I></B>&#148;)
Accounting Standard Codification (&#147;<B><I>ASC</I></B>&#148;) Topic 718 for stock options and awards granted to the Named Executive Officers in 2018, 2017 and 2016. Pursuant to SEC rules, the amounts shown exclude the impact of estimated
forfeitures related to service-based vesting conditions. The assumptions used in calculating the fair value of the stock options and awards can be found under Note 9 to the Financial Statements in our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2018. These amounts reflect the grant date fair value for these stock options and awards and do not necessarily correspond to the actual value that will be realized by the
Named Executive Officers. For additional information on stock options awarded to the Named Executive Officers in 2018 and in prior years, see below under &#147;Grants of Plan-based Awards&#148; and &#147;Outstanding Equity Awards at Fiscal <FONT
STYLE="white-space:nowrap">Year-End.&#148;</FONT> </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">The amounts listed for the named individuals represent cash awards earned for the year under the Company&#146;s annual cash incentive bonus program.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">The grant date fair value of the equity awards granted in 2018, as reflected under &#147;Option Awards,&#148; represents an annual grant for 2018 services
awarded in December 2018. &#147;All Other Compensation&#148; listed for 2018 represents our matching contributions on behalf of the named individuals to our 401(k) Plan. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">The grant date fair value of the equity awards granted in 2018, as reflected under &#147;Option Awards,&#148; represents an annual grant for 2018 services
awarded in December 2018. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">35 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Grants of Plan-based Awards Table </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">The following table sets forth certain information regarding grants of plan-based awards to the Named Executive Officers during the year ended December&nbsp;31, 2018: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Name</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Grant<BR>Date</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Estimated Future<BR>Payouts Under<BR><FONT
STYLE="white-space:nowrap">Non-Equity</FONT></B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Incentive Plan<BR>Awards<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>All
Other<BR>Option<BR>Awards:<BR>Number&nbsp;of<BR>Securities<BR>Underlying<BR>Options<BR>Granted</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Exercise<BR>Price of<BR>Option<BR>Awards<BR>($/Share)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B><FONT STYLE="white-space:nowrap">Grant-date</FONT><BR>Fair&nbsp;Value&nbsp;of<BR>Stock and<BR>Option<BR>Awards<FONT
STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD COLSPAN="4" VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Target</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Maximum</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><U><I>Current Executive Officers:</I></U></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart, Pharm.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/15/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">368,648</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">552,973</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">300,000</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">24.97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,815,660</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly Manhard</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/15/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">233,398</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">350,097</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">100,000</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">24.97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,605,220</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Hoffman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/15/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">142,975</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">214,463</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">71,000</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">24.97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,139,706</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><I><U>Former Executive Officer:</U></I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Rosen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/15/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">368,648</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">552,973</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">300,000</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">24.97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,815,660</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">This column reflects the target and maximum amounts payable for annual cash incentive bonuses. A minimum overall goal achievement of greater than or equal to 50%
is required for the Compensation Committee to determine that any amount is payable. The target annual cash incentive bonus can be earned if a goal achievement of 100% is obtained; for extraordinary performance in corporate goal achievement, up to
150% of the target annual cash incentive bonus for that goal could be awarded. The Compensation Committee determined that the corporate goal achievement was 150% for the year ended December&nbsp;31, 2018. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">This column reflects the aggregate grant date fair value of equity awards granted in 2018 and calculated in accordance with FASB ASC 718, excluding the effect of
estimated forfeitures. The assumptions used in calculating the fair value of the stock options and awards can be found under Note 9 to the Financial Statements in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year
ended December&nbsp;31, 2018. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Options vest monthly over a four-year period. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">36 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Outstanding Equity Awards as of December&nbsp;31, 2018 Table </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The following table sets forth information regarding outstanding equity awards held by our Named Executive Officers at December&nbsp;31, 2018: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="right" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Number of Securities<BR>Underlying Unexercised<BR>Options</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;border-bottom:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Equity&nbsp;Incentive<BR>Plan Awards:<BR>Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options (#)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;border-bottom:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Option<BR>Exercise<BR>Price ($)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;border-bottom:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Option<BR>Grant</B></FONT><br><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Date
</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;border-bottom:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Option<BR>Expiration<BR>Date</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Name</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Exercisable<BR>(#)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Unexercisable<BR>(#)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><U><I>Current Executive Officers:</I></U></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart, Pharm.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">37,091</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$12.60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">6/18/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">6/18/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">523,101</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">187,500&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$&nbsp;&nbsp;7.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">5/1/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">5/1/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">136,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151; </FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$&nbsp;&nbsp;9.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1/3/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1/3/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151; </FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$&nbsp;&nbsp;9.05</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/12/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/12/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">187,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">62,500&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$29.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/22/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/22/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">155,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">155,000&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$13.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/21/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/21/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">77,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">232,500&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$17.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/18/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/18/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">300,000&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$24.97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/15/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/15/2028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly Manhard</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$29.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/22/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/22/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">218,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">81,250&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$20.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">01/28/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">01/28/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">22,416</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">60,000&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$13.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/21/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/21/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">90,000&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$17.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/18/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/18/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">100,000&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$24.97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/15/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/15/2028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Hoffman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">24,167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">75,833&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$15.30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">04/24/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">04/24/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">14,167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">42,500&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$17.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/18/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/18/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">71,000&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$24.97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/15/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/15/2028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><U><I>Former Executive Officer:</I></U></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert
Rosen</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">31,392</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$13.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">7/30/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">7/30/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">94,036</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$12.40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">10/15/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">10/15/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">982</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$15.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2/8/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2/8/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">412,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">187,500&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$&nbsp;&nbsp;7.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">5/1/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">5/1/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">170,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151; </FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$&nbsp;&nbsp;9.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1/3/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1/3/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151; </FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$&nbsp;&nbsp;9.05</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/12/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/12/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">187,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">62,500&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$29.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/22/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/22/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">155,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">155,000&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$13.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/21/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/21/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">77,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">252,500&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$17.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/18/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/18/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">300,000&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$24.97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/15/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12/15/2028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">37 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Options vest with respect to the remaining 187,500 shares on achievement of certain performance goals. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Options vest monthly over a four-year period. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Options vest over four years, with 75,000 shares vesting on the first anniversary of Ms.&nbsp;Manhard&#146;s date of employment, and then with respect to the
remaining 225,000 shares on a ratable monthly basis over the next three years. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Options vest over four years, with 32,500 shares vesting on the first anniversary of Mr.&nbsp;Hoffman&#146;s date of employment, and then with respect to the
remaining 97,500 shares on a ratable monthly basis over the next three years. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Following Mr.&nbsp;Rosen&#146;s retirement in February 2019, Mr.&nbsp;Rosen was entitled to certain benefits equivalent to those set forth in Section&nbsp;4.4.2
of his employment agreement, as amended, which included accelerated time-based vesting of shares subject to all stock awards issued by the Company for the number of shares which would have vested accordingly had Mr.&nbsp;Rosen continued employment
with the Company for a period of 12 months after termination. Additionally, Mr.&nbsp;Rosen will remain eligible for vesting of certain performance-based stock options based on the achievement of a commercial milestone. Additionally, the Company has
agreed to provide a <FONT STYLE="white-space:nowrap">six-month</FONT> exercise period for Mr.&nbsp;Rosen&#146;s vested equity awards. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Option Exercises Table </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The following table provides
information regarding the number of shares of common stock acquired and the value realized pursuant to the exercise of stock options during 2018 by each of the Named Executive Officers. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Number&nbsp;of<BR>Shares&nbsp;Acquired<BR>on
Exercise</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>(#)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Value<BR>Realized&nbsp;on<BR>Exercise</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>($)(1)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><U><I>Current Executive Officers:</I></U></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart, Pharm.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">269,675</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">6,050,079</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly Manhard</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">37,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">624,560</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Hoffman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">686,229</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><U><I>Former Executive Officer:</I></U></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Rosen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">225,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">7,149,814</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Amounts shown do not reflect amounts actually received by the named individuals. The value realized on exercise is equal to the difference between the option
exercise price and the closing price of our common stock on the date of exercise, multiplied by the number of shares subject to the option exercise, regardless of whether the individual actually sold any of the shares received on exercise or the
amount received in connection with any such sale, and without taking into account any taxes that may be payable in connection with the transaction. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B><FONT STYLE="white-space:nowrap">Non-qualified</FONT> Defined Contribution and Other <FONT STYLE="white-space:nowrap">Non-qualified</FONT> Deferred Compensation Plans </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">We do not maintain either a <FONT STYLE="white-space:nowrap">non-qualified</FONT> defined contribution or <FONT STYLE="white-space:nowrap">non-qualified</FONT>
deferred compensation plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">38 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Potential Payments on Termination or Change in Control </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Employment Arrangements </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Below are descriptions of the
material terms of the employment arrangements entered into with our current Named Executive Officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Barry Quart, Pharm.D.</I></B><B>
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In connection with his appointment as Chief Executive Officer, the Company entered into an executive employment agreement with Barry Quart,
Pharm.D. on May&nbsp;1, 2013 (&#147;<B><I>Quart Agreement</I></B>&#148;). Certain provisions of the Quart Agreement were amended by the Compensation Committee in April 2015. The Quart Agreement initially provided Dr.&nbsp;Quart with a base salary of
$525,000 annually, which was raised to $540,750 annually for 2014, to $551,565 annually for 2015, to $579,143 annually for 2016, to $596,518 annually for 2017, to $614,414 annually for 2018 and to $638,991 annually for 2019. Dr.&nbsp;Quart was also
initially eligible for an annual target cash incentive bonus in an amount equal to 55% of his base salary, which was increased to 60% of his base salary effective beginning with the 2016 annual cash incentive bonus. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Additionally, the Quart Agreement, as amended, provides that if Dr.&nbsp;Quart&#146;s employment is terminated by the Company without &#147;Cause,&#148; or by
Dr.&nbsp;Quart for &#147;Good Reason&#148; (each as defined in the Quart Agreement), then he shall be entitled to receive: (i)&nbsp;a <FONT STYLE="white-space:nowrap">lump-sum</FONT> payment equal to the sum of his annual base salary then in effect
and his target performance bonus then in effect, less required deductions and withholdings; and (ii)&nbsp;accelerated time-based vesting of shares subject to all stock awards issued by the Company, for the number of shares that would have vested
accordingly had he continued employment with the Company for a period of 12 months after termination (which includes partial accelerated vesting of awards subject to time-vesting, but does not include awards that remain subject to performance
criteria as of the date of termination). The Company also agreed to reimburse for or continue to pay for health care benefits during the 18 months after the date of termination, or, if sooner, such date when he is no longer eligible for such
benefits under applicable law. Per the Quart Agreement, in the event Dr.&nbsp;Quart&#146;s employment is terminated by the Company without Cause, or if he resigns for Good Reason within three months before, or within 18 months following, a Change in
Control (as defined) of the Company, then, in lieu of the above benefits, Dr.&nbsp;Quart would be entitled to receive: (i)&nbsp;a lump sum payment equal to 150% of his annual base salary then in effect, less required deductions and withholdings; and
(ii)&nbsp;the greater of his target performance bonus then in effect, less required deductions and withholdings, or his performance bonus paid in the year preceding the year in which termination occurs, less required deductions and withholdings; and
(iii)&nbsp;reimbursement for or continued payment of health care benefits during the 18 months after the date of termination, or such earlier date when he is no longer eligible for such benefits under applicable law. In addition, on the closing of a
Change in Control transaction, Dr.&nbsp;Quart is entitled to immediate vesting of 100% of any outstanding and unvested performance-based equity awards and immediate vesting of 50% of any outstanding and unvested time-based equity awards. Following
the closing of any such Change in Control, the remaining 50% of time-based equity awards are eligible to vest on the earlier of (a)&nbsp;the executive&#146;s qualifying involuntary termination of employment or (b)&nbsp;six months following the
completion of the Change in Control subject to his voluntary continued employment through such date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Kimberly Manhard</I></B><B>
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In connection with her appointment as Executive Vice President, Drug Development on January&nbsp;28, 2016, the Company entered into an executive
employment agreement with Kimberly Manhard (&#147;<B><I>Manhard Agreement</I></B>&#148;). The Manhard Agreement </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">39 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
initially provided Ms.&nbsp;Manhard with a base salary of $440,000 annually, which was increased to $453,200 annually for 2017, to $466,796 annually for 2018 and to $490,136 annually for 2019.
Ms.&nbsp;Manhard is also eligible for an annual target incentive bonus in an amount equal to 50% of her base salary. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Additionally, the Manhard
Agreement provides that if Ms.&nbsp;Manhard&#146;s employment is terminated by the Company without &#147;Cause,&#148; (as defined in the Manhard Agreement), or by Ms.&nbsp;Manhard for &#147;Good Reason&#148; (as defined in the Manhard Agreement),
then she shall be entitled to receive: (i)&nbsp;a <FONT STYLE="white-space:nowrap">lump-sum</FONT> payment equal to the sum of her annual base salary then in effect and her target performance bonus then in effect, less required deductions and
withholdings; and (ii)&nbsp;accelerated time-based vesting of shares subject to all stock awards issued by the Company, for the number of shares which would have vested accordingly had she continued employment with the Company for a period of 12
months after termination. The Company also agreed to reimburse for, or continue to pay for, health care benefits during the 12 months after the date of termination, or such date when he is no longer eligible for such benefits under applicable law.
In the event Ms.&nbsp;Manhard&#146;s employment is terminated by the Company without Cause, or if she resigns for Good Reason within three months before, or within 18 months following, a Change in Control (as defined in the Manhard Agreement) of the
Company, then, in lieu of the above benefits, Ms.&nbsp;Manhard shall be entitled to receive: (i)&nbsp;a <FONT STYLE="white-space:nowrap">lump-sum</FONT> payment equal to her annual base salary then in effect, less required deductions and
withholdings; (ii)&nbsp;the greater of her target performance bonus then in effect, less required deductions and withholdings, or her performance bonus paid in the year preceding the year in which termination occurs, less required deductions and
withholdings; and (iii)&nbsp;accelerated vesting of 100% of any outstanding and unvested stock awards held by Ms.&nbsp;Manhard at such time (including both time-based and performance-based stock awards). The Company also agreed to reimburse for, or
continue to pay for, health care benefits during the 12 months after the date of termination following a Change in Control, or such date when she is no longer eligible for such benefits under applicable law. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Robert Hoffman</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In connection with his
appointment as Chief Financial Officer and Senior Vice President, Finance, the Company entered into an executive employment agreement with Robert Hoffman on April&nbsp;24, 2017 (&#147;<B><I>Hoffman</I></B> <B><I>Agreement</I></B>&#148;). The Hoffman
Agreement initially provided Mr.&nbsp;Hoffman with a base salary of $350,000 annually, which was increased to $357,438 annually for 2018 and to $388,714 annually for 2019. Mr.&nbsp;Hoffman is also eligible for an annual cash incentive bonus in an
amount equal to 40% of his base salary </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Additionally, the Hoffman Agreement provides that if Mr.&nbsp;Hoffman&#146;s employment is terminated by the
Company without &#147;Cause,&#148; (as defined in the Hoffman Agreement), or by Mr.&nbsp;Hoffman for &#147;Good Reason&#148; (as defined in the Hoffman Agreement), then he shall be entitled to receive: (i)&nbsp;a
<FONT STYLE="white-space:nowrap">lump-sum</FONT> payment equal to the sum of his annual base salary then in effect and his target performance bonus then in effect, less required deductions and withholdings; and (ii)&nbsp;accelerated time-based
vesting of shares subject to all stock awards issued by the Company, for the number of shares which would have vested accordingly had he continued employment with the Company for a period of 12 months after termination. The Company also agreed to
reimburse for, or continue to pay for, health care benefits during the 12 months after the date of termination, or such date when he is no longer eligible for such benefits under applicable law. In the event Mr.&nbsp;Hoffman&#146;s employment is
terminated by the Company without Cause, or if he resigns for Good Reason within three months before, or within 18 months following, a Change in Control (as defined in the Hoffman Agreement) of the Company, then, in lieu of the above benefits,
Mr.&nbsp;Hoffman shall be entitled to receive: (i)&nbsp;a <FONT STYLE="white-space:nowrap">lump-sum</FONT> payment equal to his annual base salary then in effect, less required deductions and </FONT></P>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">40 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
withholdings; (ii)&nbsp;the greater of his target performance bonus then in effect, less required deductions and withholdings, or his performance bonus paid in the year preceding the year in
which termination occurs, less required deductions and withholdings; and (iii)&nbsp;accelerated vesting of 100% of any outstanding and unvested stock awards held by Mr.&nbsp;Hoffman at such time (including both time-based and performance-based stock
awards). The Company also agreed to reimburse for, or continue to pay for, health care benefits during the 12 months after the date of termination following a Change in Control, or such date when he is no longer eligible for such benefits under
applicable law. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The descriptions of executive employment agreements provided above under the heading &#147;Employment Arrangements&#148; set forth the
potential payments on termination or change in control for our current Named Executive Officers. The following table sets forth information regarding potential payments that would have been made to our Named Executive Officers Dr.&nbsp;Quart,
Ms.&nbsp;Manhard and Mr.&nbsp;Hoffman on various termination or change in control events assuming such events occurred as of December&nbsp;31, 2018. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Termination<BR>Without</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Cause&nbsp;or<BR>With&nbsp;Good</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Reason</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Termination&nbsp;Without<BR>Cause or With&nbsp;Good<BR>Reason Within<BR>Three Months<BR>Before or 18<BR>Months After
a<BR>Change in Control</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Change in<BR>Control<BR>(absent a<BR>qualifying<BR>termination)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart, Pharm.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top">
<P STYLE="margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Severance</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,022,385</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,341,880</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"> &#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Benefit continuation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">39,531</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">39,531</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Accelerated vesting of stock awards</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,768,450</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">7,889,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">7,889,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2,830,366</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">9,270,411</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">7,889,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly Manhard</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top">
<P STYLE="margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Severance</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"> 735,204</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"> 735,204</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"> &#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Benefit continuation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">37,752</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">37,752</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Accelerated vesting of stock awards</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,074,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2,104,563</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,847,356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2,877,519</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"> &#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Hoffman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top">
<P STYLE="margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Severance</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">544,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"> 544,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"> &#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Benefit continuation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">37,752</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">37,752</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Accelerated vesting of stock awards</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">489,670</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,255,683</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,071,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,837,635</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"> &#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">The severance amount includes salary and cash bonus payouts, based on the terms of the Named Executive Officer&#146;s executive employment agreement.
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">41 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Represents the value of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">in-the-money</FONT></FONT> unvested stock options that would have
accelerated if the Named Executive Officer was terminated on December&nbsp;31, 2018 based on the difference between the closing price of our common stock of $25.94 on December&nbsp;31, 2018 and the exercise price of the respective options.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Robert Rosen</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">Following Mr.&nbsp;Rosen&#146;s retirement in February 2019, Mr.&nbsp;Rosen was entitled to certain benefits equivalent to those set forth in Section&nbsp;4.4.2 of his employment agreement, as amended.
Additionally, Mr.&nbsp;Rosen remains eligible for vesting of certain performance-based stock options based on the achievement of a commercial milestone. Additionally, the Company has agreed to provide a
<FONT STYLE="white-space:nowrap">six-month</FONT> exercise period for Mr.&nbsp;Rosen&#146;s vested equity awards. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>CEO Pay Ratio </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">As required in Item 402(u) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Exchange Act, the Company must disclose the ratio of the annual
total compensation of the Chief Executive Officer (&#147;<B><I>CEO</I></B>&#148;) to that of the median-paid employee (&#147;<B><I>CEO Pay Ratio</I></B>&#148;). Annual total compensation consists of base salary, annual cash incentive bonus,
grant-date fair value of equity awards and all other compensation earned. For the year ended December&nbsp;31, 2018: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">the annual total compensation of the median-paid employee was $418,130; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">the annual total compensation of Barry Quart, Pharm.D., our CEO, was $5,991,297. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">The CEO Pay Ratio was 14 to 1. The CEO Pay Ratio is a reasonable estimate calculated in a manner consistent with Item 402(u) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Exchange Act. For the
year ended December&nbsp;31, 2018, the Company experienced an increase in its employee population of approximately 38% that we believe would result in a significant change to the Company&#146;s prior year CEO Pay Ratio. As a result, we identified a
new median-paid employee for fiscal year 2018 based on the Company&#146;s employee population as of December&nbsp;3, 2018, which was the date the Company hired its last new employee in 2018. To identify the median-paid employee, we calculated the
annual compensation of each of the 187 employees who were employed as of December&nbsp;3, 2018, excluding the CEO, as the sum of: (1)&nbsp;base salary earned in 2018, which is either the annual salary for salaried employees or the estimated annual
salary for hourly employees; (2)&nbsp;annual cash incentive bonus earned in 2018; and (3)&nbsp;grant-date fair value of equity awards granted in 2018, computed in accordance with ASC Topic 718. Retirement and other benefits were not included in this
calculation. We then selected the employee who was at the median of this population, whose annual total compensation is reflected above to calculate the CEO Pay Ratio. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">42 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">CEO Pay Ratios for those of our peer companies who have disclosed them as of April&nbsp;22, 2019 are set forth in
the table below. The average CEO Pay Ratio for our peer companies listed below is 27:1. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="45%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Peer Company</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Reported&nbsp;CEO&nbsp;Pay&nbsp;Ratio&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Amicus Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">49:1</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Supernus Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">43:1</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Pacira BioSciences, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">33:1</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">The Medicines Company</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">33:1</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Momenta Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">30:1</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Halozyme Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">29:1</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Intercept Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">28:1</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Array Biopharma Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">27:1</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Ironwood Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">26:1</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Agios Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">24:1</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">PTC Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">18:1</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">TESARO, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">17:1</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Ultragenyx Pharmaceutical, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">17:1</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Heron Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">14:1</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Corcept Therapeutics Incorporated</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">9:1</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Director Compensation </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Our
employee directors do not receive any compensation for their service as members of our Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:ARIAL" SIZE="2">In 2018, the Board engaged Compensia
to conduct an assessment of our Board compensation program as compared to the same peer group used for purposes of reviewing our executive compensation program. The annual cash retainer paid to <FONT STYLE="white-space:nowrap">non-employee</FONT>
members of our Board for general service approximates the 50</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2"> percentile of
our peer companies and equity-based compensation approximates the 75</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">
percentile of our peer companies. Our Board compensation program differs from many peer companies in that pay for participating on committees of the Board is provided solely through stock option grants instead of cash retainers. The use of stock
option grants further enhances our <FONT STYLE="white-space:nowrap">non-employee</FONT> Board members&#146; long-term equity stake in the Company. Moreover, because the realization of financial gain from stock option grants is conditioned on the
continued increase of the price of the Company&#146;s common stock, the Company believes that stock option grants encourage our directors to engage in behaviors and implement initiatives that lead to long-term value creation that benefits all of the
Company&#146;s stockholders. Our average total direct compensation per director, including remunerations for committee service, approximates the 50</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2"> percentile. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Board approved
the following compensation for <FONT STYLE="white-space:nowrap">non-employee</FONT> directors: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Cash Compensation </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Annual Board Cash Retainer (paid in quarterly installments)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Monthly Pain Committee Retainer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">43 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Equity-Based Compensation (shares underlying options) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Board Grants</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Shares&nbsp;(#)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Initial Option
Grant</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Annual Option
Grant</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Committee
Grants<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Shares&nbsp;(#)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Audit Committee Chair</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">5,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Audit Committee Member <FONT STYLE="white-space:nowrap">(non-chair)</FONT></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">3,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Compensation Committee Chair</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Compensation Committee Member <FONT STYLE="white-space:nowrap">(non-chair)</FONT></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Governance Committee Chair</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Governance Committee Member <FONT STYLE="white-space:nowrap">(non-chair)</FONT></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Special
Grants<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Shares&nbsp;(#)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Pain Committee Chair</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Options vest and become exercisable monthly over a four-year period from the date of grant. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Options vest and become exercisable monthly over a <FONT STYLE="white-space:nowrap">12-month</FONT> period from the date of grant. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors receive an initial committee grant, as well as an annual committee grant. Both grants are
based on the amounts listed above in the table. The initial committee option grants vest and become exercisable monthly over a four-year period from the date of grant. The annual committee option grants vest and become exercisable monthly over a <FONT
STYLE="white-space:nowrap">12-month</FONT> period from the date of grant. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Options vest and become exercisable with respect to all of the underlying shares on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the date
of grant. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The following table includes compensation for services provided by our <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors for the year ended December&nbsp;31, 2018: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Directors<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></B></FONT>
</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Fees<BR>Earned</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Option<BR>Awards<FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Total</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Craig Johnson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">315,594</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">365,594</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Christian Waage</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">255,481</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">305,481</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">John
Poyhonen</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">62,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">748,812</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">811,312</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kevin
Tang</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"> &#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">255,481</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">255,481</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">The aggregate number of shares subject to outstanding stock options held by each director listed in the table above as of December&nbsp;31, 2018 was as follows:
183,500 shares for Mr.&nbsp;Johnson, 77,125 shares for Mr.&nbsp;Waage, 159,500 shares for Mr.&nbsp;Poyhonen and 159,500 shares for Mr.&nbsp;Tang. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">44 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">This column reflects the aggregate grant date fair value of equity awards granted in 2018 and calculated in accordance with FASB ASC 718, excluding the effect of
estimated forfeitures. The assumptions used in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2018. The &#147;Option Awards&#148; column includes the grant date fair value of the awards
granted on December&nbsp;15, 2018 for 2019 board service. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Mr.&nbsp;Poyhonen was appointed to the Pain Committee in December 2018. The amount included in &#147;Fees Earned&#148; represents the annual board retainer for
2018 services as a director and the monthly Pain Committee retainer. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Mr.&nbsp;Tang waived receipt of all annual retainers for the year ended December&nbsp;31, 2018. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Equity-Based Compensation Plan Information </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The table below
discloses information as of December&nbsp;31, 2018 with respect to our equity-based compensation plans that have been approved by stockholders and equity-based compensation plans that have not been approved by stockholders. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Plan Category</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Number of<BR>Securities<BR>to<BR>be Issued<BR>upon<BR>Exercise<BR>of<BR>Outstanding<BR>Options&nbsp;(a)</B></FONT></TD>

<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Weighted-<BR>Average<BR>Exercise<BR>Price of<BR>Outstanding<BR>Options&nbsp;(b)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Number of<BR>Securities<BR>Remaining<BR>Available
for<BR>Future</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Issuance</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>under<BR>Equity-Based<BR>Compensation<BR>Plans</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>(Excluding<BR>Securities<BR>Reflected<BR>in&nbsp;Column&nbsp;(a))(c)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Equity-based compensation plans approved by security holders:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Stock option and award plans</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">13,476,317</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$19.72</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,354,280</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Employee stock purchase plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">195,818</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Equity-based compensation plans not approved by security holders</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,788,290</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$&nbsp;&nbsp;7.89</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">15,264,607</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">$18.33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,550,098</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2"><FONT STYLE="white-space:nowrap">Non-qualified</FONT> options issued outside of the stockholder approved equity plans are governed in all respects by
terms as if granted under the Amended and Restated 2007 Equity Incentive Plan. See description of the stock option plans under Note 9 to the Financial Statements in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year
ended December&nbsp;31, 2018. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">45 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>REPORT OF THE AUDIT COMMITTEE </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">The Audit Committee oversaw our accounting and financial reporting processes during the year ended December&nbsp;31, 2018, as well as the audit of the Company&#146;s financial statements for the year ended
December&nbsp;31, 2018. In addition, the Audit Committee was responsible for evaluating and overseeing the Company&#146;s independent registered public accounting firm. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">The Audit Committee evaluates auditor performance, manages relations with the Company&#146;s independent registered public accounting firm and evaluates policies and procedures relating to internal control systems.
The Audit Committee operates under a written Audit Committee Charter that has been adopted by the Board, a copy of which is available on the Company&#146;s website at <I><U>www.herontx.com</U></I>. The current members of the Audit Committee meet the
independence and qualification standards for Audit Committee membership set forth in the listing standards provided by Nasdaq and the SEC. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The
members&#146; functions are not intended to duplicate or to certify the activities of management and the independent registered public accounting firm. The Audit Committee serves a board-level oversight role that provides advice, counsel and
direction to management and the auditors on the basis of the information it receives, discussions with management and the auditors and the experience of the Audit Committee&#146;s members in business, financial and accounting matters. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Audit Committee oversees the Company&#146;s financial reporting process on behalf of the Board. The Company&#146;s management has the primary responsibility
for the financial statements and reporting process, including the Company&#146;s system of internal controls over financial reporting. In fulfilling its oversight responsibilities, the Audit Committee reviewed with management the audited financial
statements included in the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2018. This review included a discussion of the quality and the acceptability of the Company&#146;s financial
reporting, including the nature and extent of disclosures in the financial statements and the accompanying notes. The Audit Committee also reviewed the progress and results of the testing of the design and effectiveness of its internal controls over
financial reporting pursuant to Section&nbsp;404 of the Sarbanes-Oxley Act of 2002. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Audit Committee also reviewed with the Company&#146;s
independent registered public accounting firm, which is responsible for expressing an opinion on the conformity of the audited financial statements with accounting principles generally accepted in the United States of America, their judgments as to
the quality and the acceptability of the Company&#146;s financial reporting and such other matters as are required to be discussed with the Audit Committee under generally accepted auditing standards and applicable Public Company Accounting
Oversight Board standards. The Audit Committee has received the written disclosures and the letter from the independent registered public accounting firm required by the Public Company Accounting Oversight Board regarding the independent registered
public accounting firm&#146;s communications with the Audit Committee concerning independence. The Audit Committee discussed with the independent registered public accounting firm their independence from management and the Company and any additional
matters required by the applicable rules of the Public Company Accounting Oversight Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In addition to the matters specified above, the Audit
Committee discussed with the Company&#146;s independent registered public accounting firm the overall scope, plans and estimated costs of their audit. The Audit Committee meets with the independent registered public accounting firm periodically,
with and without management present, to discuss the results of the independent registered public accounting firm&#146;s examinations, the overall quality of the Company&#146;s financial reporting and the independent registered public accounting
firm&#146;s reviews of the quarterly financial statements, and drafts of the quarterly and annual reports. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">46 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Based on the reviews, discussions, and written disclosures, referred to above, the Audit Committee recommended to
the Board that the Company&#146;s audited financial statements should be included in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2018. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Craig Johnson, Chairman </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">John Poyhonen </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Christian Waage </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">47 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>PRINCIPAL ACCOUNTANT FEES AND SERVICES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">The following table shows the aggregate fees for services rendered in or provided for 2018 and 2017, as applicable, by OUM&nbsp;&amp; Co. LLP, our independent registered public accounting firm
(&#147;<B><I>OUM</I></B>&#148;). </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>2018</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>2017</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Audit
fees</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">398,518</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">296,920</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Audit-related
fees</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">120,480</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">156,023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Tax
fees</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">52,695</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">39,820</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">All other fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">571,693</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">492,763</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:2px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:2px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:2px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:2px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">The Audit fees were for professional services rendered in connection with the audit of our annual financial statements and internal control over financial
reporting and for the review of the quarterly financial statements. The amounts also include fees for services that are normally provided by the auditor in connection with regulatory filings and engagements for the years identified.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">The Audit-related fees for both 2018 and 2017 include fees for procedures performed during that year in connection with registration statements on Forms <FONT
STYLE="white-space:nowrap">S-3</FONT> and <FONT STYLE="white-space:nowrap">S-8.</FONT> </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:ARIAL" SIZE="2">Tax fees consist of fees for tax compliance. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Audit Committee reviews and <FONT STYLE="white-space:nowrap">pre-approves</FONT> all audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services
performed by its independent registered public accounting firm, as well as the fees charged for such services, in accordance with the <FONT STYLE="white-space:nowrap">pre-approval</FONT> policies and procedures that have been established by the
Audit Committee. All fees incurred in the year ended December&nbsp;31, 2018 for services rendered by OUM were approved by the Audit Committee. In its review of <FONT STYLE="white-space:nowrap">non-audit</FONT> service fees, the Audit Committee will
consider, among other things, the possible impact of the performance of such services on the auditor&#146;s independence. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">48 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>PROPOSAL 1 &#151; ELECTION OF DIRECTORS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">At the Annual Meeting, the stockholders will vote to elect five director nominees to serve until the next Annual Meeting of Stockholders and until their successors are elected and qualified. Our Board has
unanimously nominated Dr.&nbsp;Quart and Messrs. Tang, Johnson, Poyhonen and Waage for election to our Board. The nominees have indicated that they are willing and able to serve as directors. If any of these individuals becomes unable or unwilling
to serve, the accompanying proxy may be voted for the election of such other person as shall be designated by our Board or the Board may decrease the size of the Board. The proxies being solicited will be voted for no more than five nominees at the
Annual Meeting. The directors will be elected by a majority of all votes properly cast, in person or by proxy, at the Annual Meeting, assuming a quorum is present. Stockholders do not have cumulative voting rights in the election of directors.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>The Board of Directors recommends a vote &#147;FOR&#148; each of the director nominees. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Unless otherwise instructed, it is the intention of the persons named in the accompanying proxy card to vote shares represented by properly executed proxy cards
for the election of Dr.&nbsp;Quart and Messrs. Tang, Johnson, Poyhonen and Waage. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>PROPOSAL 2 &#151; RATIFICATION OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Our Audit Committee has selected OUM&nbsp;&amp; Co. LLP as our independent registered public accounting firm for the year ending
December&nbsp;31, 2019. At the Annual Meeting, the stockholders will vote to ratify the appointment of OUM&nbsp;&amp; Co. LLP as our independent registered public accounting firm for the year ending December&nbsp;31, 2019. OUM&nbsp;&amp; Co. LLP has
audited our financial statements since 2006. Representatives of OUM&nbsp;&amp; Co. LLP are expected to be present at the Annual Meeting and will have the opportunity to make statements if they desire to do so. Such representatives are also expected
to be available to respond to appropriate questions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Stockholder ratification of the selection of OUM&nbsp;&amp; Co. LLP as our independent registered
public accounting firm is not required by law or our bylaws. However, our Audit Committee is submitting the selection of OUM&nbsp;&amp; Co. LLP to the stockholders for ratification as a matter of good corporate practice. In the event our
stockholders fail to ratify the appointment, our Audit Committee will reconsider its selection. Even if the selection is ratified, our Audit Committee, in its discretion, may direct the selection of a different independent registered public
accounting firm at any time during the year if they determine that such a change would be in our best interest and that of our stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>The
Board of Directors recommends a vote &#147;FOR&#148; the ratification of the appointment of OUM&nbsp;&amp; Co. LLP as our independent registered public accounting firm for the year ending December&nbsp;31, 2019. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">49 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>PROPOSAL 3 &#151; ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">At the Annual Meeting, the stockholders will vote, on a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory basis, to approve the Company&#146;s
executive compensation on an advisory basis in accordance with Section&nbsp;14A of the Exchange Act (the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay&#148;</FONT></FONT> vote). The
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> vote is an advisory vote on the compensation of our Named Executive Officers, as such compensation is disclosed pursuant to Item 402 of Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT> in this Proxy Statement. The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> vote is not a vote on the Company&#146;s general compensation policies, compensation of the
Company&#146;s Board or the Company&#146;s compensation policies as they relate to risk management. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">We conducted our first <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> vote at our 2013 Annual Meeting of Stockholders. At that meeting, we also conducted our first
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-frequency</FONT></FONT> vote with respect to whether future <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> votes would be held every
one, two or three years. At the 2013 Annual Meeting of Stockholders, a plurality of the votes cast selected one year as the frequency period. Accordingly, we are conducting a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> vote and our second <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-frequency</FONT></FONT> vote at the 2019 Annual Meeting of
Stockholders with respect to whether future <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> votes will be held every one, two or three years. The Board will consider such advisory vote when determining
whether we continue to conduct an advisory vote to approve the compensation of our Named Executive Officers annually. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The compensation paid to our
Named Executive Officers is described in the Compensation Discussion and Analysis, the compensation tables and the related narrative disclosure contained in this Proxy Statement. Pursuant to Section&nbsp;14A of the Exchange Act, the Board is asking
stockholders to cast a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory vote &#147;FOR&#148; the following resolution: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">&#147;RESOLVED, that
the compensation paid to the Company&#146;s Named Executive Officers, as described in the Compensation Discussion and Analysis section, the tabular disclosure regarding such compensation and the accompanying narrative disclosure, set forth in the
Company&#146;s definitive Proxy Statement for the 2019 Annual Meeting of Stockholders is hereby approved.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Although this vote is <FONT
STYLE="white-space:nowrap">non-binding,</FONT> the Board values the views of our stockholders and will consider the outcome of the vote when determining future compensation arrangements for our Named Executive Officers. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>The Board of Directors recommends a vote &#147;FOR&#148; approval of the compensation paid to our Named Executive Officers for the year ended December&nbsp;31,
2018. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">50 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>PROPOSAL 4 &#151; ADVISORY VOTE TO APPROVE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In accordance with Section&nbsp;14A of the Exchange Act, stockholders will vote, on a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory
basis, to approve the frequency of future <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> advisory votes. Specifically, stockholders may vote on whether to hold <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">say-on-pay</FONT></FONT> advisory votes every one, two or three years. Alternatively, you may indicate that you are abstaining from voting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">&#147;RESOLVED, that the stockholders of the Company recommend, in a <FONT STYLE="white-space:nowrap">non-binding</FONT> vote, whether an advisory vote to approve the compensation of the Company&#146;s Named
Executive Officers should occur every one, two or three years.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Board has given careful consideration to the preferred frequency of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> advisory votes. After considering the benefits and consequences of available options, the Board believes that <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">say-on-pay</FONT></FONT> advisory votes should continue to be held annually to give stockholders the opportunity to provide regular input on our executive compensation programs and to provide the Board with timely feedback
from our stockholders on this important matter. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Although this vote is not binding on the Board, the Board will review and carefully consider this vote
when making its determination as to the frequency of future <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> advisory votes and expects to be guided by the frequency that received the greatest number of
votes, even if that alternative does not receive a majority of votes cast. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>The Board of Directors recommends that stockholders select every
&#147;One Year&#148; for the frequency of future advisory votes to approve compensation paid to our Named Executive Officers. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">51 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>PROPOSAL 5 &#151; AMENDMENT OF OUR 2007 PLAN </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>General </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">At the Annual Meeting, stockholders will vote to approve an amendment to our 2007 Plan to increase
the number of shares of common stock authorized for issuance thereunder from 18,800,000 to 25,800,000 and to approve a limit on the compensation payable to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors pursuant to the 2007 Plan.
Such amendment will require the affirmative vote of a majority of the votes cast at the meeting, provided a quorum is established. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Our 2007 Plan
provides long-term incentives to our employees, consultants and directors in order to encourage such award recipients to act in the stockholders&#146; interest and share in the Company&#146;s future success. Subject to stockholder approval, our
Compensation Committee has approved the amendment to the 2007 Plan to increase the number of shares of common stock available for future grant thereunder by 7,000,000 and to impose a limit on the compensation payable to our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors pursuant to the 2007 Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Reasons for Seeking Stockholder Approval </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Board believes that equity-based compensation is a critical part of the Company&#146;s compensation program. Our 2007 Plan is overseen by the Compensation
Committee of the Board as the delegate administrator. Stockholder approval of the 2007 Plan share increase would allow us greater flexibility to continue to attract and retain directors, officers and other key personnel through equity-based
compensation. In 2016, 2017 and 2018, the Company granted equity awards totaling 4,920,661, 4,300,621 and 4,052,011 shares of common stock under the 2007 Plan, respectively. The equity award grants in 2016 include one set of annual grants and one
set of special <FONT STYLE="white-space:nowrap">one-time</FONT> retention grants for all <FONT STYLE="white-space:nowrap">non-executive</FONT> officer employees. The equity award grants in 2017 and 2018 each include one set of annual grants. The
footnotes to the Company&#146;s financial statements in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for each of 2016, 2017 and 2018 set forth detailed information regarding the equity awards granted each year, as well as
the total number of outstanding shares with respect to each type of award. As of March&nbsp;31, 2019, the total number of shares of common stock available for future grants under the 2007 Plan was 1,605,911, and the total number of shares of common
stock subject to outstanding awards under the 2007 Plan is 13,044,163. In addition, we granted <FONT STYLE="white-space:nowrap">non-2007</FONT> Plan equity award grants to certain executives and employees during 2012, 2013 and 2014. As of
March&nbsp;31, 2019, the total number of shares outstanding of <FONT STYLE="white-space:nowrap">non-2007</FONT> Plan equity awards was 1,236,346. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">52 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The following table includes information regarding potential dilution from equity awards outstanding under the
2007 Plan and shares of common stock available for future grant under the 2007 Plan as of March&nbsp;31, 2019, outstanding <FONT STYLE="white-space:nowrap">non-2007</FONT> Plan equity awards, as well as the proposed increase in shares of common
stock available for future grant under the 2007 Plan: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Number&nbsp;of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>shares</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>As&nbsp;a&nbsp;percentage</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>of&nbsp;common&nbsp;stock<BR>outstanding&nbsp;as&nbsp;of<BR>March&nbsp;31,&nbsp;2019<BR>(78,906,156&nbsp;shares)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Total shares of common stock subject to outstanding awards as of March&nbsp;31, 2019 under the 2007 Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">13,044,163</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">16.5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Total shares of common stock available for future grant as of March&nbsp;31, 2019 under the 2007 Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,605,911</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Total shares of common stock subject to outstanding awards as of March&nbsp;31, 2019 not under the 2007 Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,236,346</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Proposed additional shares of common stock available for future grant under the 2007 Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">7,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">8.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In addition to overall dilution, the Compensation Committee reviewed annual dilution from the Company&#146;s equity incentive plans
during 2018 in approving the amendment to the 2007 Plan. The Company measures annual dilution as: (i)&nbsp;the total number of shares of common stock granted as equity awards during the year; less (ii)&nbsp;cancellations and other shares returned to
the reserve; divided by (iii)&nbsp;total shares of common stock outstanding at the end of the year. The Company&#146;s annual dilution for 2018 calculated on this basis was 4.3%. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">The Company also monitors stockholder dilution by tracking the number of shares common stock subject to equity awards that it grants annually, commonly referred to as &#147;burn rate.&#148; Burn rate shows how
rapidly a company is depleting its shares reserved for equity-based compensation awards, and is calculated as: (i)&nbsp;the number of shares of common stock granted as equity awards; divided by (ii)&nbsp;the weighted average number of shares of
common stock outstanding during the year. The Company also evaluates and considers factors that may impact the burn rate. Such factors include significant new hires and special <FONT STYLE="white-space:nowrap">one-time</FONT> retention grants, such
as in 2016. The Company has calculated the burn rate for the past three years in the following table: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Equity<BR>Awards<BR>Granted</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Weighted&nbsp;Average<BR>Number&nbsp;of&nbsp;Shares&nbsp;of<BR>Common Stock<BR>Outstanding</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Burn&nbsp;Rate</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">2018</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,052,011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">73,192,790</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">2017</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,300,621</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">54,040,345</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">8.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">2016</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">4,920,661</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">37,924,747</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">13.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">53 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The three-year average burn rate (calculated on the basis shown above) is 8.0%. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">An additional metric that the Company uses to measure the cumulative impact of its equity program is &#147;overhang.&#148; Overhang is calculated as: (i)&nbsp;the
number of shares of common stock granted as equity awards, but not exercised or settled; plus (ii)&nbsp;the number of shares of common stock available to be granted; divided by (iii)&nbsp;the sum of the total number of shares of common stock
outstanding at the end of the year; plus (iv)&nbsp;the number of shares of common stock granted as equity awards, but not exercised or settled; plus (v)&nbsp;the number of shares of common stock available for future grant. If the proposed amendment
to the 2007 Plan is approved, the Company&#146;s overhang calculated on this basis would increase from 15.9% to 21.8%, and then would be expected to decline as awards are exercised and/or become vested. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Company estimates that the increased number of shares of common stock available for future grant requested under this proposal would enable the Company to hire
additional personnel supporting the commercialization of <FONT STYLE="white-space:nowrap">HTX-011</FONT> (if approved by the FDA) and continue to grant equity awards at historical average annual burn and overhang rates for the next year. In
approving the increase, the Compensation Committee has determined that reserving shares of common stock for future grant sufficient for an additional two years of new equity awards is appropriate for our industry and consistent with the practices of
our peer companies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">If stockholders do not approve this proposal, the Company can continue to make awards under the 2007 Plan, but the Company will
have limited shares of common stock available for future grants, which may significantly negatively affect our ability to grow our business by not providing equity-based compensation to attract and retain key employees. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Summary of the 2007 Plan </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>General.</I>&nbsp;A copy of
the 2007 Plan, as amended and restated, is attached to this Proxy Statement as Exhibit A. The following description of the 2007 Plan is a summary and so is qualified by reference to the complete text of the 2007 Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The purpose of the 2007 Plan is to encourage ownership in the Company by key personnel whose long-term employment or other service relationship with the Company is
considered essential to the Company&#146;s continued progress and, thereby, encourage recipients to act in the stockholders&#146; interest and share in the Company&#146;s success. Stock options and stock awards, including restricted stock,
restricted stock units, stock appreciation rights and similar types of awards, may be granted under the 2007 Plan. Options granted under the 2007 Plan may be either &#147;incentive stock options,&#148; as defined in Section&nbsp;422 of the Code, or <FONT
STYLE="white-space:nowrap">non-statutory</FONT> stock options. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Administration.</I>&nbsp;The 2007 Plan may be administered by our Board, a committee
of our Board, or an employee or director delegated by our Board or our Board committee in accordance with the terms of the 2007 Plan (as applicable, the &#147;<B><I>Administrator</I></B>&#148;). Our Board has delegated this authority to our
Compensation Committee. The Administrator has the authority to, among other things, select the employees, consultants and directors to whom awards are granted under the 2007 Plan; determine the number of shares of common stock to be covered by each
award; determine the type of award granted to the selected employees, consultants and directors; determine the terms and conditions, not inconsistent with the terms of the 2007 Plan, of any award; and to construe and interpret the terms of the 2007
Plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">54 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Eligibility.</I>&nbsp;Awards may be granted under the 2007 Plan to employees, including our officers,
directors and consultants of the Company or our affiliates. Incentive stock options may be granted only to our employees or employees of our subsidiaries, if any. As of March&nbsp;31, 2019, 214 individuals were eligible to receive awards under the
2007 Plan, including 207 employees, three executive officers and four directors. The Administrator, in its discretion, selects the employees, directors and consultants to whom awards may be granted, the time or times at which such awards are
granted, and the terms of such awards. However, no individual may be granted equity awards under the 2007 Plan covering more than 50% of the number of shares authorized for issuance under the 2007 Plan (<I>i.e.</I>, 9,400,000 shares prior to the
adoption of the amendment) in any calendar year, except that in connection with an individual&#146;s commencement of service with us, he or she may be granted awards covering up to an additional 200,000 shares in the year in which such service
commences. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Securities Subject to the 2007 Plan.</I>&nbsp;If the amendment is approved, an aggregate of 25,800,000 shares of common stock will be
reserved for issuance under the 2007 Plan. As of March&nbsp;29, 2019, the closing price of our common stock was $24.44 per share. Unissued shares subject to awards that are canceled, expire or are forfeited will be available for <FONT
STYLE="white-space:nowrap">re-grant</FONT> or sale under the 2007 Plan. In addition, if an awardee pays the exercise or purchase price of an award through the tendering or withholding of shares or if award shares are withheld or tendered to satisfy
applicable withholding obligations, the number of shares tendered or withheld shall become available for <FONT STYLE="white-space:nowrap">re-issuance</FONT> under the 2007 Plan. Shares available under the plan may be either outstanding shares
repurchased by the Company or newly issued shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Director Awards</I>. The aggregate dollar value of cash compensation and awards (based on the
grant date fair value of such awards) granted under the 2007 Plan or otherwise during any calendar year to any one <FONT STYLE="white-space:nowrap">non-employee</FONT> director shall not exceed $750,000. However, in any calendar year in which a <FONT
STYLE="white-space:nowrap">non-employee</FONT> director first joins the Board or is designated as Chairman of the Board, the maximum aggregate dollar value of equity-based and cash compensation granted to the
<FONT STYLE="white-space:nowrap">non-employee</FONT> director may be up to two hundred percent (200%) of the foregoing limit. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Terms and Conditions
of Options.</I>&nbsp;Each option is evidenced by a stock option agreement between us and the optionee specifying: (i)&nbsp;the number of shares subject to the option; (ii)&nbsp;the type of option; (iii)&nbsp;the exercise price with respect to the
shares subject to the option and the means of payment for the shares; (iv)&nbsp;the term of the option;, (v)&nbsp;the terms and conditions relating to the vesting and exercisability of the option; (vi)&nbsp;restrictions on transfer of the option or
the shares subject to the option and forfeiture provisions; and (vii)&nbsp;such further terms and conditions, in each case not inconsistent with the 2007 Plan, as may be determined from time to time by the Administrator, and is subject to the
following additional terms and conditions: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Exercise Price.</I>&nbsp;The Administrator determines the exercise price of options at the time the
options are granted. The exercise price of an incentive stock option or a <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock option may not be less than 100% of the fair market value of the common stock on the date the option is granted and
the exercise price of an incentive stock option granted to an employee who holds more than 10% of our voting stock may not be less than 110% of the fair market value of the common stock on the date the option is granted. The fair market value of the
common stock is generally equal to the closing price for the shares as quoted on the principal exchange or quotation service for our common stock as of the applicable date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><I>Exercise of Option; Form of Consideration.</I>&nbsp;The Administrator determines when options vest and become exercisable and in its discretion may accelerate the vesting of any outstanding option. Our standard
vesting schedule applicable to options granted to employees has been a four-year period from the date of grant or the date of hire, assuming continued employment with us. The </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">55 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
means of payment for shares issued upon exercise of an option are specified in each option agreement. The 2007 Plan permits payment to be made by cash, check, wire transfer, other shares of our
common stock (with some restrictions), broker assisted <FONT STYLE="white-space:nowrap">same-day</FONT> sales, a reduction in the amount of any of our liability owed to the awardee (including any liability attributable to the awardee&#146;s
participation in any of our deferred compensation programs or arrangements), any other form of consideration permitted by applicable law (which may include a &#147;net exercise&#148; program) and the Administrator, or any combination thereof.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Term of Option.</I>&nbsp;The term of an option may be no more than ten years from the date of grant, although the term of an incentive stock option
granted to an employee who holds more than 10% of our voting stock may be no more than five years from the date of grant. No option may be exercised after the expiration of its term. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><I>Terms and Conditions of Stock Awards.</I>&nbsp;Stock awards may be restricted or unrestricted stock grants, restricted stock units, stock appreciation rights or other similar stock awards. Each stock award
agreement contains provisions regarding (i)&nbsp;the number of shares subject to the stock award, (ii)&nbsp;the purchase price of the shares, if any, and the means of payment for the shares, (iii)&nbsp;the performance criteria, if any, and level of
achievement versus these criteria that will determine the number of shares granted, issued, retainable and vested, as applicable, (iv)&nbsp;such terms and conditions on the grant, issuance, vesting and forfeiture of the shares, as applicable, as may
be determined from time to time by the Administrator, (v)&nbsp;restrictions on the transferability of the stock award or the shares, and (vi)&nbsp;such further terms and conditions, in each case not inconsistent with the 2007 Plan, as may be
determined from time to time by the Administrator. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Performance Criteria.</I>&nbsp;The grant, issuance, retention, settlement and/or vesting of each
stock award or the shares subject thereto may be subject to such performance criteria and the level of achievement versus these criteria as the Administrator shall determine, which criteria may be based on financial performance, personal performance
evaluations and/or completion of service by the awardee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The 2007 Plan provides that the Administrator may grant awards that vest or become exercisable
upon the attainment of performance targets which are related to one or more of the following performance criteria, either individually, alternatively or in any combination, applied to either the Company as a whole or to a business unit, affiliate or
business segment (which may be measured either annually or cumulatively over a period of years, on an absolute basis or relative to a <FONT STYLE="white-space:nowrap">pre-established</FONT> target, to previous years&#146; results or to a designated
comparison group): (i)&nbsp;cash flow; (ii)&nbsp;earnings (including gross margin; earnings before interest and taxes; earnings before interest, taxes, depreciation and amortization; earnings before taxes; and net earnings); (iii)&nbsp;earnings per
share; (iv)&nbsp;growth in earnings or earnings per share; (v)&nbsp;stock price; (vi)&nbsp;return on equity or average stockholders&#146; equity; (vii)&nbsp;total stockholder return; (viii)&nbsp;return on capital; (ix)&nbsp;return on assets or net
assets; (x)&nbsp;return on investment; (xi)&nbsp;revenue or growth in revenue; (xii)&nbsp;income or net income; (xiii)&nbsp;operating income or net operating income, in aggregate or per share; (xiv)&nbsp;operating profit or net operating profit;
(xv)&nbsp;operating margin; (xvi)&nbsp;return on operating revenue; (xvii)&nbsp;market share; (xviii)&nbsp;contract awards or backlog; (xix)&nbsp;overhead or other expense reduction; (xx)&nbsp;growth in stockholder value relative to the moving
average of the S&amp;P 500 Index or a peer group index; (xxi)&nbsp;credit rating; (xxii)&nbsp;strategic plan development and implementation (including individual performance objectives that relate to achievement of the Company&#146;s or any business
unit&#146;s strategic plan); (xxiii)&nbsp;improvement in workforce diversity; (xxiv)&nbsp;growth of revenue, operating income or net income; (xxv)&nbsp;efficiency ratio; (xxvi)&nbsp;ratio of nonperforming assets to total assets; and (xxvii)&nbsp;any
other similar criteria. The Compensation Committee of the Board (or another committee of directors appointed by the Board) (the &#147;<B><I>Committee</I></B>&#148;) may appropriately adjust any evaluation of performance under the criteria specified
above to exclude any of the following events that </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">56 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
occurs during a performance period: asset write-downs, litigation or claim judgments or settlements, the effect of changes in tax law, accounting principles or other such laws or provisions
affecting reported results, accruals for reorganization and restructuring programs, any gains or losses classified as extraordinary or as discontinued operations in the Company&#146;s financial statements, and merger, acquisitions or divestitures.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Adjustments upon Changes in Capitalization, Dissolution, Merger or Asset Sale.</I>&nbsp;Subject to any required action by the stockholders of the
Company, in the event of any stock split, reverse stock split, stock dividend, combination, reclassification of our common stock, payment of a dividend or distribution in a form other than stock (excepting normal cash dividends) that has a material
effect on the fair market value of our common stock or any other increase or decrease in the number of issued shares of our common stock effected without receipt of our consideration, proportionate adjustments shall be made to: (i)&nbsp;the number
of shares of our common stock covered by each outstanding award under the 2007 Plan; (ii)&nbsp;the number of shares of our common stock which have been authorized for issuance under the 2007 Plan but as to which no awards have yet been granted or
which have been returned to the 2007 Plan upon cancellation, forfeiture or expiration of an award; (iii)&nbsp;the aggregate and individual share limitations set forth in the 2007 Plan; and (iv)&nbsp;the price per share of our common stock covered by
each such outstanding award under the 2007 Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In the event of certain mergers with or into another corporation, sales of substantially all of our
assets, direct or indirect sales or exchanges of more than 50% of our voting stock, liquidations and/or other transactions set forth in an award agreement, our Board or the Committee, may, in its discretion: (i)&nbsp;provide for the assumption or
substitution of, or adjustment (including to the number and type of shares and exercise or purchase price applicable) to, each outstanding award; (ii)&nbsp;accelerate the vesting of options and terminate any restrictions on stock awards; and/or
(iii)&nbsp;provide for termination of awards as a result of the transaction on such terms and conditions as it deems appropriate, including providing for the cancellation of awards for a cash or other payment to the awardee. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Term of the 2007 Plan and Amendment and Termination of the 2007 Plan</I>. The 2007 Plan shall continue in effect until June&nbsp;12, 2027 or, if stockholders
approve this amendment of the 2007 Plan, ten years following such approval, unless terminated earlier. The Administrator may amend, alter or discontinue the 2007 Plan or any award agreement at any time. However, we will obtain stockholder approval
for any amendment to the 2007 Plan if stockholder approval is necessary or desirable to comply with any applicable law or exchange listing requirements. In addition, we will obtain stockholder approval of any of the following: (i)&nbsp;a material
increase in the number of shares available for issuance under the 2007 Plan (other than an adjustment on a stock split or other corporate transaction), (ii)&nbsp;a change of the class of persons eligible to receive awards under the 2007 Plan;
(iii)&nbsp;a reduction in the minimum exercise prices at which options may be granted; or (iv)&nbsp;any amendment of outstanding options or stock appreciation rights that effects a repricing of such awards. Generally, no amendment of the 2007 Plan
shall impair the rights of an outstanding award without the consent of the awardee. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">57 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Awards under the 2007 Plan. </I>The following table sets forth the options issued under the 2007 Plan that
were granted during 2018 to the following persons or groups: (i)&nbsp;each of our Named Executive Officers; (ii)&nbsp;our current executive officers as a group (iii)&nbsp;all current directors who are not executive officers as a group; and
(iv)&nbsp;all employees who are not executive officers. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Name</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Position</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Number&nbsp;of&nbsp;Securities<BR>Underlying&nbsp;Options<BR>Granted</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><U><I>Current Executive Officers:</I></U></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry&nbsp;Quart,&nbsp;Pharm.&nbsp;D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">President and Chief&nbsp;Executive&nbsp;Officer</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly Manhard</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Executive Vice President, Drug Development</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Hoffman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Chief Financial Officer and Senior Vice President, Finance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">71,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><U><I>Former Executive Officer:</I></U></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Rosen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">Former President</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">All current executive officers as a group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">471,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">All directors who are not employees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">104,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">All employees, other than executive officers, as a group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">3,176,511</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>New Plan Benefits</I>. The amount, if any, of equity-based compensation that may be awarded to officers, directors, employees
and consultants following stockholder approval of this proposal is determined from time to time by our Board, as applicable, and is not presently determinable. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><I>Federal Income Tax Consequences</I>. The following is a general summary of the federal income tax consequences of the issuance and exercise of options or other awards under the 2007 Plan. This summary includes
general tax principles that apply only to employees who are citizens or residents of the United States and is provided only for general information purposes. The following discussion does not address the tax consequences of Awards that may be
subject to and do not comply with the rules and guidance issued pursuant to Section&nbsp;409A of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The following discussion does not purport to
be complete, and does not cover, among other things, state and local tax treatment of participants in the 2007 Plan. Tax laws are complex and subject to change and may vary depending on individual circumstances and from locality to locality. The
summary does not discuss all aspects of income taxation that may be relevant in light of personal investment circumstances. This summarized tax information is not tax advice and participants should consult their personal tax advisors concerning
federal, state, local and foreign income tax consequences associated with their participation in the 2007 Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Options</I>. The grant of an
incentive stock option has no federal income tax effect on the optionee. Upon exercise the optionee does not recognize income for &#147;regular&#148; tax purposes. However, the excess of the fair market value of the stock subject to an option over
the exercise price of such option (the &#147;option spread&#148;) is includible in the optionee&#146;s &#147;alternative minimum taxable income&#148; for purposes of the alternative minimum tax. If the optionee does not dispose of the stock acquired
upon exercise of an incentive stock option until more than two years after the option grant date and more than one year after exercise of the option, any gain (or loss) upon sale of the shares will be a long-term capital gain (or loss). If shares
are sold or otherwise disposed of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">58 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
before these periods have expired (a &#147;disqualifying disposition&#148;), the option spread at the time of exercise of the option (but not more than the amount of the gain on the sale or other
disposition) is ordinary income in the year of such sale or other disposition. If gain on a disqualifying disposition exceeds the amount treated as ordinary income, the excess is taxable as capital gain (which will be long-term capital gain if the
shares have been held more than one year after the date of exercise of the option). We are not entitled to a federal income tax deduction in connection with incentive stock options, except to the extent that the optionee has taxable ordinary income
on a disqualifying disposition. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The grant of a <FONT STYLE="white-space:nowrap">non-statutory</FONT> option having an exercise price equal to at least
the grant date fair market value of our common stock has no federal income tax effect on the optionee. Upon the exercise of a <FONT STYLE="white-space:nowrap">non-statutory</FONT> option, the optionee has taxable ordinary income (and we are entitled
to a corresponding deduction) equal to the option spread on the date of exercise. Upon the disposition of stock acquired upon exercise of a <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock option, the optionee recognizes either long-term
or short-term capital gain or loss, depending on how long the stock was held, on any difference between the sale price and the exercise price, to the extent not recognized as taxable income on the date of exercise. We may allow <FONT
STYLE="white-space:nowrap">non-statutory</FONT> stock options to be transferred subject to conditions and restrictions imposed by the Administrator; special tax rules may apply on such a transfer. In the case of both incentive stock options and <FONT
STYLE="white-space:nowrap">non-statutory</FONT> stock options, special federal income tax rules apply if our common stock is used to pay all or part of the option price, and different rules than those described above will apply if unvested shares
are purchased on exercise of the option. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Stock Appreciation Rights</I>. No taxable income is reportable when a stock appreciation right is granted
to a participant. Upon exercise, the participant will recognize ordinary income in an amount equal to the amount of cash received and the fair market value of any shares received. Any additional gain or loss recognized upon any later disposition of
the shares would be capital gain or loss, which will be either long-term or short-term capital gain or loss, depending on how long the stock was held. We are entitled to a deduction in the same amount as and at the time the employee recognizes
ordinary income. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Restricted Stock Awards</I>. Shares issued under a restricted stock award are subject to a &#147;substantial risk of
forfeiture&#148; within the meaning of Section&nbsp;83 of the Code to the extent, among other restrictions, the shares will be forfeited in the event that the participant ceases to provide services to us and are not transferable. As a result of this
substantial risk of forfeiture, the participant will not recognize ordinary income at the time the award shares are issued. Instead, the participant will recognize ordinary income on the dates when the stock is no longer subject to a substantial
risk of forfeiture, or when the stock becomes transferable, if earlier. The participant&#146;s ordinary income is measured as the difference between the amount paid for the stock, if any, and the fair market value of the stock on the date the stock
is no longer subject to forfeiture. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The participant may accelerate his or her recognition of ordinary income, if any, and begin his or her capital
gains holding period by timely filing (i.e., not later than thirty days after the share issuance date) an election pursuant to Section&nbsp;83(b) of the Code. In such event, the ordinary income recognized, if any, is measured as the difference
between the amount paid for the stock, if any, and the fair market value of the stock on the date of such issuance, and the capital gain holding period commences on such date. The ordinary income recognized by a participant will be subject to tax
withholding by us. We are entitled to a deduction in the same amount as and at the time the participant recognizes ordinary income. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Restricted Stock
Unit Awards</I>. A participant will generally not recognize taxable income at the time of the grant of a restricted stock unit award. When an award is paid (assuming the award is settled at the time that the award vests), the participant will
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">59 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
recognize ordinary income. In the event of an award that is settled in shares of our common stock at a time following the vesting date, income tax may be deferred beyond vesting and until shares
are actually delivered to the participant if deferred in compliance with the timing of distributions and other requirements under Section&nbsp;409A of the Code. We are entitled to a deduction in the same amount as and at the time the participant
recognizes ordinary income. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Section&nbsp;409A covers most programs that defer the receipt of compensation to a succeeding year. It provides rules for
elections to defer, if any, and for timing of payouts. There are significant penalties placed on the participant for failure to comply with Section&nbsp;409A. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">Section&nbsp;409A does not apply to incentive stock options, <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock options that have an exercise price that is at least equal to the grant date fair market
value and meet certain other requirements, restricted stock and restricted stock unit type awards provided there is no deferral of income beyond the vesting date. Section&nbsp;409A also does not cover stock appreciation rights if the exercise price
is not less than the fair market value of the underlying stock on the date of grant, the rights are settled in such stock and no features defer the recognition of income beyond the exercise date. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Tax Effect for the Company</I>. Generally, we will be entitled to a tax deduction in connection with an award under the 2007 Plan in an amount equal to the
ordinary income realized by a participant and at the time the participant recognizes such income (for example, upon the exercise of a <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock option). Special rules limit the deductibility of
compensation paid to our Chief Executive Officer and to certain of our other most highly compensated executive officers. Under Section&nbsp;162(m) of the Code, the annual compensation paid to any of these specified executives will be deductible only
to the extent that it does not exceed $1,000,000. For 2017 and prior years, Section&nbsp;162(m) included an exception from the deductibility limitation for qualified &#147;performance-based compensation.&#148; This exception, however, has been
repealed by the Tax Cuts and Jobs Act of 2017 for tax years beginning in 2018. As such, compensation paid to our Chief Executive Officer and to certain of our other most highly compensated executive officers in excess of $1,000,000 will not be
deductible unless it qualifies for certain transition relief applicable for compensation paid pursuant to a written binding contract that was in effect as of November&nbsp;2, 2017. The Compensation Committee believes that stockholder interests are
best served by not restricting the Compensation Committee&#146;s discretion and flexibility in structuring compensation programs, even if such compensation results in <FONT STYLE="white-space:nowrap">non-deductible</FONT> expenses under applicable
law. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Vote Required and Board Recommendation</I></B><B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">The affirmative vote of a majority of the votes cast will be required to approve this amendment to the 2007 Plan. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the
outcome of this proposal. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>The Board of Directors recommends a vote &#147;FOR&#148; the amendment to our 2007 Plan to increase the number of shares
of common stock authorized for issuance thereunder from 18,800,000 to 25,800,000 and to approve a limit on the compensation payable to our <FONT STYLE="white-space:nowrap">non-executive</FONT> directors pursuant to the 2007 Plan. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">60 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>PROPOSAL 6 &#151; AMENDMENT OF ESPP </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>General </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">At the Annual Meeting, stockholders will vote to
approve an amendment to our ESPP to increase the number of shares of common stock authorized for issuance thereunder from 475,000 to 775,000. Such amendment will require the affirmative vote of a majority of the votes cast at the meeting, provided a
quorum is established. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The ESPP permits the Company&#146;s employees to purchase our common stock at a discounted price. This plan is designed to
encourage and assist employees of the Company to acquire an equity interest in the Company through the purchase of shares of our common stock. Subject to stockholder approval, our Compensation Committee has approved the amendment to the ESPP to
increase the shares of common stock available for issuance thereunder by 300,000. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Reasons for Seeking Stockholder Approval </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Board believes that equity-based compensation is a critical part of the Company&#146;s compensation program. Our Compensation Committee acts as administrator
for our ESPP pursuant to authority delegated by the Board. Stockholder approval of the amendment to the ESPP would allow us to continue to offer shares under the ESPP as a means of allowing employees to invest a portion of their cash compensation in
our common stock, which fosters ownership and encourages employees to focus on long-term growth in value. In 2016, 2017 and 2018, the Company issued a total of 54,932, 77,283 and 71,499 shares of common stock under the ESPP, respectively. As of
March&nbsp;31, 2019, 279,182 shares of common stock have been issued under the ESPP and 195,818 shares of common remained available for future issuance; if this proposal is approved, the ESPP would have 495,818 shares available for future issuance.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The proposed additional 300,000 shares of common stock available for future issuance under the ESPP represents potential dilution of 0.4% as of
December&nbsp;31, 2018 (potential dilution for this purpose is determined by dividing the 300,000 additional shares by the total number of shares of the Company&#146;s common stock outstanding as of December&nbsp;31, 2018). The dilution attributable
to the ESPP for 2018 was 0.1% (which was determined by dividing the number of shares issued under the ESPP during 2018 by the total number of shares of the Company&#146;s common stock outstanding as of December&nbsp;31, 2018). The Compensation
Committee believes that this is a reasonable amount of potential dilution and appropriate for our industry and the practices of our peer companies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">If
stockholders do not approve this proposal, the Company will have 195,818 shares available for issuance under the ESPP. Given the significant increase in number of employees eligible to participate in the ESPP, this could limit the Company&#146;s
ability to offer this type of equity-based compensation plan to its employees in the future. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Summary of the ESPP </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>General.</I> A copy of the ESPP, as amended and restated, is attached to this Proxy Statement as Exhibit [B]. The following description of the ESPP is a summary
and so is qualified by reference to the complete text of the ESPP. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">61 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Eligibility. </I>All employees, including executive officers, customarily employed more than 20 hours per week
and more than five months per year by the Company or any designated subsidiary are eligible to participate in the ESPP as of the first semi-annual enrollment date following commencement of employment, unless the employee directly or indirectly
(including through ownership of options) owns 5% or more of the combined voting power of the Company. As of March&nbsp;31, 2019, the Company had 185 employees eligible to participate in the ESPP, compared to 139 eligible employees in the prior year.
Participation in the ESPP terminates immediately when a participant ceases to be employed for any reason or otherwise becomes ineligible to participate. Participants may elect to make contributions to the ESPP up to a maximum of 10% of earnings. On
the last trading date of April and October, the Company applies the funds then in each participant&#146;s account to the purchase of shares common stock. The cost of each share of common stock purchased is 85% of the lower of the closing prices for
common stock on: (i)&nbsp;the first trading day in the enrollment period in which the purchase is made; and (ii)&nbsp;the purchase date. The length of the offering period set by the ESPP may not exceed a maximum of 24 months, and is presently set at
six months by our Board. Enrollment dates are the first business day of May and November. The Board may limit the maximum number of shares that may be purchased by a participant during any enrollment period and may limit the length of the enrollment
periods. No participant&#146;s right to acquire shares may accrue at a rate exceeding $25,000 of the fair market value of our common stock in any calendar year. Shares of common stock available under the ESPP may be either outstanding shares
repurchased by the Company or newly issued shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Administration. </I>Our Compensation Committee acts as administrator of the ESPP and may amend or
terminate the ESPP at any time and may provide for an adjustment in the purchase price and the number and kind of securities available under the plan in the event of a reorganization, recapitalization, stock split, or other certain similar events.
However, amendments that would increase the number of shares reserved for purchase, would otherwise require stockholder approval in order to comply with Section&nbsp;423 of the Code, other applicable laws, regulations or rules or with respect to
which the Compensation Committee otherwise concludes that stockholder approval is advisable, require stockholder approval. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Awards under the ESPP.
</I>The following table shows the &#147;dollar value&#148; and number of shares of common stock applicable to the named individuals and groups under the ESPP during 2018, purchased on the April&nbsp;30, 2018 and October&nbsp;31, 2018 purchase dates
under the ESPP at a purchase price of $13.22 and $23.60 per share of common stock, respectively, which represents 85% of the lower of the closing price on the first trading day of the offering period or the purchase date. Our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors are not eligible to participate in the ESPP. The &#147;dollar value&#148; is calculated as: (i)&nbsp;the number of shares of common stock purchased under the ESPP on the April&nbsp;30, 2018
and October&nbsp;31, 2018 purchase dates; multiplied by (ii)&nbsp;the difference between the fair market value of a share of common stock and the participant&#146;s purchase price per share of common stock. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Name and Position</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Dollar&nbsp;Value</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Number&nbsp;of&nbsp;Shares</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><U><I>Executive Officers:</I></U></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Barry Quart, Pharm.D., Current President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">27,452</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">1,607</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Rosen, Former President</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Kimberly Manhard, Executive Vice President, Drug Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">2,057</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">494</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2">Robert Hoffman, Chief Financial Officer and Senior Vice President, Finance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">12,709</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">744</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:0.50em; text-indent:-0.50em"><FONT STYLE="font-family:ARIAL" SIZE="2"><FONT STYLE="white-space:nowrap">Non-Executive</FONT> Officer Employee Group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">888,459</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2">68,654</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:ARIAL" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">62 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>New Plan Benefits.</I>&nbsp;Because purchase rights are subject to discretion, including an employee&#146;s
decision not to participate in the ESPP, awards under the ESPP for the current fiscal year are not determinable. No purchase rights have been granted with respect to the additional 300,000 shares for which approval is requested. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><I>Federal Income Tax Consequences</I>. The following general description of federal income tax consequences is based upon current statutes, regulations and
interpretations thereof. Because the applicable rules are complex and because income tax consequences may vary depending upon the individual circumstances of each participant, participants should consult their personal tax advisors concerning
federal, state, local and foreign income tax consequences associated with their participation in the ESPP. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">In general, participants will not have
taxable income or loss under the ESPP until they sell or otherwise dispose of shares acquired under the plan (or die holding such shares). If the shares are held, as of the date of sale or disposition, for longer than both: (i)&nbsp;two years after
the beginning of the enrollment period during which the shares were purchased; and (ii)&nbsp;one year following purchase, a participant will have taxable ordinary income equal to 15% of the fair market value of the shares on the first day of the
enrollment period (but not in excess of the fair market value of the shares at the time of sale over the purchase price). Any additional gain (or loss) from the sale will be long-term capital gain (or loss). The Company is not entitled to an income
tax deduction if the holding periods are satisfied. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">If the shares are sold or disposed of before the expiration of either of the foregoing holding
periods (a &#147;disqualifying disposition&#148;), a participant will have taxable ordinary income equal to the excess of the fair market value of the shares on the purchase date over the purchase price. In addition, the participant will have a
taxable capital gain (or loss) measured by the difference between the sale price and the participant&#146;s purchase price which gain (or loss) will be long-term if the shares have been held as of the date of sale for more than one year. The Company
is entitled to an income tax deduction equal to the amount of ordinary income recognized by a participant in a disqualifying disposition. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B></B><B><I>Vote Required and Board Recommendation</I></B><B> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The affirmative vote of a majority of the votes cast will be required to approve this amendment to the ESPP. Abstentions and broker
<FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the outcome of this proposal. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>The Board of Directors recommends a vote
&#147;FOR&#148; the amendment to our ESPP to increase the number of shares of common stock authorized for issuance thereunder from 475,000 to 775,000. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">63 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>OTHER MATTERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">As of the time of preparation of this Proxy Statement, neither our Board nor management intends to bring before the meeting any business other than the matters referred to in the Notice of Annual Meeting and this
Proxy Statement. If any other business should properly come before the meeting, or any adjournment thereof, the persons named in the proxy will vote on such matters according to their best judgment and in their discretion. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>Our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2018, containing audited consolidated balance sheets as of December&nbsp;31, 2018 and 2017 and audited
consolidated statements of operations and comprehensive loss, stockholders&#146; equity (deficit) and cash flows for each of the three years in the period ended December&nbsp;31, 2018, is being distributed along with this Proxy Statement. The Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> is not incorporated into this Proxy Statement and is not considered proxy-soliciting material. This Proxy Statement and our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2018 are available to you at no charge electronically at http://www.edocumentview.com/hrtx. Additional copies of the Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2018 are available at no charge on written request. To obtain additional copies of the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended
December&nbsp;31, 2018, please contact us 4242 Campus Point Court, Suite 200, San Diego, CA 92121, Attn.: David Szekeres, Senior Vice President, General Counsel, Business Development, and Corporate Secretary. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%; text-indent:-1%"><FONT STYLE="font-family:ARIAL" SIZE="2">BY ORDER OF THE BOARD OF DIRECTORS </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="43%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:ARIAL" SIZE="2">/s/ David Szekeres</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">David Szekeres, Senior Vice President, General Counsel, Business Development and Corporate Secretary</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">San Diego, California</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:ARIAL" SIZE="2">April&nbsp;26, 2019</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">64 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>EXHIBIT A </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:ARIAL" SIZE="2">HERON THERAPEUTICS, INC. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2">AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>1. Purposes of the Plan. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The purpose of this Plan is to
encourage ownership in Heron Therapeutics, Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), by key personnel whose long-term employment or other service relationship with the Company is considered essential to the Company&#146;s
continued progress and, thereby, encourage recipients to act in the stockholders&#146; interest and share in the Company&#146;s success. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>2.
Definitions. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">As used herein, the following definitions shall apply: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(a) <B>&#147;Administrator&#148;</B> means the Board, any Committees or such delegates as shall be administering the Plan in accordance with Section&nbsp;4 of the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) <B>&#147;Affiliate&#148;</B> means any entity that is directly or indirectly controlled by the Company or any entity in which the Company has a
significant ownership interest as determined by the Administrator. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c) <B>&#147;Applicable Laws&#148;</B> means the requirements
relating to the administration of stock option and stock award plans under U.S. federal and state laws, any stock exchange or quotation system on which the Company has listed or submitted for quotation the Common Stock to the extent provided under
the terms of the Company&#146;s agreement with such exchange or quotation system and, with respect to Awards subject to the laws of any foreign jurisdiction where Awards are, or will be, granted under the Plan, the laws of such jurisdiction.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(d) <B>&#147;Award&#148;</B> means a Stock Award or Option granted in accordance with the terms of the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(e) <B>&#147;Awardee&#148;</B> means an Employee, Consultant or Director of the Company or any Affiliate who has been granted an Award under the
Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(f) <B>&#147;Award Agreement&#148;</B> means a Stock Award Agreement and/or Option Agreement, which may be in written or
electronic format, in such form and with such terms and conditions as may be specified by the Administrator, evidencing the terms and conditions of an individual Award. Each Award Agreement is subject to the terms and conditions of the Plan.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(g) <B>&#147;Board&#148;</B> means the Board of Directors of the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(h) <B>&#147;Cause&#148;</B> means, unless such term or an equivalent term is otherwise defined with respect to an Award by the Participant&#146;s
Award Agreement, any of the following: (i)&nbsp;the Participant&#146;s theft, dishonesty, willful misconduct, breach of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">
fiduciary duty for personal profit, or falsification of any Company or Affiliate documents or records; (ii)&nbsp;the Participant&#146;s material failure to abide by a Company&#146;s or
Affiliate&#146;s code of conduct or other policies (including without limitation, policies relating to confidentiality and reasonable workplace conduct); (iii) the Participant&#146;s unauthorized use, misappropriation, destruction or diversion of
any tangible or intangible asset or corporate opportunity of the Company or an Affiliate (including, without limitation, the Participant&#146;s improper use or disclosure of confidential or proprietary information); (iv) any intentional act by the
Participant which has a material detrimental effect on the Company or an Affiliate&#146;s reputation or business; (v)&nbsp;the Participant&#146;s repeated failure or inability to perform any reasonable assigned duties after written notice from the
Company or an Affiliate (including, without limitation, habitual absence from work for reasons other than illness), and a reasonable opportunity to cure, such failure or inability; (vi)&nbsp;any material breach by the Participant of any employment
or service agreement between the Participant and the Company or an Affiliate, which breach is not cured pursuant to the terms of such agreement; or (vii)&nbsp;the Participant&#146;s conviction (including any plea of guilty or nolo contendere) of any
criminal act involving fraud, dishonesty, misappropriation or moral turpitude, or which impairs the Participant&#146;s ability to perform his or her duties with the Company or an Affiliate. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(i) <B>&#147;Change in Control&#148;</B> means, unless such term or an equivalent term is otherwise defined with respect to an Award by the
Participant&#146;s Award Agreement, the occurrence of any of the following: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">i. an Ownership Change Event or a series of related
Ownership Change Events (collectively, a &#147;<B>Transaction</B>&#148;) in which the stockholders of the Company immediately before the Transaction do not retain immediately after the Transaction, in substantially the same proportions as their
ownership of shares of the Company&#146;s voting stock immediately before the Transaction, direct or indirect beneficial ownership of more than fifty percent (50%) of the total combined voting power of the outstanding voting securities of the
Company or such surviving entity immediately outstanding after the Transaction, or, in the case of an Ownership Change Event described in Section&nbsp;2(bb)(iii), the entity to which the assets of the Company were transferred (the
&#147;Transferee&#148; ), as the case may be; or </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">ii. the liquidation or dissolution of the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">For purposes of the preceding sentence, indirect beneficial ownership shall include, without limitation, an interest resulting from ownership of
the voting securities of one or more corporations or other business entities which own the Company or the Transferee, as the case may be, either directly or through one or more subsidiary corporations or other business entities. The Board shall have
the right to determine whether multiple sales or exchanges of the voting securities in the Company or multiple Ownership Change Events are related, and its determination shall be final, binding and conclusive. The Board may also, but need not,
specify that other transactions or events constitute a Change in Control. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(j) <B>&#147;Code&#148;</B> means the United States Internal
Revenue Code of 1986, as amended. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(k) <B>&#147;Committee&#148;</B> means the compensation committee of the Board or a committee of
Directors appointed by the Board in accordance with Section&nbsp;4 of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(l) <B>&#147;Common Stock&#148;</B> means the common
stock of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(m) <B>&#147;Company&#148;</B> means Heron Therapeutics, Inc., a Delaware corporation, or its successor.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(n) <B>&#147;Consultant&#148;</B> means any person (including an advisor or an employee of an entity)
that is engaged by the Company or any Parent, Subsidiary or Affiliate, to render services and is compensated for such services. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(o)
<B>&#147;Continuous Service&#148;</B> means that the Participant&#146;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant
renders service to the Company or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#146;s service
with the Company or an Affiliate, shall not terminate a Participant&#146;s Continuous Service; <I>provided, however</I>, if the Company for which a Participant is rendering services ceases to qualify as an &#147;Affiliate,&#148; as determined by the
Board in its sole discretion, such Participant&#146;s Continuous Service shall be considered to have terminated on the date such Company ceases to qualify as an Affiliate. To the extent permitted by law, the Board or the chief executive officer of
the Company, in that party&#146;s sole discretion, may determine whether Continuous Service shall be considered interrupted in the case of: (i)&nbsp;any leave of absence approved by the Board or the chief executive officer of the Company, including
sick leave, military leave or any other personal leave; or (ii)&nbsp;transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a leave of absence shall be treated as Continuous Service for purposes of vesting
in a Stock Award only to such extent as may be provided in the Company&#146;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(p) <B>&#147;Conversion Award&#148;</B> has the meaning set forth in Section&nbsp;4(b)(xii) of the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(q) <B>&#147;Director&#148;</B> means a member of the Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(r) <B>&#147;Effective Date&#148;</B> means the date of approval of the Plan by the stockholders of the Company in the manner and to the extent required by Applicable Laws. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(s) <B>&#147;Employee&#148;</B> means a regular, active employee of the Company or any Affiliate, including an Officer and/or Inside Director.
Within the limitations of Applicable Law, the Administrator shall have the discretion to determine the effect upon an Award and upon an individual&#146;s status as an Employee in the case of (i)&nbsp;any individual who is classified by the Company
or its Affiliate as leased from or otherwise employed by a third party or as intermittent or temporary, even if any such classification is changed retroactively as a result of an audit, litigation or otherwise, (ii)&nbsp;any leave of absence
approved by the Company or an Affiliate, (iii)&nbsp;any transfer between locations of employment with the Company or an Affiliate or between the Company and any Affiliate or between any Affiliates, (iv)&nbsp;any change in the Awardee&#146;s status
from an Employee to a Consultant or Director, and (v)&nbsp;at the request of the Company or an Affiliate an Employee becomes employed by any partnership, joint venture or corporation not meeting the requirements of an Affiliate in which the Company
or an Affiliate is a party. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(t) <B>&#147;Exchange Act&#148;</B> means the Securities Exchange Act of 1934, as amended. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(u) <B>&#147;Fair Market Value&#148;</B> means, as of any date, the value of a share of Common Stock or other property as determined by the
Administrator, in its discretion, or by the Company, in its discretion, if such determination is expressly allocated to the Company herein, subject to the following: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT
STYLE="font-family:ARIAL" SIZE="2">i. If, on such date, the Common Stock is listed on a national or regional securities exchange or market system, including without limitation the Nasdaq Stock Market, the Fair Market Value of a share of Common Stock
shall be the closing price </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">
on such date of a share of Common Stock (or the mean of the closing bid and asked prices of a share of Common Stock if the stock is so quoted instead) as quoted on such exchange or market system
constituting the primary market for the Common Stock, as reported in <U>The Wall Street Journal</U> or such other source as the Administrator deems reliable. If the relevant date does not fall on a day on which the Common Stock has traded on such
securities exchange or market system, the date on which the Fair Market Value shall be established shall be the last day on which the Common Stock was so traded prior to the relevant date, or such other appropriate day as shall be determined by the
Administrator, in its discretion. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">ii. If, on such date, the Common Stock is not listed on a national or regional securities exchange or
market system, the Fair Market Value of a share of Common Stock shall be as determined by the Administrator in good faith using a reasonable application of a reasonable valuation method without regard to any restriction other than a restriction
which, by its terms, will never lapse. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(v) <B>&#147;Grant Date&#148;</B> means, for all purposes, the date on which the Administrator
approves the determination of grant of an Award, or such other date as is determined by the Administrator, provided that in the case of any Incentive Stock Option, the grant date shall be the later of the date on which the Administrator makes the
determination granting such Incentive Stock Option or the date of commencement of the Awardee&#146;s employment relationship with the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(w) <B>&#147;Incentive Stock Option&#148;</B> means an Option intended to qualify as an incentive stock option within the meaning of Section&nbsp;422 of the Code and the regulations promulgated thereunder.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(x) <B>&#147;Inside Director&#148;</B> means a Director who is an Employee. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(y) <B>&#147;Nasdaq&#148;</B> means the Nasdaq Stock Market or its successor. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(z) <B>&#147;Nonstatutory Stock Option&#148;</B> means an Option not intended to qualify as an Incentive Stock Option. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(aa) <B>&#147;Officer&#148;</B> means a person who is an officer of the Company within the meaning of Section&nbsp;16 of the Exchange Act and the
rules and regulations promulgated thereunder. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(bb) <B>&#147;Option&#148;</B> means a right granted under Section&nbsp;8 to purchase a
number of Shares at such exercise price, at such times, and on such other terms and conditions as are specified in the agreement or other documents evidencing the Option (the &#147;Option Agreement&#148;). Both Options intended to qualify as
Incentive Stock Options and Nonstatutory Stock Options may be granted under the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(cc) <B>&#147;Outside Director&#148;</B> means a
Director who is not an Employee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(dd) <B>&#147;Ownership Change Event&#148;</B> means the occurrence of any of the following with
respect to the Company: (i)&nbsp;the direct or indirect sale or exchange in a single or series of related transactions by the stockholders of the Company of more than fifty percent (50%) of the voting stock of the Company; (ii)&nbsp;a merger or
consolidation in which the Company is a party; or (iii)&nbsp;the sale, exchange, or transfer of all or substantially all of the assets of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(ee) <B>&#147;Parent&#148;</B> means a &#147;parent corporation,&#148; whether now or hereafter existing, as defined in Section&nbsp;424(e) of the Code, or any successor provision. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(ff) <B>&#147;Participant&#148;</B> means the Awardee or any person (including any estate) to whom an
Award has been assigned or transferred as permitted hereunder. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(gg) <B>&#147;Performance Criteria&#148;</B> shall have the meaning set
forth in Section&nbsp;13(b) of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(hh) <B>&#147;Plan&#148;</B> means this Heron Therapeutics, Inc. 2007 Equity Incentive Plan.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(ii) <B>&#147;Restricted Stock Unit&#148;</B> means a bookkeeping entry representing an amount equivalent to the Fair Market Value of
one Share (or a fraction or multiple of such value), payable in cash, property or Shares. Restricted Stock Units represent an unfunded and unsecured obligation of the Company, except as otherwise provided for by the Administrator. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(jj) <B>&#147;Share&#148;</B> means a share of the Common Stock, as adjusted in accordance with Section&nbsp;14 of the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(kk) <B>&#147;Stock Appreciation Right&#148;</B> means a right to receive cash and/or shares of Common Stock based on a change in the Fair Market
Value of a specific number of shares of Common Stock between the grant date and the exercise date granted under Section&nbsp;12. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(ll)
<B>&#147;Stock Award&#148;</B> means an award or issuance of Shares, Restricted Stock Units, Stock Appreciation Rights or other similar awards made under Section&nbsp;12 of the Plan, the grant, issuance, retention, vesting, settlement, and/or
transferability of which is subject during specified periods of time to such conditions (including continued employment or performance conditions) and terms as are expressed in the agreement or other documents evidencing the Award (the &#147;Stock
Award Agreement&#148; ). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(mm) <B>&#147;Subsidiary&#148;</B> means any company (other than the Company) in an unbroken chain of
companies beginning with the Company, provided each company in the unbroken chain (other than the Company) owns, at the time of determination, stock possessing 50% or more of the total combined voting power of all classes of stock in one of the
other companies in such chain. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(nn) <B>&#147;Termination of Continuous Service&#148;</B> shall mean ceasing to be in Continuous Service
as an Employee, Consultant or Director, as determined in the sole discretion of the Administrator. However, for Incentive Stock Option purposes, Termination of Continuous Service will occur when the Awardee ceases to be an employee (as determined in
accordance with Section&nbsp;3401(c) of the Code and the regulations promulgated thereunder) of the Company or one of its Subsidiaries. The Administrator shall determine whether any corporate transaction, such as a sale or <FONT
STYLE="white-space:nowrap">spin-off</FONT> of a division or business unit, or a joint venture, shall be deemed to result in a Termination of Continuous Service. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(oo) <B>&#147;Total and Permanent Disability&#148;</B> shall have the meaning set forth in Section&nbsp;22(e)(3) of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>3. Stock Subject to the Plan. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) <I>Aggregate Limits.</I> Subject to the provisions of
Section&nbsp;14 of the Plan, the maximum aggregate number of Shares that may be sold or issued under the Plan is 25,800,000 shares of Common Stock. Shares subject to Awards granted under the Plan that are cancelled, expire or are forfeited shall be
available for <FONT STYLE="white-space:nowrap">re-grant</FONT> under the Plan. If an Awardee pays the exercise or purchase price of an Award granted under the Plan through the tender or withholding of Shares, or if Shares are tendered or withheld to
satisfy any Company withholding obligations, the number of Shares so tendered or withheld shall become </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">
available for <FONT STYLE="white-space:nowrap">re-issuance</FONT> thereafter under the Plan. The Shares subject to the Plan may be either Shares reacquired by the Company, including Shares
purchased in the open market, or authorized but unissued Shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) <I>Individual Award Limits</I>. Subject to the provisions of
Section&nbsp;14 of the Plan, the aggregate number of Shares subject to Awards granted under this Plan during any calendar year to any one Awardee shall not exceed 50% of the maximum aggregate number of shares that are authorized for issuance
pursuant to Section&nbsp;3(a) of the Plan, except that in connection with his or her first commencing service with the Company or an Affiliate, an Awardee may be granted Awards covering up to an additional 200,000 Shares during the year in which
such service commences. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c)<I> Director Awards</I>. The aggregate dollar value of cash compensation and Awards (based on the grant date
fair value of such Awards) granted under the Plan or otherwise during any calendar year to any one Outside Director shall not exceed $750,000; provided, however, that in any calendar year in which an Outside Director first joins the Board or is
designated as Chairman of the Board, the maximum aggregate dollar value of equity-based and cash compensation granted to the Outside Director may be up to two hundred percent (200%) of the foregoing limit. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>4. Administration of the Plan. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a)
<I>Procedure.</I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">i. <I>Multiple Administrative Bodies</I>. The Plan shall be administered by the Board, a Committee and/or their
delegates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">ii. <I>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></I>. To the extent desirable to qualify transactions hereunder as
exempt under Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act (&#147;Rule <FONT STYLE="white-space:nowrap">16b-3&#148;),</FONT> Awards to Officers and Directors shall be made by the entire Board or a Committee of
two or more <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> directors&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT
STYLE="font-family:ARIAL" SIZE="2">iii. <I>Other Administration</I>. The Board or a Committee may delegate to an authorized officer or officers of the Company the power to approve Awards to persons eligible to receive Awards under the Plan who are
not (A)&nbsp;subject to Section&nbsp;16 of the Exchange Act or (B)&nbsp;any other executive officer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">iv. <I>Delegation of Authority for
the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Day-to-Day</FONT></FONT> Administration of the Plan</I>. Except to the extent prohibited by Applicable Law, the Administrator may delegate to one or more individuals the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> administration of the Plan and any of the functions assigned to it in this Plan. Such delegation may be revoked at any time. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">v. <I>Nasdaq</I>. To the extent that the Common Stock is then listed on Nasdaq, the Plan will be administered in a manner that complies with any
applicable Nasdaq or stock exchange listing requirements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) <I>Powers of the Administrator</I>. Subject to the provisions of the Plan
and, in the case of a Committee or delegates acting as the Administrator, subject to the specific duties delegated to such Committee or delegates, the Administrator shall have the authority, in its discretion: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">i. to select the Employees, Consultants and Directors of the Company or its Affiliates to whom Awards are to be granted hereunder; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">ii. to determine the number of shares of Common Stock to be covered by each Award granted hereunder;
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">iii. to determine the type of Award to be granted to the selected Employees, Consultants and Directors; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">iv. to approve forms of Award Agreements for use under the Plan; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT
STYLE="font-family:ARIAL" SIZE="2">v. to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder. Such terms and conditions include, but are not limited to, the exercise and/or purchase price
(if applicable), the time or times when an Award may be exercised (which may or may not be based on performance criteria), the vesting schedule, any vesting and/or exercisability acceleration or waiver of forfeiture restrictions, the acceptable
forms of consideration, the term, and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator, in its sole discretion, shall determine and may be established at the
time an Award is granted or thereafter; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">vi. to correct administrative errors; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">vii. to construe and interpret the terms of the Plan (including <FONT STYLE="white-space:nowrap">sub-plans</FONT> and Plan addenda) and Awards
granted pursuant to the Plan; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">viii. to adopt rules and procedures relating to the operation and administration of the Plan to
accommodate the specific requirements of local laws and procedures. Without limiting the generality of the foregoing, the Administrator is specifically authorized (A)&nbsp;to adopt the rules and procedures regarding the conversion of local currency,
withholding procedures and handling of stock certificates which vary with local requirements and (B)&nbsp;to adopt <FONT STYLE="white-space:nowrap">sub-plans</FONT> and Plan addenda as the Administrator deems desirable, to accommodate foreign laws,
regulations and practice; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">ix. to prescribe, amend and rescind rules and regulations relating to the Plan, including rules and
regulations relating to <FONT STYLE="white-space:nowrap">sub-plans</FONT> and Plan addenda; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">x. to modify or amend each Award,
including, but not limited to, the acceleration of vesting and/or exercisability, provided, however, that any such amendment is subject to Section&nbsp;15 of the Plan and except as set forth in that Section, may not impair any outstanding Award
unless agreed to in writing by the Participant; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">xi. to allow Participants to satisfy withholding tax amounts by electing to have the
Company withhold from the Shares to be issued upon exercise of an Option or vesting of a Stock Award that number of Shares having a Fair Market Value equal to the amount required to be withheld. The Fair Market Value of the Shares to be withheld
shall be determined in such manner and on such date that the Administrator shall determine or, in the absence of provision otherwise, on the date that the amount of tax to be withheld is to be determined. All elections by a Participant to have
Shares withheld for this purpose shall be made in such form and under such conditions as the Administrator may provide; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">xii. to
authorize conversion or substitution under the Plan of any or all stock options, stock appreciation rights or other stock awards held by service providers of an entity acquired by the Company (the &#147;<B>Conversion Awards</B>&#148;). Any
conversion or substitution shall be effective as of the close of the merger, acquisition or other transaction. The Conversion Awards </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">
may be Nonstatutory Stock Options or Incentive Stock Options, as determined by the Administrator, with respect to options granted by the acquired entity; provided, however, that with respect to
the conversion of stock appreciation rights in the acquired entity, the Conversion Awards shall be Nonstatutory Stock Options. Unless otherwise determined by the Administrator at the time of conversion or substitution, all Conversion Awards shall
have the same terms and conditions as Awards generally granted by the Company under the Plan; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">xiii. to authorize any person to execute
on behalf of the Company any instrument required to effect the grant of an Award previously granted by the Administrator; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">xiv. to
impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by a Participant or other subsequent transfers by the Participant of any Shares issued as a result of or under an Award,
including without limitation, (A)&nbsp;restrictions under an insider trading policy or under any other Company policy relating to Company stock and stock ownership and (B)&nbsp;restrictions as to the use of a specified brokerage firm for such
resales or other transfers; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">xv. to provide, either at the time an Award is granted or by subsequent action, that an Award shall contain
as a term thereof, a right, either in tandem with the other rights under the Award or as an alternative thereto, of the Participant to receive, without payment to the Company, a number of Shares, cash or a combination thereof, the amount of which is
determined by reference to the value of the Award; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">xvi. to cause all outstanding Awards held by an Awardee to terminate immediately in
their entirety (including as to vested Options) upon first notification to the Awardee of the Awardee&#146;s Termination of Continuous Service for Cause. If an Awardee&#146;s Continuous Service with the Company is suspended pending an investigation
of whether the Awardee shall be terminated for Cause, the Administrator has the authority to cause all the Awardee&#146;s rights under all outstanding Awards to be suspended during the investigation period in which event the Awardee shall have no
right to exercise any outstanding Awards. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">xvii. to determine whether and to what extent the vesting of Awards shall be tolled during
any unpaid leave of absence. In the event of military leave, vesting shall toll during any unpaid portion of such leave, provided that, upon an Awardee&#146;s returning from military leave (under conditions that would entitle him or her to
protection upon such return under the Uniform Services Employment and Reemployment Rights Act), he or she shall be given vesting credit with respect to Options to the same extent as would have applied had the Awardee continued to provide services to
the Company throughout the leave on the same terms as he or she was providing services immediately prior to such leave. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">xviii. to make
all other determinations deemed necessary or advisable for administering the Plan and any Award granted hereunder. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c) <I>Effect of
Administrator&#146;s Decision</I>. All decisions, determinations and interpretations by the Administrator regarding the Plan, any rules and regulations under the Plan and the terms and conditions of any Award granted hereunder, shall be final and
binding on all Participants and on all other persons. The Administrator shall consider such factors as it deems relevant, in its sole and absolute discretion, to making such decisions, determinations and interpretations including, without
limitation, the recommendations or advice of any officer or other employee of the Company and such attorneys, consultants and accountants as it may select. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>5. Eligibility. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">Awards may be granted to Employees, Consultants and Directors of the Company or any of its Affiliates; provided that Incentive Stock Options may be granted only to
Employees of the Company or of a Subsidiary of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>6. Term of Plan. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">The Plan shall become effective on the Effective Date. It shall continue in effect for a term of ten (10)&nbsp;years from the later of the Effective Date or the date any amendment to add shares to the Plan is
approved by stockholders of the Company unless terminated earlier under Section&nbsp;15 of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>7. Term of Award. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The term of each Award shall be determined by the Administrator and stated in the Award Agreement. In the case of an Option, the term shall be ten (10)&nbsp;years
from the Grant Date or such shorter term as may be provided in the Award Agreement; provided that an Incentive Stock Option granted to an Employee who on the Grant Date owns stock representing more than ten percent (10%) of the voting power of all
classes of stock of the Company or any Subsidiary shall have a term of no more than five (5)&nbsp;years from the Grant Date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>8. Options.
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Administrator may grant an Option or provide for the grant of an Option, either from time to time in the discretion of the Administrator or
automatically upon the occurrence of specified events, including, without limitation, the achievement of performance goals, the satisfaction of an event or condition within the control of the Awardee or within the control of others. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) <I>Option Agreement</I>. Each Option Agreement shall contain provisions regarding (i)&nbsp;the number of Shares that may be issued upon
exercise of the Option, (ii)&nbsp;the type of Option, (iii)&nbsp;the exercise price of the Shares and the means of payment for the Shares, (iv)&nbsp;the term of the Option, (v)&nbsp;such terms and conditions on the vesting and/or exercisability of
an Option as may be determined from time to time by the Administrator, (vi)&nbsp;restrictions on the transfer of the Option or the Shares issued upon exercise of the Option and forfeiture provisions, and (vii)&nbsp;such further terms and conditions,
in each case not inconsistent with this Plan as may be determined from time to time by the Administrator. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) <I>Exercise Price</I>.
The per share exercise price for the Shares to be issued pursuant to exercise of an Option shall be determined by the Administrator, subject to the following: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT
STYLE="font-family:ARIAL" SIZE="2">i. In the case of an Incentive Stock Option, the per Share exercise price shall be no less than one hundred percent (100%) of the Fair Market Value per Share on the Grant Date; provided however, that in the case of
an Incentive Stock Option granted to an Employee who on the Grant Date owns stock representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Parent or Subsidiary, the per Share exercise
price shall be no less than one hundred ten percent (110%) of the Fair Market Value per Share on the Grant Date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">ii. In the case of a
Nonstatutory Stock Option, the per Share exercise price shall be no less than one hundred percent (100%) of the Fair Market Value per Share on the Grant Date. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">iii. Notwithstanding the foregoing, at the Administrator&#146;s discretion, Conversion Awards may be
granted in substitution and/or conversion of options of an acquired entity, with a per Share exercise price of less than 100% of the Fair Market Value per Share on the date of such substitution and/or conversion. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c) <I>Vesting Period and Exercise Dates</I>. Options granted under this Plan shall vest and/or be exercisable at such time and in such
installments during the period prior to the expiration of the Option&#146;s term as determined by the Administrator. The Administrator shall have the right to make the timing of the ability to exercise any Option granted under this Plan subject to
continued employment, the passage of time and/or such performance requirements as deemed appropriate by the Administrator, or to grant fully vested Options. At any time after the grant of an Option, the Administrator may reduce or eliminate any
restrictions surrounding any Participant&#146;s right to exercise all or part of the Option. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(d) <I>Form of Consideration</I>. The
Administrator shall determine the acceptable form of consideration for exercising an Option, including the method of payment, either through the terms of the Option Agreement or at the time of exercise of an Option. Acceptable forms of consideration
may include: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">i. cash; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">ii. check or wire transfer (denominated in U.S. Dollars); </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT
STYLE="font-family:ARIAL" SIZE="2">iii. subject to the Company&#146;s discretion to refuse for any reason and at any time to accept such consideration and subject to any conditions or limitations established by the Administrator, other Shares held
by the Participant which have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which said Option shall be exercised; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT
STYLE="font-family:ARIAL" SIZE="2">iv. consideration received by the Company under a broker-assisted sale and remittance program acceptable to the Administrator; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT
STYLE="font-family:ARIAL" SIZE="2">v. cashless &#147;net exercise&#148; arrangement pursuant to which the Company will reduce the number of Shares issued upon exercise by the largest whole number of Shares having an aggregate Fair Market Value that
does not exceed the aggregate exercise price; provided that the Company shall accept a cash or other payment from the Participant to the extent of any remaining balance of the exercise price not satisfied by such reduction in the number of whole
Shares to be issued; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">vi. such other consideration and method of payment for the issuance of Shares to the extent permitted by
Applicable Laws; or </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">vii. any combination of the foregoing methods of payment. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(e) <I>No Option (or Stock Appreciation Right) Repricings</I>. Other than in connection with a change in the Company&#146;s capitalization (as
described in Section&nbsp;14(a) of the Plan), a Repricing (as defined below) is prohibited without approval by the stockholders of the Company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-10 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">&#147;<B>Repricing</B>&#148; means any of the following or any other action that has the same purpose
and effect: (a)&nbsp;lowering the exercise price of an outstanding Option or Stock Appreciation Right granted under this Plan after it is granted; (b)&nbsp;any other action affecting an outstanding Option or Stock Appreciation Right granted under
this Plan that is treated as a repricing under United States generally accepted accounting principles; (c)&nbsp;canceling an outstanding Option or Stock Appreciation Right granted under this Plan at a time when its exercise or purchase price exceeds
the then fair market value of the stock underlying such outstanding Option or Stock Appreciation Right, in exchange for another Option or Stock Appreciation Right or a cash payment, unless the cancellation and exchange occurs in connection with a
merger, consolidation, sale of substantially all the Company&#146;s assets, acquisition, <FONT STYLE="white-space:nowrap">spin-off,</FONT> <FONT STYLE="white-space:nowrap">spin-out,</FONT> or other similar corporate transaction. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>9. Effect of Termination of Continuous Service on Awards </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(a) <I>Generally</I>. Unless otherwise provided for by the Administrator, upon an Awardee&#146;s Termination of Continuous Service other than as a result of circumstances described in Sections 9(b), (c), (d) and
(e)&nbsp;below, all outstanding Awards granted to such Awardee that were vested and exercisable as of the date of the Awardee&#146;s Termination of Continuous Service may be exercised by the Awardee until the earlier of (A)&nbsp;three (3) months
following Awardee&#146;s Termination of Continuous Service or (B)&nbsp;the expiration of the term of such Award; provided, however, that the Administrator may in the Award Agreement specify a period of time (but not beyond the expiration date of the
Award) following Termination of Continuous Service during which the Awardee may exercise the Award as to Shares that were vested and exercisable as of the date of Termination of Continuous Service. To the extent such a period following Termination
of Continuous Service is specified, the Award shall automatically terminate at the end of such period to the extent the Awardee has not exercised it within such period. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(b) <I>Disability of Awardee</I>. Unless otherwise provided for by the Administrator, upon an Awardee&#146;s Termination of Continuous Service as a result of the Awardee&#146;s disability, including Total and
Permanent Disability, all outstanding Awards granted to such Awardee that were vested and exercisable as of the date of the Awardee&#146;s Termination of Continuous Service may be exercised by the Awardee until the earlier of (A)&nbsp;twelve (12)
months following Awardee&#146;s Termination of Continuous Service as a result of Awardee&#146;s disability, including Total and Permanent Disability or (B)&nbsp;the expiration of the term of such Award. If the Participant does not exercise such
Award within the time specified, the Award (to the extent not exercised) shall automatically terminate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c) <I>Death of Awardee</I>.
Unless otherwise provided for by the Administrator, upon an Awardee&#146;s Termination of Continuous Service as a result of the Awardee&#146;s death, all outstanding Awards granted to such Awardee that were vested and exercisable as of the date of
the Awardee&#146;s death may be exercised until the earlier of (A)&nbsp;twelve (12) months following the Awardee&#146;s death or (B)&nbsp;the expiration of the term of such Award. If an Award is held by the Awardee when he or she dies, such Award
may be exercised, to the extent the Award is vested and exercisable, by the beneficiary designated by the Awardee (as provided in Section&nbsp;16 of the Plan), the executor or administrator of the Awardee&#146;s estate or, if none, by the person(s)
entitled to exercise the Award under the Awardee&#146;s will or the laws of descent or distribution; provided that the Company need not accept exercise of an Award by such beneficiary, executor or administrator unless the Company has satisfactory
evidence of such person&#146;s authority to act as such. If the Award is not so exercised within the time specified, such Award (to the extent not exercised) shall automatically terminate. The Awardee&#146;s service shall be deemed to have
terminated on account of death if the Awardee dies within three (3)&nbsp;months (or such longer period as determined by the Administrator, in its discretion) after the Awardee&#146;s Termination of Continuous Service. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-11 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(d) <I>Termination for Cause.</I> The Administrator has the authority to cause all outstanding Awards
held by an Awardee to terminate immediately in their entirety (including as to vested Awards) upon first notification to the Awardee of the Awardee&#146;s Termination of Continuous Service for Cause in accordance with Section&nbsp;4(b)(xvi) above.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(e) <I>Other Terminations of Continuous Service.</I> The Administrator may provide in the applicable Award Agreement for different
treatment of Awards upon Termination of Continuous Service of the Awardee than that specified above. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(f) <I>Extension of Exercise
Period.</I> The Administrator shall have full power and authority to extend the period of time for which an Award is to remain exercisable following an Awardee&#146;s Termination of Continuous Service from the periods set forth in Sections 9(a),
(b), (c), (d) and (e)&nbsp;above or in the Award Agreement to such greater time as the Administrator shall deem appropriate, provided that in no event shall such Award be exercisable later than the date of expiration of the term of such Award as set
forth in the Award Agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(g) <I>Extension if Exercise Prevented by Law.</I> Notwithstanding the foregoing, other than a
termination for Cause, if a sale within the applicable time periods set forth in Section&nbsp;9(a), (b), (c) and (e)&nbsp;above or in the Award Agreement is prevented by Section&nbsp;18 below, the Award shall remain exercisable until thirty
(30)&nbsp;days after the date the Awardee is notified by the Company that the Award is exercisable, but in any event no later than the Award expiration date. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%;padding-bottom:0px; "><FONT STYLE="font-family:ARIAL" SIZE="2">(h) <I>Extension if Subject to Section</I><I></I><I>&nbsp;16(b).</I> Notwithstanding the foregoing, other than a termination
for Cause, if a sale within the applicable time periods set forth in Section&nbsp;9(a), (b), (c) and (e)&nbsp;above or in the Award Agreement would subject the Awardee to a suit under Section&nbsp;16(b) of the Exchange Act, the Award shall remain
exercisable until the earliest to occur of (i)&nbsp;the tenth (10</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">) day
following the date on which a sale of shares by the Awardee would no longer be subject to suit, (ii)&nbsp;the one hundred ninetieth (190</FONT><FONT STYLE="font-family:ARIAL" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:ARIAL" SIZE="2">) day after Awardee&#146;s Termination of Continuous Service, or (iii)&nbsp;the Award expiration date. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>10. Incentive Stock Option Limitations/Terms. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(a) <I>Eligibility.</I> Only employees (as determined in accordance with Section&nbsp;3401(c) of the Code and the regulations promulgated thereunder) of the Company or any of its Subsidiaries may be granted
Incentive Stock Options. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) <I>$100,000 Limitation.</I> Notwithstanding the designation &#147;Incentive Stock Option&#148; in an
Option Agreement, if and to the extent that the aggregate Fair Market Value of the Shares with respect to which Incentive Stock Options are exercisable for the first time by the Awardee during any calendar year (under all plans of the Company and
any of its Subsidiaries) exceeds U.S. $100,000, such Options shall be treated as Nonstatutory Stock Options. For purposes of this Section&nbsp;10(b), Incentive Stock Options shall be taken into account in the order in which they were granted. The
Fair Market Value of the Shares shall be determined as of the Grant Date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c) <I>Transferability.</I> An Incentive Stock Option may not
be sold, pledged, assigned, hypothecated, transferred or disposed of in any manner by the Awardee otherwise than by will or the laws of descent and distribution, and, during the lifetime of such Awardee, may only be exercised by the Awardee. If the
terms of an Incentive Stock Option are amended to permit transferability, the Option will be treated for tax purposes as a Nonstatutory Stock Option. The designation of a beneficiary by an Awardee will not constitute a transfer. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-12 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(d) <I>Exercise Price.</I> The per Share exercise price of an Incentive Stock Option shall be
determined by the Administrator in accordance with Section&nbsp;8(b)(i) of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(e) <I>Other Terms.</I> Option Agreements
evidencing Incentive Stock Options shall contain such other terms and conditions as may be necessary to qualify, to the extent determined desirable by the Administrator, with the applicable provisions of Section&nbsp;422 of the Code. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>11. Exercise of Award. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) <I>Procedure
for Exercise.</I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">i. Any Award granted hereunder shall be exercisable according to the terms of the Plan and at such times and under
such conditions as determined by the Administrator and set forth in the respective Award Agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">ii. An Award shall be deemed
exercised when the Company receives (A)&nbsp;written or electronic notice of exercise (in accordance with the Award Agreement) from the person entitled to exercise the Award; (B)&nbsp;full payment for the Shares with respect to which the related
Award is exercised; and (C)&nbsp;payment of all applicable withholding taxes (if any). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">iii. An Award may not be exercised for a
fraction of a Share. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) <I>Rights as a Stockholder.</I> The Company shall issue (or cause to be issued) such Shares as
administratively practicable after the Award is exercised. Shares issued upon exercise of an Award shall be issued in the name of the Participant or, if requested by the Participant, in the name of the Participant and his or her spouse. Unless
provided otherwise by the Administrator or pursuant to this Plan, until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive
dividends or any other rights as a stockholder shall exist with respect to the Shares subject to an Award, notwithstanding the exercise of the Award. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>12. Stock Awards. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) <I>Stock Award
Agreement.</I> Each Stock Award Agreement shall contain provisions regarding (i)&nbsp;the number of Shares subject to such Stock Award or a formula for determining such number, (ii)&nbsp;the purchase price of the Shares, if any, and the means of
payment for the Shares, (iii)&nbsp;the performance criteria (including Performance Criteria), if any, and level of achievement versus these criteria that shall determine the number of Shares granted, issued, retainable and/or vested, (iv)&nbsp;such
terms and conditions on the grant, issuance, vesting, settlement and/or forfeiture of the Shares as may be determined from time to time by the Administrator, (v)&nbsp;restrictions on the transferability of the Stock Award and (vi)&nbsp;such further
terms and conditions in each case not inconsistent with this Plan as may be determined from time to time by the Administrator. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b)
<I>Restrictions and Performance Criteria.</I> The grant, issuance, retention, settlement and/or vesting of each Stock Award or the Shares subject thereto may be subject to such performance criteria (including Performance Criteria) and level of
achievement versus these criteria as the Administrator shall determine, which criteria may be based on financial </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-13 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">
performance, personal performance evaluations and/or completion of service by the Awardee. The Committee shall establish the Performance Criteria applicable to, and the formula for calculating
the amount payable under, the Award no later than the earlier of (a)&nbsp;the date ninety (90)&nbsp;days after the commencement of the applicable performance period, or (b)&nbsp;the date on which 25% of the performance period has elapsed, and in any
event at a time when the achievement of the applicable Performance Criteria remains substantially uncertain. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c) <I>Forfeiture.</I>
Unless otherwise provided for by the Administrator, upon the Awardee&#146;s Termination of Continuous Service, the Stock Award and the Shares subject thereto shall be forfeited, provided that to the extent that the Participant purchased or earned
any Shares, the Company shall have a right to repurchase the unvested Shares at such price and on such terms and conditions as the Administrator determines. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(d) <I>Rights as a Stockholder.</I> Unless otherwise provided by the Administrator in the Award Agreement, the Participant shall have the rights equivalent to those of a stockholder and shall be a stockholder only
after Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) to the Participant. Unless otherwise provided by the Administrator, a Participant holding Stock Units
shall not be entitled to receive dividend payments or any credit therefor as if he or she was an actual stockholder. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(e) Stock
Appreciation Rights. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">i. <I>General.</I> Stock Appreciation Rights may be granted either alone, in addition to, or in tandem with other
Awards granted under the Plan. The Administrator may grant Stock Appreciation Rights to eligible Participants subject to terms and conditions not inconsistent with this Plan and determined by the Administrator. The specific terms and conditions
applicable to the Participant shall be provided for in the Stock Award Agreement. Stock Appreciation Rights shall be exercisable, in whole or in part, at such times as the Administrator shall specify in the Stock Award Agreement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">ii. <I>Exercise of Stock Appreciation Right.</I> Upon the exercise of a Stock Appreciation Right, in whole or in part, the Participant shall be
entitled to a payment in an amount equal to the excess of the Fair Market Value on the date of exercise of a fixed number of Shares covered by the exercised portion of the Stock Appreciation Right, over the Fair Market Value on the Grant Date of the
Shares covered by the exercised portion of the Stock Appreciation Right (or such other amount calculated with respect to Shares subject to the Award as the Administrator may determine). The amount due to the Participant upon the exercise of a Stock
Appreciation Right shall be paid in such form of consideration as determined by the Administrator and may be in cash, Shares or a combination thereof, over the period or periods specified in the Stock Award Agreement. A Stock Award Agreement may
place limits on the amount that may be paid over any specified period or periods upon the exercise of a Stock Appreciation Right, on an aggregate basis or as to any Participant. A Stock Appreciation Right shall be considered exercised when the
Company receives written notice of exercise in accordance with the terms of the Stock Award Agreement from the person entitled to exercise the Stock Appreciation Right. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT
STYLE="font-family:ARIAL" SIZE="2">iii. <I>Nonassignability of Stock Appreciation Rights.</I> Except as determined by the Administrator, no Stock Appreciation Right shall be assignable or otherwise transferable by the Participant except by will or
by the laws of descent and distribution. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-14 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>13. Other Provisions Applicable to Awards. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) <I><FONT STYLE="white-space:nowrap">Non-Transferability</FONT> of Awards.</I> Unless determined otherwise by the Administrator, an Award may
not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner for value other than by beneficiary designation, will or by the laws of descent or distribution. Subject to Section&nbsp;10(c), the Administrator may in its
discretion make an Award transferable to an Awardee&#146;s family member or any other person or entity as it deems appropriate. If the Administrator makes an Award transferable, either at the time of grant or thereafter, such Award shall contain
such additional terms and conditions as the Administrator deems appropriate, and any transferee shall be deemed to be bound by such terms upon acceptance of such transfer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(b)<I> Performance Criteria.</I> For purposes of this Plan, the term &#147;Performance Criteria&#148; shall mean any one or more of the following performance criteria, either individually, alternatively or in any
combination, applied to either the Company as a whole or to a business unit, Affiliate or business segment, either individually, alternatively or in any combination, and measured either annually or cumulatively over a period of years, on an absolute
basis or relative to a <FONT STYLE="white-space:nowrap">pre-established</FONT> target, to previous years&#146; results or to a designated comparison group, in each case as specified by the Administrator in the Award: (i)&nbsp;cash flow;
(ii)&nbsp;earnings (including gross margin; earnings before interest and taxes; earnings before interest, taxes, depreciation and amortization; earnings before taxes; and net earnings); (iii) earnings per share; (iv)&nbsp;growth in earnings or
earnings per share; (v)&nbsp;stock price; (vi)&nbsp;return on equity or average stockholders&#146; equity; (vii)&nbsp;total stockholder return; (viii)&nbsp;return on capital; (ix)&nbsp;return on assets or net assets; (x)&nbsp;return on investment;
(xi)&nbsp;revenue or growth in revenue; (xii)&nbsp;income or net income; (xiii)&nbsp;operating income or net operating income, in aggregate or per share; (xiv)&nbsp;operating profit or net operating profit; (xv)&nbsp;operating margin;
(xvi)&nbsp;return on operating revenue; (xvii)&nbsp;market share; (xviii)&nbsp;contract awards or backlog; (xix)&nbsp;overhead or other expense reduction; (xx)&nbsp;growth in stockholder value relative to the moving average of the S&amp;P 500 Index
or a peer group index; (xxi)&nbsp;credit rating; (xxii)&nbsp;strategic plan development and implementation (including individual performance objectives that relate to achievement of the Company&#146;s or any business unit&#146;s strategic plan);
(xxiii) improvement in workforce diversity; (xxiv) growth of revenue, operating income or net income; (xxv)&nbsp;efficiency ratio; (xxvi)&nbsp;ratio of nonperforming assets to total assets; and (xxvii)&nbsp;any other similar criteria. The Committee
may adjust any evaluation of performance under a Performance Criteria to exclude any of the following events that occurs during a performance period: (A)&nbsp;asset write-downs; (B)&nbsp;litigation or claim judgments or settlements; (C)&nbsp;the
effect of changes in tax law, accounting principles or other such laws or provisions affecting reported results; (D)&nbsp;accruals for reorganization and restructuring programs; (E)&nbsp;any gains or losses classified as extraordinary or as
discontinued operations in the Company&#146;s financial statements; and (F)&nbsp;mergers, acquisitions or divestitures. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c)<I>
Certification.</I> Prior to the payment of any compensation under an Award subject to any Performance Criteria, the Committee shall certify the extent to which any Performance Criteria and any other material terms under such Award have been
satisfied (other than in cases where such relate solely to the increase in the value of the Common Stock). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(d) <I>Tax Withholding
Obligation.</I> As a condition of the grant, issuance, vesting, exercise or settlement of an Award granted under the Plan, the Participant shall make such arrangements as the Administrator may require for the satisfaction of any applicable federal,
state, local or foreign withholding tax obligations that may arise in connection with such grant, issuance, vesting, exercise or settlement of the Award. The Company shall not be required to issue any Shares under the Plan until such obligations are
satisfied. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-15 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(e) <I>Compliance with Section</I><I></I><I>&nbsp;409A.</I> Notwithstanding anything to the contrary
contained herein, to the extent that the Administrator determines that any Award granted under the Plan is subject to Code Section&nbsp;409A and unless otherwise specified in the applicable Award Agreement, the Award Agreement evidencing such Award
shall incorporate the terms and conditions necessary for such Award to avoid the consequences described in Code Section&nbsp;409A(a)(1), and to the maximum extent permitted under Applicable Law (and unless otherwise stated in the applicable Award
Agreement), the Plan and the Award Agreements shall be interpreted in a manner that results in their conforming to the requirements of Code Section&nbsp;409A(a)(2), (3) and (4)&nbsp;and any Department of Treasury or Internal Revenue Service
regulations or other interpretive guidance issued under Section&nbsp;409A (whenever issued, the &#147;<B>Guidance</B>&#148; ). Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement provides otherwise, with specific
reference to this sentence), to the extent that a Participant holding an Award that constitutes &#147;deferred compensation&#148; under Section&nbsp;409A and the Guidance is a &#147;specified employee&#148; (also as defined thereunder), no
distribution or payment of any amount shall be made before a date that is six (6)&nbsp;months following the date of such Participant&#146;s &#147;separation from service&#148; (as defined in Section&nbsp;409A and the Guidance) or, if earlier, the
date of the Participant&#146;s death. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(f) <I>Deferral of Award Benefits. </I>The Administrator may in its discretion and upon such
terms and conditions as it determines appropriate permit one or more Participants whom it selects to (a)&nbsp;defer compensation payable pursuant to the terms of an Award, or (b)&nbsp;defer compensation arising outside the terms of this Plan
pursuant to a program that provides for deferred payment in satisfaction of such other compensation amounts through the issuance of one or more Awards. Any such deferral arrangement shall be evidenced by an Award Agreement in such form as the
Administrator shall from time to time establish, and no such deferral arrangement shall be a valid and binding obligation unless evidenced by a fully executed Award Agreement, the form of which the Administrator has approved, including through the
Administrator&#146;s establishing a written program (the &#147;<B>Program</B>&#148;) under this Plan to govern the form of Award Agreements participating in such Program. Any such Award Agreement or Program shall specify the treatment of dividends
or dividend equivalent rights (if any) that apply to Awards governed thereby, and shall further provide that any elections governing payment of amounts pursuant to such Program shall be in writing, shall be delivered to the Company or its agent in a
form and manner that complies with Code Section&nbsp;409A and the Guidance, and shall specify the amount to be distributed in settlement of the deferral arrangement, as well as the time and form of such distribution in a manner that complies with
Code Section&nbsp;409A and the Guidance. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>14. Adjustments upon Changes in Capitalization, Dissolution, or Change In Control </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) <I>Changes in Capitalization.</I> Subject to any required action by the stockholders of the Company, the number of shares of Common Stock
covered by each outstanding Award, the number of shares of Common Stock which have been authorized for issuance under the Plan, but as to which no Awards have yet been granted or which have been returned to the Plan upon cancellation, forfeiture or
expiration of an Award, the price per Share subject to each such outstanding Award and each of the share limits set forth in Section&nbsp;3(a) and 3(b), shall be proportionately adjusted for any increase or decrease in the number of issued shares of
Common Stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, payment of a dividend or distribution in a form other than stock (excepting normal cash dividends) that has a
material effect on the Fair Market Value of the shares of Common Stock, or any other increase or decrease in the number of issued shares of Common Stock effected without receipt of consideration by the Company; provided, however, that conversion of
any convertible securities of the Company shall not be deemed to have been &#147;effected without receipt of consideration.&#148; Such adjustment shall be made by the Administrator, whose determination in that respect
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-16 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">
shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any
class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Common Stock subject to an Award. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(b) <I>Dissolution or Liquidation. </I>In the event of the proposed dissolution or liquidation of the Company, the Administrator shall notify each Participant as soon as practicable prior to the effective date of
such proposed transaction. To the extent it has not been previously exercised or the Shares subject thereto issued to the Awardee and unless otherwise determined by the Administrator, an Award will terminate immediately prior to the consummation of
such proposed transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c) <I>Change in Control.</I> In the event there is a Change in Control of the Company, as determined by the
Board or a Committee, the Board or Committee may, in its discretion, (i)&nbsp;provide for the assumption or substitution of, or adjustment (including to the number and type of Shares and exercise or purchase price applicable) to, each outstanding
Award; (ii)&nbsp;accelerate the vesting of Options and terminate any restrictions on Stock Awards; and/or (iii)&nbsp;provide for termination of Awards as a result of the Change in Control on such terms and conditions as it deems appropriate,
including providing for the cancellation of Awards for a cash or other payment to the Participant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">For purposes of this
Section&nbsp;14(c), an Award shall be considered assumed, without limitation, if, at the time of issuance of the stock or other consideration upon a Change in Control, as the case may be, each holder of an Award would be entitled to receive upon
exercise of the Award the same number and kind of shares of stock or the same amount of property, cash or securities as such holder would have been entitled to receive upon the occurrence of the transaction if the holder had been, immediately prior
to such transaction, the holder of the number of Shares covered by the Award at such time (after giving effect to any adjustments in the number of Shares covered by the Award as provided for in Section&nbsp;14(a); provided that if such consideration
received in the transaction is not solely common stock of the successor corporation, the Administrator may, with the consent of the successor corporation, provide for the consideration to be received upon exercise of the Award to be solely common
stock of the successor corporation equal to the Fair Market Value of the per Share consideration received by holders of Common Stock in the transaction. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>15. Amendment and Termination of the Plan. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) <I>Amendment and Termination.</I> The Administrator may amend, alter or discontinue the Plan or any Award Agreement, but any such amendment
shall be subject to approval of the stockholders of the Company in the manner and to the extent required by Applicable Laws. In addition, without limiting the foregoing, unless approved by the stockholders of the Company, no such amendment shall be
made that would: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">i. materially increase the maximum number of Shares for which Awards may be granted under the Plan, other than an
increase pursuant to Section&nbsp;3 or Section&nbsp;14 of the Plan; or </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">ii. reduce the minimum exercise prices at which Options may be
granted under the Plan (as set forth in Section&nbsp;8(b)); or </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">iii. result in a Repricing (as defined in Section&nbsp;8(e)) of Options
or Stock Appreciation Rights; or </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">iv. change the class of persons eligible to receive Awards under the Plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-17 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) <I>Effect of Amendment or Termination.</I> No amendment, suspension or termination of the Plan
shall impair the rights of any Award, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by the Participant and the Company; provided further that the Administrator may amend
an outstanding Award in order to conform it to the Administrator&#146;s intent (in its sole discretion) that such Award not be subject to Code Section&nbsp;409A(a)(1)(B). Termination of the Plan shall not affect the Administrator&#146;s ability to
exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c)
<I>Effect of the Plan on Other Arrangements.</I> Neither the adoption of the Plan by the Board or a Committee nor the submission of the Plan to the stockholders of the Company for approval shall be construed as creating any limitations on the power
of the Board or any Committee to adopt such other incentive arrangements as it or they may deem desirable, including without limitation, the granting of restricted stock, stock options or cash bonuses otherwise than under the Plan, and such
arrangements may be either generally applicable or applicable only in specific cases. The value of Awards granted pursuant to the Plan will not be included as compensation, earnings, salaries or other similar terms used when calculating an
Awardee&#146;s benefits under any employee benefit plan sponsored by the Company or any Subsidiary except as such plan otherwise expressly provides. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>16. Designation of Beneficiary. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) An
Awardee may file a written designation of a beneficiary who is to receive the Awardee&#146;s rights pursuant to Awardee&#146;s Award or the Awardee may include his or her Awards in an omnibus beneficiary designation for all benefits under the Plan.
To the extent that Awardee has completed a designation of beneficiary while employed with the Company, such beneficiary designation shall remain in effect with respect to any Award hereunder until changed by the Awardee to the extent enforceable
under Applicable Law. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) Such designation of beneficiary may be changed by the Awardee at any time by written notice. In the event of
the death of an Awardee and in the absence of a beneficiary validly designated under the Plan who is living at the time of such Awardee&#146;s death, the Company shall allow the executor or administrator of the estate of the Awardee to exercise the
Award, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may allow the spouse or one or more dependents or relatives of the Awardee to exercise the Award to the extent
permissible under Applicable Law or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>17. No Right to Awards or to Employment. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">No person shall
have any claim or right to be granted an Award and the grant of any Award shall not be construed as giving an Awardee the right to continue in the employ or service of the Company or its Affiliates. Further, the Company and its Affiliates expressly
reserve the right, at any time, to dismiss any Employee, Consultant or Awardee at any time without liability or any claim under the Plan, except as provided herein or in any Award Agreement entered into hereunder. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-18 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>18. Legal Compliance. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">Subject to Section&nbsp;22, Shares shall not be issued pursuant to the exercise of an Option or Stock Award unless the exercise of such Option or Stock Award and the issuance and delivery of such Shares shall
comply with Applicable Laws and shall be further subject to the approval of counsel for the Company with respect to such compliance. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>19. Reservation
of Shares. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Company, during the term of this Plan, will at all times reserve and keep available such number of Shares as shall be sufficient to
satisfy the requirements of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>20. Notice. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">Any written notice to the Company required by any provisions of this Plan shall be addressed to the Secretary of the Company and shall be effective when received. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>21. Governing Law; Interpretation of Plan and Awards. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(a) This Plan and all determinations made and actions taken pursuant hereto shall be governed by the substantive laws, but not the choice of law rules, of the state of Delaware. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) In the event that any provision of the Plan or any Award granted under the Plan is declared to be illegal, invalid or otherwise unenforceable
by a court of competent jurisdiction, such provision shall be reformed, if possible, to the extent necessary to render it legal, valid and enforceable, or otherwise deleted, and the remainder of the terms of the Plan and/or Award shall not be
affected except to the extent necessary to reform or delete such illegal, invalid or unenforceable provision. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c) The headings
preceding the text of the sections hereof are inserted solely for convenience of reference, and shall not constitute a part of the Plan, nor shall they affect its meaning, construction or effect. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(d) The terms of the Plan and any Award shall inure to the benefit of and be binding upon the parties hereto and their respective permitted heirs,
beneficiaries, successors and assigns. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(e) All questions arising under the Plan or under any Award shall be decided by the
Administrator in its total and absolute discretion. In the event the Participant believes that a decision by the Administrator with respect to such person was arbitrary or capricious, the Participant may request arbitration with respect to such
decision. The review by the arbitrator shall be limited to determining whether the Administrator&#146;s decision was arbitrary or capricious. This arbitration shall be the sole and exclusive review permitted of the Administrator&#146;s decision, and
the Awardee shall as a condition to the receipt of an Award be deemed to explicitly waive any right to judicial review. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(f) Notice of
demand for arbitration shall be made in writing to the Administrator within thirty (30)&nbsp;days after the applicable decision by the Administrator. The arbitrator shall be appointed in accordance with the Commercial Rules of Dispute Resolution of
the American Arbitration Association; provided, however, that the arbitration shall not be administered by the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-19 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">
American Arbitration Association. The arbitration shall be administered and conducted by the arbitrator pursuant to the Commercial Rules of Dispute Resolution of the American Arbitration
Association. The decision of the arbitrator on the issue(s) presented for arbitration shall be final and conclusive and may be enforced in any court of competent jurisdiction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2"><B>22. Limitation on Liability. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">The Company and any Affiliate which is in existence or hereafter comes into
existence shall not be liable to a Participant, an Employee, an Awardee or any other persons as to: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) <I>The <FONT
STYLE="white-space:nowrap">Non-Issuance</FONT> of Shares.</I> The <FONT STYLE="white-space:nowrap">non-issuance</FONT> or sale of Shares (including under Section&nbsp;18 above) as to which the Company has been unable, or the Arbitration deems it
infeasible, to obtain from any regulatory body having jurisdiction the authority deemed by the Company&#146;s counsel to be necessary to the lawful issuance and sale of any shares hereunder; and </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) <I>Tax Consequences.</I> Any tax consequence realized by any Participant, Employee, Awardee or other person due to the receipt, vesting,
exercise or settlement of any Option or other Award granted hereunder or due to the transfer of any Shares issued hereunder. The Participant is responsible for, and by accepting an Award under the Plan agrees to bear, all taxes of any nature that
are legally imposed upon the Participant in connection with an Award, and the Company does not assume, and will not be liable to any party for, any cost or liability arising in connection with such tax liability legally imposed on the Participant.
In particular, Awards issued under the Plan may be characterized by the Internal Revenue Service (the &#147;IRS&#148;) as &#147;deferred compensation&#148; under the Code resulting in additional taxes, including in some cases interest and penalties.
In the event the IRS determines that an Award constitutes deferred compensation under the Code or challenges any good faith characterization made by the Company or any other party of the tax treatment applicable to an Award, the Participant will be
responsible for the additional taxes, and interest and penalties, if any, that are determined to apply if such challenge succeeds, and the Company will not reimburse the Participant for the amount of any additional taxes, penalties or interest that
result. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c) <I>Forfeiture.</I> The requirement that Participant forfeit an Award, or the benefits received or to be received under an
Award, pursuant to any Applicable Law. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>23. Indemnification. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">In addition to such other rights of indemnification as they may have as members of the Board or officers or employees of the Company or an Affiliate, members of the Board and any officers or employees of the
Company or an Affiliate to whom authority to act for the Board or the Company is delegated shall be indemnified by the Company against all reasonable expenses, including attorneys&#146; fees, actually and necessarily incurred in connection with the
defense of any action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with the Plan, or any right granted hereunder,
and against all amounts paid by them in settlement thereof (provided such settlement is approved by independent legal counsel selected by the Company) or paid by them in satisfaction of a judgment in any such action, suit or proceeding, except in
relation to matters as to which it shall be adjudged in any such action, suit or proceeding that such person is liable for gross negligence, bad faith or intentional misconduct in duties; provided, however, that within sixty (60)&nbsp;days after the
institution of such action, suit or proceeding, such person shall offer to the Company, in writing, the opportunity at its own expense to handle and defend the same. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-20 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>24. Unfunded Plan. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">Insofar as it provides for Awards, the Plan shall be unfunded. Although bookkeeping accounts may be established with respect to Awardees who are granted Stock Awards under this Plan, any such accounts will be used
merely as a bookkeeping convenience. The Company shall not be required to segregate any assets which may at any time be represented by Awards, nor shall this Plan be construed as providing for such segregation, nor shall the Company nor the
Administrator be deemed to be a trustee of stock or cash to be awarded under the Plan. Any liability of the Company to any Participant with respect to an Award shall be based solely upon any contractual obligations which may be created by the Plan;
no such obligation of the Company shall be deemed to be secured by any pledge or other encumbrance on any property of the Company. Neither the Company nor the Administrator shall be required to give any security or bond for the performance of any
obligation which may be created by this Plan. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">A-21 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:ARIAL" SIZE="2"><B>EXHIBIT B </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:ARIAL" SIZE="2">HERON THERAPEUTICS, INC. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2">1997 EMPLOYEE STOCK PURCHASE PLAN </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="2">(as amended through June&nbsp;18, 2019) </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">1. PURPOSE.
This Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan is designed to encourage and assist employees of Heron Therapeutics, Inc. and participating subsidiaries to acquire an equity interest in the Company through the purchase of shares of
Company common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">2. DEFINITIONS. As used herein, the following definitions shall apply: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) &#147;Administrator&#148; shall mean the entity, either the Board or the committee of the Board, responsible for administering this Plan, as
provided in Section&nbsp;3. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) &#147;Board&#148; shall mean the Board of Directors of the Company, as constituted from time to time.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c) &#147;Code&#148; shall mean the Internal Revenue Code of 1986, as amended from time to time, and any successor statute. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(d) &#147;Company&#148; shall mean Heron Therapeutics, Inc., a Delaware corporation, and Participating Subsidiaries. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(e) &#147;Common Stock&#148; shall mean the Common Stock, $.01 par value, of the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(f) &#147;Employee&#148; shall mean any individual who is an employee of the Company or a Participating Subsidiary within the meaning of
Section&nbsp;3401(c) of the Code and the Treasury Regulations thereunder. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(g) &#147;Enrollment Date&#148; shall have the meaning set
forth in Section&nbsp;6. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(h) &#147;Fair market value&#148; means as of any given date: (i)&nbsp;the closing price of the Common Stock
on the NASDAQ Stock Market as reported in the Wall Street Journal; or (ii)&nbsp;if the Common Stock is no longer quoted on the NASDAQ Stock Market, but is listed on an established stock exchange or quoted on any other established interdealer
quotation system, the closing price for the Common Stock on such exchange or system, as reported in the Wall Street Journal; or (iii)&nbsp;in the absence of an established market for the Common Stock, the fair market value of the Common Stock as
determined by the Administrator in good faith. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(i) &#147;Lower Price Enrollment Date&#148; shall have the meaning set forth in
Section&nbsp;6. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(j) &#147;Option Period&#148; shall have the meaning set forth in Section&nbsp;7(b). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(k) &#147;Participating Subsidiary&#148; shall mean a Subsidiary which has been designated by the Administrator as covered by the Plan. </FONT></P>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">B-1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(l) &#147;Plan&#148; shall mean this Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan, as it
may be amended from time to time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(m) &#147;Purchase Date&#148; shall have the meaning set forth in Section&nbsp;9(a). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(n) &#147;Section&#148; unless the context clearly indicates otherwise, shall refer to a Section of this Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(o) &#147;Subsidiary&#148; shall mean a &#147;subsidiary corporation&#148; of the Company, whether now or hereafter existing, within the meaning of
Section&nbsp;424(f) of the Code, but only for so long as it is a &#147;subsidiary corporation.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(p) &#147;Trading Day&#148; means
any day on which regular trading occurs on any established stock exchange or market system on which the Common Stock is traded. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">3. ADMINISTRATION.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) Administrator. The Plan shall be administered by the Board or, upon delegation by the Board, by a committee of the Board (in either
case, the &#147;Administrator&#148;). In connection with the administration of the Plan, the Administrator shall have the powers possessed by the Board. The Administrator may act only by a majority of its members. The Administrator may delegate
administrative duties to such employees of the Company as it deems proper, so long as such delegation is not otherwise prohibited by Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> under the Securities Exchange Act of 1934, as amended, or other
applicable law. The Board at any time may terminate the authority delegated to any committee of the Board pursuant to this Section&nbsp;3(a) and revest in the Board the administration of the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) Administrator Determinations Binding. The Administrator may adopt, alter and repeal administrative rules, guidelines and practices governing
the Plan and the options granted under it as it shall deem advisable from time to time, may interpret the terms and provisions of the Plan and the Options granted under it, may correct any defect, omission or inconsistency in the Plan or in any
Option; and may otherwise supervise the administration of the Plan and the Options granted under it. The Administrator may establish, under guidelines from the Board, limits on the number of shares which may be purchased by each participant on an
annual or other periodic basis or on the number of shares which may be purchased on any Purchase Date. All decisions made by the Administrator under the Plan shall be binding on all persons, including the Company and all participants in the Plan. No
member of the Administrator shall be liable for any action that he or she has in good faith taken or failed to take with respect to this Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">4.
NUMBER OF SHARES. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) The Company has reserved for sale under the Plan 775,000 shares of Common Stock. Shares sold under the Plan may
be newly issued shares or shares reacquired in private transactions or open market purchases, but all shares sold under the Plan, regardless of source, shall be counted against the 775,000 share limitation. If at any Purchase Date, the shares
available under the Plan are less than the number all participants would otherwise be entitled to purchase on such date, purchases shall be reduced proportionately to eliminate the deficit. If, at any Purchase Date, the shares which may be purchased
by a participant are restricted on account of a limit on the aggregate shares which may be purchased per employee, purchases under each option shall be reduced proportionately. Any funds that cannot be applied to the purchase of shares due to such
reductions shall be refunded to participants as soon as administratively feasible. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">B-2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) In the event of any reorganization, recapitalization, stock split, reverse stock split, stock
dividend, combination of shares, merger, consolidation, offering of rights, or other similar change in the capital structure of the Company, the Board may make such adjustment, if any, as it deems appropriate in the number, kind, and purchase price
of the shares available for purchase under the Plan and in the maximum number of shares subject to any option under the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">5. ELIGIBILITY
REQUIREMENTS. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) Each Employee of the Company, except those described in the next paragraph, shall become eligible to participate in
the Plan in accordance with Section&nbsp;6 on the first Enrollment Date on or following commencement of his or her employment by the Company or following such period of employment as is designated by the Administrator from time to time.
Participation in the Plan is entirely voluntary. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) The following Employees are not eligible to participate in the Plan: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(i) Employees who would, immediately upon enrollment in the Plan, own directly or indirectly, or hold options or rights to acquire stock
possessing, five percent (5%)&nbsp;or more of the total combined voting power or value of all classes of stock of the Company or any subsidiary of the Company; and </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(ii) Employees who are customarily employed by the Company fewer than twenty (20)&nbsp;hours per week or fewer than five (5)&nbsp;months in any calendar year. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">6. ENROLLMENT. Any eligible employee may enroll or <FONT STYLE="white-space:nowrap">re-enroll</FONT> in the Plan each year as of the close of the first trading day
of: (a)&nbsp;May and November of each such year; or (b)&nbsp;such other days as may be established by the Board from time to time (the &#147;Enrollment Dates&#148;); provided, that the first Enrollment Date shall be April&nbsp;30, 1997. In order to
enroll, an eligible employee must complete, sign, and submit to the Company an enrollment form. Any enrollment form received by the Company by the 20th day of the month preceding an Enrollment Date (or by the Enrollment Date in the case of employees
hired after such 20th day or in the case of the first Enrollment Date), or such other date established by the Administrator from time to time, will be effective on that Enrollment Date. In addition, the Administrator may <FONT
STYLE="white-space:nowrap">re-enroll</FONT> existing participants in the Plan on any Enrollment Date (the &#147;Lower Price Enrollment Date&#148;) on which the fair market value of the Common Stock is lower than the fair market value on such
participant&#146;s existing Enrollment Date. A participant may elect not to <FONT STYLE="white-space:nowrap">re-enroll</FONT> on a Lower Price Enrollment Date by filing a written statement with the Company declaring such election prior to the Lower
Price Enrollment Date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">7. GRANT OF OPTION ENROLLMENT. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(a) Enrollment or <FONT STYLE="white-space:nowrap">re-enrollment</FONT> by a participant in the Plan on an Enrollment Date will constitute the grant by the Company to the participant of an option to purchase shares
of Common Stock from the Company under the Plan. Any participant whose option expires and who has not withdrawn from the Plan will automatically be <FONT STYLE="white-space:nowrap">re-enrolled</FONT> in the Plan and granted a new option on the
Enrollment Date immediately following the date on which the option expires. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) Except as provided in Section&nbsp;10, each option
granted under the Plan shall have the following terms: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(i) the option will have a term of not more than twenty-four (24)&nbsp;months or
such shorter option period as may be established by the Board from time to time (the &#147;Option Period&#148;). Notwithstanding the foregoing, however, whether or not </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">B-3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">
all shares have been purchased thereunder, the option will expire on the earlier to occur of: (A)&nbsp;the completion of the purchase of shares on the last Purchase Date occurring within
twenty-four (24)&nbsp;months after the Enrollment Date for such option, or such shorter option period as may be established by the Board before an Enrollment Date for all options to be granted on such date; or (B)&nbsp;the date on which the
employee&#146;s participation in the Plan terminates for any reason; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(ii) payment for shares purchased under the option will be made
only through payroll withholding in accordance with Section&nbsp;8; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(iii) purchase of shares upon exercise of the option will be
effected only on the Purchase Dates established in accordance with Section&nbsp;9; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(iv) the option, if not altered, amended or revoked
by the Company prior to the relevant Purchase Date, may be accepted only by (x)&nbsp;there having been withheld from the compensation of the employee in accordance with the terms of the Plan amounts sufficient to purchase the Common Stock intended
to be purchased under the option, and (y)&nbsp;the employee being employed by the Company and not having withdrawn from the Plan on the relevant Purchase Date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(v) the price per share under the option will be determined as provided in Section&nbsp;9; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(vi) the
maximum number of shares available for purchase under an option for each one percent (1%)&nbsp;of compensation designated by an employee in accordance with Section&nbsp;8 will, unless otherwise established by the Board before an Enrollment Date for
all options to be granted on such date, be determined by dividing $25,000 by the fair market value of a share of Common Stock on the Enrollment Date, dividing the result by the maximum number of percentage points that an employee may designate under
Section&nbsp;8 at the time such option is granted, and multiplying the result by the number of calendar years included in whole or in part in the period from grant to expiration of the option; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(vii) the option (taken together with all other options then outstanding under this and all other similar stock purchase plans of the Company and
any subsidiary of the Company, collectively &#147;Options&#148;) will in no event give the participant the right to purchase shares at a rate per calendar year which accrues in excess of $25,000 of fair market value of such shares, less the fair
market value of any shares accrued and already purchased during such year under Options which have expired or terminated, determined at the applicable Enrollment Dates; and </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(viii) the option will in all respects be subject to the terms and conditions of the Plan, as interpreted by the Administrator from time to time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">8. PAYROLL AND TAX WITHHOLDING; USE BY COMPANY. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) Each participant shall elect to have amounts
withheld from his or her compensation paid by the Company during the Option Period, at a rate equal to any whole percentage up to a maximum of ten percent (10%), or such lesser percentage as the Board may establish from time to time before an
Enrollment Date. Compensation includes regular salary payments, annual and quarterly bonuses, <FONT STYLE="white-space:nowrap">hire-on</FONT> bonuses, cash recognition awards, commissions, overtime pay, shift premiums, and elective contributions by
the participant to qualified employee benefit plans, but excludes all other payments including, without limitation, long-term disability or workers compensation payments, car allowances, employee referral bonuses,
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">B-4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">
relocation payments, expense reimbursements (including but not limited to travel, entertainment, and moving expenses), salary <FONT STYLE="white-space:nowrap">gross-up</FONT> payments, and <FONT
STYLE="white-space:nowrap">non-cash</FONT> recognition awards. The participant shall designate a rate of withholding in his or her enrollment form and may elect to increase or decrease the rate of contribution effective as of any Enrollment Date, by
delivery to the Company, not later than ten (10)&nbsp;days before such Enrollment Date, of a written notice indicating the revised withholding rate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(b) Payroll withholdings shall be credited to an account maintained for purposes of the Plan on behalf of each participant, as soon as administratively feasible after the withholding occurs. The Company shall be
entitled to use the withholdings for any corporate purpose, shall have no obligation to pay interest on withholdings to any participant, and shall not be obligated to segregate withholdings. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c) Upon disposition of shares acquired by exercise of an option, the participant shall pay, or make provision adequate to the Company for payment
of, all federal, state, and other tax (and similar) withholdings that the Company determines, in its discretion, are required due to the disposition, including any such withholding that the Company determines in its discretion is necessary to allow
the Company to claim tax deductions or other benefits in connection with the disposition. A participant shall make such similar provisions for payment that the Company determines, in its discretion, are required due to the exercise of an option,
including such provisions as are necessary to allow the Company to claim tax deductions or other benefits in connection with the exercise of the option. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">9. PURCHASE OF SHARES. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) On the last Trading
Day immediately preceding an Enrollment Date (other than the first Enrollment Date), or on such other days as may be established by the Board from time to time prior to an Enrollment Date for all options to be granted on such Enrollment Date (each a
&#147;Purchase Date&#148;), the Company shall apply the funds then credited to each participant&#146;s payroll withholdings account to the purchase of whole shares of Common Stock. The cost to the participant for the shares purchased under any
option shall be not less than eighty-five percent (85%)&nbsp;of the lower of: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(i) the fair market value of the Common Stock on the
Enrollment Date for such option; or </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(ii) the fair market value of the Common Stock on the date such option is exercised. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) Any funds in an amount less than the cost of one share of Common Stock left in a participant&#146;s payroll withholdings account on a Purchase
Date shall be carried forward in such account for application on the next Purchase Date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(c) Notwithstanding the terms of
Section&nbsp;9(a), no funds credited to any employee&#146;s payroll withholdings account shall be used to purchase Common Stock on any date prior to the date that the Plan has been approved by the stockholders of the Company, as noted in
Section&nbsp;21. If such approval is not forthcoming within one year from the date that the Plan was approved by the Board of Directors, all amounts withheld shall be distributed to the participants as soon as administratively feasible. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">10. WITHDRAWAL FROM THE PLAN. A participant may withdraw from the Plan in full (but not in part) at any time, effective after written notice thereof is received by
the Company. Unless the Administrator elects to permit a withdrawing participant to </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">B-5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
invest funds credited to his or her withholding account on the Purchase Date immediately following notice of withdrawal, all funds credited to a participant&#146;s payroll withholdings account
shall be distributed to him or her without interest within sixty (60)&nbsp;days after notice of withdrawal is received by the Company. Any eligible employee who has withdrawn from the Plan may enroll in the Plan again on any subsequent Enrollment
Date in accordance with the provisions of Section&nbsp;6. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">11. TERMINATION OF EMPLOYMENT. Participation in the Plan terminates immediately when a
participant ceases to be employed by the Company for any reason whatsoever (including death or disability) or otherwise becomes ineligible to participate in the Plan. As soon as administratively feasible after termination, the Company shall pay to
the participant or his or her beneficiary or legal representative, all amounts credited to the participant&#146;s payroll withholdings account; provided, however, that if a participant ceases to be employed by the Company because of the commencement
of employment with a Subsidiary of the Company that is not a Participating Subsidiary, funds then credited to such participant&#146;s payroll withholdings account shall be applied to the purchase of whole shares of Common Stock at the next Purchase
Date and any funds remaining after such purchase shall be paid to the participant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">12. DESIGNATION OF BENEFICIARY. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) Each participant may designate one or more beneficiaries in the event of death and may, in his or her sole discretion, change such designation
at any time. Any such designation shall be effective upon receipt in written form by the Company and shall control over any disposition by will or otherwise. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(b) As soon as administratively feasible after the death of a participant, amounts credited to his or her account shall be paid in cash to the designated beneficiaries or, in the absence of a designation, to the
executor, administrator, or other legal representative of the participant&#146;s estate. Such payment shall relieve the Company of further liability with respect to the Plan on account of the deceased participant. If more than one beneficiary is
designated, each beneficiary shall receive an equal portion of the account unless the participant has given express contrary written instructions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">13.
ASSIGNMENT. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) The rights of a participant under the Plan shall not be assignable by such participant, by operation of law or
otherwise. No participant may create a lien on any funds, securities, rights, or other property held by the Company for the account of the participant under the Plan, except to the extent that there has been a designation of beneficiaries in
accordance with the Plan, and except to the extent permitted by the laws of descent and distribution if beneficiaries have not been designated. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(b) A participant&#146;s right to purchase shares under the Plan shall be exercisable only during the participant&#146;s lifetime and only by him or her, except that a participant may direct the Company in the
enrollment form to issue share certificates to the participant and his or her spouse in community property, to the participant jointly with one or more other persons with right of survivorship, or to certain forms of trusts approved by the
Administrator. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">14. ADMINISTRATIVE ASSISTANCE. If the Administrator in its discretion so elects, it may retain a brokerage firm, bank, or other
financial institution to assist in the purchase of shares, delivery of reports, or other administrative aspects of the Plan. If the Administrator so elects, each participant shall (unless prohibited by the laws of the nation of his or her employment
or residence) </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">B-6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">
be deemed upon enrollment in the Plan to have authorized the establishment of an account on his or her behalf at such institution. Shares purchased by a participant under the Plan shall be held
in the account in the name in which the share certificate would otherwise be issued pursuant to Section&nbsp;13(b). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">15. COSTS. All costs and expenses
incurred in administering the Plan shall be paid by the Company, except that any stamp duties or transfer taxes applicable to participation in the Plan may be charged to the account of such participant by the Company. Any brokerage fees for the
purchase of shares by a participant shall be paid by the Company, but brokerage fees for the resale of shares by a participant shall be borne by the participant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:ARIAL" SIZE="2">16. EQUAL RIGHTS AND PRIVILEGES. All eligible employees shall have equal rights and privileges with respect to the Plan so that the Plan qualifies as an &#147;employee stock purchase plan&#148; within the meaning
of Section&nbsp;423 of the Code and the related Treasury Regulations. Any provision of the Plan which is inconsistent with Section&nbsp;423 of the Code shall without further act or amendment by the Company or the Board be reformed to comply with the
requirements of Section&nbsp;423. This Section&nbsp;16 shall take precedence over all other provisions of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">17. APPLICABLE LAW. The Plan shall
be governed by the substantive laws (excluding the conflict of laws rules) of the State of California. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">18. MODIFICATION AND TERMINATION. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(a) The Board may amend, alter, or terminate the Plan at any time, including amendments to outstanding options. No amendment shall require
stockholder approval, except: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(i) for an increase in the number of shares reserved for purchase under the Plan; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(ii) to the extent required for the Plan to comply with Section&nbsp;423 of the Code; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(iii) to the extent required by other applicable laws, regulations or rules; or </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:ARIAL" SIZE="2">(iv) to the extent the Board otherwise concludes that stockholder approval is advisable. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:ARIAL" SIZE="2">(b) In the event the Plan is terminated, the Board may elect to terminate all outstanding options either immediately or upon completion of the
purchase of shares on the next Purchase Date, or may elect to permit options to expire in accordance with their terms (and participation to continue through such expiration dates). If the options are terminated prior to expiration, all funds
contributed to the Plan that have not been used to purchase shares shall be returned to the participants as soon as administratively feasible. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:ARIAL" SIZE="2">(c) In the event of the sale of all or substantially all of the assets of the Company, or the merger of the Company with or into another corporation, or the dissolution or liquidation of the Company, each option
outstanding under the Plan shall be assumed by any purchaser of all or substantially all of the assets of the Company or by a successor by merger to the Company (or the parent company of such purchaser or successor) in compliance with
Section&nbsp;424 of the Code, unless otherwise provided by the Board in its sole discretion, in which event, a Purchase Date shall occur immediately before the effective date of such event. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">B-7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">19. RIGHTS AS AN EMPLOYEE. Nothing in the Plan shall be construed to give any person the right to remain in the employ
of the Company or to affect the Company&#146;s right to terminate the employment of any person at any time with or without cause. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">20. RIGHTS AS A
SHAREHOLDER; DELIVERY OF CERTIFICATES. Unless otherwise determined by the Board, certificates evidencing shares purchased on any Purchase Date shall be delivered to a participant only if he or she makes a written request to the Administrator.
Participants shall be treated as the owners of their shares effective as of the Purchase Date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2">21. BOARD AND SHAREHOLDER APPROVAL. The Plan was
approved by the Board of Directors on March&nbsp;5, 1997, and by the holders of a majority of the votes cast at a duly held shareholders&#146; meeting on June&nbsp;18, 1997, at which a quorum of the voting power of the Company was represented in
person or by proxy. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:ARIAL" SIZE="1">B-8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g655532img1.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">4. To approve, on an advisory basis, the frequency of future advisory votes to approve compensation paid to the Company&#146;s Named
Executive Officers. 1 Year 2 Years 3 Years Abstain 01&#151;Kevin Tang* 04&#151;John Poyhonen* * Each to serve until the 2020 Annual Meeting of Stockholders and until their successors are duly elected and qualified. 02&#151;Barry Quart, Pharm.D.*
05&#151;Christian Waage* 03&#151;Craig Johnson* For Against Withhold For Against Withhold For Against Withhold 1 U P X Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas.
0329KD + + Proposals &#151; The Board of Directors recommends that you vote FOR all the nominees listed, FOR Proposals 2 and 3, for every &#147;1 YEAR&#148; in Proposal 4 and FOR each of Proposals 5 and 6. 2. To ratify the appointment of
OUM&nbsp;&amp; Co. LLP as the Company&#146;s independent registered public accounting firm for the year ending December 31, 2019. 3. To approve, on an advisory basis, compensation paid to the Company&#146;s Named Executive Officers during the year
ended December&nbsp;31, 2018. 1. Election of Directors: For Against Abstain Date and sign exactly as name(s) appear(s) on this proxy. If signing for estates, trusts, corporations or other entities, title or capacity should be stated. If shares are
held jointly, each holder should sign. Date (mm/dd/yyyy) &#151; Please print date below. Signature 1 &#151; Please keep signature within the box. Signature 2 &#151; Please keep signature within the box. Authorized Signatures &#151; This section must
be completed for your vote to be counted. &#151; Date and Sign Below 5. To amend the Company&#146;s 2007 Amended and Restated Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder from 18,800,000
to 25,800,000. 6. To amend the Company&#146;s 1997 Employee Stock Purchase Plan, as amended to increase the number of shares of common stock authorized for issuance thereunder from 475,000 to 775,000. 7. In their discretion, the proxyholders are
authorized to transact such other business as may properly come before the meeting or any adjournments or postponements thereof. qIF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.q Annual Meeting Proxy Card For
Against Abstain For Against Abstain For Against Abstain 000004 MR A SAMPLE DESIGNATION (IF ANY) ADD 1 ADD 2 ADD 3 ADD 4 ADD 5 ADD 6 ENDORSEMENT_LINE______________ SACKPACK_____________ 1234 5678 9012 345 MMMMMMMMM MMMMMMMMMMMMMMM 4 1 6 5 9 1 MR A
SAMPLE (THIS AREA IS SET UP TO ACCOMMODATE 140 CHARACTERS) MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND C 1234567890 J N T C123456789 MMMMMMMMMMMM MMMMMMM
000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext If no electronic voting, delete QR code and control # &Icirc;&#148; &acirc;&#137;^ You may vote online or by phone instead
of mailing this card. Online Go to www.investorvote.com/HRTX or scan the QR code &#151; login details are located in the shaded bar below. Save paper, time and money! Sign up for electronic delivery at www.investorvote.com/HRTX Phone Call toll free <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-652-VOTE</FONT></FONT></FONT> (8683)&nbsp;within the USA, US territories and Canada Votes submitted electronically must be received by 1:00 a.m., PDT,
on June&nbsp;18, 2019. Your vote matters &#150; here&#146;s how to vote! </FONT></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g655532img2.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Small steps make an impact. Help the environment by consenting to receive electronic delivery, sign up at www.investorvote.com/HRTX
Proxy Solicited by the Board of Directors for the Annual Meeting of Stockholders to be held June&nbsp;18, 2019 The undersigned hereby appoints Barry Quart and David Szekeres, or either of them, each with full power of substitution, as the
proxyholder(s) of the undersigned to represent the undersigned and vote all the shares of the Common Stock of Heron Therapeutics, Inc. (the &#147;Company&#148;), which the undersigned would be entitled to vote if personally present at the Annual
Meeting of Stockholders of the Company. The Annual Meeting of Stockholders of Heron Therapeutics, Inc. will be held on June&nbsp;18, 2019 at 9:00 a.m. local time at 4242 Campus Point Court, San Diego, CA 92121, for the purposes stated herein, as
more fully described in the accompanying Proxy Statement. The Board of Directors recommends that you vote FOR all the nominees listed, FOR Proposals 2 and 3, for every &#147;1 YEAR&#148; in Proposal 4 and FOR each of Proposals 5 and 6. This proxy,
when properly executed, will be voted in the manner directed. WHEN NO CHOICE IS INDICATED THIS PROXY WILL BE VOTED IN ACCORDANCE WITH BOARD OF DIRECTORS&#146; RECOMMENDATIONS AS STATED HEREIN. This proxy may be revoked by the undersigned at any
time, prior to the time it is voted, by any of the means described in the accompanying proxy statement. CONTINUED AND TO BE SIGNED ON REVERSE SIDE. If you vote by telephone or the Internet, please DO NOT mail back this proxy card. Proxy &#151; HERON
THERAPEUTICS, INC. qIF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.q <FONT STYLE="white-space:nowrap">Non-Voting</FONT> Items + + Change of Address &#151; Please print new address below. Important notice
regarding the Internet availability of proxy materials for the Annual Meeting of Stockholders, The Proxy Statement and <FONT STYLE="white-space:nowrap">10-K</FONT> are available at: www.edocumentview.com/HRTX </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g655532img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g655532img1.jpg
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M  $  @,  P$! 0          !P@%!@D#! H" 0L! 0$  @,! 0$
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M;5-R6HH;E/F5O^O%* ^P98:B40!J98.-K@YZ4QV$0;#VT:LT1#8(.T1(C!;
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MM0YSF\.#B[B2*$GB2OCNT]B[)GQ_=-\^'Q;W6/:3;%U;%UK 3;W,^"LY9KB
MF/\ )3S2N=)+-'IDD>XO<XN)*KEQ_>MVR"D.>7-^N&T7MQ=QP;ZU7N\^E3DM
M<_F_*-4$)5?/JECJ<>LTHAC@H:!_$$+W-AYB7?[ ,0-]WN#%XV+)WC(K>!K&
MF2@$; !3&S/% !PH\!W]\ [GQ7UKOQVV[=8ON-NJSQF PMO:0>LZ3(K*VC9'
MI[=92\;H:R,-9INV,NAI I<,;,/RC0X;Q,;KN1/OQ@;3VS99'VVY^[Q=IE\&
M=2<K4M=8O6DO61ERDNBW0.GU?'5B<LU"<J^*8D, $16P"UK><>WQN.)S@-O
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MNBE.H6$: H.(4& &/81BUO3M7&XZ?'6#YH(7O=DYVDN8TDM$%R0TD@U +6D
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MWE:?PVQ750_R2[8?S(VQ_P!>-K*0^@/\65@_TP- _P" 6M\X>-_RR[^;\O\
M"7KRG;#^F&Z_J&S7^>K]0#&?_-/I#^-1Y(/[)>.L[EW[-9_O*P^]>KZ?E_\
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M!*B<??4#9$XXN:Q::H7&VY=('A6\C3!5O4DL.5GMY:5L.+]P0Z**$6 1P@%
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MO-&RLVL+M7%3IMJZ5AA$[4$MC96RU[8_J&4BTD$!S3(AGB_7DZ,+_7X10?\
MZS1X/OSYV']YGHW^"#"+NJWKTCH@1.: [2A"XI$R]$?H(P:/2*R0*$YV@&!
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M_C>^3#_LQRO.7;_3Q?[PQO\ "(UW^.Y]L/YB=O\ _K!;*S-Y?^V_(?\ ISK
M_P ,TDSI,;]._P#YKL_@X7Q[MO\ LV^O_P &VR_S3 JN\W_VC&O_ *3=$?\
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M/\?_ .TC=:^FBK?_ #ROG^^3%_\  94.?$;_ /Q:T_P#OV^9?QYWI_D#;/\
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MFM_:'[:MSVHV]M3 1[<COAM?<>2RH>;XP^I^L;.\M# 6BUDZ72%X9.KJDUZ
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M5CX[4%;2RI927;"QW%5CA4*\I$.&D(@O>ZHAG1</**,4!DJK:#3X#H$:@6]
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M,5F%IA*EJA6<88;O6B"R.Q=F6LN8IK.WBABA:\-8"YU2\$.<YSB7./&@XT
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MU43)?LPM:%9C:,LUWVY2<U:IVI*/3*%!8/>3LOW%BXWU]=^HCN=+.HRYDF/
MT<Z73J!%>5&AHH00*T->*\\>]^Z3G;'<3H;,Y&SW!D,P\:9!'<7.2-OZADK1
M("(NG;MACZ;F21QN=ID#Z.&C/7%K3*D20B86?*9&I=9D^S.RU*N,P$LF>KGY
M%$V<\M DU&QAKP]/&86E9P+60:9<-K4K2S3C#E&E!7*BW*^W<3;01L:(VLC
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M8@:W]_[T$0@:W_:(<=^W8@ZW_P#,+TWZ;WBGL'W4K[5X'VU7E/:TYACK;S5
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MUM=2A-<DD@35!A"30%8Q"( )8 WX)>R= &+AYK&P8R6"."5LHEM8I32O!TC
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M5)IZ%0XJDYQ2C02S ?"WNP>&EDDE@9*VULI9V3 R NE$,3I&N!T#IF0L<UP
M<&@@CB#7N;CLUVER=]?Y3"VF4AVYM'*9FSR<3KUKYLG'BL=<7MM<12&V:+*2
M^FM)H)XVLF9!&^-\57L=KS9%[]-RI[=:%BTTK]IMRJAWZ[3*Q7.O#G%FGK34
MFJG45XWIX<5*$9$9-GZ6Y$'UX<0K.VD$VJ/D@E_,%[(U'%82")N5GBE=C[CH
M!D8DH8S+U>H2_0=73,+M (%=0U5H:]=)VT[.X3'0=S<UC\I/L3-C"Q6EA'?!
MDME+D_K)M\]UT;=SK@63L5-Z-CXF"43Q>H+^D_J3K++SG$TJ;EAPJY6TP29=
M7KX22W/KVT:EB:OV9YJ*37/)5Z=D-6-29^=TC'$SF]&$\P!&E*D!Q@# %[*'
MU=OB[6VR%^R^#I;;'A]6M.@R$3-A:-5"6@N>'&@K04%*U'S3!]MMN;>WSO6U
MWI'/D]O[(BNS)##+Z9U]+%E+?$V['3!LCH8G37+9Y2QI?TXW1L<USP]M9575
MG2#[%ILYQYSKQG?>6JIGEC7<B.B"YQ;[>?*YMVWZT51B._&D)*FOF:2,=$O#
MF \!CBI2JW-&7[C"DQP5/=MP.&BGB9,V9T5_<,C@.L PMDBAD#G>[20M,[&T
M.D$-<>!((^Q0]DNTF-S6.L\K#E9\9O3-V5AB'BZ9&_%PW^+Q>0;<3T@+;Z6W
MFS-K;ECA!')%;W#Z-?+&8ML>>M[1BZYWO-S7QERY^.M6[J;::W31HY-+$7W.
MUU8\F1S\<XV[F[4KI1,JI<$!S>-OTF3-R],8#>SB#1'\>/;]C.QN+C:\9<00
MS&35[AZTD;3'HT\ UDK7!VJI<UP/ BG1X_L7LS-6T';:SBO(NZ3<)B,K)?NN
M ZV?]:W]A;OLA9](:66]IDH)V3B8R23P3-<!'(P18[70_2D74L52RV6P!UM"
M[&SGB05[-FROSVYDK8%RO\R;K$9%<9'*E8)F57#3"C5#&><J2F+S58 +=""4
M+XF?U/AIP_(6\<K;"U=<-D89*F3HM88W!V@:.H7@/ !T@'32O#E_Z*NT.9AN
M=\X*PRD&S-NS9V"^M)+X237YQ4-K)8S-N!;--H;^6[:R\8R.1L+8G.MZ%XT>
ML=TETE(RI+7D4E$!:[+H2+="2ZR),X5^H<&6U3Z9G"2+P"/H(_J6)109!93,
M<-8\J2%*TYN4!T6DU[-^N9#"X:$LO+B.5UE=OMV1M$E#%UF%SW%V@ZS&># 0
MT.'%W%;H^T?:+$OL]UYNRR<VS]SWN#M;"W9>M9+C1EK-UQ>SOG],[UC\?*!%
M:QOCB9.PE\YU*ZL@Z+C<>JRJ[)W&I5(W&YPPM)75>Q,EH62V32&:QLV6HV)"
M<_.T;CB/ZLCR)8M6K'!<A1)DB(XPPT/H$(O,PX>::_GLM<;&6VLR2/J&-:QV
M@N.D.<:N(: UKG$D !?GC%]I\OE=ZYO:(O+*TM=O&[=?WUR966MO!:7 MG3/
M$,5Q.[J3OBBBB@AFFDEE8QK#4D1L+NBG2RX2!0SV&E=[&3FHX/&U,;0DO\DG
MC39@*GFE3-R0Q["G,LFNI2: U[2;.TD3-6QN!:HY&2H.*YOYKY F6CH3'":O
M<'$M:PQ]5DI.G]CD;P8:5+O<+0X@'UP^S9OY[\BZ*XQ3['$N#[RX;.\PV]E+
MCSDK3)R.$.H6%_; MM)0TRR7.FU?#'<211OD;FBXI'=T'E,IDT-<82M8[AN6
MO$;>O+; ?/,]=61(X@TN9/U9(9&$PT:%I 2L&,PG0G(A1\(KY?X(Q\/-XZ'%
MW4<$,C96OMH9"17@9(VO(XM;XFK>!]TMJ:U \GW@V#B>W.Y++"X?(19&WN<!
MBKYSV&0Z);^P@NI8SU((" 'RE\0#7TMWQ:W]7J-;8?.G7RE,(F$3")A$PB81
M,(F$3")A$PB81,(F$3")A$PBT2#01+!S)J8E<%*_<UG;W.U.E)1)6D"I[2MB
M8UO3_"_WQ,0%L#L(A_K]['OU_4UE)K]Q0"B_5<P9+747+BZ-P4N9!;W*WOYM
M6442=LV5RIYE)Y&P$?L?PT9[R(D&_P!40 :WOZ=[P34U0"BT:>T<VSM1:"E1
M('%M'9U=,%>*])DJ0X+0EC[C)7$AT1Z.U_5"H\R2C",!G['K10?3]7>4.I3V
M%0MK7VK)ZB%MA!H(;A0Z]H=!#O=:M._3TUZ:WO\ \N?3BH\DH[S6=C,!!'IE
M-)L:\*')SF[9"6]R)&D(2I4YL-0.B(*M* H0QAVYB=1F# (6]%[#K0=^GKD)
MJ /)4#C5:Y8-0ZFT@')6^6N\0=E%>R2M5JUE2HQK36&3/,?=E*A,K/U\5&Z(
M LQQ:0[7OTG$M,-"'X@0[RAU!3VH17BL@GHRF$S62SE537NV\AO UEE&Q!A/
M-VB+3:2:+,5'(1JCAB(UZ",&,1@M^N]BWO>]XU.YU*:12E%A832I$-=H*Z"E
MCV_;KV(3&",0'4I.8H,C4E?8\[-:5Q7!WL]6IBZ"-D("3M^@E!.O>;ZF>HMB
MZM?:4 HIK-+T:485O>]:,+&7O>OU=:&'8?77_=UZYBJH AE26' HI'X9'[?+
M"R1EK3,[7I=7K0J6:1(P?#(TI4A=R GG:!Z:V+0 :WZ?J9D7 FM%C0C@"L\\
MU:].ZJ(RD,\5MMDQ!&^-1$N0L#;IM>620JD2EQ8WV*GG'I5+:,;6D&#9*@A0
M4>GT,!H="&$0. X4X)0^?%>(RK9#(WV+N]BSW[3((:]IY.QQMBC":)LQDD0D
M*4[8[O0QND@=G,33\V,U.0!4G3Z/]IA@#-@![6H 4 YJTKS6X2F#)93(Z[D1
M[@I2'5Y(W*1I$I)10RG(YRBK]%1IE0S/UY)11#Z([6P?KMC+UK?T;WD!H"/-
M"*E>-_@""0S>&318K-]\/9YJS :!)TYZ!U338EB(6_.[-"(>M)2V,.@AU^M'
MHT6A?1K6 :"B4XU6EL552V#-Y,=KNRAM$.0@$2QQR511-,-QE#L8A$M#&\%O
M$><]LZ (O8E*7#7#(*"$L)GPPA#JEP/$CBI0C@.2_(Z-2*$3NK5S:8&3YZ?8
M])5%AIU2)$Z)G2)@-+CJ%"R$)/LT7%6\E4>4)K-2G$*0*CA'[-.,V=C5[!16
MGW5Z\IJ.7V&QGP^PK)2N\-<3$?UXU,$&11YS>TJ)8G7 0J'I4^/^D1)ZA*#X
MHT:=.HT'U^$84+T%H' <0.*E">?)3YF*R3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PBIOT)S3,K8DSZ\0:
MQ6>#M]I5&?0-SI'F*JY(M=*S->'AU(<(*K22!C)C\W;TTK?$11ZTIP1;+=-&
MB)]Z8(3?1XC-VUA V.ZA?*^"XZ\):\- EH!1X+7:F$M8XAI:?=I7WN'W_M7W
M?V_LC#VUAN7$W&2NL+G1FL2Z*Y;;LCR BBC++QKH)C/9O=;6<KF0N@EU6Y8)
M-,SBS5%7&2YUF#DQ/$U9%/.)]A6!;S?6Z>+K$\W33JRJ\DE?OS0?-!2 UG'!
MT!TS=GI$2!I M"XJBBS#AD)]:-Y#=R-9;-ECC>,R(8X3)J&CIQR-D:=&G5K.
MAC"==-() J>'=P_:"MK+ 0Y*PQURSNTW%6.+??NN6.LW6>/OK>]AE%IT!*+Q
MXM+:TE<;DPF"-[V1MDE]S7$/&=GJFPI\EMO0]YMBOVFCXY2<I0UX\-T<:&>@
MY*ZR9F66"P&SE:X2)ZLHQZ/22(3>N;2"DWL^2 4,.]BW/W)8MDZ5O;RMQ\SI
MG3-,C2XF=H:X1NZ8#1'0&/4UQ)^E5=M<_:!V9#>.QV#P-_;['RD^8GR]L^^B
MDGEES5O';RML9A9L9!#CQ$R6Q$\-P]TFKU#GM( +N,[/2MIKY$K=A[+;%@-5
MX1R[)0NKUW<8Z[L]^25JDSPLK]A*G")?'GJM3&5.DCHG!:Y$&IO?\Z T8_4)
MNY+%S^E<6\KK"%T+H6B1H<# TM:)'=,APDU$R:6M(/T:);?:!V9->-QN=P-_
M<;'Q<^'GQ%NR^BCGBEPMO+;Q-OIC9O9/#D!,^2^$$-N]LFGT[F-%#L:3C)<U
M3!M8F>:LB?G$BP:^MYPK=1%UBB;J)W6E>1NOV%H(F@9 4S@@[@;#&EZ6DC:1
MK1."4TLLX)"C>BM+MR,?;.EDC><R89(1('#1TY)'2.)9IU:QK>P'73202*CC
MU,_V@K:]P$V2O\=<O[M.Q5]BV7[;EC;-MGD+ZXO9I3:= RF\8+NYM(G"Y$(@
MD8]T9DB!?I[;PW/#8XD9I-<;&O<*GKZ#5IS0]MD"5)#(<TUK9$+M&+2&R$BN
M5K03.1JG>LHXWN.F\;.F/0-QVRM%&K-[(Y#]T6@F,D%N\,N)GR7+3(#K,D;X
MGMC(8-#0))'-U:R'.%:AO'O[O[2&V699^0P^ N8K7.96\R&X(9+UKA=2Y"PN
M\=<P6#VVS#:0-BR%_- 9Q=2,FGC#R]D $F=_).N9N5EVK&K?@K7T6^2:T'6<
M25973PXULK8K6C=>1)6P1Z*@FJ*1H]P9KJ.-'M1ZIV4?,JF\_P"8+T!9O1&K
MZ_QCVFPFMYG89K(@QHD:) Z)TCPYSM!:=9ED#@&"@<*&K>/6?Z<.WUW =DYC
M Y*;M-;6>.CL[=E_%'?MFQMQ?7+9Y[DVCX'^LDR>09<LCMH^G'/%TG%UN#)O
M#OS%,$-=5K 8#/XZT$\^;IQVH12_P]>YC122MHV_PV4[LHQOD[8*3LMA11]-
M2; WA:U#:,XTX)A^]@ 'BQYNV=>37=W$]QN^L)]+P*MD<U[>G5ITNC>T'WM0
M=0"@YKSECWCP%QNO+[GW/B[N>3=/UK%FFP73(P^WO[B"ZMOJ\/MY!;RV-S"V
M6LYN67 :R,LB <XQ<Z<16$!@5)XO<$;;)5:<)M>ONC)"X5^O6)92T7-8D@LN
M2/U;-2:8(MQ"219TF+P@9-.![NE @6E[4 --3Z$;SX]S69E!GMY'6\$L4ENT
M2 %IAC;&ULA+#K:X,8Y^D,.III0'A[.R^T9M5V49+F<#>383"Y'&WV!@9>L8
MZVEQ-C!C[>&_D=:O]5;W$=K:S7?09:R&:)PB<QDI#-O,XT6'S4YG/F# +G$5
ME.MSE5J"+N(9J"=O%;*ZZ5, IIN2B9]U^4H<#WXLK33IQ^LQZ*$HVG!Z"XPW
M(T6HD$;_ *YZ(AZFH:.FV02!VC3JZG ,)UZ=/&E5T+?M 6\>W6W\=A=#NT,1
M'B3D#<1^D-E%?MOVS"T]/U?6EK&63G>IZ'IP7B(2NJ-3;>*;'.9$Q\JMZ*.U
M@5G%J8A5 R=!7SHA:F!HHJ<IYZP/%CLBB;+3Y3(9XM;TJ&0?5RIJ2Z0D;^3
M2:9L0>0_<MD)2(+>1MI.^9]PTR EQG9TW"-P8-+6 ET>H.-3[U0%WEW]HC:4
M>2?'A,#?0;6S%[EKO-V[[Z-\L\N9LW64\5A,VT8VV@LF/DFL>O'<R=9XZ[GL
M: ?<4\?6RA3;F$1M^%LEVS35VH+<E2ZNW=SB#DS7NNAZMS!!XX";(G9D<:T*
MK]G)CYBYP7EJ $'?.@'M1ZE8MW%CW.]/<6\KL9'T3$T2-#PZ / UNT$.$G4>
M9-+6D5&D\./'B[];&N9OJ#.X'(7';K'_ %0_&6S+Z*.ZCEPS+IL9O)S:/BFC
MR!OKIUZV&"%S"^/T[F]+WY1NGDV/V-1U4U P"BOP:-=Z]>J_06?$DUB01XW7
MD;70U(Q6!%#%33M\9G>*NJH@P9!Z<]*J&4J*WL9.BQ<'&9^:RRD^1EZE;ILC
M9#$_IR#J.#RZ-]#I(< >(((JT\ZKQG;SOCE-I=R,WOS*"]U[D@OH;Y^.NG6-
MY%ZZX9=NFL;D-EZ,L5S'&]H>Q[)(P^!_NR%PAC?"$G-8*U3$6;#8:]4VMD=F
M5BDJ^IFZOH!&K\DTT.>S)4="6!\3)7N#LD#&;$B&M8:<N6MKJY*5BTY:>2:F
M[$[I@ZTSG0221W ;'(993)(Z!K-.D/<TEKW/_*ES0&AS6-:T-!!^@C[2^&9E
M,O-)ALAD,=GXX,?D'9')OOKVXPMO:"$6PNYH7.AO)KP-R;[B)K88KBVM(;>V
MCMXI&2VVI*KI!50;2;W21M$@99E<4_M"+%H618TN;"BL=W'*WA@?E1[PY)7U
M2W29Q6:3*TY"$(D.R0#)V: 9@^@R=]#?]!\;',ECMHXG5<"'&,:&N: T%H+0
M*@EWO5H:4 ^&=Q=Z8O>QPMU96D]KD,?@++'7)?,R6.9]A$+:*>%K8HW0M?;Q
MQ=2)[YB)A(YLFAS6-G#.K7SA,(F$3"*F5^<Q2^UI9*'&(V&S0V*W%6L?IN]V
M=SBJM]=WF!1N0R5Z1*H$ZII T)8[*E;7-GII..7)G%-I.N+/"5HQ+H!WI,3G
M+>PMV,N(7R3VTSIH"'AH;(YK01("TES06,> TM-6D5HZH_07;#O)@=D8.RM,
M[BKC(9O 9>?*X:6.Y;#%%>W$%O$]M[$Z"5T]LV2TM+EC(9().I"^-SRR8NCT
MYSXK=)*_OT6E-@-:SGDZ5WA8D9@;;%3T,W;9GT!$9M$I>F<I><^*V17%X_JS
M9$N:2B6DA4%2XDA--$!'K9_)9N6.&%D\$3AF!'!&Z0O!860/8]A#-(<'.Z<;
M7$O(HTT%7<._L_M#V6(Q=KFL+BYX^ZK;'#V-Q>R7(?9R6F$NK2YM71VHA;,V
MXG^K[&&Y<^Y?&8X)"Q@=<'I8\GD*W7 K4YEMP0MYO:'J*6(JN5(:[=VR$M[+
M1HYQIN33.,CFRUZ=UUDIK,?0/QJ)R1 3Z5D?)@U\M^S9G<./8?2V]O*W%2";
MJL,C2\NGT5+': T",QLT:FNK0ZOI<.5)WXV):/\ S;P6!R-OVTOV98Y*V??1
M27;Y<P+/J.M+@6C(HF6#L?9FS;+;RE_3DZ[CUOR?H.?$UB%L2G[+6]%VJ;6A
M#[@@?0TD7U\Y+6^2-%WS]TL60OE;LR:9HC(G(X8X2%R0,.G!0[)=(%0-J@&F
MDZ$9DS<UF91U[>1UM!)"^W:) "TPQB-HD)8=;7AK7/TAIU#W: \.59_:)VH[
M),^NL#>S[=PU_B[W!V[+Z-C[>7$64=C!#?RNM'BY@NV0037O09;2&:-W1<QD
MFENV_D:*_MM]3_:]@_)Q^\K[Z/NU^R[C]M?MY]VWW=?4'VT^TOU/]W_S'_E[
MX7U3]8_6?[%\Q\O]&<?\XV^EZG3?]<]'H]34-'3ZG4U:-.KJ?J*Z].GC2JZ+
M_P!X"W_-WU_H+K_2U]4?5/UAZB/TGHO7^OZ_I/3]7UNG]Q:O4]#T_O\ 2ZJU
M%LXFL0QA3:E%OQ=UFU7P^H('SS)4%?.2)OC;12%@-5BQU\LAF4S-:9+9',W"
M/-J!^TWJ&E+M E'M* HT[8@<B3<UF)3T+>1MK/),^X:9 2XS1F-PC.@:&L#G
M.9J#SJ/$D#CWMY]HK:C,F\X7 WL&W<S?Y2]SEN^^C>^XER]E)83PV$K;1@MH
M+1D]Q-9=>.YD$TC>LY[(P'9 [D*W6\O[<Q*X(6RWK+U%T$6I*5U=N[G"7%EO
M(<'"XI8;&@35"\M"VMTU9L0&(U:Y+0*/E#_G "^:]2<1N''//I;BWE=BHQ#T
MFB1H>'0:Z%[M!:1(9'ZPUK:5&GZ/'BQ]^-B73_S;SN!R-QVUL&8DXVV9?11W
M;)L.+S0Z[N#:/BE9?NR%X;QL4$)9U(^@X='\I(\CYOG1$4K6.US/8HQ"YX<*
MU<>?/M%#7-W);2X=6S[5LI9++/;Y4UJ92VS&+2-4668WZ:CF\W8#/ZH]GM%P
MH,S:FXFFO(I'"\$@N-+P*ZY&RM='5A#2QS03JU!PJ.%5Y+$]V]M29O+Y7=N,
MOKD;KBR$><Z%W'$9#=7\.1MIL>U]M(VVDM;F"-SFS^I;.T.;^2U5$1./#,Y(
MCBF/QBXV9"9:]=RFLNF79T@:E4JFC5.K(G-HRF15P0CE*(F%R(3O:<F;T07#
M;PG3M[D1L>C#4>OC]@S=%J9A+/;O/IYFR6P$@&@LC9$ULE6'6VD4;CIT$N:>
M0=P]W:?:2VW)EF93,X"XD9A,M;9#;\4=ZUK;22SL+/'6T%^YUL\W<'2QN/GE
M, M9'SP2!I8RX/2VY;Q@X/<L=X^_3EF5\YJ)Y:%L--=)(LJ2S=).;=@,L@DE
M;%4S&_'LYL+:S)\]N[>46TEK KEI19APR4NOC<=NY&1V[9HHGC,B**(R%P+"
MR*1CVD,TUUGIL8XEY&EI(%7<.BM_M!VN.P<&4QF-N&=V68S'8R6_=<M=9NL\
M7>VU[;R-M! )1=R"RL[6=SKET1AB>YD;9)CT\$CXWM-6@+DLNMZ&O=Q0-'1[
M+34J15X\-L7:V>A'R1/;2;/8\.<+'-_=K,U*UZ:1#0+VXHD@97R0"Q%>IFYV
MX[!K^C;V\K<=*9C,TR-+B9VM!Z;M #1'H:8]37$FNKGP[.X[_P"RH+HXC!8'
M(6VP<G)F)<K;/OHI+F27-0P0RBRG%FR."+'^FADL1-#.Y[P_U#GA]&^%?Q=9
M:=I/<XG;L19[-L5@NZ*7I)U]>NS@Q/31?<N33![<J\8B)NB61I^KE0G^3CNW
M%8Z)AI![^= :9^NPS<EDZ3IW%O*ZQA?"Z!HD:'-,#-#1([00YL@XR:0TU^B0
M%G:_:$V?+?-L\Y@;^XV=B;K$7.&MV7T3)H9<+:NM88[Z8V;VW$-^UW5ONA%;
MR"4#T[F-X*7K^Y38[7JZJ8&P$0?XE'R*-2&",]JPTNR*[=T\=ASY !1N;Q4:
MYI-<FU;%Y"?HM00>4I1+RB%1?N^$(HSK\3GI<??SW<QEI=,<V0Q/Z<@U/;)J
M8ZAH0YHJ""'-JT\ZCPG:_O;DMC[SS>YLH[):-QVEQ!>RXV[-A?1.GNH;WU%G
M<ADHCD9<0,U1O8Z.6%TL+M.L/;#A7"\G+;ZC/2VA%(Q(:%"OE]4)Z^JMN@$
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MA#26:XO+9EL^6".",NF+@V[M]/Y.DA?I87%K@)2 ,!H &%C"868$(RS "T,
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M1K&\QT..T6J" (=[%L.%PT^N]MV3-L;5UPV5AD!=)T6-<QP=H&CJ%U'C2X-
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MA,4'J%2U6A1)D:,]0><446+>O/#"SOREQC6/8T6SI-<CR0QK8W%I>Z@<:5H
M&ASB2  25\+B[19B\[D9SM_:W5G##M^>_%Y?7+G16MO;8^9T$MU-TV32Z7/#
M&,CABFFDEECBCC>]X!T%3W13;>BC)SHU6&U.LR*?VR-19;&D89.\63%+$;ZO
MD])HFTEZ. =;3)*74C9C>$S:4YM$-P(5'(B3SR^6W:^1>]XC="YD9:7.#CI$
M;HS*V8G3^Q.:#[U*AWN%H<0#Z>'[-F_[JXO&64^*GL<>Z&2XN67#_3Q6%S8O
MR-OEWR&$$8R:VC>&SEO49.&VLL,=Q)'$^0N;[GD-ULEF.LBA;E"SH1>5MU8W
M)W MN+T[-%?2Y='F]V*$WR!_"<<<2ET!4/8B0;5@-T4#96@#%Q,UC8<9+!'#
M*V42VL4I(KP,C XCBUOGPY\*5-:KRW=OM]BNW>1P]EBLA#D8\EMO&9&1S#(>
ME+?6K)WQ'7!!0 NK& 'GI%A>[67-%BLZ9?)TPB81,(J"](WO<L-E]H&5>NAR
M*+<T4K%;ULMED4;6/;I9B.3/T]+-A#.[IWQJ!#-((?6#HH+7A3KC#'%6ET(O
MX!)Q9_K<+BL;<VT OFR&>]N701.:X-$9:UGON&DZZOE:--6^Z'<:D$?I_M'V
MT[?[@P.&;O.*_DS6\-PW.&Q\T%PV&/'OMX;(B\EB,,AN]=UD;>-T)?"T013$
M/ZDD;HXWD77EL0C;Y>;R;#WFA%\_Z3JR-U^BCZU!+6M;S]"K7D+9,54X$\*B
MG(4Z?:4>$AZ$3824C3."(19FQD'[4<R';UA=!N+B$C<L(K:5TA<"PBX?$TL#
M-(IH;,PAVHU+75%"*>MQ/8C8^XQ;=M\>V_M^YT6+P&1N+Y\['VLC,W=XV"2U
M;9])IC%G#E[65DPN'NED@N YH;)&(AU^],Q5Y:J,EDJK9RMVUC:"<X+8+57[
M@WQZ#-=NZM53/VY;#SY@M^U:BNT=.N&V8X:])\_MQ3?-@W\ W9P8G"3QNREO
M',W'6XG$D9D!<\P](,(?H&GJ&9NL:3ITNT\Q1'VP[/9K'S]R<'99>'8F$;FH
M[RQDOF/GO),7]6MLI&70M6>F;?.RL'JF"&3H]";H._*,Z>%6=1]'/C5*X]%7
MBN&Z?<YP&]9W;SDN@[HX,=KKZ;LZ1P"+1B.M7VO2*8 W60SPY<Y+E>E#F>V*
M#R"2 F%@'LS8W!X:*2.:=DSK2\E@9"!( Z(31-D<YQT$2&,O:UHHT. )/$BG
M8V_9CM+C;VQRN;M\O+MC=F3PUGBXV7D;)L:S*XZ"]N;B>3TKFWLEA+=0V\,6
MBW9<1LDDD+'.:&[/^5W8NWO[Z=+8W^3F&Y?N.' /LLIW-]%?=?J5[LO<Y^T/
MR^EX9_OZJ^J/JOY;ZK_9OC_,9I_-ZSZ7U91_USZ;K]36-'[+HZ>C3RZ?O:]5
M=7"E%TW^@G:@QW^CTQWG^ED[?^N!>^I;Z.OUCZ;ZO]'T-6CT7[I]5ZGJ>I_)
M]/I+6$?4G1C&TQ)BE3Q7#C..CH%1$YIYT0P=T;V*JG*YK.C4!DT6D+9]KU:F
MP&^N6:9H7)"K^8;#W-00>2<$LLPO9>]V"P\LDDL#9FVME+.R8&0%THAB=(US
M3H C,A8YI%'!H((X@U[FX[+]ILE?7V2PEOEHMN;2R>9L\I&^\C?-DH\5C[B]
MM[F"3TK6V+[^6TFMYHM%PRW8^.2-SW-<'9HF_>FI2].E$Q655NV7!5AE^.LV
ML!UK]P7Q^=M%1:JE1 $*&&D2]%]EC[$2W&W?7!Q:]7\AMO4_*!U\<K9.HXG"
M01MRMQ',['3] ,C$@#F&;JZR7Z#JZ9A=H&D:M3=7(UZZ3MAV=PN/A[EYNRR\
MVPLT,+':6,=\QD]G+E/K)MZ]]V;5_J18NQ4_I6.ACZPGAZ[OR;^I.DMO:;S&
MI^6W*JSV6$S/JY?"2&EZD309+4-?L[U4LEN62.(6,*]C+D+JA8(F<@2%FGDD
M?-J0'&:& L10^JM\5;6V0OF7X=+;6 ?5K3H,A;*V%HU4=I!<\.- 30$"A-1\
MVP?;7;N WQO2SWLRXR.W]D17;I88)1:OO98<G;XJW9UM$Q@C?-<LFE<UCW].
M-T;"US@]M9U76/1KW%YFZ1U56[2^<O53.['O1"IB;JY(;7>JZMRW:S6Q:);'
M)4JFO6N1L]%/3H6IV)V/2J7)$5OXA9!^E'=MP&&BGCCF$SHKZX9' 0\ Q"2*
M*0.?[IZA:9V-I[@(:X\"13[!!V/[38[,X^RRS,O/C=YYNSL,,]MS%&_&Q7^,
MQ>09<W-+=S;Z2"7,VENZ,"V9)'!</]Q\L?2VMXZZLZ,+W:[G13%'#GDVU+LI
MMIK]+&UB::I#*=KJQ90FGYLX$]FIU1\IF%5N3<:VB; $I4"Y*: P1Q)WQ]$>
MWK&=C<7&)!F.A#,9"X%AZTD;>GHT\-+)6NU:JES7 BA%.CQ_8G9V9M8.W-DR
M^B[JC"XC*RWSIVNM'#*W]A;NLA9]$.:+:UR4$[;@7!?)-#,QS!')'T\<'HSI
M.,J&.J)?)*X<K4NELYYD%<S%J@#BWQZN2[G?YBVV R.<9.F2L4U#6;5"CE+.
MH&M0#<S518%80Z+%LS/ZFPTX=D+>.9MA;.N&R,,@+I.BUAC<':!HZA> \:7:
M:$MY\.6>TW:+,17.]\%9Y:'96WILY!?VLEZQ\]^<3#:R64T=P+1HM/K"2[9'
M=,$4PMVQO= 27@-]<[ICI&0E22OXH_5RVV;0\6Z#EUFR)R@+DX,-H&TO-TD7
M@L?9H^"9HSH(DL]H.&M=50%;B:U'AT4E"8#?KE&$PT)9=W#)G65W);LB:) '
M1=9A<]Q=H.LQG@T4:'#BY;8^S_:/%/M-TYRURTVSMS7N#M<?!'>QLFQPRUFZ
MYO)Y9S:/%X['2@0VT9B@;<L)?,6N%%=-_P"B8Q'JMJZRA1V62);<@88EKNOH
M@C;G.92A_FL<-EB)A;=.SE'V%.-NCR)8M6*UZU"A2HT1QIIH-!UK?FHL//-?
MSV6N-C;;69)'DAC6L=H+C0.=Q<0T!K7.)<  OSUC.U&9RN],UM!MW8VEOM\W
M;KZ^NG21VMM!:3BV?-)THYYG"2=\4444,,TTDLT;&,<22(X'W)31)4-"I;K
M2.UA)!)X3&U<7*2R"2S=MLPNI9A5#8@/="P&V77DN/+V^(=F!(1MPA+PJ#49
M1YQ7,_-?(DR:70F.$^^X.JUK#'U62D@?L<C/H.YEWN%H<0#ZUOV;NX$C\@8I
ML6^QQ3PZ[N&W!=!;V<F/.3M<E(\1DC'WUJUWHY@TOEG MG1,N'QQOD+FBY7^
M\8/*95(H8YPA6Q7!<E=)&YR*0%;7M-=6-(8@UNA/R#\_A-,-1-0"E@Q#*UMQ
M)4:*+^!HH8^)FL;%B[J."&1LK7VT,A(KP,D;7D<6M\34<_=+:FM:>5[P=O\
M&=M]R66$Q60AR,%S@<5?.?&7G1)?V$%U)&=<,% 'RET0 <>@Z(O?U"]K;#9T
MZ^5)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%PZM.^*3J__
M #P=?61;-=P.=3HYY-A4.E\P88[)I:4\<0U@Q-)L;9'5<E<7HMR>TQB,@2<L
MS1JD&R@^H_UN?4+#%9.^_-V\L[>:6TA#=;V,<YK*7LKCJ< 0VC>)KX<>2_H_
MLKMGW$WE_H$W3M+!Y;)[:QC8A=W5K:S3V]J8MWY&:47$T;',B,<+A*\/<W3&
M0\T;Q6]1ZV*PHCHSD&1W78$.J6/N'C4519"]V-(FN&M2J2E3FAEYK 0O?U*!
M*8\%(DAIPDVA?&"66(6PZUK>\XLMA?97#9&#&0RW$PS0>6QM+R&Z)QJHT$TJ
M0*KS65V/O+N9VGWYB>W>+O\ .Y2+N^VY?#80274K;<V>:8)W,A:]PB+W-:)*
M:2YP -2H,:IO#F[E.B[6<)0PH:Q*\N<UGYU@K'5$FAA4&7=/W6J1S$V2'' :
M"XPJ3+"C"UPC=)A ,#O0_06L[1]M</SUU8,8\WIV\R,1@'7U!;0C1IYZJBFF
ME5])OMN9^[[V[EV1:V5S+O%W8JTLA8LC>Z[-XS;V):^U%N 93<-<UP,(;U 6
MD%O K=;&L: W8M\O$QIV9QBTHDIX$KJ/)Y-7[TWRYB/?T,%ZI4+60EU8CUR(
MQV1D.! S4^A[.+"<#8@Z]VLXUE9W6,;MZVR,<D%P,M(XMD:6.#2^UH:. -#0
MT/(T7GMI[3W/VZMNQ&W]_8^\PN<9W0OYW6]["^UF;"^\VVUDQCF:QXB>6/#7
MD:7%KJ$T*DACO>E+HZD\;[34-LUU9[I"(#?1TR;X#,6&6+8H4JI&+-J8V1IF
M-<M.9BU#D':< E&B]"/#LO7Z_6]:X4N+R6-P69DR%O- R:6#09&.:'TF<3I+
M@-5!QX>'%>2R7;3N'V][+]W+[?>#RV&LLEE,*+1][:S6S+DMR]S(X0.F8P2E
ML9#R&%U&$./ND%5<DEYTPGXEM[G\^U:_)O-;W/,R4=/&2QD!9BHU5Y("Y*F+
M(A.UFI$:)1'M_/%Z"GW[TO[+KU!].=]#B\D[<]OF!!,<4,6RLVAW3%,=I/OT
MT_2]WGSX+[-B.VW<&7[16![HQX3*.[;1]MK0NR@MICCVANPC;N+KO1T!IG_(
MFK^$GN'WN"L'Y)*?Z#8XYVI>E=CIURK"Q>+T=:6 VS%WFR"?LZ*N-VX^N+G#
M43'&G&/.2M>W6"(!):U8G!\8C7NV$.][WT^S,CB)9L9BKSU OH<D9(RP,,9,
MG2: \N<'  Q\=+3P/BOEGV1]^]K,EENWG;;=8S\.\L3W"?D+&2UBM'V4K[_Z
MLACCNWS7$<\;626(+W0Q/.AYI4\!UY@_UIN%Q#;V!"6];B\?^MRVLQ0:V%NG
MU2D^? W&JRB%9B$*OWZ)$: !FR_38@ZWZZSYY==/U,G2KTNHZE>=*FE:<*TY
MT7X0W'Z,;AOQCC*<?ZV?I&0-$ACZKM!D#26AY;34&DM#JT)'%;1FA=,F$3")
MA$PB81,(F$3")A$PBIIT-S5.+5D[^[P*PF&%MMJU =0%SI7Z,+I"N65L8\/;
MHG=H$I1/C,0SS9O22Y\1%#7%K$0@N8#A%^Y+HL[TF'S5K80,CNX7R/@N.O"6
MN#0)*-%) 6NJPEC"=):?=I7WJC] ]JN[VV]DX:UL-SXJZR-WA,\,WB70W#(&
M,R BAC='>M?#*9;1[K6SE<(712@V[HP^DQ='J*OC)T=I>YQUXF3 ?S<?8=A7
M W5^EC2\B>$3BS*\DL!?6)1+1OAK(*$-JF:NSVC"!LTM^?4$DF&")3^IW(;N
M2..V;-'&\9H0QPF0N'3T1R-D:X,TZM9T,8?>TZ02!4\.]@^T%96.!ARUAC[I
MO=QN*L<7)>NN&&R=9X^^M[V&9MJ(1-ZR1MI;6DI-P8>BR21K1)+2/747&MKK
M&TA_EUL0AWMJNVFCHY24D;X&^((PWM-"29VDS8NL-D.F2MR>GFSA/9Z.0?5R
MQ"0E3>S:+6AAWL6YVY+!K^E;P2MQ\SIW3M,C2XF=H:1&[0 T1Z06:FN)/TEV
MUS]H#9$%V[%X'!Y*#8V5GS$^7MWWL+[A\N:MXK>1EC,+1L<46/Z+);+KQ3/D
MDU"X):10NXUM9&W'2"(6Q"&>V;$:;QCEVR-P@;XX1E>T7W)FF3.:ZO&0F9)'
M%E>:Q$R$(V#ZQ5KR%2;W[6:V,6MA-W'8.?T;B"5V/A= Z!HD:' P-+0)':""
M)*DOTAI!^BI;?: V1/=MQ>=P>2GV/BI\//B(&7L++ADN%MY;>-E],;1T<L60
MZSY;WH10OCDTBW.EM#L:3C)T:9>VQUGF3 1S<385?7 XU^JC2\^>*)Q6E>QJ
M L;&1+@OI;)J$.2B%M+VL"-LVM^?3G$EF:)4>I.EVY(Y+8S21O.:Z,D(DU#I
MADDCI'.T:=6L:WL'O:=)!(J./4S_ &@K*^P,V6O\?=.[N.Q5]BX[UMPP63;/
M(7UQ>S3&U,)F]9&V[N;2(BX$/1?'(YIDBI)IS;P]8IT<1,TGM^-+'*HJ]@M:
M\SO37!5Z848;*TLF$6C%Y)9J)7*%(95(%SI6$<;G$MM,:TYJ% H&5LLU9Z)^
M0_=%F)C)!;R!EQ,^2Y!>#J,D;XG-B(8-#0)9'-+M1U.%:AO'O[O[1^TX\M)?
MX; WD=IG<K>9#<$,EXQWJ),AC[O'7%OCWMMV^F@9'D;^>!T[;A[9IHFOULMZ
MRY_7*5W-BTNVHS;%>MO1C])K1=)P^+H$^N%9G,%JQJN8D>PQV/%2U%)4YD$;
M:@C2AM/5.)NEBE$IT>66!9_4^KZ_QCV_5\\$SL,QD08T2-$FJ)TCPYSM!;[Y
MED#@&B@<*$Z>/6?Z;NW-Y;G8V8P>5F[36MGCH[.%E["S(";&W%_=":><VK[=
MPO9,ID&7#(X&]*.:(Q.>ZW_*[P[\R39!7-90& 3N+-A7.^Z;=Z&52")NBXP$
MDKF,R&%R[5FFM\D1;?F6P(J_&I0A;BVY0V&'&GZ$IW["P\6/-VK[R>[NXI'&
M\ZPG#7@>[(YKV=.K3I,;F@^]J#J >[S7G+#O%MVZW9F-S[HQE[,_=?UK%FFP
M7,; ;>_N(+NU^KP^W?T9;*YA;(3.Z=EPUC(Z0^\\Q:Z<2V26PK"8M;<3;I9;
M$(MBONCG]Q@CFJ1R!KN>Q9%94AD-9-:66)1QF11%QF;PWLH'$]R2_(JRA*-#
M-3_LW/9N:R,P,]O(;>WEBDMVB0 M,,;8VMD)8=37AC'/TAIU TX'A[2R^T5M
M!^3CDS6"OI<'@\CC+[ P1WL;7P28FP@Q\$&0D=;.%Q!=1VEK/=F!EO)UHGB(
MM9+^3V\SC1Q/FIS"?+8[OFT=E.MT%5Z"..89V&<O-;+*\51L4MW(-L>X"4L<
M3W\O6FSZP^L!A(V;L@'N%QAN-@M1*(W_ %UT1#U-0Z>AL@D#M&G5U* ,^EIT
M\:570M^T#:1[=;DX[&['=T8B+$F^,\?HO1Q7[;YLXM>AUO6ED;+)Q]1T.@#(
M&"1U!JC=Q99Q[(E52NV(:Z6'5\5I>%4!(VZ!O*-F:&JBIRGGK*]V4S*9BK52
M"06"K;TB!^"VJ6Y,4B($)($)AGJ'D/W+8B4M@MY6V<\DS[AID:7$SLZ;A&0P
M!K8P2YFH.))][@%W=W]H;9L61?#@\'D(=JYF]RUWFX)+V)TLLF9LW64T./E;
M:M;!!8M?+-9&XCGD=*\"<N8RCO<4<@W WIQ32(6Q!&>[YOJ[F^W)(XP)\<H:
MM9KV70U4MU!F(N8(WAK<:O)KUH)8AKEJLM: D_YP.MJ-;)Q;N''/=Z:XMYG8
MN+HF%HD:'AT >!K=H((EZCR_2T::C3RX\>+OSL*ZE&WL]@\G<=N,=]4/Q=NR
M]ACNV2X9EVUGK)C:OBDCR)OKI]X(8HW1%T70)$1ZDH79R6QV-153T_'MQ4TJ
MC'>O'J!-UH1<N>05]^[R,KH6F89_&P*6LUU:7>+.RHD1J<TDY(L$4J+T(1.B
MA\'&;@ELLK<9&;J W39!(8G=.1O4<'ET;J&A#@#0@@BK3SJ/&=NN^62VEW*S
MF_<KZUK]R07T5[)CK@V5Y#ZZX9=NFLK@MD$<L5S%&X->US)8@^!Y:)-;87_(
M0E@X_625)8\$A+U3#A)+2K-!5]5I8'7[!?TGF:AX'(E</9WLD#Y!&2OS3HF4
M@5G&N"]"[.2Q8L,6&IQINQ.Z;<S3N=#++'<!L4AEEZDCH&LTZ0]S?=D<_P#*
MES0&M+6-:T-!K]#_ />8P;<KF9I\3D\CC]P16^.R#\CDG7M[-A+>T;$(&W4L
M),-[->AN3=-$UL$$UM:6\$#;=DK9;=4A5\CJH-IMSO(&5^99C<=@VA% MS0N
M:W-E;[(>#)8[L,@4*75P2O*MMDKDL F5)RD8!H?@A&3\4(QC\_E+Z&_Z#XV.
M9+';1Q/J00XQC0'-H 0"T"H)/O5H:47PCN/O/$[V.%N["UN+7(8_;]CCKGJ2
MLDCF?81"VBF@:V-CHFR6\<1DCD=*1-U"V306M;.6=6OFZ81,(F$5+K^YCFEJ
M2V5.$-L!AB$4N>LX_3-[M;O&%SV].4$C4@D[PC7U^Y)'QK2,LJ6-,Y>FDXQ>
MG6I@DK"5 0?$2_#/]+B<W;6%O&RYB?)<6T[IH"'!K0]S6@B0%I+F@L8X:2TU
M!%:.J/T+VO[Q;>V5@[*UW!B[J_SFWLQ/E<-)%<,ABCO+B"WB>R]C?#(Z:V9+
M9VERP0OBD+XI(B[3-KBTUTXK>Y._/\1E,^9E/.QLLO*Q8Q"VR,*D<\03'H&)
M3F)RM"Z2@YX4L*F,1K=H2)<U!);2E7S"\@!H]@1^Y1R6;EB@B9<01/&9$<$;
MGEP,99;O8]A#=(<'.Z4;75<11I(^E[O?V?VAL=AL9:YW"XNX9W7;8X>PN+N2
MX:^R?:X2ZL[FV?';B)LS;BX^KK"&Y+[AT>B&5S&ZKBD7H%<BW*Y%AGLNMJ!N
M][PU12Q%5R-O@3XVP9(RT<.=A2$3-@-EZU[<%]FI;.?0/9B)<F+1?,I_E B^
M6W\?([AQK#Z2WMYFXJ03=5ID:7ET^BNAV@- C,3-&IIK0ZJ:N'*?WV[?V;SM
MC!8/)P=L\@S+.R4#[V&2\=-F!9ESK286K(6,Q[L?9FT$T,CI>G+UR.L.GCW/
MBBRRF)4**VU$&R;VI#KA@?0\A<8([*VQ\:KOL!VL5]?JT:$TN2G1R0P9=(W)
MO8@.2AQ2C0J2Q*@C-)]3,X]S61E'7MY76L$D,ENT2 %IAC$;6R$L.IKPUKGZ
M0TU!T\#PY5G]HC9[\DP9O!W\VW,)?XN]P4$=[$V2&3$645A##D)76KA/!>,@
MMY[PP,@D$T;A"6LDHS;?R-'#[:[8?M;'?R;?O,^^K[O?LXZ?;S[<_=M]W?V;
M^UWVA^H_L!\[_P"_!Z?5GUC]8_L'Q?@?3G'_ #D9Z;J]-_UUT.CU-0Z?3ZG4
MU:-.KJ4_)_2TZ>-*KHO_ '@+3\W?K/T-W_I=^I_JGUW7C]%Z/U_KO4>EZ'6]
M;H_<7^,=#H?E-'4X+4FSBBS#6%)N56U$'.<57#Z>@?/$A;X&[)&QC:Z0L!JL
M5A?[+:%,O5'220SA='6UO?0-RAN2@0IC!)0@-.]2^0_<UB)3T+>5MK/),^X:
M9 2XS1F-S8R& -:P.<YFH..HC5P''O;S[1&SV9-XPF#OX=MYN_RE[G8'WL3I
M)I,O92V$T./E;:M%O!9LGN)[,SQSR&:1HF+F1^_D#>1;E;0;GT1MJ!M%[S)1
M=*>U)$XP)[<H,K9+Q'! K$\,82I<B>V]=62:L6(#*-:N4EK=)E'S80_,ZV1@
M-PXUY])<6\SL5&(3$T2-#PZ#70O=H+2).J_7I:--1IKIX\5G?;M_=N_-C.X/
M)S]M,>S$NQL$=[#'>-FP_K-+KN8VKX9&9!V0O#=B&&-T/4BZ!/1_*21(^<9^
MEB=91VMYQ#F87.;A6CAS[]I(D\.1:<F(5H_57+&.SE3=)D)T@02^+R14 @YM
M+;C6XW8#-A4^S8!<.',VCKB>:]BE=ZP2"XTO:*ZY&RL=&"TZ2QS14.U:A4>[
M5>1Q/=K:\V<S&6W=CLA<#=D609F_3W,49<;K(0Y*VFQ[9+=X@?:W%O&7LN'3
MMG;J8##JU"('#ANP4\<6,$7M^/)#;=KJ55ETT[NL'7*%$J;9W94\M&426LTR
M.3)BHH_A=+7DS<B*<1NB<E"O3C'LPQ%Z*>P9NBS=,)I[=Y%O,V2V > &ED<<
M36RDL]]M(HW$MTDN:1P#O=][:_:0VK+EH\IF<#=R1X++6V0V]%'>,:VVDL\?
M98ZWM\@Y]NXW,/3QN/GF= +9[YH)6M#&7%8MN7<8.SY*G>,OTV85/-Y\]M*V
M6B!(XTM33Q--[>@,N@LC9U<L&]G,@X:T'V"]O" );:!9\ZK(*,'LI+ZGZ&[D
MCBMVSQ1/&:$441D+@8]$,C'M(9IU:STV,=5U* D"KN'0VWV@[''82#,8S'7+
M.[;<9CL9+>ON&.LG6>+O;6\@E;;"$3"[E%C:6LQ=<&+I12/8T/FI'@DG'5MK
MD)4HE]L09XN2 (Z.9:9DC? GQNB:%HH1\D;TW*)^QFS%6ZN[M: 9:O2O^V]:
MB)2$"*VCU[BM[,V.W%CVOZ%O!,W&RF<S-,C2\F=K0>F[0 !'H:6:FN)-=7/A
MV<_?W8MM<NPV!P>2M]@923,39:W?>PON7RYJ&"*1ME,+5L<46.]+#)9=>*5T
MKP_U!H\:?$OXQM-*U*':)6Q"FJS[)8+NB=ZR-Q@;VNC[DTWU+DTP=G2N&9/,
MD:YC?*U/3[11_3DK<$ZA(/>U@1&>F\K-R6#I.G<02NL87PO@:)&AP,#- $A+
M"'-D'&32&D'Z/!9VWV@ME37K;'.8/(S[-Q%UB+G#0,O863QRX6U=:Q1W\KK1
MS)H<@'=:]-O'!(R4 6Y#>"EWH'E)EM>K*G@4>30<PRCI'&9!!F.UHIN?5Z^)
M8[#7ROQ1N:Q\M:UJ%:%9&)$?LI4G, H1.!)"D 3-%B),Z_$9Z3'W]Q=S&4"Z
M8YKW1/Z<C=3VR:F.H0"'-%011S21PK4>$[6][LALC>N<W/E7Y(-W):7$%Y-C
M;GT5]"Z>ZAO1<6DY9(UKV7$#-4;VEDT#I87%I>)&PV3PO+26ZGST5E0N*R&@
M?K":52BKVKTL#KYHN&83USD%@O3C"X\\I27&%.E=KAPU(@-.,7 ;U[@O4JU#
MBH <3V+MT6[I+@/AEDANZ,E,DO4D,3(PV,![FDAXD'5+A1NH-8UH8"#[^3[2
M>"DN\]%<XC(WN*W1T[3)/OLBZ]OI<7:V4<%C%'=SQ.,=W'?,&5EF:UL)GAM;
M:*"*TB=');>C*RD-3LT[CCP_,S^TO-P6K8<0-;&A<TKVN/VA-':PCF*1"5.S
MHG=7=FD$D7$ 6)@I"3D82/4@)NC!#\_E+Z'(2131L<R1MM%&^I!!=$P1ZFT
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MH(KQWMIL=K+@S[$&J4UG'RT9[_,XHYJB#T#ZULB=S2&JBBC/G"25A!@B?8:
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M*U*)$F2)#U!YI))8Q:\^W"SORD^,8]C?3NDUR/.EC6QN+7/=0$TK0  .<20
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MTM71] \$B2/3T$\Y02E]JH7N*+TK 8$L&RPA&+BYK&18N6".*5LHEM8I32O
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MP*]9W<2YPA3VX,-H+::LZ10"-1>*-@9FA60!#931#U[FJ6C4.YK4><0046<
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M0?H$$6]""/\ 6[UH7T8^KIJ5ZEO_ ,M%_P!TH=@Y0,+_ %N#H"1_E7'UX&G
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MUO8=;UK>\GU=-0'J6_'_ +]'\_O<%C^864TL?ZW!T>0!_P Z8^HJ"?>'J*M
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M#"(Y+-N%E;:O8/==;MED$)!8'NI50Q]=PK\SN_O_ $345_RC,[*EQ_TC:_\
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M"2D'&''F!7%GFDF:V'0M;YEU)8/S-UA6QMK#<9233I&@--F!'I'($.C)%.5
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MBD;;',Z2SM]Y(YQD9[G+'U2:H6H8!Y%YC,WLU:\N(E:DY0GC$6/T0$>Q;&,
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M,$ AC>WFIM7^9;A-MDDRBJJ>R@+K!>)FOO\ ?- A3L)*+GQXC[+*D![<I]=
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M]AV(LT&P#U[@[UO7J$6_IU].<8$@U',+SL<CHI&RLX/:01\8-0M-K6NXG4D
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M$P7<6'EBN0U@ Z\4LC)::VO<#4PU]T/BZ_-J;O\ TG_.'^4)G9>MWS_\>?\
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M176Y=%\+%,(F$3")A$PB81?-C?;+RX;>%OF2+B+EB7/X[)F0WJ52.2=CD/\
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M5V9B=;P.!U10NBC,;"&%C2**!OOEJ3\Y+QK_ /HZ)_\ Y/V=K]7Y7_XME_\
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MHH.-PHZNT[;(HS!EJ=6E<%!K@F4*$X"A%$A,&(("&,4Y\>/S*?\ Q<>;=O\
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M<*%>0[O8+%X;<5M=;?@QL&VLEC8;NT-C+?RP21.?+"Y__.9-XR03P312QRT
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M%LLPC8)'@N#16BA?\ECHW\QOR5?^D#B?\$.=C]=X7_I+$_\ D;__ #E?0?\
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M2LBFS76R>V:_FM<R^K;"C#-/'U,L88S*D[9)R5J ]<7\KO:8P(M^[8 #+-A
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MU^95J[)\"'7S_(HJY<PE(F]%37CRYN2UJ0WSZ*1<IU[UH 4=J9)M24Z.239
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M^O?9?5/;[;<U%-1C@)]^7 7(ZW(,5G+MCTG:QZ^74C*.W[,*ZVU^4?>4ZO\
MQ-TMUAR/YD)6DJ)^:[XZ?DM3\N4# ;% 37R];17&Z.OH>S.J5SFAC0B0QJPI
MF&7/R94(P"5Q).)/*$,)I0A50.#7-X\!^%:S:_A!DR:==)5=27,T&C'(EN=6
M^)F>)H-&9W'(JV.M6T838Q?7KB6C^TJ60LKBB%+_ '@!H9*YS-4;&A^((.]Z
M(). )/O4/Z2F&HO&CU'5O'_(W+"&I(<E'R9YEH?>9<N:)5!4!UH<F0^U)G,&
MF^I,:4Z@6N-A"B<H2-RYN5ZV_GB; >A0P^S"A>TN)\V_.I>BW*_D$;/+JZ>1
M9PB#3JMYO.Y1QJ_5(5-8#M8P\*1V"LS[6?0@%VG0PQ9*G;H9N5NBV/EG#=D[
M.N"7HC0PB "*5;HT>//Y5]!N5:TPB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PBXI>16M9E<'87,M;PRU&&FC)?R_V>PRJ<R.'I)LV(X"[-E:-DR1C:UL@
MC!"$U8SK!^UPVK!\E[=F>T7IZ9Z#$S16]E+-)&9"V6(@ T-021X'QIPIQ7]$
M?LG[OV_L+L)O'=VX<)=;@98;SVG-;6=O=.M)'7L4F0DM'B1D%PYX9*P5@$1Z
MU0RK>:A!D<>BXI5L%YBZ&HZG+=9:R=6-DJR_([V+27/LQ#1K2M8FN%/[$Q%#
M=Y>T(I-!H^5IV*)<?_+[<<:B4;,+,'H7)>RUEF==VTLC'/J7,Z3WC7Q)!-0#
M0GAPX'C0<E]'R-IVGSF],GWD[5;DW!@LCF89ILEA9]JY?-VIS$K)I+N":8B*
MUE?;WD[O3.?!^XIV,N(@US6TRES6RK@?2ML= <\'0^ T'77+D<YKF5QDLS4I
M0T'N)VPY2X<[A?/VB6E]NVM3R)&A:T*F.[*:#5"LP1"L>T9Q6+>$36;+6ZU.
MNG3EX9Q]^K0*%_)CN!)U<>'+BN'V^V-!N?M!@^UO=9M_E.Y^6WI/N"TQ1ED:
M_->IQD=J+*[S=98<1D&F":YFCOM5TV.)C9(&BXC>JR]EK+B?8PP<5H+;8&KE
MRQ>I*HA=7='E=%1F>SAHKF80U[*EL?MB&DRTJ?3>/*Y:]."PU0^.*9&0F2)T
MAFO9\ 8>5C6PL>[(.83=LA<XQZ'-%010M<00#P_4CQ^-?8/L^V^P,;F+K[0]
MS@KJ?O/B=EY*[R.!."N+*SEO[6ZA-K/C+LVILK.=MM##$UEG!)*^266=IU=5
MIQZ>S(AXYY/RA":LJ"*VR?=V[@JJ94HZW[$;>) ^+)-'(3 WR&V$O12QEI^.
MW$*3G.S\R)$Q2=6%2!,N&<)#HS670DRK9Y9I'1B/0X.T.;R!)!;4:BRE ?E%
M*KER[.SOVLL/OC<6]<]>X.+;GU7DK7+QX2ZQ9Z++>>\O8;NQ8^VERD^*%NVV
MLKN61SXC&Z:V;&+G0;U0>XGRX^Z>8U"VC5(:<KK[R*EKA5$',#6R\S]+5Y6,
MG8^CX-)4K-'TR><1)(@"AC[(N, WLIIQ?S#<(WU^'KK)+?T^/F_*CJO#7&H-
M9&.=5CJD\"?I$<7<PY?FO<>P,=L#[->\HK?<C#O_ "WH,G?MNHS)-N#;]]D+
M>; WENZ6=SK.Z<_K7UW"TSW;6NZ5V&4U'N1GG5_-Q0Y>G0E)<RP,ZS[^LZ(U
M/ B75N8OM-,G4IL0J7QW$;IL9F\(M#5.;LM"G-&6F3EFG;*),,]OL+&()4 D
MT'-:+OM+E#=CU54)'0%8+K,O&*L4ZJ&&-<G1.SU8<(DZ!]<X[,8N0V"5@<HJ
M](8RN,3. 1?*&Z3BT$S8MAT(FEU*TX!;!*^I^=(/=D)YPEUR0-@O:QV\+I":
MM<'L@J7/Z SZU^54)FW7NV3IQ^H5WR83A%B6;1*/@:,^";[2:32O@HK0^1;A
MET@=G6<T]2TZ\0*FI.U0RS),S2Q([H(K)GY:<W1YJ5!;=*E*TV1KTIQ+:-*6
M>4X&D&A3B-V49H)70ZM*<5YW/R'<.,SM3[$Y]44JC=;^8H5**:2&3=J%NPXU
M8KTMC4'D$>.+-&G/99+)6\YM3*1C 2)P#I-L6CQ!!LFEWER7K=,]QU+RQ<O(
MU-V.O:VUSZVLN3UU'7=TD"5G2QLR/PQQ?$CHJ2G)E!SJ&03 QFCJ8H B=:7/
M9(Q&>T.PB(&D@D>"T3E/R9<P=01>P5Q%B02OI[4(;=>;>J^0SEF.D=7P.I[4
MFU:K)[,E0RVU VL"M/$ .2HWU$2U%KRBE!FA;",PA81\2M'3'1]$]$5P=;M(
M6K#;-K9*M>&U;+HH[%.#6VN4?  YZ;77Z *6IQ;DQI9QA"@LHW1!I9OM^&86
M(10@C@5RYC'F40N5>V?:<NY9L. PDKD.Y.XN7')VG<0<%'3=!THH2$R168@;
MDPSZBFJU'(&)S3-#A]8[VS/A"@1VC2E"8HL]'&E>-:*W?(?:DAZ*GMJ4W:="
M/O.]RU7"JBM)9$U=@1*U(](JOO F7_8.5,<SAX$A)*T3C W5(O;%R-&K2F$%
MC!\8DT)FBQ<VG$&H4E&=S\=$2R[8,HZ5IU-+.;X\XRR]655-V9,IJ^.LIR1*
M^.TK&>H+3H4K N<$R9P]!C$@5J22%&BSCBP"*:7>7-1W8WDLXJKSF\CJ0SH6
MK'JKG\$O;J^=$<Q;$X;!FL-:'MT=8 Q_,;^93R=()@4%+"5!)8FW8=B5:*#K
M>\*ACB:4XK.U7WOS;8!O.4,D-H0"OKYZ2I>N[FB-!O,Q;5,Z);;"A9<S1,P2
M] 2!6N $9*T*8(BR#G(MN4G)R1 )-]A"TBOD%=/"Q5;>N>BD?*'/TXOE?%5D
MV3PU=!6[[,H'1.S*'%1.[$B==HQ_6:E*M*2D-ZR6%JCM_",$(HD00ZV+>L*M
M&HT7]:>PN67VWK!H-IO^JEMQU0QN$EL>OBYBT D$.8V=,A6/S@]DFJ"R$Q4;
M2.B4UT#\38VPM42)4$G1I>Q$TFE:<%"[1Y%.;K4;82[<TW!1EWM[U?-54K,%
M)5NH(IJ*F6F0]JV4YI+4,+P;*YJZ(6;:AEC^@HQO:<6S250"]!$,KH(Y@\E+
M]#]G<I]0/LNC//5_5E;\@@:1M<)<T0:3(WI:R-[LK<&Y X*"21:$:@-<VE4E
M$<5\0HI6G,(,$$T.P:*%KF\PHGEOD.H!D[ J7BJ,2R+3NX9P^6&V6*T,<M;=
M+Z20P*G7JWOK&9-FB5 S37=&@2)/E@FDF(_GRCC]AT(L!I72=.H\E&%R^7?B
MBM:9;KRAUUUC;<&%T?4G.$E=XG/6H+=#GNS)$D3.,D>EFB%QFV2*04+A)=#+
M*$2Z-K<8)*<(&_BA*ACB:>Q6$D/<?,Z.96#3\8NJIWZ_(-5TAM/=3NLY21E<
MI962'))MHYQ>5*)<F:FXMA=D"UP/ 4K/;&U86L.3_"V'W%-)I7P4#Q#RB4.G
M*M5SOA]@5&1"IXAR>\K[&6V4WRV S&2]358MM!HCU>O2!D;%,K0,R%$,M(N)
M3?$=TP#%@4R<@L6%=!\.?'YE=N97Q3=>U ;?TSL>*L%,%1YBE?WD*W,L<6/C
MTH$W C3HB7IM'Z<")"8\) (=$:,&K,4E!*"(0PZV6(!)H.:AA%Y >*G)71R!
MNZ8J5Q<.E24ZFAV]!*$RQ?:2<^2"AXCXHB3:-5+2D4K )N5B$ &D*T(B5'PA
MAWK172[CPY*1J*ZEYTZ<)F2CGRZ*]N FO7X,:FAD#D:%^U'G<X!YB,I=\H8+
M?R;F6E.$B5@]Z1:$DS9!IFBQ["4+2.:GO"B81,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81
M,(F$3"+D?Y )S.&R_J4@4':>9&_4BY[ZFE,XLCHBK9#9!4;K&&MD'-L".-Q<
M7?F9V)CTLC[B9IU2! H"M+3 #L&_;H(N[QD<3K:220S$B6,-:QP;5Q)H>(Y@
M\O)?NK[+FV]MWG:_<6YMR3[QE-INK;EM9V&"R,%@;C(W<EX+*=YN(98C/;3Q
MM-M(2PQ.D<0X5J.4\LLYALR#O5Q- /%-U0V4F?0%=REF9N/K2;Y1&Z]G%@,E
M5PED8W6PG](A0M+$0O-"C3%A-+3%)]AT .MAUONH[8Q2B%WK(72A[@>JVA+6
MEQ)TU/'\*_;>#V=D]G[CM]@WQ[V[*O-Q-S=_;2R[IQS[>XOK.RFR5W--'8PO
M>^69S&F61Q:Z1SZZB:D0/U_0]@QGHR^:@"]V"5/+M5N-+<?<NP"7-,69RN>&
M61;F\+<)"%Q/!!"N>MK65[2-T7+6-RY*\)M*!$ +%K9G*Q]Q$;6*<-88(P'2
MR%M2'TH0/U6KZ-74/ TKY?3>PO<S:V8[3;9WX;;%';.W8X\MNG<5[:RW,ISL
ML'H[MD&@&\.<T2V<D^1=%/#):R=(2.>"&QAU6_>.^V:9?+/CL 1UU=:A$?$J
M;YPY^A&JV?(0C&U.(%,PZ04GQ!7&;+6(IJV:'\PQ+4HOJIP3$>S9I9A@=EC'
MEX)^D]VN#FY[SJKRX,][AP\QS!^7V79/&?:MV/W!MMF9;*29;MVR0765SV;N
M_7PW;A)&6VN!:VZ;<8]K[22FB\AD'J8)I=08YC3/-TVWP8BJ6)J:!=>06.W(
MS8''<DKU=#.?9FQ6-!U,(6,KA>3]<<F2,"#4M8$S\C^<.):QI% D!1Q8]G'#
M /6B"WRG6<+@3F!S9 ZKVZ37@P-%>'#AQ^9?,>WFQOM-W.^;Z'NA!ORYV+>8
MO=5O?,N\W:36%XV\;,S#PXJW=._TTSH7=)KKD2,$SHWM$<;7-/:[A"6&2!4C
MUSK)HW,Z1D\^L.X^@KC=T#B4U6K=]H(U+M.HAS_'W%8PR^#,4(G6B%POKUO<
M23698600K./ 8<'SV386$B[:YL[6-:QO#W6-X O(K4EOE3C]P?SO^TQ@V8N&
M0]V+.[Q_<6SQ=CBL'BHGQF3&X?'/;%9W6;GC;/:WDUY9ZX1Z.>!S;N)\DD$<
M;F1GK1G2+\,KG;W?5=W/TOX^OZBZR07K(N5[QEL^>J/6S6.5ZLG,?G]&6?3I
MKI&)5,A%1%!+(2XSI.X$ 7FD%G(M*P%FZ/V4 PLFD<0?$*NOC1X<N_D^>,:^
MTFZ+[;&_@CG.EE#I&WU*YMS=:,:O7J2V)Y X^D,+3N^H?!6VWVAO;EQA!!"T
ME/KX8 _#V )9/<'<O->?JCFWIF8=T0>Q^;H'):S9IS$8U573'0">YH2;5EDT
M*F:+.+71";\_.B74]'<59O,NTI@LD8!D[+&Y*25ZL"+0DPRC2--"H&9Z8\C;
M7Q+SESTQ\].=..?-+WSE4=H[Y^ZCKF$V?U-2%4UC,8;)'JJ[(+0M(:?8A3P,
M<?"DSHYH7]>V"=$GL1&>T*XK5NHGS5;X;XN>R&SF0ZNG6OHP7-A\,\C4J4C/
MLN+NHRK,J?R(6GT9-VPZ1:$G)5@:JWDK>O Z>PHE>NWLLO03P;"$LM;:U\*_
M@7:+L&K+AE-Z^/ZWJJ@*>QVRA.CI8\V@RZET?B+HS0"SZ)LVGULY;C9*<E0O
MA4)<IHG7*VX@S;@K3%B"E+--] X6MM*$'R7(Z0>*_JN94,55/U1%(H_+.-?)
MU3JIZ',VD2,J>]#=UP+HFE&!P4-8'!:*/SB$Q=0%R6%$*@-(E(P'%&&_L0RS
MUM!K[1]Y=.>#>99!"JMZ%<[7@=U5I9'3$T4.=E-=TW] ^@YFY_5M7Q>KFR4!
ME-:,C+#&CX\>9"D120C1YXDS<G/4# :9L@DL7'B*4H%R.:>"O(]-ZOE?/UJ4
MQ7+!'N5/$_TGPQRA.HO9D9<4_1-EV]&X!7">5R,*AX+<:_8ED3JAL5ID[BVH
MQ)5+FI+4#'I*4<H+/4P<0>9J5U.\<'%+QQ%8?7,3:JZCT=IJTY'2-H5;+4T@
M)DDQ&Y"J!IAMH5-)'-R7+Y@?&:VG,5/<HW\V<<C*1R<\E*(/PC [+!SM5/-5
M!<>.^QS^7.B^/".?( O*B5]37I2H;W>+?BA;9TV-R[Q8.PVBH'R($,J^60A3
M+XNE/8I"XO9A3>0ZHD@R@+DA@SDI74VH=[/P444RWB3ND;M)>FF?FR*N\ZNZ
MSO(,O?N7_OIKQO<:=CO7'/E(4Q!)BOG:L0JZ?9(D=Z&VX2LIH5*QZ(E)P4>U
MIA!VC8KJ;RKPX<?B61I;QCW_  [HNFE=K0*QI95YS9X]K-<W^N>D8#"X!45P
M\<<\P6M%K79%;N4:<9Q9JAMF]<E*68Z.K/JU>WO2DE68F^$(2HA>*<.?'YUV
MJZ!X8Y(ZJD;#+>AJ*A5K22,,IL<8'>3EN8U36R'KC',UM3;0N*,O2<:\X1N_
M<'>_=O\ 5],JUAQ')0MV#R'MXX!DG*'*E?QYC3-R^GBJ^@)#J0PQ]M9HC?5?
MV)($Q+D]*3"DQ9+.S+U 0FF;$:;Z%A_7"#K"K3[U2N74_P#&SV!:;]:U*&P>
M#P>OV&4^6:SH)TT98C0O77 O\A\+LEAKN!K88UHS)M&5,+76L(,L5.)0$1Q,
M80[0#5;-UI-%GJ:./CP^91?R[7]Z=9W+8T^9*DC$-U37<_B^U83?'[2@D]A+
M8GY*HR11FZDT5L.&J%$,ECM"W)^1ISVIN4*%B$1@$JG1*PI0E3U4D-%/8?G5
M\O')Q)T#SE8W-LDM&)L#$V5YX[7SGJ9J&J4L;R<FM19T^KM%&SE$MAPS7)N^
MRJPQ3\\#W)PGFC+]?B"WZEBYP(('FJ]/7C^Z_E70LMK]16T<CE,J^A/)E<K7
MU"GLB+*S5K/W5S?-H)!6P5;$&DV$3)*ZF$OTW.0S"P)ODFY(8E,. (7RY74T
M"OC0?,M'K3Q[=50SFTU^WS_9"[I:O[%\:P5L.L+K&IIXR7'7W"ULH9NJ;:<<
M&J/Q2*U?&T:-T> 1XN2G%N9Z0\!*H"7900#)J:3_ +GC\ZVR><6>0BUNRI39
M5BQ^72B(LYW>Z:"RI[Z&ARVH&ZMKZYR=Z]YVK^MJ-($D<X3+HJX. 6F6/:E,
M4-P4A&KVH6IC0"2D#FAM![%@%7CPZCC-3S31]&2Z7V4EB'C9,I1^I#HVM:HM
M.G[FYBY"E%33"U(C))K\U!G<,2FKJ-B5M+P$;?((^[K1A*5%A^7-*ZA7GY_?
M72SHN =YRKA*BXM'7HY?TVV*^<5?4Z&B9PQ4Q)+$CS()D'T)%Z-LA\ V,5=/
MK^M+-,;UOQFH.D91I"<]&(XH998 MU&O)4KXE\>'3%>@C2*U60J @7\/]U42
M[R!58[-94KBD^Z,[BE5U0<3D_-8TRN7NH:X?"7!Q=R@E@.<BQ@,V$X7IHLG.
M:>7F/O*<?$KQG:/-R1W?[WK^U(?:\;H>A>80R&9=%P:Z8+.X;2:>4";U=4Q>
M$Q>/*J\KQH=GQ2<RIW[>WS21T&G.))TG]YQ1[@>7)=H\+6F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB81,(F$3")A$PBX_>0J,30WHBCY>CI"^+?K9;SCUG2\[44%%F:42N,'7
M,TP1@:UI:>0O#(S%'?+)51I>SC1:]Q/K\,>M;#G>XIT?IY&F2*.42QN&LT!T
MDGPJ5^]?LK9G;S.U.X\#<;CVS@=W1[MVSEK)N;N9;:VN!B9;R>1A=!%-*1J=
M&UVAHX.IJ:2"N344Y1W4%.6U4] <I^2!SDEZS#FO3D\WK5E6M<1C3/3UU,4^
M5K-K8-*%#F2(]M J"+8TYX?<$'K[ ^X>N]DONO<1SW4UIHB;)P8YU27L+?U0
M ^?XO)?N/-][_P _-_X+?'='>_:.'$;:L,_TXL-DLC)=7$N5Q$UDUFB\MFQG
M3(8R*/8:%U-1HTW7[3YNN3KFT(%,EG(T"=9[7W8DSIIG?+#33U' IMRI&JV=
M))#I?9+A'5JMX2Q5RL"0J_@J&\H !N))(-:UK8];ZW'WD%A$8VSO$3X XZ=.
MILA-"!7QH!PXGCY+\[?9Y[N]O^Q.S,GM^WWWDX-L978-IE98;%UD^]L]R7%_
M';W5K8,G8V)US'901:XYW$B!\CB20VFP2F%=2;>&>WJYB_2"V?1[Q@]-PR)S
M.TXC%T5MH[N6VTPNL%C3TU1<I3%"I<J2-8C6E,26/X[<42,>MF;,UFL26@B=
M;/=%H-VPD-/NZ0P@D:J<./$GA6JZO"[B[+C'W&P]VWNT8]L77>7;UW<VF-NK
MA^,?B&8R:.\N(9+DMN3:M=(&W,CG#1.Z1K2&!JP:GB=ZC%S0^VJ"Y:CD?-KB
MDWULZR060@E+=KJ(F^X&P.5@-E/ZCJUU^TMBQ],A?&Y0G7B8D1;XZ$D[&,@0
MC2MK;^-UNZ"YF)UR5CTT_)Z'&A?PX-)H:C4: GFNRA^T5CLSV_O]C=S]Z7=T
MS+[BADVR^P?;2?FZ<+>S1V4F4Z[(_3V$[GV<[)(1>2NL[>232V0!CYA8^/00
MWJ'QZW? *_LX](6?<.IDY3AH;$4CHFG'"BG!+2]"RI.P&?534Q5@N=1,K< P
M:Q7\Q[P&JU&]:,WQC?Z[*[MI7LJ=-*<GN#ZN>*T)U<_P+P.1[^.W!V8[J]N-
MT93#-G+<7Z2.SED?!F<JS,L=ELU;.F'4DFR+(Q=SEHBBZ>ES((A5J[59Y]?S
MP5=+QZ&;Z3G/,4&5Q=?(5?3%YG4FUKTKBF0)8DI35):-M'R)R+.(/.<DWR-8
MFH@)R= &(Y8 >QA  7J5 J"?):Y&^Z^-)A&+EFD7Z>I%]B//)QQ-W21NL..*
M&6L]DFK$VCI4X!7?+-Z-2L;E"=.H]PB%2E.:22,PTL8-$TN\N:QBWR!\2-L:
MIJ9+^I:41Q7H5P4M5+R!1.F8IJL)P0OJ2+.*5C6#4:*^(U2E>0UJ_C;*TD<C
M0)3M@/%HO970[RY*)JW\H_)<R#V"MEEIP"L&3C2]5U*6,\2J<LFR#?A%L38R
MR[99.@";T4KG:MT8&Q'ZJ%2M>S'@!K8]_""0L/#VA>WUCY.N4>5J!:[S76G7
M4^'/X,HG-#PB/6'&B':^F\HQG))%7B\1RU,X(#3GY(':L #2@C. 6'0SA@+$
M1K"3167M:[$]63VDXHYE0@AFM1YL) ]/<HLEJASQ'V^ 5=*;*6.$1B2]K5K;
M+4@2Q@SY]*E/1C;&W1S@8(92<9>R@%5Z= ]8\T=4HY0X<X7G6=V(H4L:$,K5
M5Q*VN3DL2B0-PG9AVO&W'G:*3O3>6,U(=KU)4:*,T6(6RC-!(6EO-<]47FMY
M660<-CB=XVDA3;W/)N+YO(E-B1X+97B1F3VVOCUSRQ0%,+22,3]LJ0\]G0 T
M)0ITO3AT;L6AZT6?3-:>-*J]2_MWD!K4T8D<.E:82*.F$3:Y4$6;/X_K=L-K
MR8B3L[C#1:6[ Z('9<Y)TJ4[6]%J%IY:8O8E PE[+#2[RY+;;QZ?YXYH3P]5
MT!<U>5 18#_]EX6.>R5OC_VE? @*,/1-0%IH!J HBU!8E)WIHA*$T&S1@T,/
MJ0 GDH$I3R(<\6_?MY\Q*IE$H)>5-VQ/*[0UC(9FR"FL\C=>PR#R]\LMF8 ;
M(4I(]HN7F@"2/9IX4[<:I%Z%^[194M(%?!;.T>1#AE^K&;W.S]64>X596TG9
MX9.9NGGK*)CC4ID1B4J-L;B?M0$S2Z2[6%";0@ /3@6+WI]F UL6B:75I0U4
M=4SY.>5;'I;GJX; LZO:+_*BD,V8:7B5@6#'"W6:_92RWNN$*YC6!-2HW%'(
M%"!">6<7_4I1KJE3?&&::5LPA802/);1)O('0C9V'47$D3E49L&Z9^\V"V3N
M/QJ7LRAXI=-!:F<[5*6S5A*^97[-?TR9*D*(#LH:<2TLT[8=;+ :32=.KP7C
M*\A% -W9<^XFGLLB];6DP(::'7">73!F;W"ZGBVV.:/^V.#1\[X2T:J-)HF
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M")A$PB81<K>F/Y6+Q8?WD_)-_P @\HX1=4L(F$7(.I_Y<OM'_1R\/_X<^O\
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M;'WN/$29))+BJ!HJ5,BA*E5*$KJN52<"C;>F1H$01K*I6C:.\:?(% G14,N
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M5>WSQQ<&R6O*XJ:0<CT*\5K49<G*K>%.%=,"F/Q,J;C"=,RVY"8DV6,N6K
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M(O65K$C>F.6+U29$D3@V8>J5GE)DQ(-?JC./.$ HL&O]G>]:PBPS)+XG)1'
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M2FT223!EYOE-HI'=8@;K@"B6!2J$19)Z,EPT(C:K?M$/2J=-U*J=NZO([4/
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M)+194FN&CA0R!0_H"*MKH\NE%S23AD[F6VV62T->SS$1!2HM*%02%280(0]
M*&-P%>"F;E7S'<D=?7VDH*M&N[6!QF+78S[1-E615;G#*BZ<8JB?#(_9+Q0,
MS5+5'VS11-<08-1\9,A'M.4,P 1>P6M%"QS14T4C]X>2:L_'XE972S*,ZNM*
M.K(K))[*9?0%(N-CPJKX+#U;8CD<ILV7F.S%'HHB;Q.Y(]%&*!J3"M[&$O8
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M);.26OQS<-VT?8O?ZSL>ONEH7V\=5=(5=$'F0)I^@4S'G$M:8?,[@K>7D[1
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MH0*30@,*/"$98M"UK>%!4<N:WYSED694Y"MXDK TI5) 5292YO+<@3J$PQ%
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M F+IZ*GU])X#.[03 V:V4Q<, JRRFR$2A$EZR((2B86]P3-OLD2I0W"T4 D
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MG6LI+8 5D>>N@R((P5]'HI02I)*':R&>,L*YP#MH7FC0)]JDVT*;9YN$ :?
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M,N)\[<//OE'N2.H5!RAI9[.N2ND$$H:/J?F-F>]1&'I]<'-($SU-&G_7^O\
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M-?(LB8Y.K=CW!8H<C%"\XS":S2BVJU?'+6=KVO.+8<+/MZ.KY@L#+&^-1Q9
M@1N%VX2U4HT(KAC7UO G9^-E2 CG>(C+0N"Y<P"-;C1&(#/FC]"*!Q HLN^^
M/6H9'4]=U*[2VRSV^OH_>C0&2@=HZ7)I2[]&-DB2VG+Y&9J+[9_KYW=Y8O<R
M0(D:- E6'^T"?2<("-$UFM5@(KXVZMAM@,]CL5EVT2]1&V6&QZ_1GJH&I:8)
M&6=^O>2KJ>9TYD$^8<8"_NO2DNVH4.9JZ0E%*TI:=R)"@3>PFHTHO;LGQI\\
MVET&_P#3$B53PFR9">0>JVW/K:2Q)_@43/*!T2D;5#&J&!.;'9P!U& 9H]"?
M61L4[_6)MDF$UD"G@O0DWC-H^5'-(E\LLXM(BA$1K-V;R7:-?*R:OHSSY:?-
M2Z-.@C8J8I3!E=>VVX#7*T1B5:4X$)SDAJ8(3"S":BMI1\#P%IYZAE#QV>RV
M'.->6$UVM#;>@<.H^"3AFL%G$J2(I..-Q&IV>HW9Q-C:TUJ5F+8VH&M2F;,/
M$-3[3PDU&M5$#9XFZ4CIZX$1M.[(RQIF"&M4"C25RKYR:ZV>(=(^7Y8"7,*I
M[KUQ>WM[?7SD6)&K27I6YMV];7!)3$Z5?L976?A\/:LL^^+BIY'+YU83E:]P
M%3B862\6TVOC*"J8XCAD_5+JZ=V*5,<2C]8-L,72-A>JM9U1[BXMZQ;(#$^M
M/1KAH(/:365NG/WCEIGG2TF2VXF^R21RIL@J.).*Z;1FH'MY?7M$E=FH,\^V
MA-9()Y$WQ9'WH] K01YS:&!61[1&H!&>\8RA<2*+'+?&C2;R:[@DDOL^0,[I
M(I@[EL"MTBR1O;V:<=.(>L'R'IU#5$D#LH8QV40H( <H4G.(&E::1\S\0!!Q
M1-96;B/CXK*"\V-7.$4F4ICJ:-6# ;0B-F1J(4G$YVP32JWZ)/-?/BA!%*I9
M*]E[DSIX2@1*U3ZQN:MW2A,TM-.&((@$U$FI43,/B3H.),4W88O*Y,F*GU.1
M*H'USDM<<VV*_G$QF%P6N5TGV_6'1LF=1JIE!J[;T+JT?&U&QFB/5IVY,L&
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ME3U4LWZ[[5?9HM6QMY$AA'1<'XJC%?265$/NT?U:*+7>S/@-D./O^6<'*/#
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MZ&J#)JRMX#VTC7NV-];T0=>T)AF]U8Q/TNH>14K^#3QMM?C>XCBD3?V1 BZ
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M%":]C#'UQ<$'D$02KR)-/V*(TDND-F'*])-)EDH;Y%6;Q&FPYMVG'\(+2B0
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ML=9E,>V^?=.Q]NZW<T 0E\VAA%/>!$FLDT-=3B.)H.5+8]RMB6N];W<UQL3
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MO%901S,+=4C72ETE!0AP=(6C4>)TM;0_1H."VYS?FS\KMC&X+';/PV/R]D^
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M;P7.7?'DF'I_DKET^0EEC8-#A6U? _\ *.J[@S3^"J,MT%3*:^'US<!TT.E
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M\._K[1ENNM80^#-W7-PQZ71QR<5KY;;=$:142^<)%ASB8E:GUH<ZS6PE"D;
M+"@%#;FQ&<(*4&S!C$(S8D>4Q[+V2Z?C[=UN]H#8B^8,80!4M(D#R30DZG$5
M/ 4X)C>Y.Q++>5_N2[V)@+K!7<,;(<9)=9=MK9N8(PZ6&6/(,NWND+'.<)[B
M5@,CM+6@- R<QIJTI(\UTY,74=JP9!#6MB02AB8HM3RY!:"QJ5DJ'%XE1\AK
MQW<6M9(2"Q$J0,YS>06 >]D *%K6\PM\C8PQS,EL8)72.<6N<Z4&,'D&Z9 "
M&^&L./F2N'@.X.R\1C\M9Y+9>$R5SD)IGVTTUSE&/QS)&EL<5LV"^BCD9 2'
MQFZ;.]Q $CGC@LH.J+&%=(;,#T79((#KV^M"ACE6;K\?I'ML^];?Q07=DZT)
MT_\ *F_1YU_57ZS_ -M_V',!?V?U;Z+T</J_^'U2]3Z5?HZ^GR]WZ'+CSXKA
M-WOM,=O#L\[3Q!W/_P!-=?(^N_9^K^P^L]!^Q_N?_%/V/WOV7\HL;#J;M&.2
M&PWA]Z@M2<MDP;7]%&(R^Q>H$+762MV7#5-KK%U4>KQH=W-7'$XM)TP'=0X$
M&%A]3P&C_79G<9&QFBACBL8(GQN:7.:Z4F0 <0X.D( =S.@-/D0N9G^X&S,M
MBL588W9F%QMY830ON+B&XRCY,@V)@;)%<MGOI8HVW#O?D-JR![7&D;F-X+$Q
M^C+=:*SF<(<^N;ADLLDJYM5,-L.<1I)-+H(G1'(3%3>P-+56:&%KTSH!*86:
M)R;5AH J![+$ 6@;#G+D\>^]CN66%NR!@(=$'S%CZ@T+B9"\$<_=<!4<>'!<
MW*=R=B7V\,?N.SV)@+3!V<<C9L9'=9=UK>N>'AKYY9,@^[8Z,N:YH@GB:2QN
MIK@7 G>B[><:MBT#1==7"RS!B>E[F\7 AB%('S*7H%8W029@>6=?62J#(V]N
M"N)"68A:TJD6DA?O,%L1FQV/*8]E])=.Q]NZW>T 1%\VAA%*N!$FLDT/TG$<
M30<E;#N5L.UWI>[FN-B8"XP%S;LCBQ;[K+BTM7M$8=/%*S(-O'/DT.+FS7$D
M8,KM+  P-R$SI>U)*KKA0P]3VO!"(8SL[=*D3!%:<7DVDN;CDABY\E8Y'73P
M>U+WP"<8#P,XFY.#1PME%E[T'TUV^2L86S"6Q@E,CB6ESI1T@>36Z9!4-\->
MH^9*XNW^X6RL1!EHLGLK!Y.3(7$LEL^:YRK#CF2!P9#;""^B$C(2X%ANA.\Z
M!K<ZIKF%=46,HNA-99/1=DHH$3\#XM#$1RK!P!5\)A$TF?&?E$%-L@'S#D+3
MD+V/(?13KV:]"/V+,&W]F,:;(V<)NC_O^J7J#WJ_1U]/E[OT.7'GQ77P;WVG
M%V]?L^3:>(DW.ZM,T9\B+UM9NJ*0MO!8'3'^YQ6T/Y/WC63WUZ,/IZSHY+K
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M=6#-JW426QT+Q XQ8L@<GM?5,K20AY>J?KXJT;7JZ(S,TG3%);?KN&&_,.C
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M5/'V+8(VD-YU=]Q:Y/\ RE]C4A75UQ2[JKYCCG3M?&<5S>)JVI]L(VA%M/\
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M..!9D"J8BL/R?IV5=;A*;8B+Q.JG5-57'$EO[I&+-BS$H4LKB1\0I5H.@[T
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M(ZP/E!-8D[8916CW4<PTTJW^VWFOHPU*6 G[4(_@IDBS00!-*+UK4TFBS$S
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MDSNX'&K#O@$;*S&IIR6X1L+J5\3\RO+W=V2[\-!I&W)=&&=VY:>YP^P'H>8
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M^Y_=73'*M:81,(F$3")A$PB81,(F$3")A$UO>OU-[U_WM^F$7Z]X_P#PA?\
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MR11"NYA-).D9$W54EK][K:.PUQET=1.[^VQ%#%STBY2Y'EJM! 2/W*!C&+0
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MHO([DJ.:O9FM;$PB81?+UVUU#T="?TC/QU<Y0^[[)C-!V+4C6[SVGF:1J4<
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M/L-#?Q88_P!K4O\ 2\5*4"?8:&_BPQ_M:E_I>*E*!/L-#?Q88_VM2_TO%2E
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M]AH;^+#'^UJ7^EXJ4H$^PT-_%AC_ &M2_P!+Q4I0+RIX;%$AY*I-'6<A2G-
M<0>4@3@-)-+%H19A8P@T( P"UZZWKZ=;Q4I0+9<BJ81<-O)_X[_(?U]=4#G_
M "%Y(YKQG (W5Z>'R2NXTX64C1R:8%2N1O1LS/+A<NC[<)2:RNJ5#ZFE#/\
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M/=G5L86IS?'I>D:F9F;UCJ[.B\\M*A;6QN3&+%Z]:I.$ I,D1I21F&&"WH(
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M$<K20U(EU)'N*R.1-:@<I=8Y(6DK2E0PZ3[^:^5(+T;[Q':T'V[+-C0ZM30
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M%RK!<-)3_P"J.*J_T0\\_P"U6AR>*V?[U_V2[EY5K7#3R*?RL7@E_OE]R?\
M9O:\+8WZ#OD7<O"UK5)W_P"8\R_Z*2+_ )(685'-<B?T>3^1MXC_ .B%D_X<
MK0PLI/IE=H<+!<,_!!_:K\A7^ES[L_LGB.0+9)S']Z%W,RK6O1=%X&ML<7,P
MHPXMN0JUXR2=>XXT"1.8H$45K?T;,,"7Z!U_L[PB^>UG[.[DD-!V1,=62A73
M)XXXY\\@]=E4YS(DLN5Q>+72Y6TSK>:FV$*IVF(F**/KXDR*/M0I']9[;=._
MO(T/28]*6RC:_+1=?H;T.H55MRM(WV'RB>//1,7@"Q7)J(B3[/ZIB[K*8:RR
M-;*'J4E:"*,U<I4.0MM[JNUK1J?V;%^N]<+"G$^Q5=E/0/1!W374+S')K!F/
MG;A]BC&[)J!?!-O$VN8N1\]O-WO4@8;"W(&\Z%/#,K=&)O:2/DU+><4D=-J@
MF&&IMI2RH-(\RHO>_*NH;-T!%9;4*. S#I"K7.;IVJ,V]'+'G=.ZDM96Q9E1
MN,FC9<'2Q=4GED;K TT>U3BGT2M-V2G3N:=,K/+)HY^Q2!SAY%EMN6O3M,#J
MB2K6&;Q=(PG7N\2F(H5+E;4=YGJ+HV:LSC6C(U$;0I QNW6\@+@D/"C,="EA
M12<M,40:>0MH*K;>H>RYKSQT?&H(V1A/8,>E5$)5D1KQ&I;X\]R^^I[U'1G/
MM9-ATZ<_F$,7BVU-I&B=#S4QX4J8L:@)9QA0"#2!M1\JJ\T>6"9F7,VK7*EG
M#=%/5;U$Q2IM#)HP1,J4Z#D-M=EU/*F)P, 4I!9L<<YOS8%I)6H#49*),6%?
MHHWYD1!170*>W^XMO@OEP5RUIJ<][YH<*_=K*N6K:T<E$NN&,):[@S%=%&5M
M?M7OK_9R>-'LA$RGD8LM.V-$=4DHPN,A1*&\EP$:-)M40L]O@O-_G;%KLN R
M0WEV3/\ ()_-HDQ<YH7.THI'$5PP^56W9E*:G+ZXG,S@*K?JV95F:H,;%9*]
M2-H<T1X![4;4HTQ31[5+O/G2_6O0UW4]/V"GXVQ<(7#S1"[;;9@[+TAUDLDU
MF,402$$5<DZ1]$C-,:W9;M$8H)"/X@ ;]J+X6]..$(:!3]55=-L+!,(F$3")
MA%PAZ%_]4+>.O^(?V-_9-"<+8/V,_&N[V%K7"/RV_P".KX+_ /2"2#_ =,L>
M*V,^B[XEW<PM:]%S_P#>:X?^X*O_ (N9A%Q1_1T?Y(?F7_Y^] _]HNUL+9+^
MR%=O,+6N&7A%_P#;SRQ_Z8'K[_Q%?X6R3]3_ 'H7<W"UKA7YCO\ & \*'^E3
MJW_!U8>%L9R=\2[J86M<*OTC#^3.?OXRG'__ &CZ[R'DMD7TOD*[JY5K3")A
M$PB81,(F$3")A$PB81,(F$3")A$PBCNV:I@5XUU*ZHL]A!)8+-&W38_-.UKB
MUGC+)5)W! N;7=G5H'ED>F=T1D+$"]$H(6(5I!1Y!I9I8!Z*@D&H4;5GRA1E
M1*:V<(3%7%,\U2SVTSQ60O4OF$ID:@5[RJ-SBX7V6/TE?75TG,ML*81-$XN+
MN\&K7$Q4 8@G!T:9H1"XGFI2M"M89<M<SBI[%:-O\"L:+O4,F+)I<X-FW:.2
M% <V.[?IQ:52%S1;5(E P?%3G%' ]?4(@[UK>% :&H4##XBYW+LI/;K-'9=$
M+ *L22V:L?8):MHP7Z]?IF*"J9BTR9!$Y>SMTC@TK>:U971QCJTHYD6.R02P
MQ*(]2K&>5U&E/!8A9X_>2E[9/6<^J"0MUG67=]OS=.GE,S2Z>["Z,JY]IFX9
M ,::0E&(]RRN9*M0:3I]E)4.S]GI"R%&@FZ*ZBIKB]#59#&.T(W'(SMO9KE?
M7.26,D^MWI5]?O+S"(U7+BKT>K<3U#9\Q#X@WI/8D$06'X'Q AT:,8Q%*E5B
M7^,/C%R5'G+*UD)B!371M8&QH%LVT1#A1U52+=S>O<?L@1-BXY]M7*CV5!'%
M#_\ +?71J! G]5/Q"]#V5UN6K7KXS:;MB<5].HHJ7U>]M%_-MWV@[LCQ8"IT
MM!(DLJ"W,Y05>C36"SQ$QE?;.J]A7; \-3ZB:@$*!-J-(L4?-EE0\C[BZ386
M"81,(F$3")A$PB81?+U!.A[JX(\D/E?E;[X\N^^@83TM<="2FM)WSK1!DTAJ
M]I@%&M<:>S1OSP^QM(J]7APV27M)M2#WIS0C$ 0/3<6X@.:T5 H%;K_/3S7^
M9]\OG_5=9?X1,JQT#\8*'>$9O<'3'F1Z!ZY?^.^L^7ZH=^ *[I=F4].U,IKE
M6\3>*W6;)7%$UJ$[B]LBSXK4]:,*+ KVH$ @T8BP!UK>RKJ!@;4$U7T6X6I<
MHO.-6-BW-XI.RZQJ6#RJR;$ET C3?%X1"&-PDDID"PFS(.O/3,[&U$*7!P.(
M0(SCQA* (02BA"]/0.\+.,@/!/)5MAOF-GD:A\3CJKQ!>7<]4P1E@951R?EU
MG^7-5-;2D0J3$^S+" 8).(\@6P;$$(MA]-["'?T:*Z!^,%'W1GE@LRXN>KXJ
M)@\17EK;7ZTZ8M&N&-P=^7VTMH0O,W@[Y&6M6ZF(YXK6%-J9<YEC/$42<:$K
M0M@ ,7H'94, -=073#Q3P69UCXV.':[L2+/T(G4+YFJ:-RV(2EK6,DBCC\TQ
M1O2.30]-#@40N;7%$I+$ TDT 3 "UZ;UK>%@_BXD<JKH!A8KYQ>LK+N+DOS3
MZZK;.*^PNGZFD7CD8:) [\Q5 HL,#7/#N@WR<F(G5>L<V)E3_)LC0$1Q>E0E
M(/FR-_"V ?NT6UH!92H!JIO_ ,]/-?YGWR^?]5UE_A$PIH'XP574=\7/W1Y:
MO&5:R#@+NSG*N.<&3L)+8<WZ3H\V"Q8DZU::):XL%,^-3U(VXGXSG'MIM_-F
M)MC/4D@+T/8M^D65 UA%02:+Z;<JTIA%6VR^2:&MZVX!=\\B*]TL.M]1\#(N
M1R^9,3(\%0V4BG<#3SN(L3\W12Q4U>SP8GR/EOB-P S/ Q*TFBCA"%LJ'$"@
MY+\<X<F4]RBS.,:ID-CML87IV](FB\QN>W+/C4;1MJMW7$(X2PV5-96U0=(:
MK>U SRFDI&!2+8/BZ'\,OVD+B[FMWO"C*ZZ)@8ZXL]"_+(W]I(A,$AT6F4OK
M^2M$J@,F:YC#Y PS&"/<=E3"[,,E9DRL@](L)'HPK6M[V'>];("0:A5H3>,W
MC1"[PAX;:R>VP<!:6QK:FYNM*UDC&]J64=D&M,GGS*5-=-UE3I =<,I, _2
MMR=Q'/JHP:@1@@C"5U.4NAY4JA@CK^WU_'4$;?5W,\>Y4971W.?96U-M405#
M+2*_CKG'W)] 0^H(\LF:TP\8S2U[@6;LLY5O6@; 4U'Q\ZK%0GCJG8WQU .)
MI QE2NH(53\%J(])L:]@5.R6#-+.E0R9*M9G$AXCTF^O&8IW3K4:LM:A<P@4
M$'A.+ 9HA<=6KQ4/,7BQXKCD:IV)-==2@ECHY6ZJX<EU;5K%C=_K:YFCH,Y)
M99Z:9$'6XWIKC84;\0GDVW4HI:G#O0?;[@[*ZW?=6]U)X^>5Z1D<?ED @\B3
M/\1D+#(XDND-H6A,]18R)UY8M30]BCJ673!Z1LT-A]<6L^-#6RD%@:T254'9
M9&C"21@(7N*W*N^2JSJ>P6J<0!TL!C;6M9?KZ"NSI_+'JOARWHZ;0R>SZ3$Q
MU]=G),V&)7Z)GF-:!)\!K;!/KH-.G 8K,%A0N)'%;"JY=H]9 YK6:F&[,A5A
M6THO*7,_U](P[=;/566U6^?(_G@.P7%'H=A,J9?\H0:4CU\/X.BO@"$7LFHU
MJH15>-;CU5-$\\W7#ZF>BWB0218C;[1M-NC+[)I&]VX_JI+)XDAF2>-29_;5
MM\2T#:J7I5!K8F>C"$NRBBTX"2NMRDL?&/.)BZ!.(Z_%M9644HF$PHW[3RW7
MU/&N:IJ.PZ8;M@T^:+7_ &1EQFU6S5&C3EWK\-6(\K]9A345&[QXWN3WJ",=
M:*(O8R*%19= 7")L[#?E[QH4045O I=6,>U$'&/6,V.L5)60:>.Z!V WGI@O
M@%HQK]*3=!&$KJ-:^*LK5=*5S2B-Z:ZS9UT;87D<7T7& R*1N45C:&&P:,US
M&V."QEV=5S' 8VVQ6(HBM-K,0B1&* F*1E"4GG&C*$D\U*V%%SD\O-?3BUO&
M+W'6]:1*0SN?37G:P(]$H=$VE:_221O;BV;)1-;*S-I*A>Y+U)F_0!10!#%_
M0UO"R80'@GE5<^:(\M5D571U,U@]>(CRW.#S7%3US WA<V<O-@FQ8ZQ"',T?
M<E+:-5/DRHQO/6MXQ$"-**,$5L.Q  +>PZ+,L!-=06QV-Y@K F=>3V'H/$)Y
M=$J^5PJ5QM I5\NM&DA"Y\85[8C-5[*L$PX"4"E4'9H@ &,(/780BWK0=E-
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M,*;T:MP7^-7R\(D#>D4KUZY7Q,Y)TB)"B(,5+%JM0;-P$ITB1,4(PTP>]
M.Q"WK6M[PG2/FW[JZC\D=.U]V;SA4W4%5()0V5Y<D;'*8J@FC>WM4H3-H'1Q
M:-@>&]J=7QN3*1*6TP6@E*SP[!L._=Z[WK18$%IH>:L9A1<MNQO*]4G&W0$2
MYF=^?NNK^MF8U(.[$##S!3:6W#T4#*ECK#%3BZH4\L:'M)\D]-7M.'I(-,6%
M03ZF^XSVZ+-K"X5X *OO^?.BO\V9Y@/^I [?NVPKTSYM^ZMWI;S54[;W1E*<
MR/G)G?% 3SH!QES56KMT?SP14\0>5D'B+G-)& EU=9JH7+/D&AM]!Z2)5(BS
M5!.C- "9H6B&,@5J" NRF%K6/=G(AG:W)W5!-&F:F]8Y*0D!",X1"%.8J."2
M 0P!$;LLK>@ZV+6M[_HZPBX+0/\ 2#J9M.),T^K'@'RJ6+!9$4I.C\T@W(/V
MKBCX2C6J6U6<SR%BL!<TN125P1G$&")-'H!Q0P;]!!WK1;>D1S(K\:V_7G,B
MPMZ"'QE>8$0A;UK6M</N^][WO?IK6M:FOKO>]X4Z?M;]U7TX0[KJ[R"5)*[?
MJF&VQ &N$6S,J5E$3NF*MT+G;-.H&E8E,D0.,>;W^1:0:0F/Y9 @'G%J2U!1
MH#"@;!])8N:6FA5UL+%,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$5=NK+O
M<^>:.DUF1^,HYE+0/E=P."Q=S=C6)H>; MVR(E4T$3/KTG0N:EJCI4MFJ,UQ
M/)3'GE(2S1%%C,T$.RH%31<_W[R@RB(5Y6;<]4^S/O1;KUN9S!;$*B$F=5%>
M0:/0_HB%459%](90YL21Y-@0AV)'QL:-8D3KU;O($K>/UT2J4 ++1QY\*+IV
MJN>K$5MM=#JYRPD7"]0U58357IBD6I&NA2)P-:E<D3I/A[ )L(<21$B'[O70
MP[UZ86-#2O@JMWAW&P<_WK(*PFD/?'I@0TS5$XB^H&@6RFRI[9=NW-*JCB]7
M1*%$@3)W%<O41\"D!XE9191>SC% B4Y SM%0VHJH"BWEVI)VL^:LKQ'9LCI\
MJLH;9-9VXV0Z0KFE^^L:"LWH:7PF:EJ$Z0R%6.TPVIWS2-D-+$H./:5))HBE
M B21E2PT]JER0>0F'/'%?3W6540V5"<><8G/7%UKFY&)TK%Z+DT5K=CM)D02
M1.84YK&MBDT-ES.Z$K"0G[T@< ;V )P3"@%-/O!I\5"E->6RM7=I1MUT-S4*
M2#M615_NPN;3I+=7.SK"&=[JV(H[\164?'HV:V5&JL>W6^(GK#$ZG2:2(7$
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M](0\0C' X0RN77:-.Y-,/C+:X)]4[?YGRZY"R(4RM/LPNJQ%&"3J"Q V( A
MWL/J'>]>F]E3&^O)1?U?Y\/$Y9/+72U=PSJY(\S&>\_W+#(FSAJ*^$8G>32B
MN9(R,+6!6OK!*@2C<'5<43HP\THD&Q^X8PAUL6B"-]1P70/PXEC)\5/CY*-
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M[_-[IN^PYFC!0*A^FTP>8HN?Y:\\_3J]K"8G5UVFB:- B+?7KH!U3GH4)*5
MA;4*!(@*2E$;T866K[B]&5>->O'VLFVM6FS)LQI&SD2L.+Q+W2)T]8J-YJFL
MG4#B4=(XC9=<2N&N[W)R@[)7&;0E@*_6F) IC0:'A-9K7VU7JH?&+5J,*AJ.
MM>Z7.(FN]#R,J/N;['5#D7):+YU6<P)I";. 1DJ;+':<5K\@-U-,7;V!U;PJ
MTGRPSCPC)K*AR#^%VBH=")A"C;6M-U*FE?V;6[DX(V2GX6!*P694M%TPK.;F
M&"5I'(V0[L\1Y^9S2U0TAAJQR4K5*S:@1P=%DUE6N[+X#H_N1+&$MRBD@ Q&
MONA*[9!QY6VI3$S;T=6)U6R]SUMP;''6GAE:AEK6LS6M (<$Y1A@#0A]FRC7
M%O)5DGWAMH6>6#:$[-L6R&0JQXL]L!$;;&:J5"&-+GR.4A'3E^GMVKQQEDOC
MZ(GGR/B31I\7N,:*)&N3?);2J]E *]0K2'+Q.+X1*.;R:6M)]U$F"VXQ-.EP
MR[5=LS-8L2K_ */L?K&*MC7 874:!&VO2:S[7>FMN*85\5;&]D5ZTI+7_+$D
M#*Z^=?+])7NXTXQ@'%,&>:]KQY.?&!8L:R&0UQ@511)]9XE&T FR*1=YD-8U
M]"'BQE+$B-,#]<R4YU>5(C1C,4;$,>Q%BYQ=Q*N)A8IA$PB81<N/-H48?XE/
M(.22 1AIO,%EEEE@UO8AF#:=A $.M?J[$+>%G'],?&J6\U>??Q+P#G*@()+.
ML4C7*87254123->ZAOI4)LD$=@; T/3:)2CJ]0C4C0.20TH1A)AA(]@]0#$'
M>A;*F-Y)-/%;9;'Z03XBI-5=FQQEZX1K'E_KV:LK0C^YZ_2=K'1SC3FB;T@3
MCZL+(*$J5G +T(P02P[%ZB$$/KO1!&^O)39X!RC"/#IP.2< 19I5,&%F%CUL
M(@#!-)8$0=ZW].MZWK 4D_9#\:[ X6"^9_M3K[G?B3SUT[<73UA@K&MW#Q:2
MJ#(Y*=&9C*23I6\=,JW=L:/D(3'Y(ZEF*T# K'HP1 2 _"]!##L0=;GBMK07
M1T'.JME_K$GAW_/ 1_O-=!?P4Y5CTW^2H-:?D9XW[W\M7AE2<G7"7;!]6V#V
M"MG@"(18L3"P)I=SL:FCQAIDZB49+6:<3F!6'6DVSME_"_7^WW!]2S#7-8ZJ
M^J?"TK5)W_YCS+_HI(O^2%F%1S7R@^&?S1^-3ECQG<L4'?'2)$#MJNXY.$$Q
MB)]7W,]FLRMVM:>2-O*&ZQJO'EC6?,LSRF.UM.I-T'1GM%O0M"#HMKV/+R0.
M"Z>!_2(_#OO>M;[!1!UO>M;$*F>@_0/KOT]=^VJ-[]-?]S6]X6'3?Y*-_P!'
MFFD:LGG/M:QX6X[>(987E&[)G,/>=HU[?IXBTL7P9]C[J!"Z)43BD X-2\HW
M19Y)1P/=[1@"+6PZ+*7F![ N^N%J3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$6(4,#"K.,4JF1H4J#=Z$:>
MH;49QQF]!T'6S#3"1#'O00ZU].]_1K"5*\/V7C/XNL7[4-__ +KX5J5[B-G:
M6XP9K>UMR$TP'PQF(T29*8,OUT+V#&04 0@>[6M^F_H]<*+(X1>%0F3JR3$R
ML@E4G-UH)I"@H!Q)FM;T+6C"C B /6A:UOZ=;^G6$6(^R\9_%UB_:AO_ /=?
M"M2GV7C/XNL7[4-__NOA*E9@DDE,460G**(() $LHDDL!1118=>@0%E@T$
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M<62")'HUP,*"D+V'?N,UZ;PK0K=BC2CRBSB3"SB3BP&E&E#"84:48'0RS"S
M;V 98P;UO6];WK>M^NL*+'"?60#N)@&\-0'T#5M]&RB<$@7<+(%3\D)X$V[.
MTL"U!6:^%M1L'P=&_K?=[OHPB\K2[-3\V-[VQN;>\LSNB3.34[M*Q,XMCFW+
M20*$:]O7HS#DBU$K3F!&4:6,0# "T(.]ZWZX18Q3,(BB1/SBLE,<2-\57:;)
M.O4O;80BCCEM,WK=-[\J-5 (9UVT;LE-^$H$69\)24+T]I@-[(MCPB81,(L<
M-W:2W9.PF.C<!]5MRQW2,HUJ8+LJ:6Y2A1.#HG;A&Z6'-R%8Z)BCCP@V44:H
M*"(6A& ULBR.$6IN<^@K*MVVO,TB;2XA>(W'1('.1LZ!:&03(\2:(,>TJI84
M?IXE2D.RVU+[?CKAZV$D(]_1A%[2>7Q-6ACSHDD\=4MLM4$I(HXIWIM.0R=4
MI1+').FCRLM2).]*#VYO4*  3"-$(@@P>M;" 6]$7OL[TS2)N3O$?=FQ\:%>
MSM)'1G7I7-N5;3*#4BC2=<B-/3';(5$#*'[1;]I@!!WZ;UO6$7@:I)'7U8_M
M[(_,KPOBCL!AE"%J=$+@LC;X:U-KZ6S/Z9(><<SNQC(\HU@4Z@)9VTJLDW0?
MAF@$(BS6$3")A$PB81,(F$3"+'(WAI<%CJWH'1N7+V%4G0OB%&M3*5C,M5H$
MCJE1NJ8DT9S<J4M:\A266<$ QISBS-:V 8=[(OXV/+0] 6&,[JVNQ;>Y+V9>
M8V+DJ\"%W:U DCFU+!)330IG)N5 V6>0/VFDF:V$8=;UZ81>\<<2G)-4*#2R
M"""QG'GG#"42224'8S#33![" LLL =[$+>]:UK7KO"+UFUR;GEN0.[0O1.K2
MZHDKDUNC:J(7-SDW+B"U2)>@6I3#4RQ$L3&A,*-+$(!@!:$'>];UO"+Q?7+1
M];ZC_P!:MOU_MMV\Z9/GDOUOMHTJTBVZZ;?B_._5NEHM$_']GPOB[]GN]WT8
M1?US=VEE)(4O#HW-*=4X-K0E/<UJ9 2I=7E<0V,[80:J-* <X.KDJ*3IB0[V
M8>>8$L&A#%K6R+(X18YW>&B/MBY[?G5N9&9L3F+')W=UR9M;&](5KU-5+EZT
MTE*D3EZ^D0S!A#K^CO"+(X1,(H]>[;JF,F.Q,DLVO8^<PMTG>'PI[FD;:C&9
MHA+>Q.\S='8M>Y)Q-S=$6J4-BIT/.T I G<4IAXBP'E"&5H5FHI-X7/$*ET@
M\OB\S;42W3:L<8H_M4B0I'$2! ZA0*5;0K6)R%NVMU2J=%#%H?RZDHST]A@-
M[*++:>6?;P*/:=6W;^%M \B8]+DOUP%G,5#0@=1-GQ?G=-HUI8B='^SX6S0[
M![O=K>L(LEA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%"?1M$Q7IFD;%HF;.#
M\TQ>R&+;&ZN<87:;'Y" "Q*X)U38XZ+&<B4DK$18OB$[+/"'6_AF%#]I@2H-
M#5<P.\>9"*PXUY"I*LFZP91"Z1Z@HI:YO2.E7'J*4L$(82IP)VF,@J9CC;\N
ML)*A5.I8%.S$*HWU/"><(TX(C1%FTU<3XD*IMUV?W&^W]<)W-4&Z;KBKF[F^
MPXU%(FRU]>K0TJ(<TP+G%_@MDU_%IM%VJF*[M5Q9WB9H8S&&1&3,4CVSG)W0
ML1@TR0B*@-IQYU_14D,E=VZAZWJV]:,6]JK( )-P;6QSY:Z"TV]TLBH76T>[
M$]M!O5AGT<:9')C*^97QB5)5LC3%N[$C7MZHX8#EFS3JE12AI7C^!97I&%6Y
M"NJ^V)O$ ]8,,;LYY\>BRQ)+3K?<+J:/FIE=W:)WLY4F;"&AV#]XT<$@3EN2
M6.:.F:%C6KE:!.'XOQ<*"E!6GBMMNE]Z_0^,SF"6R)TZ/UT!'WR+22;UY H[
M;*&Y;VC[8SSH,:J6PIE0\6D,LI.>3%G-95:M]5H-,),N2%('T &]8KT$@TZS
M2E%!<C3^1&96+UR0KG_1L,*=KGA41)KV',%UIW%DIV4]ET&@K^<4O92>*?<=
M&A1GF V2D204/=G!T5A5K5SR @]O"8&*^[0<N7X/T5M/2*#R%0RP.J:^J1XZ
M/<JBJ.(U]-JZG&W"?R5SG<+O&7\PQ"QH9&9.QI'R>RR=4+ JCM)U#MI NDZ+
M<N3*$8#7 U%K*@TT!-*JT"N2]+5EQ5Q],WF7W+:3]%>BZQ>;ED$)J^Y#[/?N
M='&P9:E);I36$BB">\I*-CA;NQ(WL2YE ]./R9CBJ(#L9NPECP+CRY+F@XP#
MR#VM3BPN>+>SW-RL#F1DIV85Z['31LCSLEFOBAM^7S98\Q4YO3(TE@J^LV5A
M:U;H/X:TA\5;:MC!M8:0:6=6@^'/\*N'2\&MQ?TQR"Z$Q"[W*FX(;S8ZQR1V
M9#IND=F)(H\??9,2FCG,G.:LK=*D3Z&9OC(V.FG?V*$KBM2)A *$<6 18DBA
MY5_3"BN].89]+.C^B6YA2]8MB^2^1:JKH3RZ'+[1:FA@@17C1L"-,L_JF=HT
M(HVR*";90'19T-:E6UB4HMO;502BC483"H/ <N7X5*/$KOWS*NNX4\= 3&UH
MM'R:2K!SD=>RZ 7.&$S:)O7)]-'N2DI<5#R*"@-K1_J13(E#MM0Z$3(T0%C>
M)%IK"BV64=IT\/-1#TU7B^^;9[GD#1SA9,8G%>1UUK&!0.)<N3R*MW2M-I[4
MYKLCJ:PI=>_V+;X)=DSNN.UR?&H?%BW@XT;2VJ-Z*5*W/84A4&@''YUJ[/!&
MA_FM8U_*N:K3@?.MF=B7!U)!9XW<96U(Y]!ZVC_05026H*3CP6.N%TCY49;O
MN2-N4_D!SLF95**+)O9\%*J<MJ4)*TXUXTIS^%593QH5#/(=T2>X/M/3:N9#
M7= 7'6'3\YDD&=X@SW-?DKZZD%D0J4,4K<F]"WW62*&B?'XM^;3G-(B1RTA*
M-06I,/2DE'D$?+^!5(IRM>W$\RO!4[UU?%,L_>W4/-?2;O):F>+&:9Q&H([=
M33.LK5CE@NH8='UU*S)'R[J!DK6],L6C2,K,8KTM+,"<6E+(EOLX!"DOE!<H
M&U31*_=F!M%-1D"K-)'5&Y2VQ]<Z// '6CE)Y@\Q=2UIF45G$]#Q*"[,?3@E
MJD4B/2D:&4)<86=$]SV4_3"S=H7KW=,TK(\UK%.Q&= ^]7"FE92ETKOI:-.P
MX3&@<4Q]15KS533%FPE!"Y*A?+ >]+;#2@BNT[6Z *+-6FE&)Z@#?&G+]%6#
MNSFJX+&\7$>HZ*Q";QFSE/<:N71],FC[HG?XCIL\BTQM&&6 K1;2_-H8R@2$
M-[V:N&'1'U2/YC8_A"T/(L01KJ>5/P*C4&K7R15]%1D*5MMT7++\[*O:][=F
M<.@EURUN8K]N"B>0IC5Z)<Q4U#I1)YI2,(EKG,HP EP(!"UA\>TE>%)/PB,<
M5D2WX^"E&;0/LRT67I4_H&6=(+66'=7T3*9)5M=1#I<3VP-$(\@S4\Q.RZ$?
MDD0+B;I$&+ETDM8-FKM6^'[&B0.[D IY(4;'4JT4I3E[/)31(V;N;=_/D@8%
M?3[%%X)T(Z2*)L$92R=EKF:L4E\EE6PQT#-F9M:BFZ>QG\E5Z?%8=K-G:)9
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MW#CT<P#DDX?GN!.+)*G=OZ'A\*AD&>);+$#XI@;PC0L3<D5G'&(Q&:5"" P
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M5PRMC<96P.#\URFB&!T8@;9T;ZO/^"8TFI2T;L>=HHT@#BL>U\4V'"O&-**
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M]8DQ;G;LZ"7JF<B(=.)(A=6)/:=B11Q/ GVX#<-'IU! !F)#0)ZJ7-\>//\
M ND'BBYXL_G>A)$QVJALB+2*1REA<EU>STJNPMD:D+'6L(B,T?X(=7=H6RF<
M(]8LM85;RI7.#@C<G=W4*W(] D,6B",L7D$\%U$PL$PB81?._P"0)/T]>WEN
MYAXUJ#M>_.0ZYF/%-N7/)5E(&10Q6\2R#V>UL;::M0RQD>$)GQVYY^$,>M!'
MH!(=!]/7>\+:V@87$ FJD3_-&]E_SYOD._:RDOW%84UM_%"JI/:G[*X-[_\
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MS69PV[]!.A=?VQ'9RK#:1O0@:5BL:;I@&.LQ:M(N=SD3<XA5)FTU@5*U7SY
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M6SU%PK8M%[=OM0S*(S.*?N>DFFM*HG:R<H#JLJX"25N7Q6:(*BVWY9&- <F
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M,VF]<G)411RR9V?8THL8QS:I(GF3)*?O;>90KLPJ91Z7(T[DV.Q;J!<VJTI
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M%J3/DTD#7&FA9((K%$C@[J@)$RF2SB2M4.B#&0,?^^N4BE#XD0)"@^HC5*@
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M):O4I24^Q!&887*K+IFM"5IDF\MTP;)+ 9&5SG,FZO(XT=,+.E8,H?Z\<)_
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MR#342)DLA<+$^S];*K:L:8S6R[NGK\-Y8)[2T;J.U$MIR"0OQNW^OU%65RT
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M-I5M4_;[FL=)9[6]-=IW#<(Y*AGY3_J1$21YF%^2[3@LT=LU:@>C4AGJ0$L
M":W*Z%7UO$Z<K6OJD@:)0VP>L(5%Z^A[<K<%KLJ0Q>',J*/L*-2Z.1ZEQ<E"
M9K;R@#//,,..%K8QB$+>][+$FIJ>:WK"B81?,WROX^O.3Q74*:@J!ZM\=R>K
M669V/+8^3.Z9NJ2R@H=C3E^G3D2Y/"-V9TJGX+B_&Z+T!.'V ] ^HO30L+<7
M1N-2#56,^ZG](O\ SM/%_P#]7N\_W4X4K%Y%6"\6'%?1/'S%U@\]06/4UF6S
MU-U/+>E) [TTRRB/PY"NF,5B30YMR9IE8=N"+T=F$\TLL)IX $& U\00M"PL
M7N#J:>0"ZK86"Y0^4WBCH_KPCD*5\M6345:6OR?TPU=$,3G=+)*I%#W):R0Z
M31YN;E#3$M <%NOGWP!AA8CB B* +6C-"],+-C@VNKD0H$^ZG](O_.T\7_\
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M-WAMR<Z2&S$K58KT[3PB.!D)<@N98\3&;2U<X2$8UR]8<H)6KU:<XP6@>P1
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M,"TIR^$G4$'E%-#>=./!5QB_E%NR,TYQ_P TQ'H&(75!'CQ_H8O=J21L56H
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M0%[,4KCDYFR.(T^'A^FJPH:<[O4W*T3_ %KI!&Y0NYH8"$:761-R:YU$)IY
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M/]AF-8WJQE5MK&ZP9B5&[*YI6]$<TNE%PGE1..;EIV2Z6+E%MGK<Z&L)#/(
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MX.!(/-=$?'3]/C]X;WKZ=;Y"YN]-Z^G6_P#X#L._4WA8O^D?C5R<+%,(F$7
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MG%ZA;42.KTIG0 93T*JY7'(*Z6.UG-S8S,,?NY)]7KA2<]@4?5ZA,Y$$GHU
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MF6+Q=F:HY&HVTMS#'H\Q-Z1I9&)D:$A*!J9V=K0%$(FUK;4*<LE.02 !1)0
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MX5M&*T?'6524^0KI&DCEB6W:ZJ5OAYY!0ELWEM@W?(7)W7:]@%)JH 0%%%E
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MBS7-+GCC#.K3:[MB2!@F;.B#0]JMEC.UM[F5(J#8HI5Q]8XV$_+5ZE,ZF/2
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MJ>HK1UPGTT9.44A9WZ*V&YI(=&)>IE4%=(\Y.2-=$1E2@M,G/&;\0\P@P?L
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M7Z^_+5$XY6+5%&"1.Y<PZ?8*Y:^?^CR8U(W!(D+A;T>Q*T_VB)]3V?6MGAT
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M7-4]7;+;V8"F%8T.R)? D4 G$VV>UG,0FT\M622M,,&NWM0(H7N*]2<\Q>/
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M^CE+*48XO3(Y,<B0)%[<0\,<@C3DS2!E7#:G96B.&E5%?,H5AZ8WWD'FEC*
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M%FM!&AQ04>3?&>EH&0J"7 JOR%(FO;@ZJQHFR)6\M,>VY(7L*5&?O1918$X
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MM6F>)A$U PEJ=J0IVY(,THX\[20P!XB:3\RBH[R_<C%0U;-RV^_5;8G<VPA
MWI*#L0V02&-/5136_&>R(ZQ[:@+G2M7.F:]=9$4[!"$GY%/H(M!/&$G970>7
M!>WT_P"4.J:%8+33QB'6!8EAP:H(U=D08TL/D),8M&"OTIJF-KW>$R9"@<-N
MH(N"XV90N!L@H7H>(!>QB*4?!(&$_$I&EWDFYA@[+(GF0.-ADCBYUF(G=B25
ME+W"3EN]1RVCX+-6!,P(VXY>M?4DKZ(C").E*"(Q6:J.T5H6DQVPE PE;A5O
M==$VS<?W#LFY\P61MD7N&FR:P)]B[<.21V-P:73VLBGQ:3MI46A64>LIC42!
MG+-&<@TN]NA&#3J@D$+2!7P4?O7DNY?)D$IKEDF2X=K,*9Y3@BCK#I:#Y1[:
M[!N:JS2GD*!L4*RF]JF-$OQKALD)AQ#022MT'9*I.(PF@\_!5;WY<U"'ZQ&=
M0\UE3:PW)RK62E\@D3GSH7.&7H;E]-T*YRFK&%7&R'J3NC$>,29.RCT4K"TG
M$+U0RO>(D)9:%,#SY7^<H;]<R22NLCD=?.A,8D\!<:QJZSY6^(JR<.=:OZ*D
MT_LI)]GR$S P1N#V6G=5"I,(XI,V[T4=K2X!J?1302I+ZH[@4<Y6A'JW;ZM?
MYN7(.5>K.CRY8E(=2XFWJN=&.'/;5&GN0(6MP;V5KEFI"<0H<31;^14#0%Z*
M-$N![2@;45]H4=1?RV<O*J^@<KG0;+@LA?EHFF>Q!VJN;IG6I!-3!4KY*)Q8
M*12UEJXU4C2GO*)FER!0'Y<Y,_)3-:] J=$%=#JT"E.WNZHK1W6T*YQG\4D*
M:)3>M8+)T]K,S*^R!CC$RLFZ=4K#&&P#FQL-;(-&7V4*D2-,[K5 237%P*)V
M$LL!ANB@;5M1S6G[\KO'*:$2NR7B33^-06(N\82K9-):JG3,VN48L!ML!75E
MG1\2MG"<]U?;3K63LS1IY)!LAT?0$(0:">K3!-*Z'<O%=#V-U+?61G?"D3FV
ME/+6WNI;<]H#FMY0%N*0E6!$[-BG6E#<YI0G>Q009K0R30B +Z=;PL%E,(F$
M3")A$PBI1W;U#+.3ZJA\YB<7@;J=+;9B5:.LQMZ8OU?4K4S=)V^0*D\]MZ;Q
MJ(3EUBL.4OC.C8"UXF_:),ZOB,:LXA-HP>%DT5*B^=^2:J*/=+&;+L"XF.<*
ME)38KCU,0NQ;2<XC&V2BJ1MNQIC-5Z>,-B,Z%0Q9=+:2-]0E_(F)7)!H00*A
M*B""H83R6YMOD9Y_>WZ[HNQ,]QO$@HQ-,5CPV):EE)&YVFKNV%U(3Y15*YQ(
M0M<Y20RS$&VYR4$'EITWQ '"'\#W&!*:3P]JC>K_ "BT]9UGO4?01B>HZH6P
M?C*25G;)\)E1;3,G[LJ>/-=0^,N1*AJ3@CBU!*?JY(()HQB"86Z"-^&!O,V(
MJ6$#V\?F6R)?*/RVXD29>T!MQY9HE!XC-7A_:ZAF2EDTIL><**VJ^ (G#:(L
MMQLZS9NE,0,K(3[U2@8?B&?")WHS930Y2I)NH@RWDY5TWSPKJY6T[;')X-=^
MC9=)*3@4%;(@_N+#9ZBSG--#99(8XYUJN8'-*X-XD(1:<$)A CR@ZV;A />H
M5XX5VA6J3EVBND^E7&/<LD7+$8>[F1NTI(0S 8I3*8Z9(M10IS>TC$H6J/DD
MIYZ?1Z1(K,2@]YJ<DS0R@$TFM!Q6F=.=Q1BL.78OTG1\AI:RXO.;5JBLHW.Y
MK9VX92*$FQ[4:ZO<YC*K(9V64::HU#EJP\U8<6E-T$280-^WZ=Z(&U-"J[U/
MY<(5(X:KG%JUJ_Q!&9":5<HFP5H6_P!Q22R9C9DAZ?0/!-;(&F-,JN5U^FA_
M-"Z6,SW\NF^LXNH^<&21O0"C"I9Y?#E^BK 3?R;<HUXH&.32&9)HTKY[4=-Q
M.>IH%(5D(L*L$K%%I*:?!7HA,(;T]_4DU;#PIADD!%\P(&C/>0H"24T'YUM;
M1WY0CC:U:4LXE65$;!LULC!R5JF=<2./I89)IRSS>106MK'=5) FV&V1-8_6
MSZM:VI09L:I,W^\(_12B^9)I-*^"CMS\DM.P>XNLJFM'2J/+.9%+0YF?9Q ]
M2]T>8,ZUS1+^UOCJWMK=K30_36RKM*BL8:"Q'JWU:A.VGT+X*G2<KH- 1XK-
ML_DTY3>GRJ(X0_3=*[6HX 8C27&O)0B*JN4*K/D5(-$1NQ4:B^6K222"Z8BZ
M15 G6B]%+PA,"$7P=@/&4T.I5;91??O.O0-=6;:41<)U'HG4D*9+/EX[$KF7
M0=VU5DHB#G.8K9C*R.[:!S?H7*(ZQ.!B!4E+,&H,;U!>B]#!H.R%I'!1IKR0
MU9\K"ITI:9LU5Y/J6%9L0B+K5]@E7M,W-]N>LZ;K9'#8:F;%+.]MUD/]FMI+
M. "O:MP&X)CR@Z2!4'%$TGEXK(UWY/N7;0GU9UU&!6R%YM1&TC8G!YJ";LL=
M:'V0);<5QR$2][7MI26,SJ0 HJ4A2M:GT/&:UB +VB.(T:300*E1N+RNU(YV
M%5$;C%?VLIBTF>NE(];;T]U]*&I\IEVYWJR#VTL*D3&2@6)]I)#$I^@6EG_-
M>A2<T =A^.(911705,)WDAYI^T$-B[8HL>0/$W?&=G0$,-:2A>G9T3I2]5]!
MK);*UWRA2*,PJ,5-<C(Z.KFK,+(1?$.(%O:@D16%-)6PUKW[SM:U-7%><6<9
ML5#*+CVYG8*!]@$F8IBD@BN!I;2C,Z:X@X(BGMXBDXK=:4\LRDDL6UB00@^T
M!Y9Q)9"T@T\U&SKY+*#?UJ9GJ"5$S%Y;+G2U9+$QT1G2PKX[?<AU*OK-&CF)
MG5A6RU^EJ4TF.;.V!M<@ VIV=I+^R85T'Q4(4GY;H_8#MRVFL.G9W6S-TSS[
M55G)7T<8F#JB@EB6Y<*VF8A$YJ9I@3EQJ"R64%)"621+-EDNXW-.(!116Q#T
M5+.=/ J=J'\D%+VQ*:5J=>=(3+0MB#5]("Y!&ZYL--2NY/8=0/=X1V(()Y*6
M5LV@?G^N(J[.B)O<"R%OR[<: X)9VRRS"Q+"./@HFM/RCBJZR[9A:WG^T'EF
MJ3KJMN;G%U8(C+'IVE,?FW,;KT"Z2Z!LK>RF;ET@8U;.8E&U)C/:!F.(<S#]
M -T5A4,J.?@K.UOY .9[9MR*TU!93('>03B*-$FB$B'#)(A@4@6O-7QV[T\%
M;Y>M0$-@K%3TW+&Z3J&@>P*"6E1[Q?LA9Q190M(%2H0C?E)J!'+.DH;;L=FE
M?NU&6):L7BQC?#9?)FNY&.M)I65<C3UJZHV4"67V8MFUN1Y ;'$'QE*=0])
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M$%7QEFZ&IOI1VA:1\8(PU2:;QETF](-*5"6_*UYS*V'JP)C/F#]J J+/40*
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M$"R0QIU9J#>UI$U;8"SU:GE47M9TCBFWX<C/@3$F2*F=M>D[:I/T8>,'JH4
M-*5.G2ITKUNI"NK)OVS&VXHLX.?0<SALUD;:X3&'_5S&NAE40>I42-C^64$J
MMHUC/!4ZH[Y@PX?S1QGM$$OV@"HH:D >2E-WL2I7=H=6@VS8$02[-RUM.-(F
M,:T:64N3&I1F%^Y>('Q"P&[V'UUO7K^KK"<50F0\;\@2KG^@.;GJXFG=>T-5
MLOJ<GZKE]=M#K.F.<<X2WFJ0.LG4)$VDQ,A41>8'N6E*0DG_ ,JE%C$$16A%
M"466HU)\2JY2#Q?\J2EBI9L=^FH8C<:F<G)6Y.D0K[DZ"(IF0JLJI[.2*BXO
M$H"U1J"31.XTTT-ZF3L:9)('!I,4ICU0@#(^745UGR69F/C<YDG3O/9C)>IH
MR\S^:7[J]T[N]PKE1]@[4Y*()**S?D+C2KQ EE12V0RZ'RP>G>2N+0:^+W!L
M:U9AVQ(O8<HFL^7@K*=*\N\K=+2#GR5/=QQN%R'EQ,[J*0<8=(*S2?826+))
M4$B9IDQI%"0Y$UND<*J EM((2ED(S6AV7I#"ME'!T!18AQ%?:JME>+WC=OJ]
M=63)>E9-R=FMQDM.J7Q767([XOA1+"WSYD0PV=D.U=J4O03(7'[.=T8#YKIV
M7$>J922:6L)&H.466LUJI.H[E2OJ\ZHF]ZR3HN ZKN.6*BE_/M+Q-VJIABK&
MYCY&I[E]ZG\G"QQUA5-SX>P0UX0HV!L.+CJ)&J+/)3EF[T42HH75;2G']-9Y
MZXWYXE=]V/?<MZ?1.KK8$]I&8FQAI4TG#F$"&BYHY32+,<I'$V1H<+'<0Z<Q
MLQ3^]F*G]''@!1%*_3W&"434:4HJO4AX\(0UBLIGN+JAJ<8DS+"JSY\&AG=4
M+Y@DHB,\@6KQS%P3U8UPZ+L8WM/#K<6KD99:=2K >WIC%ZU8,\\DM14N\A\*
MU6WF^+[E+3Y;[VBZQ.;U%I51,:S1JR#Z%%(HLKFIM$.:R4J)F9&MRN<Z8)!S
MXSGLK0]JU;0T)%*M$G( 08#1:B:SY+=7_P ?_/TKGE@3"1]E/+@TSI=(Y$5#
M"GBDT+1&YI8-A<S6A:$H;').Q:?U8YK+^76<T*)4I.1MA#@L*2E@T(D110.(
M')6!J[G#F.INJ+=ZACEL5B>ZV\N<Y*Y1US9J&5O,?G$B:(FP2A^8+A%'_OF3
ML;VUP\G>V$3V)I*4JU9NBMA,*+(44))%%#"KQ\\8'7]+NBR+T$CF\QL"^[!7
MI29] 1LJ=7T!1K#2;^R)DIQ S=L<:&W.$D:RQC$,J0/JXX8AEF!+"HKJ-*+-
M1/BSG2)OK O3=3GK6"-2_FVP6J+*Y'5 4I4TYRYU6\RH7<UU3MY3L<EF]?Z;
MS7%)LWX)#@WZ-2_!">:#9-1\E'Q'C>Y(3PY1"P=/.FT*FBY%0PE>YC5GS88_
M(^1JQX^4O0?1MT1]=IX95R1U+]0_+_6JD[W%[3^PD"B:SY?"M5:;H&E:0OQ\
MB+RLZ/;X86P45T5SN_-S!(ZV6IYA7G1L2BL??P+CGTEQ4-#S&7F#M+JWJ40B
M=B.3#(/":G.&#%% 2/!5HD/CMY#?;#C-FCOF(+9(QR]([KR9RR\YVO'WB'[J
MOG2KGF%%QVS8A*&AB4N2;F=D7D/J$HEY;U*UP+(.T0> LI174>5%-O0'-=$]
M!7Q#;G?.G2(XT,\?K.*SNK65^JE3%K18*ANQOZ#@R!Z>'E X2R/Z266RHC58
MVI:D$M;RC$H_0)NQA('$"E%7 _QH\KO=:2.HIIU]+Y;!'I+5$,;V\V=50PKX
M_2G/0+0>N>*@2.\<9VQ8O;*JLVSMRL#LJV<[.KJQM@%9PTQ!A)RBNLUK1=,*
MQD<>A*%^33+J1GMI0Z.S8O:ELH=JJ8S8TWH8=%XZJ8VT$-0L(%J-T?6-8]FF
MKOFE05KN>4 W28M.24H5@?8%)OWL59_=+K_^O*._\Y84H4^]BK/[I=?_ ->4
M=_YRPE"GWL59_=+K_P#KRCO_ #EA*%9-IG\$?UQ;8Q36)/3D: PPIO:9(S.2
MXPLD/O.,+2(UIQXP% UZBWH.]!U].\(MMPBJOUG"$%M5PKJS\I%1SHO?P*PN
MKHW)ZD?395#'ID?8G)8D_P 1M^.RF//,8?&QZ/\ 404Q9Q*Y.08$W82S"32H
M-#6E5RBZ/\<]:+*Q5QSEOI9LC$SD3:STVY+9K9M;K8\FH!ZI'G#G^=L<D&Y1
M22O<C&7%.7X\\DB1";W=0][/++7HTI^]DJ+,/->(X*<K)\??+%B%.)@^F2FU
MP426QY<@^>=:=E<>+>;%[!1]DJTT@ATF:E\<FD;;ILCTTA;',D](H:MZ$<$2
MLLM0!10.(\/A2B]&.>/Z@H1!&J"P;LQSCB:/57RE"8ZY_/4:XJVF><;7(ZW+
M35M 1J6 +2<YE.CVI;W)D^7"PK$!GH%,48$ PJ*ZSXCS^=>PR>/#DMKH>T*,
M<.D]2E)9T<H5O5RF3O-,.RUMD_.TV?;'@TO%&5#"*$ONW"9/.CW9J7MQ[0O2
ME;2[3@),,#M134:UHIFL;FZE)YRI7G+C7TQ$*Y;X#,ZXGVY37T>YRCS7(Y!7
M,Z3V6F3O%0)8H"F_LP]SA&2O6M9;+I*<84'9FACV8,:BE36M%<6"3J&QJ&QR
M/3#H&)67)6AK3HWJ>/;S7+ ZRIP*UO1SRO9(B!EC#8I5;WZB*0I$Z</_ *R#
M6%%'M\Q^@^@HU#(I+;7AJ-IAMP5%<12=#*H4J)>'2H)XRSYI8'9,ZFKDIS"]
M+V0"=:$( F[3C%\,8!^@M$%0JK=-\:<N=+RJ23MXO:(Q^6.2ZC7:-?-D4;8T
M,BSG1S/>$8;1G5W9;%)XA+&^2Q:_GM(L2N:<\H@TE&I2_ /3Z&(L@XCAX*,]
M>/'F1KNV97?#^G8W%'J2P*7PMK8BHMS \L+!N<U)6--OY9J5Z@ZL$A@ 8O5*
M#:&&+ BBS8):O E1E%'E 3J*ZS2E%E>?/'WR7SK:-3VC&[[ATI<JY@###71+
M.V3G:4+7UPA^YT&%OL0EKI%5,QI-#%44^.0)&>(+FIM+:FQL1A+"4F-TI44+
MB12B_5T^/'C.[+1Z%MUZO- RR_I=J$PV2<V2&J5J1R8V>,42AKAH6(WQL=$S
MZV5=/* ;).U)G("M,):YNJ506<A7FI\40.< !Y+VV#A'E:-V-1]LI;BI=5+J
MDAB:(2)$"I^1FF+6"6R367V1%W9DC[;7A**CY$TS.;KS3'.&Z:G!<G&7I2>8
MI)+5A434>7Z*S/!/-L:Y7HP^/S_JV,S&[Y?1].4_(9@W/]6"8*Y8::@[Y&X+
M%JZ;3H\WMT@:X6ZS%W5DKY @6JW4Q2'YT RPZ*Q1'.J> X542(?'C0$%K,2*
M'=2&+K(B**5RJNW%H?:(@<?8K./Z+K7JN*J89"4,565O7T8;+.J9O2ELJ=J-
M8PHW%P&:E,-4;&%174:\N'Z5%A*7\=%,):;AC'>G4#>JM!6W0QRLY97-AP9M
M9ARE@CG53 M!%7K;,TNJ8)Z?K-W$-<6F1"$M:DAZ=.D*$8FQ1"\UX#A_<_06
MY5-XZ.9:I:(PU(NJD*L#;-;7D,J3LZ3GZ!L,PB]R<Z5[S?,(("+0:-L;%$T1
ML<JYG="W%M*)<Q.P5)IIQNE(PZ44+B?!;51O"?.=3NS"^R_K);<KLT))HS+3
MI6_5!&T[W&);SG37+Q$>6)(*U1X!!#%6=(M?PE!.P*E"\]2><8/W@" A<3X*
M7>8.9>8N9:!FO/#;;=8RN)S5H5Q!P=@,//\ 7$@5P34.)@C*Q2E55<:AY4^>
MVZ/%F:/?'H"QS7*5!IAA@0BT6%10DDU4&4?XYN-J#3-A$.Z'7*S43]QI)EJQ
M\GM=KE+N^\;(U1;*Z+3 I"=A76P[KCG.4FE^T2I>9LPCX/IK6E%2]Q^?YUFX
MCPMSA'(U6,==.K5DH%5,"Y^K*.NBZ15*W*E$,YGZ;0])U@@<B&EM2I#UI![2
MCCRY2$ #%C:1L_?M6&".Q1-1\O@5L50\7<NTZ^U._,O1@G914DBI*1LY#M,:
MW^ Z*:.YALOEMA(=/DTJ8SX#S$[.5.2SX.RQ?628GX6P$>\H1"XGP6V2KF>A
M9=<,RM5PZ;))0RV\8'T(7!$LCJ\+*R6+#>;I+S O/1.QB0R0J6B4P-X1*%"4
M]08%,XM@3$X@ /.+$HI4TI1:9S7Q/RGS!;S-:\*NZ"/9[76, @QR.6,O/+K*
M#Y+ *=@]$IYVVVWN*EVM&-/U>0%&6O8VQV2LIJT]4?H@(5!A6U%7.+A0K39-
MP%SI+9Q;DT>.P'C8IM++!LJK6E(_4NE3T):EDV=35O/T[B2W3$-QERA/-J C
M!J1%(#'%$2F)6$; ,"P7PU$U&E*+/0GB*@(7950W.3V"_NEK4X98;@QRM;+:
MG)3.;]?<RM"P>G'AVC")K3QLS=[R^Q$2E8G F"0TEQ%C*0!)"E.VI434:4IP
M/P"Z&P2=0B+0J)1J37]%[%D;!'&5F?9_()%7S2^S5W;6].D<)2\-<5"R1IN<
MGU44)2>2@1I491AFPE% !H(=*%8GXEM?WL59_=+K_P#KRCO_ #EA2A3[V*L_
MNEU__7E'?^<L)0I][%6?W2Z__KRCO_.6$H5NC>XM[LB3.34N1N;<L*T<C7MZ
MHA:B5$B]=!-3*DPS"#RA;U] @BWK>$7N81,(F$3")A$PB^0WPJ>(;QM]8\%1
M:[NB.3:]M&U9)<O2B!\F;VOF21R<4<<OF?L+(0<2R2=K;PA;VAO)(!["0[V$
M&MB]1;WO9;Y'N:Z@/"@76+_5]O#9^874_P"W-D?NWPM?4?YI_J^WAL_,+J?]
MN;(_=OA.H_S3_5]O#9^874_[<V1^[?"=1_FG^K[>&S\PNI_VYLC]V^$ZC_-/
M]7V\-GYA=3_MS9'[M\)U'^:?ZOMX;/S"ZG_;FR/W;X3J/\T_U?;PV?F%U/\
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M)YI_J^'AK_,1K+^N:U/W?83JR>:?ZOAX:_S$:R_KFM3]WV$ZLGFG^KX>&O\
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M$7HX5=0WU#W7UB6#VG-Z[<0D*QIY(J1YUKXJ<W[87 TK9>I1'A_9$,(+]=;
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MTFM/.E*T7+;MO<3K\XIMA>G*-9K,(@EZH9P]XQZ=8;Q'O$4XCCQ3[<PG;/\
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M!WO6MY0UQY E;(X)I03$QS@/($_>7Z*/)/#L9!Q1P-;]NQ%& ,#H6M:WL.Q
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M!(X\Z@/,:WYF<BTH!#4C0.B%8!.   F"&>).>8$D 0#T+>Q>FM:WK>5\,T9
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M&OB$K2YC@#$302"H%8R> >/=)X U7E"YMP]&" X(AA)&46:(*H@6BC%!VTQ
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MF+@M2OH-&*'<Y8827L90- ]YVS&7S;KTQQVX+8X]+@[4\NU"-C32IHP MY,
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M.;5,+0:T$1UZ?Z_6R%QV^E[<E8J:M939%=OA:;9>PGK3W>2."Y4 P8=_$3E
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M?I&_^)]47\8UB_P;V7GE>S7\HKC]YG]LC7Y._P!4Q_3SGOYI3?P_'KD[./\
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M  ?PG'KQ^$G_ 'OR!?Q+YS_[*KR=ROIXC^,(?PK+_6*_3[7?UA6?_:K>4/\
M)^>&3^.S(_\ #:\9U[_Y4[@_BV/^#A>:NO[4?V@?ZNK?_-$2ZQ\S?RZ7D!_O
M!UM_R'16>'S7]&&)_?+_ -=<K\/]X?\ 9L]KOYSW_P"W9E<//,;_ "L4C_\
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M)TF 6<L.'IK#K^<P!:L/;D<YATFAZMP2EEFJ4":3,JUE/6)BCOV(P]*4MV,
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MF)W?$T6Y7D9DJCK8M$F<E$Q?A5U-8$6[RQ>864(QU^9G:QX-.) #XCB+UT$
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M']/.>_FE-_#\>N3LX_\ 4_M.?QS'3_Q=J9[NT_I9N?XO'ZZ)?M_;G^U$S_\
M5_'^NQJ_*/\ D E?\=,K_P 0BS%_]+ _>'_;E+C_ &H,?]7I_7/772/?RZP_
MXA[?_P 4:<^?3?T9_P#SD?UQ7X4RO^S7']9;_P!=*MS_ $?G_$BF?\96SO[&
MZ]S1W9_E-'^\V?MDJZ#_ %H_]HS'_P T,?\ PB^7"_PX_P K#'/_ &MT%_8E
M,<^I=QOY!/\ ^)_;&+^DOV_/[$-W_>X3^%6J\/C3_EGXY_??Z6_L1M?+O+^C
M1_\ @(/VR)9_:]_V?%W_ !#M_P#A6-4M3O\ Q%O,=_I V/\ PQ!SJK?^4N _
MBEW[0%X?;7]I+L%_5;-_FI=$'C^55\1_\28/^#.V,\HS^0^X/XR/[; ORG8_
MV*.^G]8I_P X8Q4\_23/[>'-?]ZF6_V7%9Z/LQ_DZ\_PH_6A??/]47_1QN[^
M.[;^"E0+Y=_\6[Q-_P 4-!_8E4.=QV\_R[G_ .,'?KY5]-^PE_2YWQ_GX_\
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M?\=VG?[)X)GU#%?T6._BV;]K<OZ/=M_]FD?ZN<K_  :\7A[;_EP'3^-#S?\
M\3J7,]L_T7M_>4_WY%G]G7_9QP?S,SWZ_)KJQ+?Y1WS+?Z/-T_P-5SG@+?\
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MAYYC?Y6*1_\ M?GS^Q*'9]/[=_R!9_QO[8]?T=^P)_8@M/[W-_PJ[7G\[?\
M*0.G][NH_P#B:C)VJ_D?_P ;)^N*U_ZM+^R5#_&N3_7M7:66?RYC-_$ =?\
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M4TE4RB<\M!S9WA@@D5D$:J=\M!)$(N\." E+/)<>WMZ<U<! (Q$V)3PZ-/\
MF1Z(#Z>WVW))@;C-SRQMZ4;'LC#FN>YKI6Q:W-!JQM20VO%Q!H*<3^CL%]GR
M[O>R&>[R9K*65L_'V-K<V6.CEBFO+F"XR<..==7,3'EUE:A[WMA,P;+<2,)9
M'T6]1UW\\POSBF$3")A$PBU.=1)FG42?(E(#3R65[2:2N)B8T@D[28)Y2@6@
MFJ25! 0CV3K0O< 6MAWO6<BUN)+6X9<0T,K34?'\B[S;6<R&VL[;9W%-:[(V
MTFJ,.!(U4+>32UW"M10CC15@_(QH5$D5MKFJ>%@W!K>&1O4OKNR*71G=GA8T
M.3=)(XM4M 5;=,XRH8T8FA84+XB32<O6@BUK6=Y^<F5<X/C#0&N#B&AU" ""
MUPK0L=J.L'@:E?9O_>#[FW$[+NS9;QMBFBF>V&*9L<L43)8Y+>=C9=,EI<-F
ME%S$X:9"]U2"5**_GJ!.EE-MM.*IZ4V8U.<:<FN4;5H"G!$VQF/N<:-CB0@E
MO+2E1E]2R1S,<" E^HU#H<(L96OA!+X#,O=,LG8]@:+)S7 MH:$N<':CQKJ;
MI:&GR:*@\:^+M>ZNY[+:$VQK1ENS9\\-Q');Z7ECY+B>.X$[G%Y<;B%UO;M@
M>74#+>,.:_WRZ,1<<T](W-^<)P_R.SR%RW2-T;92OC1J4>D;-*6!C;Y(K86!
MG=Y0\QQLGSB2E<'A2L>/8H+":H,]@,Y_YQY&%C&6S&0$"H+0[Q+7.+0YQ:UK
MBQI+6!K.!H!5>Q'?W?N)L[6TVY:VF&DBCUQR6S+@.&N6VFF?;MFGEBMXIY+*
M!TD%K'%:UC<61,U.7IF\1TN8G6[>)!-';:YO5MKRL>7QB4Z<QJ2IR6_K7,HQ
M@"A-<7I!,S"7 S9>OCIVQ$$>O0DSXN0W/D@X=-D;:$%H#7"E-&D#WJT:65;Q
MX%SO,4Y#/M%]PFRQBPM<?!TY6R1-BAF;TPTV9A9&1-K$<3[1KX&ZO<?<7!::
MR-T;Q,^<H/,4KR2QR]WK^%2.M0UV_1& M];)(>OC*==+75N7$DNT)?#6I2@=
M)<N/]R0\A*H%Z:/*-#H>A<6VS-U;.:98VS7+)^HU\AE+PZC 1P>VM0QHX@D>
M!'!>;V]W:W)@)K>3)6$&4W%:9CUT-U>OOW73+AS+6-["8KN$2-?':PLI*Q\C
M!4Q/82T@[<VUO8<+CL5L%]767&V Z8#0@5IH0QM:EQF#<KCXUQK= (Q%F'ZT
M8VYU6IT!A*<L8!+31&_&-V$03,U>6ER^>T8(9GAE:%[B PAU*R.<ZCB 7 G]
M2*4"6/=W=VU=PW>;VM;1X?+W3;4/+77DTC8[61LX8)+VXN)NG-)'$^9KGN!$
M+&LZ; 0=4>N0*R,61R5ESN=QV81,ES^#.R'B*&N+BO5VDT6N%XD:)\B[C&'=
MT9Y:WG%IC347[$D<E1(M"^( 1?(BW%?!K[<Q1/MI*>Y1] !$8J-+7AP#F$$@
M.XEK3X&O=X_OSO%L%WA'8S&7> OG1ULC%<B.-C<=+C3%;OAN([B*.6V>UTC6
MS>]);PR"FEP=N+]S#74GAL1AKN]RY43'%\B?$C\!Z;BI$^2&7/?VID\B<5Q+
M4%,-R>G8Q0<;\H0F3@+5&EEE@*]@ <:+.7D-S)<QLC!>&M+:'2UK&Z6M K6C
M10"I)X DDU*Z'&=Y-V8;<%_N"QMK%DEW%!"Z$Q/,$,%K#Z:W@8PR%PCAB#&-
MZKY'ET;'/>Y^ISO%">::B@\F87^**E268QYU5O*9W*5,(WY4P.<,;(0LA[D:
M0TEJ%D%4I69"M"D%KT+<T9!Y9@=@T'=NLWD+J!\,X!MGM (H[2'!Y>'BIX/!
M+FU\6D@CBL]Q=W]][DP]SB\XQC\!=P-B=$6S"%L\=W)=LNHP9"UEXUTLT)E'
M%UO+)$YIU57XCG+U<0)BER"#/\KA!DHC,=9Y3(F9X; .:UYB+JZ2 F=NQS@U
M+&]7)W)6\J?K;2DD;:XI31$*$@R-[!M-G+RZFC?=,CE#'N+6N!H&O ;TQ0@A
MH &BAU-/$.KQ666[S;MW/D[&YW):V.2;97D\MM!+%(8V174<<!LHA'(Q[;>-
ML4?IC&\7$$C1+%.V0!RT1/P]1PFC0C'.0J7@_P!ZY)-$JR,-CBA9ER64%OS/
M'T3-'D,398=(-3]Y,/0I$!:0OZT,^#HH.BM Y1W/D^K]%@C' L(>07 MTEQ<
MXO<]O38 2ZONBM>*]++]H[N.+[2V&U9CVT8ZT<RXD8^5CK<PRSOEG?<S74'H
MK1K)I9G2.],SJ%Y+R[:6/DRBHF[MCJN3[?0M[ZI=T#3-SH^^M&G9>;+]M7L1
MN;1Z_%8V^6FH6SVBT8G1(TQ8=[^&/8]$N?RD\;HV'1J;0EFIIH-%>(/ZHL#G
M>!<2?$4Z7)=\>Y6;L)K*V=Z8RVS8GRV8GAEZ3!:]2KXY>4S[5LUQ4:7RRS/(
M&MH;X)#S,P'EH3EMQ35L0L<]F4UB)+@UTNYML7<9XHE2F4,R$J4U@ZD.B!4J
ME"@16W'YQ:F^" )9^@_$T9E#FY@2&6T3GNB8Q]#,"X,TAI.F44(#1731IJ:C
ME39BN\.3C=+';8#'S7-SC+2TNC')EHY+B.R;;-MY7FVR$;HWM;;,#NATH9-;
MBZ,G06YBPN5:MLE]<Y;)U\A^V3D2U$ERY$Y-B-Y:X\TQ=TB:N/M/JU&($L=>
M6^3.9BTK9 _<H<SA@$7KX02]5GG;ZRB;;P!GIFD^X02"XN#@X\:Z@6M#37DT
M UXUX.U>]F]-HXV'!8:*U_-^%TI-J^.1\4D\MQ'<MGE_*![IXGV]NV)VL49;
MQM<UWOEVLJ^0*O3O\B4-DVG,706"]3-5+86VO,6TRR9LG1T,<93"TP76,N#^
MR1E:IAY1FR&I8C/*+7JBP&A*&4$K>W<5\Z%C9(HI'PM8&/(?5I9K#7\'!KG
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M&0[S]P)\];;@R(9^<]JW("VN)&2F>&/)=0F.-SY"3';/FN'V0<'=%T\G%X#
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MXF_XH:#^Q*H<[CMY_EW/_P 8._7RKZ;]A+^ESOC_ #\?_"<HKMO?^^_HX_\
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M^>77YR3")A$PB810UT-7RRUZ1LRM$)(5!\YBCA&-DB4@1Z&F=] 2+M:5&#+
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M=8L4HDS/)7"2RD<5D[B*00D^PI-'MHG"N7>'OLYC),]<V!R:761%)9008E/
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MLGTO<KK'N>]_NS]+5R"\1!]K/?$ [D!N.Q1'<PN.0JVX_<NHW)/H_P O[O\
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M&MTI'J*Z0FM(%ZK98=)"4IWP=:ULS8OUV:3OK)'(WN2Z,'5O8&Q/'OT:UK-
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M\^27G)D3MJA0DMP_4GK^'V?7Q".I9<:JL^&RUE*D9SG 4IB,DYYW$&(P:EY
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@B81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g655532img2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g655532img2.jpg
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M  $  @(" P$!            !P@&"00% @,* 0L! 0$! 0$! 0$!
M   ! @,$!0<&"!    8#  $" @4'"@0"! $= @,$!08'  $("1$2$Q05%I=8
M&2&4U=8760HBTB-6EM<8F-@:,534E22X05$R,SAXLG,T)7<Y8=%24W0F)T)R
MDK.WP=-D-55&=C=79Q$!  $# @4" P8% P,# P,%  $1 @,A$C%1$P0%009A
MH2)Q@;'!,E+PD2,4!]'A0O$S%6)R0X)3)"46%Z+3-#55_]H # ,!  (1 Q$
M/P#[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@:4I5YAX515X]EP#HN(OX(E2/35(<UT2EHZN9[:EH
MVA*K6YI#?RM"[Q-@^E337%/\@O(2C2$)R/@E%Z,]1;$/1O96(F.3L8OYZO'I
M+JWM"U6J1725$ZLC-3359MUH*SFEYF\-N>Q"ZCALKJUB7L9#G83#NT!"8E2A
MO+,"4X%# 'X@=>_8Z=T33U=[(O.1P/%JFA5M.K[<VRI?*[>B+A6J"A+/<KHK
M97SZ-%N]G:V:N0L!\FKZ.5$D=$:E\7+B@DIDZPH0-F;%O01T[JT1]UEYP^?J
M@AW5+51<9M2ZK=Y]H@=K)'EDI.SI)SP4X2NJF*TJGW-K?C#:*/,\;EC#+$"X
MPW:H@8&\M48(96B!C"6W',TKP2C"?+[0!40XY46Y%.A(2_=6QRIR$DL=.9+E
MC-316?6C)E5;QEDF4V?H^!CA()O8K2I)9"E2LXP]O-2K!"TD4DJ#"39-9I31
M7N]?/WS QTWUB[4(T6?*;KH>I+JFD!8K%I"THU7-ER6F)TEJ>:%,,K*;$Z>3
MQ:M["=T?UI5H5!936UB-4&'%@*-$46,<UBO"5Y?Q%J?@G 5?=[76ALB(5Z_Q
M>N5$@;!5%.V^>$2B<R9HKY*D056N0"FVD;M-G,'T?KX1NU+<>2I*$:48 8S.
MV=VV$+/OF\X3CM+0VZG!SNTQ-,I[;U<AJUOH&SW.\XK(.?4X'"]CYU4Z%A/D
M\29:@95"=>_K%18242142+>Q"'[-%Z=U::*=6]YQ%"2R?(!#:I)C3=!N<N:.
M>KRHJ^)?2E[3>II,19I3<^RJ2V([08"0X41?6&7,Q,,+;_EC7M0%:84:H"E/
M+)C48](KQF6P<_RX<7-%J754DBFLS;5?.T1L*2VY:@JEL;]@;,XT]&&66VU#
M6^W2F%5$E\X@C-($8UC0%2)5\944E*^,K&$C=9V74KS35RKW?078<"L.>52=
M/V8=2NWT+9L"M2N)75MI0=6IC"&;,9LAK^8-[<_)&^60UT3.C2IT6(A>C/T(
ML6Q!&$!)MF./JI4V>>7A)WJ=GN5O;NGE,3EC^N:*]1$\N6^?*K09X[#UT\GU
MAUM%R(\:ZS"KJOBS:>IDD@2@$W-?P_8,S9@@!$:Z=U::)3>O,CPRV775-&M$
MRGTZ>KA7<_M$8G4 JJ;RFH6Q_P"HT9#Q1$;F%GHVH,7BDAL*,J-.R1&L. <%
MMT(XS0/:(.B;+J5_C1T;WYI^*8HEZ)/FH.@8"IYH9XO*)HRSWG&V89))3"IA
M;2>C62<5?')''6YZGT446>K+;/F4A'NV,6C @$7_ "\'3NTX:J]7EYRJR1R;
MFVK>>X%::VV;CZ#Y7KJQV>Z*'M>#-M'06_K*6QH2"RU:]&RI(+<T@B;&K<XX
MPNB@L]4B&!9LHPO6BAEC'.M>%'G7WG9YL@=/T<\=0RUX?K M*(3"RWJ7<^\\
M7>JI^*5@S])3;GM'.Y9N0I'>0U[&V621Y.@<U3L8$ UAFC2-;*4)P;'3F9T7
M(C'E9Y$F?7A'%48=K+=[56SN>U<U2E/5$T#2[W9-50H<^LZ"LEO'-I4-=I-
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M*=>!T?21=2[E4>8YV"VI"I($DQ&:H&;H'J DP82].[X-QV',P& P& P& P&
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M*MG3J8,G2J71UD,R2*HV6=LHE8049M6)&+00"M$G);KQ]?FJ1'? 'WRW1^]
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MG(,,3)X>0B$<M5'*3!JD0=@+*&=MELS2VO"K9.Z>;+Q[-,;H67'V=,5,;O\
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M7=*WJW*7LVL6)/$:9<$+1<C<UNDKCB%-()C53NZ)4;VTH-J%:96H 0 )AON
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M/IJZ+>L5:C."F/*0HX^SE#+"L/-%[0QK?;$Q2NE?YR\7WA6YI3WSX3(I>YC
MHL^F^=Y,IZ[+J)L>EE*RZ(<32EB>>59"M=G"/,"!,O>K0E!"TIG.3E"2GB5
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MT\U\5O<373MP(M8^*=503IEBG?0[>NC"(4-2.**M6Y@5-C4-XV4H4J5P3!Z
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M.3+P*&0@(DF@#]P(M]T71IZ?@WAY7,P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M/V?<X_ZG<&V/W1\S\1FROW77DI^S[G'_ %.X-L?NCYGXC-E?NNO)3]GW./\
MJ=P;8_='S/Q&;*_==>2G[/N<?]3N#;'[H^9^(S97[KKR4_9]SC_J=P;8_='S
M/Q&;*_==>2G[/N<?]3N#;'[H^9^(S97[KKR4_9]SC_J=P;8_='S/Q&;*_==>
M2G[/N<?]3N#;'[H^9^(S97[KKR4_9]SC_J=P;8_='S/Q&;*_==>2G[/N<?\
M4[@VQ^Z/F?B,V5^ZZ\E/V?<X_P"IW!MC]T?,_$9LK]UUY*?L^YQ_U.X-L?NC
MYGXC-E?NNO)3]GW./^IW!MC]T?,_$9LK]UUY*?L^YQ_U.X-L?NCYGXC-E?NN
MO)3]GW./^IW!MC]T?,_$9LK]UUY*?L^YQ_U.X-L?NCYGXC-E?NNO)3]GW./^
MIW!MC]T?,_$9LK]UUY*?L^YQ_P!3N#;'[H^9^(S97[KKR4_9]SC_ *G<&V/W
M1\S\1FROW77DI^S[G'_4[@VQ^Z/F?B,V5^ZZ\E/V?<X_ZG<&V/W1\S\1FROW
M77DI^S[G'_4[@VQ^Z/F?B,V5^ZZ\E/V?<X_ZG<&V/W1\S\1FROW77DI^S[G'
M_4[@VQ^Z/F?B,V5^ZZ\E/V?<X_ZG<&V/W1\S\1FROW77DI^S[G'_ %.X-L?N
MCYGXC-E?NNO)3]GW./\ J=P;8_='S/Q&;*_==>2G[/N<?]3N#;'[H^9^(S97
M[KKR4_9]SC_J=P;8_='S/Q&;*_==>2G[/N<?]3N#;'[H^9^(S97[KKR4_9]S
MC_J=P;8_='S/Q&;*_==>2G[/N<?]3N#;'[H^9^(S97[KKR4_9]SC_J=P;8_=
M'S/Q&;*_==>2G[/N<?\ 4[@VQ^Z/F?B,V5^ZZ\E/V?<X_P"IW!MC]T?,_$9L
MK]UUY*?L^YQ_U.X-L?NCYGXC-E?NNO)3]GW./^IW!MC]T?,_$9LK]UUY*?L^
MYQ_U.X-L?NCYGXC-E?NNO)3]GW./^IW!MC]T?,_$9LK]UUY*?L^YQ_U.X-L?
MNCYGXC-E?NNO)3]GW./^IW!MC]T?-/')W9,=ZO672PI*?NVCIM04VCT$L6 7
MJPPYAE3>[RF#,%BL2E(7")U/FA4VKXM)4AP1_-A'K9GMV#7IE2ZVGQB5Q,,F
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!K#\1_P#\
M%6:__%I^07_SLWMAJ_\ 5]T?@V>89,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@5KZ@["YFXN@S99/45Q12G(:]OY$69'22"<5*A\D"A*J7A:V1E8T#L_.ZDE
MO1'*#_EDIH4Z<H1INP%AV+"Q;-VD)F@$_A-JPB)V56TI8YQ )W'VJ5PV81EQ
M3NT?DL<?$93@TO+0Y)!F)UB%>C/ 8 8=_EUO\OIOUUA.&DLNP*KQSMGEN76H
M@I*-6^P/-HN=IV[2J"(HD;X-<JLRA(@Q3FXXR4H$U 0;,KV.R9 -P4;.TD I
M5 3!-&I]2M%VS2OHLZX+T34@7.CDJ)0MS:D4KUZU2/12=(B1DC4*E1Y@O0)9
M*<@L0Q"W^30=;WA$?4U<5;=!5="+II^4)9M6%D,2:3P>7(4S@C0R*/K1&!1.
MR(AT2(5X4:P)6QE;,)!L8-Z%K7IO6\+,3$TGBDS"& P(\MJV*[HFLIW<EMRI
MN@]95E%W>9SJ7.VE FZ/1IB2&+G1T5%HR%2PX"9,5O>BR2C#C!>@0 $+>M;$
M:Z,N8GIMDC(SR)F4;5M#^U-[TU*ME')]J6UU2$KD*C9"@LI03LY*>$7L,"$8
M?7T%K6];U@=K@,"))[>E6UC.Z=K.;R?;+-K]DDAB53LVF20N6I3((K%G":/R
M$3BTM*]J8M(8VUGJ/BN1Z,DW8/AEC&:((-EB)F*\DMX0P&!%$%O&J;,G=OUG
M!)DW26;4)((Y%+=9$!*[WPF2RR+H)JQ,;DL/2$H#W)7%G5*M$6G-.V24H+T;
M[!B]N%F)B*SPE*^$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#6%Q=_\.#R
MY_\ Q1G-_P#Y**(R-W?IM^QL]RL& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P&!K#\1_P#\%6:__%I^07_SLWMAJ_\ 5]T?@V>89:W.
MP/(<WT18T<Y<YZJ21]=]RS]@%*(GSE WA!'6N$0K:CY+]K71EI.9"R.494A2
MW?P25RXM0Y.ZKT3MJ%4/8]EA B'BOR@]!%_3_67D[?N?"70&CA45XX:MK^OX
MS$=B%ZA1;Z"OR*6U;DY5 )] &J@((^0,?N$6D+UO6M!RS?%YT[!BQNM ^93R
M'QV6%Z")-KH@7._5-?'F@%H7L=X3*J6A[H>C/]/:8%$]-YN@[W\,TL7H+0=0
MV=]=0<22Z-5WY8H#6K95$P?VV'U_Y%^=2Y DYO421Y6@;(W&NF:WE2MWEO+\
MBD"HT@DEY.<7B&*EZK16ER,(!>@;IRC2CRBSB3"SB3BP&E&E#"84:48'0RS"
MS ;V$98P[UO6];WK>MX'G@,!@,!@,!@,!@,!@,!@,!@,!@:)_.8OHF'P/F>V
MYYTUKD'H"HK0G<QY-NV3UTYV)3(+"+JR1)9765W(=LSA&$\(MF'F&L^@K%"1
M<<J-!\ALXP!I(SICK,S$16)XOG^LVQK/ZOG48NR7/_0',+RYPKP3QYNHZFKI
MMRFX!6L?[)LJP:KO%KB\#C,@8F]H;YI &\GZ),.2Z7-B!25[1_%ULS<=*1$4
MTGC\E;.G>MK1B/,U>U DMNPX5+N99'V<\T;=5A]8='Q683E# /(2\U#!*KJN
M,Q)YU&[[M^KH9& &*U$W4+@)(RJ,!H&@A ;HU$16O.GI\&V/CTX:CRU5$>;O
MW&J/*#YS%!PO;[="./YUYI.-'Z!UH(=",'O?Y/37_JQ#%WZ)^R&:=OR>/J?,
MZX58_P!\V%=!%_5I^P)EY[I;HR^*GM;D=X>.8Y^[.4E?J7BZANKBXJ$L]"Y%
MN[C("3@ND>D/R^MF?^'^6/J6UZ=>#2*SV#*&KD7QOU]3O7.J)K)9R-:\J2V=
M:'472U65Q7_D:99S!$$EBK4Y5=&;!4R:=5+$S&K;)5BE&5%PD.;D("?2D9NC
M(Z?\IF8K-?E_'JOXXW-,F7R1V8C4=>VU'>N67OYQKJP8?$[,LN65?"^*#/'F
M*3WW<;/1BQ6*%%P6 VTC,?6]<%M3*P+DJ8H&BS1 !AFD;>&E/G5LX\ -HH9!
MSQV#6Z.Q)'=\DIJ11=+(^G&;HFWK^I*^W>55:<^)Y]4Q]OBU)*EEQY"8)TUB
M9/\ 1-+\HU[?8$8"":QEBDP^>^OPV='*5KN[VSISK?4^:>&>"^RDBIVZ>NMX
M8!7U9/DG-YQE,D=(TZ3!4S.K&IJ!/IJ"T*"C&TLL0S/@[,'L>1TTK2D<9CY,
MLZKZ>E%K7_Y(S$\P=(>R3[ESRQ1&U^<''H6^+1G,:U1+FP,$ =;AJFQE0JNI
MS3N)I/=H8WQ!,262T*CBS!C!H ABVVD1]L.LG-X=&F4S3E4WAT*^4E-&R[>U
MFWKJP[1Z@ONE*IB72+55=5R?C0$?GE)Q^7O\<@T;H]\)=J]A29O+C\D>D*S2
MC1QHM[PL1%:Q'*FG\WT@>2BYY]5WBBY/:KHE,<E4UNV0\IU#</0B2\;KY^I"
M-NS]%PR.4738UJ5"FBUM-E3REVB^R%"<@IK$M$\E%&Z(]=%[KE9$3?-.$5?-
M*GMN\Y]RS$K:=>E^B=S/F?QD@NNJ'V+7Y;;:U'S^(^6.:T[%I/)4X)$C_::G
M1U<HTT)QR(E8>H;0D_,:$,H'LCK2-U*1K/Y/IQ\T-C3^&S3@KZG3B81 $A3=
M\'OQ,3DK['"'HQB\>UYR)BV[$LRY&!P^@W]&2N1?&T/Y584 XKVF@"+5<;(C
M7[OQ?/U12.?UE.J(L=@Z+ZL<GZ*3'P S=O0R_I6Y)E%USYW[&7@SJ/<@BLDE
MCBQ2)OL$EA3)])5A)R=O3 V6G 6$6_6.LTG2D>ORX,#YQZ^?JQIVU9U7]O=#
M=%*GW@B^2>Z(HX].7J4UTO<+OW,PU%0,Y<)RB>'F2409&:ADJUQ5;C?RZHZ-
M(3E&@^@AGAI,5FDTC73^3)J2O5J<H34M>=>=HVM _'BP=A^16.'7OSUT;T*X
MQ,,_@-143*><X? +U=UKS<<MAR)=)I&\PMO>3%HWMS] "(6>@2MPF-:VQ]5(
M;9^(;AXMX?[]\N%CW-T#8$56K;0YIU&@V9-[@F)\FK;H&N*-41FQGZ"C3.GS
M[K([8E:=J0OJMN J;$9@VXL:9$4:2 Q=6ZVV(?5?E<3 8# 8# 8# 8# 8# 8
M# 8# 8# UP]A^0YHY_L&,<QT-5$EZX[DL=A-DT&YHKYV;V$B,0T"G:$=L]!V
M:ZE*HU1-.IE__AP.KD Y8YJO1.VHU9OQ/A!7]%QCY1>A2OI_K#R:._.29T!\
M45#^.&KH#"6")>X?N+1F]$W_ !.UK7G"XLCT <J);8ZF$9H0BTH-;#H(<L[Q
M==,P@ W6A/,IY%(W+2PA$E%T$?SMU-7YQP=^[VN\&EM)Q->I2';_ ))@$;PW
MFZ!O?PS2Q>@M!TB'O?J?AJ4QV"^6&!UJ534K?FZ)0;R-\X)9$AY])D#PL VQ
MUBZEJV4+'J5\QN[\K,))+?\ Z2>86>O5 )VL0AT+VANI(/(5$$J4QQ2A,H*+
M/3J"# &D'D&@T84<2:7L19I1I8M""(.]Z%K?KK ]N!K"XN_^'!Y<_P#XHSF_
M_P E%$9&[OTV_8V>Y6# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# UA^(__P""K-?_ (M/R"_^=F]L-7_J^Z/P3]WKU:W<3<DW/TBI
M8AR]\@L=2H:[@9 C-*[%MR:O+9!JCKQ&%/OYL1LTL>1MC>,1.A&DDGC-T'>B
M]X91/X[^-3..:5D$LMEY*L?K^_W'=V=GWBK"2H>;"N!U0;5+8ZUKPZWM%5=3
M(C?J]$&DCX2%N9T8!%D@-4*!##4AX[GWS;3_ (LY][1JWJJB^N&V]8BILI]Y
M9Z[KXRLWE@0N,GD @,=2]/T\E.="#U+6G3@1%2V-.Z5*+>PB4!*V'X8;(Z6\
ML]9NME1OG3L^HK,\=_4,I4Z;(G7/18F8^JK:> _! <CY^Z;BZA73-O"^84E$
MDHP+6Q]/.'H 6WW:WK V8V%7L'MF"RZLK,B;#.J]GL>=8I,X;*&U,[QZ31M[
M1FH'9F=VU6 Q.L0KDAP@# +7_#?KKTWK6\#4IXU7Z8\O7GT%XG++D;Y+6?G.
M+Q*\^(IO*W!0[2B6\.6,[N<99(&_O"L9JU^?^9+&9E,1-7G"T8I9CF<6PZWZ
MX&YS 8# 8# 8# 8# 8# 8# 8# 8# ZUU9VA]1B;GQJ;7EO&84:-"ZH4SBC&:
M08$T@T2964<0(PDT.A %L/J$6M;U^7 _#65F/-&>>TMAQYHD(S#C4"4PTP;8
M8(UM&,P96QC$WFBV(C>]^I0M[V'TW@<)3$HJMTF"LC,?5A1G+5*0*EF;C])5
M#EOW.*A-HU,/1!R\7Y3AA]!&[_\ :WO YQ3,SDJ JR6IM*5@/5J@*BD*4M0!
M4O  M<I"< K1@3UI900FCUOW&!#K0M[UK6!^"96<;J4_#:6P;X2D&WDO(D"4
M3J4@,'\4Q$4X[*VL+2#,_E;+T/0-B_+O7K@<+43BNDR1%J-1_2-O<Q/2!)IF
M;M)D3P(XU0)V2$?+?"3.8E!PQ[/!H)NQC$+W>N][P(6IGEFG*(G%\61 F)67
M-^C[57W#9\A>7 QW7+94OC,7B&TK*(\ 0,$=3,4/0EEHDP0%B, (TS9AHQ#P
MLW3-(GA"=FME9F1*8A96EL:$1IZA4:C:T"5 E,4JA;&J4&)TA110SU(]^I@]
MZ]P]_EWO>$>CZMQW16B-,++HC28A%HGZ+0_"TC2J?G4R31?P/9I,G6;^, OT
M]@#?Y6M:%^7!5ZAQ2+F*EZ\R-L USJ$P+FL&SMPE3B$T@M*:%>HVFV<L"8F)
M 6+1FQ>H Z#O\FM:P/)7%XRO >6NCK$M+4J4*Q26K:&]2!0L;-!"VJCPG)QA
M-4MX0:T08+U$5K6O;O7I@<]R;&UX1'MKNWH75N4Z!I2@<DA"Y$HT68 XO1Z5
M46:0;HLTL(@^X._00=;U^76L#@ZC,;"4(@,?8PD#3;1#)TTH-%"1[5;7;2"+
MTG]@DVUHMG?#WKV_%W[_ $]WY<%7/5MK<OV2)<@1+-I_C:3[5I2%&R/F2!IE
M'P=G%CV5\=,8(L?M]/< 6P[]=;WK XGU>8?;[0LK2#T"WA#L+:BUL'T2$0&G
M8/Z#>M;:PBWI-_\ 8/7^1Z8$&\T<K4OR92$9Y]IZ-"0UY&$#H@ 7(%/UA?'X
M+X]/4A=U$H>5Q6U#Z<N=9"L'L)NO@E%G?!*++)"$L)9NFZ:SQ33J(Q33>6TZ
MC$>TU$JTR\ELTRMOT>4O1_#^46EHOEOE@*TOP0?#,T'0P>S7MWKTUA*N0HCD
M?5J5:Q6Q,RI8O WEKE2AK1'*5I;2ITL:@*SS"!&J -JO7Q4^A[WHDS^4#T%^
M7 [G 8# 8# 8# 8# 8# 8# 8# 8# J3W9U8Q\2\EW;TR\LYLG5UO%-;AD*2[
M,^=L"T)2YM\-JFO$&B?<IVKG5CR!K:PB*",PO2K9F@B]GI@0]XW>+W'E.I7J
M:W$Z)["[3Z8=DMQ]EW0H 4>YS&V7E$$S4(8ENO<)NJ6FF\_4<B321LM"B:T?
MQ2R@'*3]C"2.O._^7>(6V-AO&>*OK_/SC$%3T774>>K.Z N-X"(11;15U.PM
M([364FF*M:)&K"F+;$A@P_-*2 []V!1G5E>9KLT.C:?JJH_%?2;K[OD;$Z;1
M(ND^R7)I4  :A>F?GB%/S=2E6N(BQ;":@E$C>UB<>M?$2ZWL00AW?BT63OH'
MFSM;GOL6P%O7(ZF[DZ^Y&ELJMJ-1, [1K2,N++IN12F)1]I;HDF0.,<EFBQ(
M4R4"4DD>BR]: $/H'%\;3Q+.3N@;]\2MA2%ZE,5HB&QCH/A&82AP5N\F?N)I
MX]KHGJKW][7F'K7UZY?LYO-C %AY@SSX\N9MCT'TUK8;I,#6%Q=_\.#RY_\
MQ1G-_P#Y**(R-W?IM^QL]RL& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P&!K#\1_P#\%6:__%I^07_SLWMAJ_\ 5]T?@BKRU$ZDUB^)
M"L'$0=16<^5>DWN3ISM:$D==4[4%[W1%&=86/^A/(.GD$:E.BQZ%H1B0/Y,,
MMO4@2&N# ]H"/7XZYH<DA/I_Q^*I1'$E^G_T_>/6!\T/)<>LN5_PZ'#;[0W0
MS=S5?--UC7$^J*62F>)8%6$OMJH95(4!5(W4H<7)I:WVK;67(5D?=F]4;\()
MBDI5[!C2!!L-B,#ZCX/\FWC.=K\Z3CU7J.:EL4D*3IR"70:S.4?I&?UUHQNL
M^+RAU-'H+.^5[("S#&MZ1&)U9J8Q&Y(# :4)Q["/.$)U87*?5DN\75GV#);C
MJT=))^H/'Y=DW=3I!/'?GE+)D,+G_/UBRI5O:F72B@9$^-.V5V/&:M=(H[)M
MJ-Z,1BU@=OU@4&*^93Q'2YEWI*[V74OD1I29#*T'1KQ!FJN:FN%F2JQ:#\0:
M5EFD+)-+UO?M"8KWOT]1>N!N0P& P& P& P&!2CLOKMMY&5\M+Y*?!&:"W?T
MTQT?/YO8<I(A\?KV,.]66Q.OK9]-KSDK.2K"]0!&A %:<4G$%:+^5\3V:V:M
MMW5^$*QUYY=J&%3ZBVKA7"1M;Q?'74%@0Z.B<_O5&]TERO:3S#I#T*[&UW'Y
M.-HJ]CB138[2"0#]K*WZ<BM /$$POW%FR:TCE#+5?DXKF"3WHAGM1K>3HI!.
MC:JYXH4-+02P[LG=TOUD<EQ#J)+MOBU>,DD<%BE:T.SGI$)(G^3VB1%C&=L1
MN]Z&R=*<F4=4>0N&5+X]';O>CT>[EB#I&*^DE;A21R:KT3XCL&6QR-)%;\U,
M+0;)V$AI+>C!+"U1*0:961\J>(DW?IHD6UNVRP9@\I=<$]?RKFVQXU-H/'GA
M/R.WTO+UM26^GVLF?4<4F+^R0^[EZZ)$L=(2ET=V1*T,S._B;G-2X[/*,+^(
M'8"B[)VUA9FB.ZN;^D;)F%4U1*I"ZRF)M[\^(U#W )Q$XO8D5B<S/KB732GY
MA)F!KC5L0V*6"F$RN+FQ*5J1,O$6$0_8<0,PDVS$5EU[QW[S(Q7T\<Y.,MDA
M<^8E+HQN+N574]4UB7/V:M3;E<JB*MDB/&5VHN%-4I(I%N- <1.OT9KWZ*]_
M\C!MFE?1&E/^5;C.\!QLN&3"?H#)C+J1B,2*G5+VS79LDWT>P3-_H^6,Y,TA
M[(<KKVR0U\[HVU^T'Z+.<DGRWQM&FD:,$V71Q8@M\I//;4ZR6QEMF,RKG1GI
M&$V B+9:DNQXN!>^R[J>8<L-SXWH6Q@6M<C@\FL)@);&A$W(CGI0H]Z[T&W'
MIC!%V3P]4GM'DKY8<[5KJEEKK9T5L"QPP%"0W3:D[6B3;!IK:S(Z26L:FMN1
M/432L%47%/X^S*5;5%WY2A>%102_0C0E"8)Q-EU*^B-V'S#\*R&)61.4\YL=
MNB]8PMDL5R<GZAKI8MRR"OEJAI N55>B<X,G<+29FZV3 L*LUA*7Z(7C"'\H
M1!%LNRYD=7>5OC6UI@XPAOE-DPAX962WW9^4W!1UO5!'V)RY_)3.%W0IVDMA
MPV/L26P*L8%Z=T>V;XXEB%M4 /,#K7NT$DV71JXJ/RR<<KZ^_:"E=[B,^-9<
M#J5LKW?.MXEW*^R^V8<]6!47T!3QD$!8;Q'[7AK I7Q]U);Q-S@46+6C@C+-
M"679=6C'J^\GM<6_UMSA1U5,4JF-3]'\FRGHJ*VFWUC:IFD;RVV$T1)LCDE4
MCC!+%!6ML1I'HE\.=QD&-CX%O;C_ ("E804>)LF(K/&KM9=Y)()57<LXY-MU
MH=XQ&$D<Y6+@%ELT(L*41X=@=)RVU(:UL=JS-D8UT%JML=9+$69I8#794D^D
MW)Q,!H>]!] #;6W="Q%3]I\]W;(:VB=<RIV>I%:L,N"?1AI/A\J:E26-4/9K
M=3=GJ90!T:$FHDJ8+,<P- $SAM.H5JBS=$ ,"28())MF.+%7OR$<MQNV+5J)
M[F$G0.%(1N52*V)^*LK(44G!#8-!&^T)E%9#=:.+J*T03F,UR[)7E6SB<M+B
MTB@L/P]G"T5@VW4KS1D1Y7.05-<DV(2ON@1RFVXY1J>KM\YW@&]CK+F]=.=M
M5\Q%T@*"ZLO::PJW:C'AD7_1VF]<CWH03M;T/0"[+JT9O!O(]RU9\PI&$UH^
MV)83G?-;0ZVXPX0JF;7DL<B,#L-RDK%!7NX)$TQ!4TTZ7*)##'AO3 D9K>,*
MQL4%FZ+]GKLFR=9Y,)2>63B)7$;>G?[0Y>FB=-,;+,'AX75!:R,J<U](+%_9
M&TV72Y!\/ KNJO%EE:$SA=HR6YI=J]!_E>PT@9I=ER-G+RQ5@]W)QC *MA]F
M2:/=(W7?E'6/],TA=C/85.S>E(L$U1&95"#X:G<X@]E2UW;3G3;P624W1D1[
MH9H",L:DH;)I,SZ#)Y;^;H)7E:NM\V")WE4V9)_-G.1T?1'0+S6$;K>'=!/5
M"*Y_+%;A%GMRKJ(1B5%(FUW<GT],EVN&-0GWM(83O!LF>'!91E\@O,TBZ:#R
M8S2&:+K5/ETRKU"X%U98VJM=+#KB":LFQ( U7 .-!K9PF<$B!I*AU;RG(2A(
M,\!(@_&T, ";9IN]$4OOD<@\![,Z>YTM-H>8+6'-?+]>=$2*YE\#L@V*I$ST
M*R76="D,S)CQL);&%HC,8;0L^P*!GO;L)R0I?C*D!R<LNVML3'&96<YOZNI[
MJF+2J3U8LER4Z!R440GL,L>OYI55DP:0#86>6-R&65Y8+)'I:RA?8E(4#HWG
M&I=$+D"PLTD8];%H)F;9C254DWE[XQ6U>QW"B77HK@TM=WE!!52;F2_#WJPF
M.)1;<SL"Q8%%RZ_%))=4]:1TL9T@DZ)*:RM@P:*,4;.,) 8:V75IZIO_ ,?_
M # HN.*TDRS&0RN1RJ(Q.;_6R&5W/I;4D38+!B3]/:\/L2WX_''"NJ\/GL(C
M"]V:2WAQ1[4MZ?X_\D!I&S2;9I5"F_)K1UH0$V3T+/$C.X-EL<K1E7N\Z9O.
M+I9/6_3MO,=>5Y/J^9!1V/2*41*X2E"Y+#I6F"?&MN).CEIFDA)V%V3''X_)
M(JOR8<=H(DDFJRR'5.QK*SLBUP:% IT-V+C-67,R<\R=O.828\8\@F:J[9"E
MC34Q:(V[/+J,12).?L ]Z)MN3;4?5%*W/3TBO.,21>QP2#JIPV63JQ8Y(*VE
M%5OE:"5:L&/6=#YJW,LD@S[#P(QFK4[@F)$!/L!X?<2868(DVS$T4Q=O*;5<
MUC%6OO/:)WD;A*^MN5^?II'+:@-D5%*8W ^F'D!L7M1JB<VC\:D#M'IA# &N
M$9<M%;;'+01[]XMD'$Z-;)]>4I-8?*3Q2_MUT/@+/=V>.4=#7VQY!)Y-7-B1
MR.S6N8U+E=>O4]I=W=HPE279$T=B(Q,&E<8$Y@.=S4Z<KWB5I=G$V7(S4>4*
M(/'1O%]00RL;GU%NHDO0R>2N,WYXON'S>NI+3"Z'L*)E?(N\P=N.C"33V_*C
M7QP=  1-+:4E5&& 3*RU&%V329Y.\2^73C=?5#%<[>KO5PA$RD;A'JX^1YEO
MM3)[5)C\/6SZ:2^K885 !2N>US7T3:E:M^D3<C/9FP*48#%'Q!% ,&RZM&;J
M/)[QV7;-?4\BG4K?7NS 4.9&9='*JLQ^J8!?4#8N=.>1/MM-L545_'!W"%O,
M(8RUJ\DU4I]I?M#O>$VW4JPBNO)E2H8Q2C?94Q%.+-N1[LDI&5SU1U^2F,,$
M4AW0+Y0B2:S=J,C$@D]9PQ),R4+ K>W[:5L6/GS!B0>T0?>66;)KIP;.<,&
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M4E6>UV)9G-4@VE.$60?HN_Z8A@COXH>B-4:[Q"*6I4K%;L=X)\;U%TW,S=S
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M@%!8.I;@[&6!1]+&E:V7I/[S@UK?%:_'\J)3F7B=L^PW^;)Y!9D#:8?8-O\
ME+ECRK9P2)=)6J%=\TT"K82%M0JVA$V+)/"5 S%3J0:I*2#+T$)!QWJ+6B;X
MCY?)P*&\6]KPI!0SY)HQSQ7UF5CU3SM:5C2F 6_TI;AUM5?S[3MOU\V:/<;O
M3+5\7DI\EM96L:F!&$#.TMR@T@2Y08  Q";X]*THD[D;@'HGEVT^1I8*24S*
MXY67/W3=!W666[35 \)D-M=&)N@X1)JP)%$QHY&K)4-B=J=$KJ8T@3@,,/(-
M4;"$H8NNBZ)^UZ>HN!NE[KZBM62Q*24>V<Y]%:X))M1PD#K.R[IAJ7BF\93=
MZD$"CS;%%4+>U%AJ'5,U%&K'=$)L#\15L)VP!(&(NB+?C%?F['Q[<TN$![3\
MF-S+0/@X.KO8=94&2_L3@Q 9(_*"$_2O0WU5"X$D_2T6DG1MS.>@KTVMI5!S
M2( !"^#O>B736V(]:.#-> NE9*@\@W.3=,:00\H]QN5Z6:&>+MSM5T! [-N:
MIXI#28P&))VY+7[I"(W/(O\ 2XW QV$L6-1_T;I&2,&EFA%T:3KNAT4#\?'4
M\EN>'=-7U*J$:;7_ ,6_/%P3:&U2XSUU@3?4_./*]W4&S((L^26)L3T\V!,Y
M?<:EZ4EK$*%"W-P0(P*% T^C3R[HI2.%$;5MXO>G:Y>."4S&]4'%7#F9N:(_
M:G1$&G]R,EP2^JSK3L:=67SJ?7Q<235S;=26(TRE$4@%)%*4Z*N^UKBC(,/$
M4(0F^-?BCJLO"]:$)YWM"CC6_GQ+-D,+JFGJ@Z$*M7I&62N959!.E()=;RGG
MU>38IW@=-;=V&NVL.VB(@7HC7XDP_1R=*:$DN+.2)FNO\0MBS\ ]"0?I:$7[
M%))3KXE9_(ET=TH_1Q^=IFT'ZHOI"A8K2SLG:UR").A9]KP\3$<N3MYI8&A=
M\0 !N!'\H6JSNBE/@KD=X?K^'2DXK,%E4]],2;ACI7EU O&HFGT:1-;G['>^
MBXW(%>]17:K47:XBY@1+1 +$KTY!%HHDPGT-W&M\5^_\GOA?/U]5CY5J<KI(
MVL$WHZ/=$]I=U*9S'X]:"9^KUGZAIF20I)#K+D#S#$%0;6?M4?'%.RD,\C=7
MQP;_ $/4M[>0C&:H>I,Q-E?6D0M#UOX_[CZ)MGL(Y@EM;,-4=;\15]0:A\=U
M$F,L"N[@IF;VS,:_>2(JC9#HY+ZZ?55FE[=]&.S>N) @$424;H_XA=9MNB(C
MG$K <;\]WK )9U)>W2J^J2;JZEFE?N[Q$*3<98^5G"8U5%2QNJXJA;I'-F*,
M220/3V)H5NB\\UN2 (^<*2%Z,"FT<:29C2(X0UXS?Q,W,HYM\>,):U=,699G
M&U2V;2\ZADPM&_J>JNQ(];L?C+<]/+18U,)$=G(CXP\PIO."VJ6_:%[;SU:5
M1\N/9!Y9K?%9Y2L1"^"[OJ*T;<AE3#H)CX_Z=J2HZ^M=D/7V27:=-$5/S<=S
MB7%J-1&(71DE$==6!G85"!=('=.H:?E%@3$JX2@L91-T3&M=T*U4?XC;8@5%
M(Z]>V7GF+VK%)YP0W)+ABEL=*6&OM6HN.;]B5NO!LJ9;8*=F^JW21)HX<>S1
MB.!4,[8Z+CP"7;3#!LHU-\3-=?7YNTG7AUL>7D>14D5FP$:7H*P*VFO);6H%
M-F]'63/%^BUG9<_@5C+(X%F>VAELSHQ[7Z.5QQ4-8@:!$*"!:5D +U$B^E/A
M_P!%W:=X= U<0W_S/*8A7U)2;IYHO--90JAL6W+M9T3]<,//KWZY&S^]1(9[
M-I6FBJ5NVM-5$H4QZA)[2R@%[]=U)N^JO&BFU)>+.W(A :S22*-\[P&T89U#
MQ394YFD$MWI2V!VQ5O(RUV6 VX+KJ3+W"'2-Q5R5U.8X\VATSM):\1!BX[VZ
M-U%F^*^M*3\T45OX4["B=$W32JH-%-LQ:JX)KWFWI(FQ>B9U+Y$WQZ_HM?\
M%6VV*BFBS=:51$W-XK:-)9 WPXQ=I8H2J%9 B0C+2ZJSDUKJV".5#]L6'=G$
M?1-E%<P-<SI5PZ8B5Q0F$RJTU,:;JJOE!!$+*X5S)WR$EN<WL")D5Z1I44XM
MT=;EYBX>RQ)PD:T:9K;$3$55^2>//JRJ.??'B@I274"_=#<4U%;5+/S=92V>
MMM.S-@N^ MD3D4A:']ABCO+T;K#7Z+M#DC3G-(2W1(!6C,-2;/ H+B[HF9K6
MDNAKSQ+6?6#3'8FR69 7J/1!X\/ VIS="I&@>'1I\<TI^F[55KVY,TKT3:Y6
M G]VX^F*4GD%&"^&J-) '0]TF_\ /YN\Y_X![%Y2L&I+"J66\VRMQ5P2QJ5O
M1#8*JRTK>Q5_(.T[9Z?BLTJS<?CVEDHEZ>(W"ZLJ]H<ALJ+;EI*J N,)3C*/
MA-UMW&O\0WBY7,P& P& P& P-2?FE@\R6<=-/0U;,#A++%X+Z!H[NZ-1-I+^
M(YRIGYYEH76UHT@+T$8SECU2#Q)R"2@ZV(\X82M>FQZWH,1\HJ1=TWP32/6O
M+K>=>Q//=Y<F>1VM8G#/8X+;MKJFI>S6,_Q^)DA]^G&0/]4.CDI:4FM;-4N9
M)"<.M&C#Z!KFZ_403R@]K\E-GC>Z'6(3^I^,)G&.^K@JP"1:W,GC@D4YCLCC
M+&_O7Q=*H%T5)[#;9#%(FE,)$\M1#Q(1JB4Y246]AMYF]5>,OQ,4W..MF3FG
MF[GI)4=:"C&II6]05]%K5EK>(EL;HY53'*6IC33.92NQ7YM;6](A-5J%+NZ"
M)$;LPSU'H.Q\2-%650_#%9I+O9!1N^[DD]L]0WK'C?3YJ.6GTY:4NNV11)?Z
M!#ZN4')FB=D4;]1>IS<+\N]>F\"!2EY75GFV;5T?%ITK/Q;<P3..25]3^X:
M'6':RN)&BA:=0$6TBQP@W/-=!5N(0;$<B,DQ!1@0;'OW!NCP-87%W_PX/+G_
M /%&<W_^2BB,C=WZ;?L;/<K!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@:P_$?_\ !5FO_P 6GY!?_.S>V&K_ -7W1^#9JI3)EJ90
MC6)R%:160:F5)5)19Z92F/+$4>G4$&A&4<0<4/81@%K81!WO6]>F&6@AE56;
MX19+)8\MA4XN#Q 2:0O$OA,AKIA>9Y9_C8<I&XJ'F4P64P)C3N4KG?' G16H
M<6AV:2%CG" F'(U:<]%\J?H+IVE0W"?EBKRM;BA5HHI>\0!2L>:&ZYY*N J-
M7/3;P\)0DNVH+:\%6JUC.)P3ZT4ZQ]V*5MJD9>@+F\9A0= " IGXC9!:L9=(
M)UKY0>_N@.=U" ]),::?IE1E,Q.>1'X(@.L8MV<4=2U:V+*XDYM_O+<2 O3>
M%45L6C1;#L6MAK"Y7Z Z#Y\EUO>)/Q&!J3LRGX<,]90/7J->)=4WCQ;)_)WA
MPFM7=23-E8E$'Z!EU:J%ZESB29E=EDI>?>%&^$>A!QP0^B_B;C^!\0T,STO#
M'I^FSTM?Y'8]NVW,C=*I]>%VS]PV^69;\\6Z&=M1(YD^F;'HOX@RT*$I.C*%
M\%,7Z!;; 8# 8# 8# 8# 8# UP^1;R+USP=5DQ<!HG*<7@"HI[:->UFU1"P)
M.VGM<-/:&44HLY]@<;D!%85K];)(VMICX\&($(E:H)(#M#T/8#5MLW3\&<.O
MD%YZ26=,Z&;9&ZN=S1%BFN@H!P>>H:V?+)K^LB+:EM/LMP&QLRMW2T(S UA#
MNZ1]*YJ'=O;#!'&D:^$=H VSQ]$'\S>2./60W5BZ71(:[AJZXJMX"=HQ!X='
M+3<7Z*VOVI6DWFS/&)E)W!H/AAL9DKK$#4<;5)3]"($3LIT$2H5(P&%FVG#X
M_)*9?E"XN/?:Z8DMF/BW]ICD6VM;^AK&S5D-C 7*X9+S_$7>S9FGB1D9JV.V
M/<D0<&",.,@5-Z-_5I]B1&&DB";LFRYVT=\D'*LHF[K!6R16$6I:+_2<MGRI
MUI2WF.ME=_*Y/,8;JM&:RGB%HH2^O:6309:C4#1K3TJ<\Q, PT(E1&AC9-*_
M!9FF+IKKH&!);.JE[.DD'7R":QIN?3&IV:"')QK^9OT DQK>0\HD"I8UD2>,
MK"4ZP -IEI1>CB!F$C 8(DQ,:2I58/DAIY97%^2*F98%,X41+XY#WFQK8I3H
M(F@71T%>;324T01"?1F$@06<M8)?\^QF?5M8O"A>RP"5>U& TW1J+)KJR)Z\
MHG&D?L6SJR=Y_+4;U4C'>[]+'T=0VR*OE"?F&.%2?H-OB=D A@H/-7^HD)P"
M7IN:EZM:E7"^5^$(_6P:)LNI5-?,W7U'=<-4V=*8>92J,KN0-4=F#%.JZGU5
MRUF42.+,TXB;DHB-DQR+R/ZOS"&R!&Z-*_2;:5>C/T,H>_06@DFV;>*&W;R@
M<5LD (L]QM1R+ABFH'J]B'(BN['6J3JRCUPL5#.KZ2SHHJH>#E9-I21&W ;P
M$"<#]'?&+)&1H1FB[+JT]5A^?.DZIZ=A#U/*I<9&>W1>:2>N9BPS&$3&NYW"
M9[#C2 2&(3* 3ED8)?&G]"2L3J-)U:,L9J540<#0BS0"V28F.+7O?GF"I>NZ
M^/E%=Q&WI%*(STIS%2EAP":\Z]$PR>1N']#3$Q(WV.VUXZ5L@F\@:GZ%,#V=
M%S"$FR'UY2%-Y(AJS2TYAJ+)]>%&PBT^EZ=I1+ 5MGR59$4EEIYHIBBARCDC
M" [5?U7++IE:=VT6U#''ES;7$&=E^DZ_2<XT2(P@L(E'H5LS$3/!7Q!Y/.*G
M1,Q+T-N&*&F1UBSV^U/885.M,AD(?J%E?3;6K4.HHX%$B=CZ0A+F^";3A@<"
MRDWP1DA4# 4(NVYRD7DOXS<26M8CM@TUK>84T3] ]?4N< 9!QM\YU?NKVPTU
MV''0H4SBHH.-+'_:(P858"BM$B+TI& D0VW,L8.U:4MFJ+=L"C9^S/VJTHB(
MW><_2&,3DF'M<=M2I5UOU:\/@$C.G>W) X0\HEQ<&]M":[I$IH2QDEJ#2@;&
MV8FDH8@_E)Y=7R*J:FE<\<W"WIQ%:4-=7*#TQ>(Z>U.KOIPJY*]CC?/WF%?0
M;"OL^-$*U$99W9<2]J]%?+#)TKT(O9=D\?1GJ[R5<?)(@TS5+8KU(&N1U%1U
MU15OBE<V+*)1+HITI+7B"44RQ2(L<772206-94LCRY&@C"5,8_:$C.,-2EDE
M#,"3;<\V/R1<H2M[HZ.0V43Z;O=_LYL@B+;"Z4N.5+(JQ)K#'4*YWN%*R0=:
MII5O:[9).C*PR4 :M(GI,H3G_#$G/V6-MRMU)^8&D9;1\GN&WF"RH&K1]/WC
MSU#(-'*(OR43.??LPEMA;:UD+B*6O3Y5.')NJN!FOLNVU(SDT5.*4I7#:8XC
MX8BS9-:1R3J_^47C9C=/H]).)M,4A7/K5U2Y2BNJ9M^P(.P4 _0V93R/V3))
MM$X2ZQ>/M3_'H$Z"1$*U12Y4I(TG+($<,(-DV7?-WMD>2+DFK]2,IZF\ID#M
M&Y+7<.W&:ZJNSK+EDCD]H56HO*,,T)C,%B3\]35433B4<E<MMI*D#0T:T>L$
M1H8-"$672A5I\K-'.?3<DK73B,//#/P[">T4/1Q,+LU3!%<3DJN=O+FZ.<R*
MBNX4Q0QNK^+)E"96I5 -7/1ZAJ+U]()#$F%V33XUI1<"B>N*-Z)@LUL&!2%\
M:&FLW56SV6SVC")E3TTKI8EC37-2QSB#V<QQ65QE Y0A\1/*-4J2%IE;6K+4
M%#$#>]Z,S$P@%M\I_'SQ4QERMC];:R*JYU$ZZAK2#G._"Y]:\DGT<532![IN
MNE%<DS.UV690A I>T#@Q(EJ(QI3'*A& **&+1=EU:.GG?ETX.KU)7SJ\6I*'
M>/V75T"NE@D\(IJY9_&F^L;.F#M74'E$O>89 WM'"0OUB,YC 6C=1)''3T,M
M&)/H\>@879<Z&[>]6^?<RUY,N1)&X(+,OGJNO.08+NP*WD#!)JZL<^U]1^["
M9W5=@-#)(FA^J>MXC*754@<498@[;@C$$18M;$(MU^KA$51I4?E?:;6GG.%9
M-R&I3+"M_JGM6A[ K]HLE.ZSJLX7S"GZ*4PV=KXH2'Z=3'3XJG&O:@*Y.F2E
M:>-[(,,UHGWRJS92)GX0@7F+RM]9]&-$78FRI.1!V;=?(LBZWIA/&+OL:0QV
M",T#G4 CDM@'3C6DK@Z40!^=F:<;,85K:%P2K7)O4)# %Z+$=JK-D1SI6CG+
MO+'U%6W(O*O6%N\X5<],_840D9-61JF)=8,D6-MT6)7<=EW'55RPY_B+4-(?
M<\H$[Q]W6)RSDK0L A&4:H">8$!-D3=-L3P_B6^:-#D)L<8#)<0U)968R-0Y
M.F83E2AC3R$:$@3T0S*%H"UI[42Y;-"G&<$)HB=!V/6A;WK#F[O 8# 8# 8#
M 8# 8'J.))4DFIU!12A.H*,)/(.+ :2<2:#8#2C2AZ$ PHP MZ$'>MZWK?IO
M ^9V_'CLSP75[=0>5J32=/< 2M4\2JCF16KE)Z[QN3Z;2#2N6-\_C,+893.Y
M_P -LZYW6R9-J/(C7J+A)4MIFM)3DRP <KAWQ/\ .3_6(.FN+?)[>"/H>[G%
MTG_3O5''-F5:JJ;H>T96\O,M=3I?SC)8G9E*15MAKM)ER5A:4S2V.S,C&(E4
M<:H&H&,-@E<>*^M6*THCT/UOTAT5W?9U2+]RFJW/JF5P@NHZ4D21.8 4\KNC
M:PA-:T^QS9,FWO87]P;7%T1["$:90G$ (M!']Z^3E?=$M?\ DSQ2)HWU+U":
M9] S>]&[8W_COCI,M]R=7-[MMII"JBTOF[(7LPYL@3"H<'MR5IQ%J@)20"^(
M%WN(^/81Q)1:"HXN_OT_E3W))'9]UW),1%FSV];SGZP+O9-NS=06,W6WJ4N_
MIHE/H9A;<W$)D10A%)@;V%N\#6%Q=_\ #@\N?_Q1G-__ )**(R-W?IM^QL]R
ML& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!K#\1__
M ,%6:_\ Q:?D%_\ .S>V&K_U?='X-GF&3 U?V]X:?'#<4[<+75\ZHJJMIV.,
M5.MI<U3NRN7IT\+3S!'*'"0///\ +ZZ^L[BH-%L9A[F6L-&/?N$+>_RX$=?@
M4^/-[5)#[9C'071B) >4I1QOI+L/JJ[(2 XDP)A>U<$F]O.4.>2@B!K^C7H5
M16]?\0X&TJM:NK2F86R5Q4->PFK:^C:?Y2/P>O(LR0R),B;U]VR6N/1U$W-*
M$ Q?RA?#*#[A;WO?KO?K@9W@,!@,!@,!@,!@,!@,#2_Y*.#.F.DYK.I3SD]4
MF B\N+)[QA9R2YG^;1H4-:7JPFVQ8U8\+.AL,FFY*O*,&YMRQK5!;2][/2J0
MJ1:(&0,Z671'&O&K%(EXO)K%^L+NLMRC52S> SFS;QZ!JRSWZ\.BT-C599MV
MU"IKUQC2/GM" _GQ:4V.;V[E;E8A_2BB/N 4PT>U!6C1#?\ 31AC?XJ.B&7G
M*VX QV-4K7<BKDWQ?0*B)B%3+5###NE/'@U/#JFF;\9N,$NA$&>)WI!\H:D)
M/<#&P2CXR<H>PEB&^*U]*S\W7 \.CS'+1H<X,7J6YZ=2<\<B4A=;#.+OZ,J5
M5&Y#R_*7Z4.5F0^(5+[8==YT[72A0O(:Y?\ (E-;\D)6!.$4H4D9*?R7J:3S
MK/+U9SU)RY9].^+KLZ/%.9#W=I?2-Z=A<].==,L@ECHVVM)NNE_0_.2(EI+:
MDCH9(292O:&]VT04-,1HU3L)PTX=F[J1,3?'*B\G%\ MJA4Z;EM?!F!FY\YZ
MYZYQBE;V*3I:*26E:RYIF.[Q7JQ"=3D 6EI7MC4HT/Y0D\]P=U(A&#"'6@F;
MIB=?69:ZIAXS.KIJ[]HHV-;0%&UGT(K@C\V5/ ;/N.6UG/+>C?4T/N5WZ.D,
M)E,%1--%6%(*PC V9Z;HMIR125]4;<%AP1%@-$:WQIQK"LUA\;=,S/J&SN,X
MZG@+U M5/Y?K!B=NI45LI$4(,\E+>8IKB+W:\NM<(X"F>6J<RYS3D$1AZDSJ
MN9VTQ:H1H-%!*/-1=%-WKI\F[3E+EZ<T3<W4%C2I[BKHSW<@Y?2QE(P'NIKD
MVF4E0,>JF3B?0.#6@3%!<GYI,/0_ ,/V-((.S?A&>I>CG,Q,1#0[=GC=[7IS
MFBT"G1%4%@MU5\[G\TT(TU0ML^6V+9BJ=^1:G^@8Q,9Y$!U^W)XJD;X\UA1N
MJ)J6O)B828]2 X90]!(CI%ULW??^3=OSES#?D*J/LP^P)G":\Z#[!MFV;9*<
MZ><Y!+(?2;S**HA5/5X*,R"41V$ODN<HNUUVWO"I8<U-?QW$XTL!(0 ",58F
M8K%.$-6]3^)?K^N:XMEP3_X<V^VWF=>-*R8FP&WE?]C1JP9OPW9DAG%F2:SK
M0L.O5DVC*^\5+O\ /$@;VYW);5!HBS FCT8I.-3?;,^M-?FVF>1_CF<=N<]P
MFLHG*HY YU&[CK">*WUR-=3&@,2T)Q@UY1UN4HFQ2XF*972<ZDS4@V806 Q0
MK*T=LH&Q# 8MNVS\&O!7X6[!US?.:1:;*@C>ZN_D/27O#WC6Y!\HQ<9ID)U+
M%4.<,+%\R"2H^59(^L!1198F[YU6 .U&B?4T)O?%:_#Y_P#5[3_#%9 >3Y70
M#=9\%229P\@A=\1J3?\ W0:1-7)*=-JB4=+'&!9-K R1'QPX.,< 464)OTY*
M- ^8^!ZG:'4UK'+YICH3QY]+\X4]?7/T+?J&D,!Z+L#KT,DD<A<)\DE\"I20
M5&&L.+()"TS?'QM"I3 6QH;D,F KT(A*@";MO$I,]NMDFZ)F)UTI_NQ: >+6
M]8HJAAZ^;U2>".7MXL[16:2.$L$(UCX=H*+55:*)-\:*E:VZR9^8S3V((O:4
M<D&':H:4S>R]#?'RGYHH+\,%NM%071'TL_@$EF#;V55=R\S1TV96G7<;!S'0
M+_.7.J*!G-CP!$@L2N7\AMN:7E!>(X6MTUK#D9Q6E  G%Y%ZD5^Y*CGXV[X:
M#^,3Z+K[F_G*64W,0S>=W+ >@NEI'9$$#-KX_:MT/6K/N:15Q%U)5]Z1KXR9
M>W3E>U)R)&O/=2R0" 5Z$WQK6LN6BX+[4K9?$)]5AW,[W8'/?9O<-Q4LRSB;
MV2V1"R:6[;5V0\NY%C+&FLWASKNR*U?)XD^6(;B7] Z)&P\L:E+M;H1--UO"
M:TI'R3AQ+XWGKF8B<PNPI1%;$KF8<0<H\J.(6XIS1NCZ]5"FZ !;3JN9UJ#;
M>U124'7* +.06K5'%)BQEGA#[ ",)=?76.-:JJT?XP>Q>;*HYSG$2G]#VUUW
M0O0%KV$ZD6 ]V!&ZDL>N9ESRFY&@C0LE[3#'V9,4L@5+0>(JOB:9U28]<B7I
M B"4I"J#&IOMF9C7;3_=Z_P@+K05>LY[06+6;C7=@^+%HXDL*Q5*N6,\MC-T
MP^?VK:3)-XA!D;"N;9#6DAEUK&D*$9[VU.#<VH-!*V>8;KV5-\5K_P"JJ?J?
MX9O6*4W/JP/K+G&IU?5RZ>07K^2QKH3J7H*7'U8IYX=:P@,RKJ97DW@=G2R6
MZ8J0!$U. 4C0AC6BR"U!RHOXF$FZ*UUTX.F3<H^0P^H>15CV1R =>7!%E0Q;
M3D;:9I;:6L;DKYHYTFO.LW5V+*55;J'NMY=)DDU&]M"=L8WE*S"2!1G'K-'"
M4E%W6UGC24+M7B O5@JTR"I;-JIV>'+G?DN O;L=J5L[:9:-5^1"==N7*L:F
MTEB=#4,"5M\\4-4:T(P:P9I!>E12<&]F:E%WQ7[_ ,J)VI+B&ZH=W"QR:?H6
MEQI&!7)WIV7%I0QNI2EJ7W!UA-&:#5;$7!F<=(7LJ55I29TM/<%($AC< ^0$
M 3*CAA,]E2;HFW3CI'\G#IGQ<26KY=RK/Q)Z.3SRGNNNZKUM.;,+2L3RZ;5[
MTREZ:35Q&4\D^J*1Y?':,AN!CTXIW XI$G"WG:3&'?"(^()OK6/28AP> ?%S
M/>(W-E.93:/0-L_X*@5!=()X.WN36IE73-3/\B'$+C9U7U0;C7UJE,0G[JA?
MU*X21Q//;VX[9)XOBB +K]W/C\F+V1XMNBK-XWX:Y,/M^%PA/Q]SX0[ E42>
M9< ]U[>JBOXY&N7ILA!]6T)ZFHJRF.G5_< *=@6KU $)>D?H P08;XBZ;N<_
M)O&B I4.)1<<[)8TTW%'604R3QA4M6QHB5;;4VY"3'EKDC;W%6Q%N_Q@I#5"
M<@\Q/H C"P"WL.JY_9P9%@,!@,!@,!@,!@,!@,#6'<7AM\<=T3QPMARYS;JQ
MMQU.-5.MJ\X3>Q^89^\+E!FS5#A()!0$NKHZ4."@S?N,.<PK#!B_*+>]_EP(
MUWX*?'J^J4IELQWH?HIO0GEJ4D8Z.['ZLNB$!-)&$POYR"S2WW"(/)(1!U_1
M+T2HK>O^(=X&TBL:IK"E(4RUM3E=0>JJ]CA&TS!!JZBK'"XDS$[W[A@;8]'4
M+<U(_BB_E#V64'8Q;WL6][WO>!GV P-87%W_ ,.#RY__ !1G-_\ Y**(R-W?
MIM^QL]RL& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M!H@Y(N+J+D*OK$I>1^-;L6R%1'4/7,_:9O6[KRX=#))$[:Z5M"SH<ZLXY;T;
M%9$$*J,RM*(PM4WIC"S/4/MWZ>N'28BZ:UCA"T7X@'07[I[OW_N''/\ JMPF
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&
MR/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0?B =!?NG
MN_?^X<<_ZK<&R/W0?B =!?NGN_?^X<<_ZK<&R/W0XGCV9[E=[J\@E\6MS]9?
M.C7T#>%126O(;;*ZNU<Q6,$&YLJZL7=U6EUG.;!8$A!LEB:K1(-K]FB*]HMA
MUZ^FH7TI$1-:-I&5@P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P/$0@@"
M(8Q!   =B$(6]!"$(=>HA"%OTT$(=:]=[W_PP(@WT/0&M;%N\J>T'6M[V+=F
M0K6M:U_QWO>WOTUK6%I/)(RB2QQ*D;EZI_9$R%X+$<TK%#JA)2.A(&X]X$:W
M*##PDKBPM*4U5L16Q:TF+$9_[ =BT1U;=8,!>&T;RT3B(.C.6YI64QV;I*RK
MFT#PN,3$HFD:Y,M-2A<UARPD!1&Q_%,$:#00[V(/J*2Y IM# +T;4.71@#FX
M.3JS(&X3^U!7KGAA3Z5OC4C1[5Z4*7)F2[T:K( $1J<O?N,"'7Y<#JD%IUBZ
MEFFMEC0-Q*(T<(\Q!+X^L+)"F0*W51LT:=P,"7I.V(#U(_7>O80289OT  6]
M%I+L5\\@[4@<'1TF<4;6QI^B_I5Q7R)H1H&SZ< 08R_2"M0L+3HOI@M26)+\
M00?F-&!V7[M"UZD<Q[E<7C)2$Z221@CY+FJ+0MIKV\-S24X+30^XI&A,7J$X
M5:HP/Y0EE[$/>O\ AK $2N+JCTR5-)&!0I6N;FRHTY#PW''JWED <8\M*8DM
M2(P]S:"TY@E1 -;-3Z+%L80Z#OT%)>1<HC1HDX"I$Q&C5O"R/)0%NR 8E+^W
M!4C<&-.$*C>SGA"!&=LY,'U/*T4/8@Z]HO0/09,H@4F+6&RJ-EHS3W=*4J,?
M&P"8Q5'REA[^F+/$JT4,]D);E U@-;]R8)!FS-!T 7H6DN_(/(5$$J4QQ2E,
MI*+/3J"# '$'D' T84<2:7L19I1I8M""(.]Z%K?KK\F$8XEF\+6J%21%+XNK
M5()!J)KDR5_:5"A'*1$B4!C2HDI6,Q/(!)P;'I&/6E.P:V+V>FO7!27ZCF\+
M<=#$WRZ,+@E2$V(F;1O[4JT7+" B$?&![(5CT"0DA +8T6__ !(=:WZ@_)@=
MLB>&ER;@/#<Z-R]H,+..+=42U,J;ADIQ& 4&@7$&F)A%D#*'H8M"] [#O6_3
MTW@8P99M;$L1,I.L&#E1E2L&W)Y$9+&$#$>X%A,&-"2[B7Z;S5@ %"WLH)FQ
MZT'>_3\F\+27@1:59*3ER=-8T$4*&M$<YN9!$OCYIS<W)M$;4."XHMP$-(B3
MZ4E^\TS02P?$#Z[U[M>HI+NUTLBK6YI&5SDT?;GE>VKWE"TKGEN2.:UH:@!,
M='5(@4*2U2AM;2QZ$H/ #91.MZV,6M81RVY^8W@9A30\M3H:2C;7 XMN<4:X
M92!X),4M"XP"8XT0$;JG*&8F-WZ / '8@;%K6]X'%+E47-TEV5)& S2Y:Z-J
M+9;PW#TL<6,*L;T@2["HW\PM: (#]JB@>IB?1)FS-!]@O04EZ&V:PUY<0,[/
M+8RZNQC8F>RVMM?FI<XC9EI1)Z-W B2JC5(FQ62H+&4HT'X1@1AV$6]"UZBD
MOW<SA^GAPCVY7&M/[0B$Y.K'M]:]/#8W )+4#7N#9M5\ZB1 3G 'LTP 0: +
M0O7TWK>"C' 7)4)@"#"[5K<PM4>-*E,!.8P("E47\OHQ,0,+IL)QX/FRO4 ?
M46OB@]=?RM>I:2[E584!1(]N*V<1!(WZ2&N&URJ2LJ='I 0YA93UNU)JT!&D
MA+R,*09GN]@5.]%;W[]^W!27)%-8: @"D<MC($QC4D?2U GYJ"0-D<%84"!X
M ;M7HL34M7#T22HUOX)AN] "+8M^F$I+U/$[@\>=4C&_S**,;VX ),0,[Q(6
MAL=5I:D\:9.8D;UJPA6I H4E"+!L !:&,.PZ]=ZWK"TEZ5MB5^VHOI)QG4.0
M-VT;4XZ<%LG9$J+Z/?=J=,B_YH]<61\F\;1G?*F^[V*/A#^'L7M%Z$H]ZR=0
MAO1,CDOF,50MTF$0".."R0M"9%(!J@ ,3 9%1RP!#J)068$0-$",V,(M;UZZ
MWK _7*<PIF6.;<[S"+-3@RM1#\\H7*0-*%8TL:I3M$F>7-,J5E'(&I0LU\$M
M0:$!(S?Y.A;%^3 ZA#;%6.:U VMMEU^XN+H<!.V($,RCJM:XJ##1D%D($J=R
M,/5G&'E" $)81"V,.]:UZZWA:2[ELFT,>BT!K-+8P[%.K@Y-+68V/S4O+<G5
MFTHV\-B :56:%8X-6DANU))?N,(T4/WZ#[=^A'XMG$+;F,$G<)?%T$;-4"2%
MR%:_M*5C,5@4'(QI0.QZL" :@*M,85L&C/=HPL0?3W!WK0I+E&2J,$N34S'2
M-A*>'U K=61J,>&\#D\M: LHU<Y-2$2C2IQ0(RCP"-.)",LL(P[%O6MZP,>'
M;%6%M8'P=EP #*8O-:RW@<RCH6LQS(3_ #9[<!PVXZ2"7DI?Z09.A_$"7_*W
MKT_+A:2[0R>08I&G<39G%"F]6](XVD7&2)H C52)P 48@84ZD2S1)STN+/ (
ME*$6SS=##L(=ZWK".P)DT;4+ -Q$@9#W QQ7M!:$EU0&+!NS4E"N<VL"8"@1
MXG%N1#T<>1H/Q22MZ&,.@[]<#C&S*($&JR#Y5&R3T 7<2XDU\;"S408^G2*W
MX2LL:K0TP61(O(-6;'K7RQ9Q8C/;H8=[%)<=ZGL%C7T;]8YI$V#Z:*V<S_34
MC9VKZ6)U\#6S6WYY81\^5K:HKU$5[]?T@?\ Z[7J*2*)]!4B02]5-(FF0A2+
M' 2U1(V<E(% W.9;(X+1*3%@2=)$#R<!(<9[O84J'HH6]#WH."DO ^P8"FCR
M67*9Q$$\36G?+HI.?)64J/*U'Q#R?@)7HQ:%M4'?%2F!]H#=B]Q8M>GJ'?H*
M2Y:.9P]PTFV@E<;7:6+$;<CVC?6M3I4X.+7].-Z%-LE4/XZQ<R?^,)*#ZC-2
M_P!*'6R_Y6"DO!LFT,>QDELTNC#N-0ZNK$G V/S4O&>]L18S7MF)"E5F[-=6
M<HL0E2</J<G"'>S AUK>!XGSB%)0R<2J819,&$EDFS,1\@:20Q$I0EVN(,D^
MS%8=,!9Z+7Q@;5_"T(K^7KU#^7 X1MEUP0L2-YU@0DE>X-A;V@0FRMB+6+68
MU"8YE.R1,-?HY2V&MI(U 5  B*$0'9FA>W6]X*2[E%*8RY,0I0W2)B7QH"=2
MK'(D3NWJF(*1%\3YQ4)W(4&-X4Z3X(_BCV9[2_;OW;UZ;P.G06373HD-7MD^
MA3BA(2.2\]:@E+$K2$H6?:0+NM-4IUYA):1JVO(TI,V+0"-G%^_8?>'U+27N
M56# D*0+@MF\01H!G.B<*U5)69.D$H9!_">B J3EH"1'-!G\E4'0O<G%^0S0
M=X*2YK%,(E*-!W&I1'9%H:0*\&V)[;'?0D(U:I %:';>I4:$D$N0GDZ,U_(V
M:2,'K[@"UHCJ]677&V]N=M6!"=M;NY*65I<M2MB^CW1X1*!I%C2W+/G_ )=:
MY)%18BC2"Q"-+,#L(@ZWKTP4EV".:PUQ?UD4;Y;&5TH;@&F.$;1OS4I?T)9&
MR0GC6,Y"L;BF 2)07H>QEAT'8P^O_'7J'6RJSJV@JI(AF]A0>'+EZ<:M"CE4
ML88\J6I2S/@F*4B=W7HSE"<L[?L$,&MAT+\F]^N%I,\'MBEC5[/!KBX/.X9,
MS&L*<;D7%)0R2(;<!7L[202X+0N6"2!5;3F:+V9[=#V6+T]?;OT)28XLSP&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M/+98)MIU;3T4(2*RVF!\_3QA8WZ'MR8Y5H$0+VNU_P"'-WO1:Q7[_P GT_\
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M+G[A+F=]"YLCB<S0U=(XRS&N9"K12$:U$DV?KXA97H<[9F-WV/GLL*DN@TM
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MM:8X9:;1XQ_ +&((/;K>]8';X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M%\0(_0'M=MY3Q^'N<N;+X_M\N+),;;+K\T6XZ5K%LVY+;IK77=,\-*:G@/\
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M>8_LICG_ $^*0=3)SD_##\<OW'>8_LICG_3XI!U,G.3\,/QR_<=YC^RF.?\
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MFU5YB/&Q=]E0BGZLZCCDNLBR)"BBD)BZ6&6<@4/T@<??\DVDK7:%(&Q,8?\
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MHY.1^-7XK_OG5U_9RSOU%QN@Z.3D?C5^*_[YU=?V<L[]1<;H.CDY'XU?BO\
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M,-]3)SEQOP%?$!]Q&G_SB;_K;@ZF3G)^ KX@/N(T_P#G$W_6W!U,G.3\!7Q
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M$!]Q&G_SB;_K;@ZF3G)^ KX@/N(T_P#G$W_6W!U,G.3\!7Q ?<1I_P#.)O\
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M #B;_K;@ZF3G)^ KX@/N(T_^<3?];<'4R<Y/P%?$!]Q&G_SB;_K;@ZF3G)^
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M:UK8MB)7UTY;-T(GBV.83N1U)3N__0;-)'"$U )6<B;Z^ECNP#=FP]$0A1B
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MUIRC$I523PKK=E\AGG_.#'Y'6#F="6B/+ZJB.X&JVWNC$)C;F9R7I0[93MA
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MKIY)0UPM'T;5%3VNW4I/Y35#2BL4]W:#6B?O*$!""6$1Q<O;7!*O3E#3&[&
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MEGC=*W&W>9:B;',E P#8%ZGJ9)8YD+FA:H^0IUA$&C#C5KJA?5AI !HE(2M
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M'4L8Z-L*21NH2J]A\J:J^Y5L#E: 5O&H@*?2I5#TK:RSU0^KG(YP=#5KH8>
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M1>D24HLX25$-]?T*$*M3\!)M:L)(T9\4T !$B)G@K?S%Y,.:NCE-NQ<<XB$
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M#1Z(&V9X5JEA@Z^YBE5VAYQC-WU_(+M'$T,X+KUE>BW-W-B[FQ-LJ;W0D]&
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MUH2BI'73-8C+$'Y,ZK8TL$O<VD!B@)6] 6MHW=D6HPK4NST8EB)01HWXQ)H
MDFV8UE6)?Y'8LQ3:2L4GIVT(["8;/.NH_)[.<69U*C;3!..JPBD\GEHF_%82
M2ML$G?Y,-C8B_F-:<C$!ZE.<: (BPFMFGQT^;KJ.\B3@_59.+OZ\Y_>^'Z@9
M8355I06R[(L:*S2&SR W+I9J(-QKE&T:)1';A;U!:-.[1$)"\].I=41254M&
M=O01-NM+9K*4Y=Y*N"(%'*ME\QZQI:/Q:ZX^;+*MD#A+T9;1+XNE>T4:<I"A
M7@T-.F96)_<"D;DI4B();% M@5B)$$6M$V7<G$7^3?@-KJQKNQ?U54R:KGN:
MR:N&B6C>E&TCC/8:T"D,FB*1$!$)V.?VF/!^D1IM)_B#;Q 4@T(@8#!#9=6E
M-4D.O;')K+85/56YW[7":>= ,4;DU,,6GTL_5BL4S)6J(6XQMU3EG,JHF9E-
MJC;/H2D W79(])=&[#O6B;;J5Y,)AGD@X3L-7*4,)ZFJ&1JH4[PMAE);?)2Q
MZ:'6Q+ )JB&I3S3"BR3=/5FJ2V )A0C"B7<T"4X19PP@V6;+HXPQ2\>]VJNU
MTH2T]5K_ -*IZ]KKKN3V6MK9V'LJ$V+RI%Z_=M4<M^#'WD*NR;+D=D(&E"D
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MQI@@1@@R4!*D]7H+DK=R4Q(-'!T$T;)I5GMW=ZU/1?6U <BRLQ&7-;^K:U;
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M%84>KM&<QRS;'AE33"-+([3\>ONSZ\;$<?L&7M?QS"G5V0%JCU#4,G1YRM8
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MIMXBZ#()B1:B.1WU:/-S8W;JW7UK:QZ+Y\D+A:*IFD9?Y/0R1#U)T0A-6O\
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MNO=HJ4U]1":/E4NK*\,A56MS@T1J*IVR<OMJH%B]6Y'-;@:D8AI  &H5B/\
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MVL6U_+U5/IR*BUS]TQ0K-5=IQ:O?HZUUY2;IF42M^EDTG2A2V"E:UH4?1HY
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MR$73OIZ4_P!&_J[C[OF'C(LE524%E]4]"2?BA^4UQ6)3HI5V%75FO%+G',D
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M)KEC:XU N;Z7B# R$SXAI:(_7L::T" NU6%GB]F_+ITK>6  [!CS B1O(_\
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MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M(YQDL;;7E4=&D,]:&"<(6,XU;L24AX0HW0DG80*B2CM#!JL3I-$J80P& P&
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ML/LZ4<>1:E O1QQ[E&&NP8[7S"UD@7*D9.E2R+G29D"0I-**V8)"8,8"Q"]
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MV_,TP;7"V3$-9ZCYE7M09HDXT?S 1 -=2)FL^DM]GB9Y7.XO:^OJ+C#=59%
M+>JII<7,RZO7IN7/A546LV-+K]2IXU)4:=<UKJWDC>K:FTQ68H&H:0)P@'HL
MD( USONW4F>-$Y>4WG.S>L^#KWY]IU,QK+'L %:!CB:2/.H^RF;B]PU]-';Y
MUW$E6Z2>QBCBH1?]$+XAN@@_)[O71+)B+HF>#75SYXWNGJX[$HNZI.UP0J#0
M#R">5CHR1*$,R M=BJQZZKYDCE-*$3;]%%;5OBUT0#TYH_B!^CP:T+8S/7TP
MU-T3;2.4?)8)L\7L$L3RG=,]M](TK5UF1P^,<H&<I2"2*A2)]A<YJJ.RY'8+
MT9$CBRVIK6)G<UG-;U*@*L?Q$^C2?@C+]=C?2S;'WJ=-OC>[8JCG_EZ8U[$:
MIL'HKDCR2=:];M-,2:S3(S"K3K/H677NB;D0;(+C;PGC$V:HM:*%R*^80&DD
MG$GD;'[_ &;$7?;,S7A,4:N$OC1[*:;2=/'5"HO6TND5C>.#GA@Z:MQPECW'
M*XH?4O\ (3<714F65P4.(N1ME*8Y[E;4V-/Q&E68$HI=K82@B+R-[[:;OC^2
M^+AXE.SC+9DD#<ZPYMM#F>I;Z\A/5]7O%@6I(D#KTR]=JUO(H>R<[VO'F>"K
M7:O66.JIFO _2$E0NTM3)DFTA(# >[59WVTKK6D1_)7R?>*7RX3+F9AJ!QV?
M)*@0N_5$7K;CM^[\L5*KH>%V76$+BG/SK-^D&"',[IT=$J4D[4^FI(@[)1(_
MHIS(1F",+$>$B+OLBZOKSHW5>-GBB]>9+!Z??K5U'61MMFA_'E7<.<XC(D[V
MYIY+SAR4W4Y9ZDU*:V%)T!;9-DXOHPP832UI 0F[ '7\C*YW71,13X_BK?QM
MX:[#XB\A%3W!!^A[@M?F^&<U7U&'HZV)-7BF7J[9N.VVF=.[ J;(O74:6/<5
MDKDH62E>YJE1KD*0I4X=G;3;V1D:NR1=;2FM4"]%^,?OVW/)*?>CDE:+&J-G
MZ.66O75G2+J":(FZ!4BOYADE5M]"Q_E=2T'P%H?V&S7@YT4RI.9I>M3+!!]V
M]&'AT6+[=E/6B)DGA[[OB<5YUED;C50O=D\O<G>*9L880ZV9]'QVQ[OX<OJP
M;%LNM7"0E1Y5ICCKS%I:7IK?3$YQ(UP A&2 .MCT-]OKZU^;8I07'/2L"\37
M;U W&S5Q!+]Z/=>_)@SL378P'^ 1UWZH?9^]P=H7V&<R- 0HT*^8D)E*P:(O
MX>@[,V#_ /!RLS=&^)CA%$ R+C"2<V5OXS;2X,AG)A/0O$[),R+=HEPG#54%
M;W._7]0<4JV[I7JQ61@7(AS9+,H>WNGTBI1[&\$$&>XS1GPPBBQ=$S,75I+7
M[9/@]DL[J&O8)()USE-9[4WCWL5F@L\<9<E+9VGR#R[L4_JC0&YD=FT\_P#9
M.YH7]WC2AV4%?#-:U8@FIO4P0=&HR4GUX_*C=_Y(>2;S[;XPY?W6K9'D=V4?
M<7/_ $BMK*(W,^4^R2=RA$<>&2=5Q75^P- >ZURYI2Y6K%')*B3ZTE/1$CT$
ML(_4%<[9BVZ:\&F+H+PM]VR&KJPK*H:M9&^MG*JB'%12;CY [A=87S=TB\=2
MJ[LMJR7Q4]Q) GZP56S!3$J#87U*!.SNX3C2-B 2G/..D9+:UGC]BV<]\=WD
M4!S+Y'^"X=6O.TAI*^9;T]<5,7VZVX[-=FRV5=!W-#;4CM?OT*%"SD,4(B "
MG=*]N2EP4%+]$-^T@?Z,>ADW65B[6L-FW+?&]GP"7>4?]I!C.PQKLB\]2RM7
M:-O 7=U3PU?S+6-0KW5T1:(1_1+RCDD:7"+3[,'L98"S/?KW^FC$W5I\&CA!
MX;O(=+J*<H%8,6H.+R6@^.N7>#Z*(AMI+G1OO*+4YVA7G04NO&8*ED1:M5Z6
MHA,)"4WL1H5JH3F<H$,T 3 ^L=-]M:Q769GY/L5RN!@,!@,!@,!@,#0EU-YA
MK=YHZQOJM/\ "W$YYS-S#+^/8A=-L(KL+CUM-IW8VF]OAKE"ZD=(::W3D,??
M59@%:0AY(4F)BM##Z;$+V'2W'%T1-=9K\EH#_-1XU4[%:<DWT9LQFIV9,]<S
M!255%U#-56"^/LICB&$0E%NN@KK)E(76%.FE"./E.1R4A&8>=HLC7Q,53IW\
MG=2KS%^-N&.]-,S[T_&RS+\A4$L>L75OB=C/,7=8'94H<(1#Y6]S!HARZ*PM
MG<)DUG-1PWI8WB0+P_!5!)'O6L539=RX,K5>57Q^H+:NJD7+I:&M5A\]1FPI
M9;"!U;96VL<?:ZD0$NEJIVZ9+(^3#Y8_UNA4EC>VMG7+W)NV/VG$!&$00C9=
M2)II+"G7S'^/%DI&/]$.MVOZ&J)),95!$3X=1U^:<T,A@[.TR*8:D,4U6.Y5
M&&:.1U]2+U3DX(DS<%(>$S1XM>OH79=6GJC=?YB^>*XM?K5EOV0,5=4]1<WY
ME@%0SR.))M9TEO-WZ!H WH(2YCAD"BS\^'(6N)[V>7I"F5EEMZ0Y8H.  80
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MS3Q&R1[1$+IOMS7(O'_1EHUA;!#4 R'@2C4RY[G"4^/:-,*":E*-VKVE,T
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MVE;'N/F#KOE3IB $23I=\J!OC/2TRBLN:[*K.93+4\LV062QIH>F1NHG8"5
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MG%ZLV02>ZI'$Y;,YS()!JH[UA">'O8W:)4W)(LQ&"<&I[,/E*)87[M)OAFA
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M\^7%T**-N$#CLAD#-%^5N=JHJR9/UWW-(B53DB8T\EDLX/;VD90"M/"\9"%
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M6]GGM>X]/)S3;6J"8]M: 1B@K>A!)T<((M:&RZE>?YL=\=/D>7]^W5V>ULT
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M*1:UZ,;G!B2K;>K1SL\[Z)TZLX#RPJ-?R@Z"(O8R=.Y![WYRZMDW07!]=TO
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M'S3TCM"^)' GN%O9S<WLBQ(.%(BXH<!Q4:4_.$[,#LI,?^7TK%MT6_SB61]
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M6(L\)VZ\."R_04RHJ=]B]9PBI'ZN)-U-/_+MXIY[QVGA*N/N<^'73-3='O\
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MA# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M#'F90<SH$9AS4Q!7GZ1IQ;V2ET<9\,(?>+U%99OA# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M2ZB:RF<@A%'.,V7*G5U4*7.;'QS;FX+DFDA(F]8#9"<O8?<*L;8WQ:JKU=Y
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M[KHI/!)4P\>W)E@7_;72TVJY+)[1O/G%;RC:2EV=G<^/RJDW13\9UC:J-!6
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M_. J5FZ$_P 4"!JTX_2WS?TL5;__ (S;A[OFQ)?_  NQ_ _D9*-=2ZM?6O\
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MC;)N/V\M?]77+\[28VR;C]O+7_5UR_.TF-LFX_;RU_U=<OSM)C;)N/V\M?\
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MC;)N/V\M?]77+\[28VR;C]O+7_5UR_.TF-LFX_;RU_U=<OSM)C;)N/V\M?\
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M )15^;G?S,!\HK_Y15^;G?S,!\HK_P"45?FYW\S ?**_^45?FYW\S ?**_\
ME%7YN=_,P'RBO_E%7YN=_,P'RBO_ )15^;G?S,!\HK_Y15^;G?S,!\HK_P"4
M5?FYW\S ?**_^45?FYW\S ?**_\ E%7YN=_,P'RBO_E%7YN=_,P'RBO_ )15
M^;G?S,!\HK_Y15^;G?S,!\HK_P"45?FYW\S ?**_^45?FYW\S ?**_\ E%7Y
MN=_,P'RBO_E%7YN=_,P'RBO_ )15^;G?S,!\HK_Y15^;G?S,!\HK_P"45?FY
MW\S ?**_^45?FYW\S ?**_\ E%7YN=_,P'RBO_E%7YN=_,P'RBO_ )15^;G?
MS,!\HK_Y15^;G?S,!\HK_P"45?FYW\S ?**_^45?FYW\S ?**_\ E%7YN=_,
MP'RBO_E%7YN=_,P'RBO_ )15^;G?S,!\HK_Y15^;G?S,!\HK_P"45?FYW\S
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MGX0P&!C09E$QS$VO@R)G%.2(TGF1T2TO3[D!435NBED32(;7[_FPLY[PB-3
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M9-A].6Q-84_)H@\2&'5:T2LX]Q.9"VZ/H([6L0KR(N*1H-2&J@?'2_,'[,&
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MO-.G9RR_)3Y"GV%48IZ-<)K$Z7Y9F$9+K^8S1NI&%1!\D?9:"]C[*CR.3M\
M-D=BQ-@:D#&-P;E;DH=4"3Y PHU,(826TVZTX_Z,>/YJZF"V<CUF2'J[< ?:
M<XA#T<N_;O<8I4*</-R/\CZA+DUC"L?=@-CGMH6Z^F H7(DM,VB"E2Z+3@ 2
M$5C6=/7_ &3EXR:BN*!W%,IQ?T+O1!:%D<4</IY'.9\_S-XBKY,J]BLNAMD,
M+Z!3)G&(%VPTNB-O/5^]&%R$4I.4@-V%8J$<+YBE(I2LJ /=&^0QAKX@CXW7
M.HI-_P!D4UZ%*-F-ZVA-]/0[5[Q8'?5>1V'7=!+,;2V9I-J-:YL,/?F5-MI3
M(#S4ZA.6N(.-5L^'\4_W3$737E!0]0UM'E$\OB94,3.>:HM/IX>]+(=J4QFR
M(=5UM]!64HCB*4.GU2'!K!Y:'&1-Z=2<! 7:*U*1LQ.>?O<2MFWTK_'^OR3M
MW,@[JDO;M<AYXB-FQQDB<-5((I/(NHL=77$M!,*1Z:(>CK)7?M2;J)BI<+MT
M,*)+0.T-=) XFJ4BTER3HT8B@5+=NW5K.F7.O2;Y0-P,;3S]WJHKVWUEI_#@
MSU)K+56_)^B5G#O(,$KZ;W(H<+&.ETKIHFUHA8B$1;PN51C2D1'Q$>T>T 0Q
MNMM8K,?Q,K9W_P _]KGQXY]C$CZHC!EC=E]F"GS[%WV\[5E,0C9$EL1IX?F<
M)JR'7M6IC+5D12KBUI"- J(C!B@QN42%N6HRM[(K,3;\.$?[N'>\'Z]1N7:3
M4PM/9EAI]6M65IQ.9MR;HB-I;2D;$LG:55RDWQ6N[O91M'/KQI&C6MUB5L*/
M*&,E>V$2-,Y;;E7S,(VZ</X]5BO)77-^3V0\D3FM*IZ'*LUDH#H9@B3A2<OD
M!BNG.CI\Z<M.%7)[9F\:DC"G=ZZ1.<2=PO"AV^=CRXAO-,6D&:V5E2V8BL5B
ME?\ 5#,5HWME_M*V72RE]OR9<A[=H.1KH0^0^P5-6KHO%?("W6)7]R5I.I=;
M<HA1T>@?-S:F2.+7$(W&24K8$D+J4>[)!F&1:VTTIP_)!Z"E/)K**X$PP5?V
M'7$ME#M2%-7/(K%LB2*ER&Y;:B%]5]V-TC51CA,7?2:GX"H>8,^QP;0%,Q$J
MV_9K.D)&6IV,M;*ZT_C@W3>/"3WLNIAF9.F(#;45O-]:E=W6*LG)>ET.9W>Y
M+%L=S;ZAA\@$\N&QN-41QE0IES6204D;4RM%\(8_C""77.ZE=.#8%ADP& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!X&"V L8]?EV  A
M:UO_ (;V$.]__JP/F>Y*[O\ .QVW2#'T71?/7C.*K&62.?L,=+GUA]#Q^5__
M ' 3E_@KB:Z-;8!\0)_C.<>.$7LM4/WE^@MZ!Z^W1UNMQVS2:U63^OW\1K]W
M[Q._:[TK^A<)3%SECDL7?Q!,^CKI$)URMX>YI$WLDM.]1>66%T'(XZ[IRE!*
MLHAT9'B.+&U>24J3EFA":4,(3 !%K7KK6]#^G'";G?$SC^(P3DE)T_//B9((
M(+ 2003;/291)))0= +**+ R! 666 .M!#K6M:UKTU@_I<Y>WZ_?Q&OW?O$[
M]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3
MZ_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:
M[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^O
MW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y<,N7?Q$Y*U4Y%<X
M^)(IQ7$)$RU>7:G1X%JQ,@$J&A3JE06+1Z@A$-:=LD Q;"7LX>PZU[Q>H_I<
MY<SZ_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q
M._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%S
MD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3O
MVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/
MK]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]K
MO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_
M?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[T
MK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\
M1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_
MH7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:
M_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%
MP4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW
M?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%
M,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[
MQ._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%
MSD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3
MOVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y
M/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]
MKO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z
M_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[
MTK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW
M\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*
M_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$
M:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ
M%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&O
MW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<
M%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W
M[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3
M%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<Y/K]_$:_=^\
M3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[]KO2OZ%P4Q<
MY/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.3Z_?Q&OW?O$[
M]KO2OZ%P4Q<Y/K]_$:_=^\3OVN]*_H7!3%SD^OW\1K]W[Q._:[TK^A<%,7.4
MJ>-'M+KWHB[NY^=>RZ[Y_@5F\=R:C(^89SRZSQ[BCWNWH/()T8::Z3Q5M>K^
M2;4J$)>P)4GM,,."+0_0(L)?;;$1-M=6WW#!@,!@,#U'_P#N#O\ Y$9_\9O
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M7BO_ 'A'(GVZP#]-8.G?RD_&"\5_[PCD3[=8!^FL'3OY2?C!>*_]X1R)]NL
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MBO\ WA'(GVZP#]-8.G?RD_&"\5_[PCD3[=8!^FL'3OY2?C!>*_\ >$<B?;K
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MX8^Y?R=_ETI_]3L&Z[G)_@*X8^Y?R=_ETI_]3L&Z[G)_@*X8^Y?R=_ETI_\
M4[!NNYR?X"N&/N7\G?Y=*?\ U.P;KN<G^ KAC[E_)W^72G_U.P;KN<G^ KAC
M[E_)W^72G_U.P;KN<G^ KAC[E_)W^72G_P!3L&Z[G)_@*X8^Y?R=_ETI_P#4
M[!NNYR?X"N&/N7\G?Y=*?_4[!NNYR?X"N&/N7\G?Y=*?_4[!NNYR?X"N&/N7
M\G?Y=*?_ %.P;KN<G^ KAC[E_)W^72G_ -3L&Z[G)_@*X8^Y?R=_ETI_]3L&
MZ[G)_@*X8^Y?R=_ETI_]3L&Z[G)_@*X8^Y?R=_ETI_\ 4[!NNYR?X"N&/N7\
MG?Y=*?\ U.P;KN<G^ KAC[E_)W^72G_U.P;KN<G^ KAC[E_)W^72G_U.P;KN
M<G^ KAC[E_)W^72G_P!3L&Z[G)_@*X8^Y?R=_ETI_P#4[!NNYR?X"N&/N7\G
M?Y=*?_4[!NNYR?X"N&/N7\G?Y=*?_4[!NNYR?X"N&/N7\G?Y=*?_ %.P;KN<
MG^ KAC[E_)W^72G_ -3L&Z[G)_@*X8^Y?R=_ETI_]3L&Z[G)_@*X8^Y?R=_E
MTI_]3L&Z[G)_@*X8^Y?R=_ETI_\ 4[!NNYR?X"N&/N7\G?Y=*?\ U.P;KN<G
M^ KAC[E_)W^72G_U.P;KN<G^ KAC[E_)W^72G_U.P;KN<G^ KAC[E_)W^72G
M_P!3L&Z[G)_@*X8^Y?R=_ETI_P#4[!NNYR?X"N&/N7\G?Y=*?_4[!NNYR?X"
MN&/N7\G?Y=*?_4[!NNYR?X"N&/N7\G?Y=*?_ %.P;KN<G^ KAC[E_)W^72G_
M -3L&Z[G)_@*X8^Y?R=_ETI_]3L&Z[G)_@*X8^Y?R=_ETI_]3L&Z[G)_@*X8
M^Y?R=_ETI_\ 4[!NNYR?X"N&/N7\G?Y=*?\ U.P;KN<I;J^B*/I$MZ)I>FJI
MJ$J2&(3I$55]>1& %OQK6!46V&O0(HSM(70QN+7'!($?HS9.CAZ!Z>\7J)F9
MXI6PA@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?F]Z#KU%O0=:
M_P".][UK6O\ T?\ '?Y,#P^,5_\ 92__ ,L/_P!7 ?&*_P#LI?\ ^6'_ .K@
M>S6];UK>M^NM_EUO7Y=;UO\ X;UO 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# XXU:4L\"8:E.!2;KU+3
MC.+">9K^5^4!6Q:,'K^3O_AK_P!&\#D8# 8# 8# 8# 8# TA_P 1DJ5(_#MU
MNI1*E2)26"F?AJ42D](I+]]]U@ ?PU"8PHXOW@%L._06O76]ZW^3>'3%^N'\
MN#ZSRC^M4I_M(]_]?D>ND/6;)Y1\(W_[JI3_ .['_P#U(]__ %N__P!_P4A_
M8"\:!II_CKX4./--/.-Y$YW,-./-&<<<8.IXH(9AIQHAF&F#%OU$(6][WO?K
MO>5XKOU3]J[N&3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8'1N<FC;(<6F>9"QM"@TK1Y1#F[($!QA.QB+T<6
M4K4%#&5L8-A]VM;UZZWK_P!&!\AG?,I9U'\4/XP%Z*2MYS(32[.6L5I'L@;0
M4<+?4'H!6:2JVB":+XI?Y![]=^X/_KUD]7>VO2E]=B*8Q%S5%(6V4QQP6J-B
MT0C1/C8K5';  1@]%)R%1AIFPE@V+?IK?H'6]_\ #65PHR/ 8# 8# 8# 8#
MT>_Q'?\ ]!PZZ_\ Q*7_ /T^U?ATQ?\ <A_++R/6]9W_ +HW_P"1C_\ C=X'
M]AGQE_\ T.?A#_XD+G7_ /1-%,KQ7?JG[5X<,F P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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$# __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
